Citrus Sinensis ID: 006480
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 643 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.348 | 0.311 | 0.491 | 1e-59 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.348 | 0.316 | 0.497 | 3e-59 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.348 | 0.311 | 0.482 | 1e-58 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.357 | 0.309 | 0.468 | 2e-58 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.348 | 0.315 | 0.486 | 4e-58 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.349 | 0.295 | 0.489 | 7e-58 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.382 | 0.343 | 0.464 | 2e-56 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.373 | 0.368 | 0.471 | 5e-56 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.354 | 0.483 | 0.443 | 3e-55 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.348 | 0.328 | 0.469 | 8e-55 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 112/228 (49%), Positives = 162/228 (71%), Gaps = 4/228 (1%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 230 bits (586), Expect = 3e-59, Method: Compositional matrix adjust.
Identities = 114/229 (49%), Positives = 158/229 (68%), Gaps = 5/229 (2%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 469
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 470 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLV 588
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 228 bits (581), Expect = 1e-58, Method: Compositional matrix adjust.
Identities = 110/228 (48%), Positives = 158/228 (69%), Gaps = 4/228 (1%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 2e-58, Method: Compositional matrix adjust.
Identities = 113/241 (46%), Positives = 161/241 (66%), Gaps = 11/241 (4%)
Query: 407 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 461
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 462 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGR+P+ P G+E+LV +
Sbjct: 503 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWA 561
Query: 642 Q 642
+
Sbjct: 562 R 562
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (576), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 111/228 (48%), Positives = 158/228 (69%), Gaps = 4/228 (1%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 470
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLV 565
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 225 bits (574), Expect = 7e-58, Method: Compositional matrix adjust.
Identities = 112/229 (48%), Positives = 155/229 (67%), Gaps = 4/229 (1%)
Query: 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 469
LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +EF E++
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476
Query: 470 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R K+A G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATRVKIAAG 534
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT T V GT
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT-TRVMGT 593
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV
Sbjct: 594 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLV 642
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 220 bits (561), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 116/250 (46%), Positives = 164/250 (65%), Gaps = 4/250 (1%)
Query: 390 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 449
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 450 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 509 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
GLAK AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+PI
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 629 DHPKGQESLV 638
++ SLV
Sbjct: 557 NNVHADNSLV 566
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 219 bits (558), Expect = 5e-56, Method: Compositional matrix adjust.
Identities = 116/246 (47%), Positives = 165/246 (67%), Gaps = 6/246 (2%)
Query: 394 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 453
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 454 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 512
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 513 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+P+ ++
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 633 GQESLV 638
+SLV
Sbjct: 487 VDDSLV 492
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 216 bits (551), Expect = 3e-55, Method: Compositional matrix adjust.
Identities = 102/230 (44%), Positives = 155/230 (67%), Gaps = 2/230 (0%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEI 468
R + ++L +AT+ EN+IG+GG VY+G L DG ++AVK +L KEF +E+
Sbjct: 140 RWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEV 199
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
E+I + HKN++ LLG+C E +LVYDF+ G+LE+ +HG+ D + W R + +
Sbjct: 200 EVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIIL 259
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+A+ L YLH G +V+HRD+KSSNILL + ++SDFGLAK + SS++T T V G
Sbjct: 260 GMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVT-TRVMG 318
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
TFGY+APEY G +N+K D+Y+FG++++E++TGR P+ P+G+ +LV
Sbjct: 319 TFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLV 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 215 bits (548), Expect = 8e-55, Method: Compositional matrix adjust.
Identities = 108/230 (46%), Positives = 153/230 (66%), Gaps = 6/230 (2%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 470
F+Y +L TS F +NL+G+GG VYKG L DG+E+AVK LK +EF E+EI
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH+++++L+G+C + + LLVYD++ +L +LH + W R +VA G
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGR--PVMTWETRVRVAAGA 444
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAG 588
A + YLH R+IHRD+KSSNILL + FE ++DFGLAK A ++H++ T V G
Sbjct: 445 ARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVS-TRVMG 503
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
TFGY+APEY GK+++K DVY++GV+LLEL+TGRKP+ P G ESLV
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLV 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 643 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.976 | 0.828 | 0.726 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.940 | 0.819 | 0.709 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.872 | 0.804 | 0.683 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.944 | 0.802 | 0.669 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.802 | 0.669 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.936 | 0.817 | 0.654 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.928 | 0.803 | 0.646 | 0.0 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.930 | 0.797 | 0.642 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.902 | 0.792 | 0.662 | 0.0 | |
| 42563282 | 794 | adenine nucleotide alpha hydrolases-doma | 0.951 | 0.770 | 0.602 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 919 bits (2375), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/644 (72%), Positives = 533/644 (82%), Gaps = 16/644 (2%)
Query: 1 MKMVQQEGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD 60
MKM+Q SG RTV+VGVKLD+ SRELLTWA+VKVAQPGDTVIALHVL NN IVD
Sbjct: 1 MKMIQHAEKKGGSGC-RTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVD 59
Query: 61 RDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIV 120
R+GKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRG+SIRKILVREA+SYSAT IV
Sbjct: 60 REGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIV 119
Query: 121 GTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRN 180
G A+ HHTIRS TS+AKYCAKKLSKDC VLAV+NGKVVFQKEG + G+S G+ED +R
Sbjct: 120 GAARTHHTIRSPTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRK 179
Query: 181 SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLG-GSVMNLEQALVKARSDCSG 239
+++ HRSIS+SK NSKV+++ G I P +G G+ QALVKAR + G
Sbjct: 180 GFVNIFHRSISLSK-----NSKVISESG--INEAPKYVVGEGNEQTFHQALVKARPNSLG 232
Query: 240 SAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQ 299
S K+NC++CG V N D SC+QS E+S D G ++SLA+VPV VE S+S L+ Q
Sbjct: 233 SIMKQNCTVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQ 292
Query: 300 LPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSDVKQITYDP 358
+PE +PGWPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D KQ
Sbjct: 293 VPELKPGWPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQ----N 348
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
G+ + +L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCRLF YQ+LL
Sbjct: 349 GEGQP-SLDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCRLFQYQELL 406
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN 478
SATSNFLAE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEIITTL+HKN
Sbjct: 407 SATSNFLAEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKN 466
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IISLLGFCFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GVAEAL YLH
Sbjct: 467 IISLLGFCFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLH 526
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+G+AQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTFGYLAPEYF
Sbjct: 527 TGTAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYLAPEYF 586
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
MYGKVN+KIDVYAFGVVLLELL+GRKPISND PKGQESLVM ++
Sbjct: 587 MYGKVNEKIDVYAFGVVLLELLSGRKPISNDLPKGQESLVMWAK 630
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2217), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/626 (70%), Positives = 510/626 (81%), Gaps = 21/626 (3%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD+ SRELLTWALVKVAQPGDTVIALHVL +N IVDR+GKSSLLSLVKAFDSV
Sbjct: 8 TVIVGVKLDSMSRELLTWALVKVAQPGDTVIALHVLGSNEIVDREGKSSLLSLVKAFDSV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+S RKILVRE +SY+ATK IVG AKNH +I S+TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSTRKILVREVKSYAATKVIVGAAKNHPSIWSSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLAVNNGKVVFQ+E P+T+G T+DH + SLL V+HR+IS K +
Sbjct: 128 YCAKKLPKDCSVLAVNNGKVVFQRERSPNTSG----TKDHSK-SLLSVVHRTISSEKKSR 182
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
+ N + +G S + D + LE+AL+KARS+ S K NCS+CG D
Sbjct: 183 ELNES--SANGGSKDDQDSDQI------LEKALMKARSNSLESIMKENCSVCGSATIFAD 234
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
S ++S E S SD G D+SLA+VPV +E ++S++ L+RQ+PE +PGWPLL RA+ PD
Sbjct: 235 DSSNESAEASSSDNGGDDKSLALVPVPRLEEPTSSVSTLIRQVPELKPGWPLLCRAVLPD 294
Query: 318 RRAPDRSSLRKISVVQW-ALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 376
++ + S +R++ VVQW L L T NSD KQ D G+++ NL+G+SGAIV V
Sbjct: 295 KKESNISLVRQVCVVQWEQLSLST------VNSDHKQDGSDKGEDK-FNLDGESGAIVAV 347
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++P + H+S PKELEGLHEKYSATCRLF YQ+LLSATSNFLAENLIGKGGSS
Sbjct: 348 GMETATAPHTPHHNSRSPPKELEGLHEKYSATCRLFQYQELLSATSNFLAENLIGKGGSS 407
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCL DGKELAVKILKPSEDV+KEFVLEIEIITTLHHKNIISLLGFCFED NLLLVY
Sbjct: 408 QVYKGCLSDGKELAVKILKPSEDVLKEFVLEIEIITTLHHKNIISLLGFCFEDKNLLLVY 467
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFL RGSLE+NL+GNKKDP FGW+ERYKVA+GVAEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 468 DFLPRGSLEDNLYGNKKDPLTFGWNERYKVALGVAEALDYLHSCSAQPVIHRDVKSSNIL 527
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
LSDDFEPQLSDFGLAKWA TSSSHI CTDVAGTFGYLAPEYFMYGKVN KIDVYAFGVVL
Sbjct: 528 LSDDFEPQLSDFGLAKWAPTSSSHIICTDVAGTFGYLAPEYFMYGKVNKKIDVYAFGVVL 587
Query: 617 LELLTGRKPISNDHPKGQESLVMQSQ 642
LELL+G+KPISND PKGQESLVM ++
Sbjct: 588 LELLSGKKPISNDLPKGQESLVMWAK 613
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2137), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/626 (68%), Positives = 485/626 (77%), Gaps = 65/626 (10%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
TV+VGVKLD SRELLTWALVKVAQPGDTVIALH+L NN IVDR+GKSSLLSLVKAFD+V
Sbjct: 8 TVIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNV 67
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAK 137
LAVYEGFCNLKQVDLKLKICRG+SIR+ILVREA+SY+ATK IVG +NH +I +TS+AK
Sbjct: 68 LAVYEGFCNLKQVDLKLKICRGSSIRRILVREAKSYTATKVIVGATRNHLSIWPSTSVAK 127
Query: 138 YCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITG 197
YCAKKL KDCSVLA NNGKVVFQ+E P+ G + S S++ I
Sbjct: 128 YCAKKLPKDCSVLAFNNGKVVFQRERTPNNTG-----------------NFSCSLASIM- 169
Query: 198 QKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPD 257
++N V GS + KP DD
Sbjct: 170 KENCSVC---GSVM--KPADD--------------------------------------- 185
Query: 258 GSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPD 317
SC+QS E S D D+SLA+VPV VE ++S++ L+ Q+PE +PGWPLLR ++ P+
Sbjct: 186 -SCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKPGWPLLRSSVLPN 244
Query: 318 RRAPDRSSLRKISVVQWALRLPTRQPSY-LANSDVKQITYDPGDNESINLNGDSGAIVPV 376
R+ +RS +R+ISVVQWA+RLP+RQ S NSD KQ D G+ E +NL+G+SGAIV V
Sbjct: 245 RKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVSDKGE-EQLNLDGESGAIVAV 303
Query: 377 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 436
G E ++PLS DH+S LPKELEGLHEKYSATCRLF Q+LLSATSNFLAENLIGKGGSS
Sbjct: 304 GMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGSS 363
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QVYKGCLPDGKELAVKILKPSEDV+KEFV EIEIITTL HKNIISLLGFCFE NLLLVY
Sbjct: 364 QVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLVY 423
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
DFLSRGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL+YLHS SAQ VIHRDVKSSNIL
Sbjct: 424 DFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNIL 483
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
LSDDFEPQLSDFGLAKWA TSSSHI C DVAGTFGYLAPEYFMYGKVN+KIDVYAFGVVL
Sbjct: 484 LSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLAPEYFMYGKVNNKIDVYAFGVVL 543
Query: 617 LELLTGRKPISNDHPKGQESLVMQSQ 642
LELL+G+KPISND PKGQESLVM ++
Sbjct: 544 LELLSGKKPISNDLPKGQESLVMWAK 569
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2110), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/633 (66%), Positives = 504/633 (79%), Gaps = 26/633 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
YA+GVVLLEL++GRKPIS ++PKGQESLVM ++
Sbjct: 596 YAYGVVLLELISGRKPISTEYPKGQESLVMWAR 628
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2107), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/633 (66%), Positives = 503/633 (79%), Gaps = 26/633 (4%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
+ RTV+VG+KLD+HSRELLTWALVKVAQPGD VIALHVL N+ IV++DGKSSLLSLVKAF
Sbjct: 17 SARTVLVGMKLDSHSRELLTWALVKVAQPGDLVIALHVLGNHEIVNQDGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
D+VLAVYEGFCNLKQVDLKLKICRG S RKILVREA+SY AT IVGTA+ HH IRS+TS
Sbjct: 77 DTVLAVYEGFCNLKQVDLKLKICRGESARKILVREAKSYRATNLIVGTARKHHKIRSSTS 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKL KD VLAV+NGKV+F++EGCP G+ G E+ R ++LL ++ S S
Sbjct: 137 VAKYCAKKLPKDFWVLAVHNGKVIFEREGCPVATGDCHGNEEQRHSNLLAAVYGSAGSSP 196
Query: 195 ITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVR 253
KV + + S+ ++ D+LG N +Q KA S K+NCSICG
Sbjct: 197 -------KVQSGESFGSLLARDRDNLGIG-KNSDQEFEKA---LSVGTDKQNCSICGSES 245
Query: 254 NLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLR-- 311
+ + QS E S SDG DESLA+VPVQ VE AS+SIT L++QLPE +PGWPLLR
Sbjct: 246 SFVE----QSAEISSSDGEKHDESLALVPVQIVEVASSSITKLIKQLPEVKPGWPLLRHV 301
Query: 312 -RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
++ R+A DRS ++ISVVQWA++LP+R P Y A D K T D +S+ L+G+
Sbjct: 302 DQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPAALDYKSNTSD----QSLGLDGE 357
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
+GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+TCRLFNY +LL+ATSNFL ENL
Sbjct: 358 NGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSSTCRLFNYHELLTATSNFLPENL 417
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E+EIIT+L HKNIISLLGFCFE+
Sbjct: 418 IGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVMEVEIITSLSHKNIISLLGFCFEN 477
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA+GVAEAL+YLH AQ VIHRD
Sbjct: 478 SKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVAVGVAEALDYLHL-DAQHVIHRD 536
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 537 VKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVAGTFGYLAPEYFMYGKVNDKIDV 595
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
YA+GVVLLEL++GRKPIS +PKGQESLVM ++
Sbjct: 596 YAYGVVLLELISGRKPISTKYPKGQESLVMWAR 628
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/642 (65%), Positives = 490/642 (76%), Gaps = 40/642 (6%)
Query: 1 MKMVQ--QEGDVISSGAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
MKM+ G SGAG RTVVVG+K+D+HS ELLTWAL KVAQPGD V+ALHVL N+
Sbjct: 1 MKMLPPPTAGGASHSGAGDRTVVVGMKMDSHSTELLTWALFKVAQPGDVVLALHVLGNDE 60
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IV+R+GKSSL SLVKAFDS+LAVYEGFCNLKQVDLK KICRG+S+R+ILVREA +YSAT
Sbjct: 61 IVNREGKSSLFSLVKAFDSILAVYEGFCNLKQVDLKFKICRGSSVRRILVREANAYSATH 120
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDH 177
IVG+++ H IR S+A+YCAKKL KDC VLAV+NGK+VF++EG P+T E KG +
Sbjct: 121 IIVGSSQGLHIIRPCISVARYCAKKLPKDCWVLAVDNGKIVFKREGSPATRAELKGLDQD 180
Query: 178 RRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDC 237
+ LL IHR+IS K SKV+ DDG+ I K G+ + +L KA D
Sbjct: 181 HKTRLLGSIHRTIS-------KGSKVLDDDGTGIHEKGC----GNGEYSDHSLAKAFLDS 229
Query: 238 SGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLV 297
K+ CSIC SEEES D + LAIVPVQ +AAS
Sbjct: 230 KEFVEKKRCSICA------------SEEESCGDASDENNPLAIVPVQTNDAAS------- 270
Query: 298 RQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYD 357
+PGWPLLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D K D
Sbjct: 271 ------KPGWPLLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQDHKANNCD 324
Query: 358 PGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
++ + L+ SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCRLF YQ+L
Sbjct: 325 QNKDQFLALDSKSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCRLFEYQEL 383
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEIITTL+HK
Sbjct: 384 VLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEIITTLNHK 443
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NIISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGVAEALEYL
Sbjct: 444 NIISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGVAEALEYL 503
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTFGY+APEY
Sbjct: 504 HNNEGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYMAPEY 563
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
FMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVM
Sbjct: 564 FMYGKVNDKIDVYAFGVVLLELLSGRKPISGDYPKGQESLVM 605
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/631 (64%), Positives = 476/631 (75%), Gaps = 34/631 (5%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTV+VGVK+D+ S+ELLTWALVKVA PGDTV+ALHVL NN V+ DGKSSLLSLVKAF
Sbjct: 10 GGRTVLVGVKMDSPSKELLTWALVKVAHPGDTVVALHVLGNNETVNGDGKSSLLSLVKAF 69
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLA Y+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 70 DSVLAAYKGFCNLKQVDLKLKICRGSSVKKTLVREANGYSATHVVVGTTHGLHKIRSSTV 129
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AK+CAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN LL IH ++
Sbjct: 130 VAKHCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVAELQGVDRHNRNGLLGSIHWTLG--- 186
Query: 195 ITGQKNSKVVTDDGSSITSK-----PVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSIC 249
KN KV++DD S + + P+ D +L K + + +CSIC
Sbjct: 187 ----KNRKVLSDDSSGMDADEKKTGPISD---------HSLAKFFLESKETVRNPSCSIC 233
Query: 250 GPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPL 309
G LPD S QS E D G + SLA+VPVQ AA T E +PGWPL
Sbjct: 234 GTTLALPDPSFYQSAEGVSGDEGR-ENSLAMVPVQPTVAAKT----------ELKPGWPL 282
Query: 310 LRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNG 368
L I DR++ RS +ISVVQWA+RLP+R SY + D K D G ++ L+
Sbjct: 283 LDGRILSDRQSAGRSLFHLQISVVQWAMRLPSRNLSYAVDRDEKSKICDQGQDQPAALDS 342
Query: 369 DSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAEN 428
+SGA+V V E+ ++ S +++S +PKELEGLHEKYS+TCRLF YQ+L+SATSNFL EN
Sbjct: 343 ESGALVLVDAELGTAS-SPENNSGNIPKELEGLHEKYSSTCRLFEYQELVSATSNFLHEN 401
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
LIGKGGSSQVY+GCLPDGKELAVKIL PS+DV+ EF+LEIEIITTLHHKNIISLLGFCFE
Sbjct: 402 LIGKGGSSQVYRGCLPDGKELAVKILNPSDDVLSEFLLEIEIITTLHHKNIISLLGFCFE 461
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
+ LLLVYDFLSRGSLEENLHGNKK+ FGWSERYKVA+GVAEAL+YLHS Q VIHR
Sbjct: 462 NGKLLLVYDFLSRGSLEENLHGNKKNSLVFGWSERYKVAVGVAEALDYLHSKDDQPVIHR 521
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 608
DVKSSN+LLS++FEPQLSDFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKID
Sbjct: 522 DVKSSNVLLSENFEPQLSDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 581
Query: 609 VYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
VYAFGVVLLELL+GRKPIS D+PKGQESLVM
Sbjct: 582 VYAFGVVLLELLSGRKPISRDYPKGQESLVM 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2011), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/630 (64%), Positives = 479/630 (76%), Gaps = 32/630 (5%)
Query: 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF 74
GRTVVVGVK+D+ +ELLTWALVKVA P DTV+ALHVL ++ V+ GKSSLLSLVKAF
Sbjct: 17 GGRTVVVGVKMDSPCKELLTWALVKVAHPRDTVVALHVLGSHETVNGVGKSSLLSLVKAF 76
Query: 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTS 134
DSVLAVY+GFCNLKQVDLKLKICRG+S++K LVREA YSAT +VGT H IRS+T
Sbjct: 77 DSVLAVYKGFCNLKQVDLKLKICRGSSVKKSLVREANGYSATHIVVGTTHGLHKIRSSTV 136
Query: 135 LAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSK 194
+AKYCAKKLSKDC VLAVNNGKVVF+++ P + E +G + H RN L+ I ++
Sbjct: 137 VAKYCAKKLSKDCCVLAVNNGKVVFKRDSSPPSVTELQGIDRHNRNGLIGSIQWTLG--- 193
Query: 195 ITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRN 254
K++KV++DD S + + + G V + +L K + + +CSICG
Sbjct: 194 ----KSTKVLSDDNSGMEAD--EKKTGQVS--DHSLAKLFLESKETVRNPSCSICGTTLA 245
Query: 255 LPDGSCSQSEEESPSDGGAGDE----SLAIVPVQNVEAASTSITMLVRQLPESRPGWPLL 310
LPD SC QS +DG +GD+ SLAIVPVQ AA T E +PGWPLL
Sbjct: 246 LPDSSCYQS-----ADGVSGDDGRENSLAIVPVQPSVAAIT----------EMKPGWPLL 290
Query: 311 RRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGD 369
R I DR++ DR + +ISVVQWA+RLP+R SY + + K D G ++ L+ +
Sbjct: 291 HRGILLDRQSADRLLMHPQISVVQWAMRLPSRNLSYAVDCNEKPNICDQGQDQHAALDSE 350
Query: 370 SGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENL 429
SGA+VPV E+ ++ L +H+S +PKELEGLHEKYS+TCRLF YQ+L+ ATSNFL NL
Sbjct: 351 SGALVPVDAELGTASLP-EHNSGNIPKELEGLHEKYSSTCRLFEYQELVLATSNFLPGNL 409
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKGGSSQVY+GCLPDGKELAVKILKPS++V+ EF+LEIEIITTLHHKNIISLLGFCFE+
Sbjct: 410 IGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFLLEIEIITTLHHKNIISLLGFCFEN 469
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
LLLVYDFLSRGSLEENLHGNKK FGWSERYKVA+G+AEAL+YLHS Q VIHRD
Sbjct: 470 GKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYKVAVGIAEALDYLHSKDDQPVIHRD 529
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
VKSSN+LLS+DFEPQL DFGLAKWAST SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV
Sbjct: 530 VKSSNVLLSEDFEPQLCDFGLAKWASTLSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 589
Query: 610 YAFGVVLLELLTGRKPISNDHPKGQESLVM 639
YAFGVVLLELL+GRKPIS D+PKGQESLVM
Sbjct: 590 YAFGVVLLELLSGRKPISPDYPKGQESLVM 619
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/619 (66%), Positives = 479/619 (77%), Gaps = 39/619 (6%)
Query: 24 KLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEG 83
KLD+ SRELLTWALVKVAQPGD VIALHVL +N + S +V +F AVYEG
Sbjct: 25 KLDSQSRELLTWALVKVAQPGDRVIALHVLGHNEMGVCRNCGSRWEIVASF----AVYEG 80
Query: 84 FCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKL 143
FCNLKQVDLKLKICRG+SI KILVRE +SY A+K IVGTA+NHH IRS+ ++AKYCAKKL
Sbjct: 81 FCNLKQVDLKLKICRGSSIGKILVREVKSYVASKVIVGTARNHHAIRSSAAVAKYCAKKL 140
Query: 144 SKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVIHRSISMSKITGQKNSKV 203
KDCSVLAVNNGKVVFQ+E T +S+ E+HRRN LL I +S+ SK + N
Sbjct: 141 PKDCSVLAVNNGKVVFQREASMRTTVDSQEKEEHRRNGLLGGIQQSV--SKKSKALNHGK 198
Query: 204 VTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQS 263
V ++ S+I C SA + L SCSQS
Sbjct: 199 VNEEPSTI-------------------------CDPSACQS--------LELGLNSCSQS 225
Query: 264 EEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDR 323
E S D D+SLAIVPVQ +EA+S+SI++L+R+LPE RPGWPLLRRAI PDR+ +
Sbjct: 226 IEGSSGDSHHEDDSLAIVPVQKLEASSSSISLLIRELPELRPGWPLLRRAILPDRQTSTK 285
Query: 324 SSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSS 383
SS+R+ISVVQWA+RLP+R A+ D + + D ++ S NL+G+SGAIVPVG S+
Sbjct: 286 SSVRQISVVQWAMRLPSRNFPSAASLDNIESSCDGDEDLSTNLDGESGAIVPVGTVNASA 345
Query: 384 PLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL 443
P S ST+L KELEGLHEKYSATCRLF +Q+L SATSNF+ ENLIGKGGSS+VY+GCL
Sbjct: 346 PPSPSRSSTKLAKELEGLHEKYSATCRLFKFQELFSATSNFMPENLIGKGGSSRVYRGCL 405
Query: 444 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503
DGKELAVKILK S+D++KEF+LEIEII+TLHHKNIISLLGFCFE+NNLLLVYDFLSRGS
Sbjct: 406 SDGKELAVKILKQSDDILKEFLLEIEIISTLHHKNIISLLGFCFENNNLLLVYDFLSRGS 465
Query: 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
LEENL+GNKKD AFGWSERYKVA+GVAEAL+YLH GSAQ VIH DVKSSNILL+DDFEP
Sbjct: 466 LEENLYGNKKDLFAFGWSERYKVAVGVAEALDYLHCGSAQAVIHGDVKSSNILLADDFEP 525
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
QLSDFGLAKWASTSSSHITC+DVAGTFGY+APEYFMYGKVN+KIDVYAFGVVLLELL+GR
Sbjct: 526 QLSDFGLAKWASTSSSHITCSDVAGTFGYMAPEYFMYGKVNEKIDVYAFGVVLLELLSGR 585
Query: 624 KPISNDHPKGQESLVMQSQ 642
KPIS+D+PKGQESLVM ++
Sbjct: 586 KPISSDYPKGQESLVMWAK 604
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42563282|ref|NP_177852.2| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] gi|332197836|gb|AEE35957.1| adenine nucleotide alpha hydrolases-domain containing protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1954), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/664 (60%), Positives = 489/664 (73%), Gaps = 52/664 (7%)
Query: 2 KMVQQEGDVISS----GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS GRT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESK---- 172
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 173 --------GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVM 224
G ED RR +LL+V+ RS++++K T KVV+ SK ++
Sbjct: 208 TVIGFGYIGKEDVRRITLLNVLQRSVTLNKTT-----KVVSHSEEDSNSKEEEEDQACGQ 262
Query: 225 NLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESL 278
NL Q L AR + NCS+CG P G S S+ + D ++++
Sbjct: 263 NLRQVLAAARLE--------NCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAM 314
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
IVPV E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+L
Sbjct: 315 EIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKL 371
Query: 339 PTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKEL 398
P R D KQ+ YD ++ LN A+VP G +++ D+ +LP+EL
Sbjct: 372 PPR--------DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEEL 419
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
EGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +E
Sbjct: 420 EGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTE 479
Query: 459 DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
DV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF
Sbjct: 480 DVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAF 539
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S+
Sbjct: 540 CWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASIST 599
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+HI C+DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLV
Sbjct: 600 THIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLV 659
Query: 639 MQSQ 642
M ++
Sbjct: 660 MWAK 663
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 643 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.959 | 0.777 | 0.597 | 2e-189 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.953 | 0.810 | 0.573 | 1.5e-179 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.629 | 0.574 | 0.565 | 2.3e-157 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.351 | 0.366 | 0.610 | 4.9e-91 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.331 | 0.367 | 0.479 | 2.6e-65 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.458 | 0.410 | 0.423 | 2.3e-60 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.511 | 0.596 | 0.418 | 6.4e-60 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.362 | 0.209 | 0.481 | 4.6e-59 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.359 | 0.345 | 0.440 | 1.7e-58 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.348 | 0.311 | 0.491 | 3.6e-57 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1836 (651.4 bits), Expect = 2.0e-189, P = 2.0e-189
Identities = 390/653 (59%), Positives = 479/653 (73%)
Query: 2 KMVQQEGDVISS---GAG-RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA 57
+M++ GD SS G G RT++VGVKLD SRELLTWALVKVA+PGDTVIALH+L N
Sbjct: 29 EMIETGGDKQSSVEEGCGGRTILVGVKLDAPSRELLTWALVKVAEPGDTVIALHILGNE- 87
Query: 58 IVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATK 117
IVDR G SSLLSLV+ FDSVL VYEGFCNLKQVDLKLK+CRG+S RKILVREA+S+SATK
Sbjct: 88 IVDRAGNSSLLSLVRTFDSVLDVYEGFCNLKQVDLKLKLCRGSSARKILVREAKSFSATK 147
Query: 118 FIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPS-TAGESKGTED 176
+VG +K+HH IRS+ S+AKY AKKLSKDC V+AVNNGK++FQKEG PS T +S+ E+
Sbjct: 148 VLVGISKSHHAIRSSASVAKYIAKKLSKDCWVIAVNNGKILFQKEGSPSSTINQSQVVEE 207
Query: 177 HRRN----SLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVK 232
DV R I++ + Q++ V + + + S +D +QA +
Sbjct: 208 TVIGFGYIGKEDV--RRITLLNVL-QRS--VTLNKTTKVVSHSEEDSNSKEEEEDQACGQ 262
Query: 233 ARSDCSGSAAKRNCSICG-----PVRNLPDGSCS-QSEEESPSDGGAGDESLAIVPVQNV 286
+A NCS+CG P G S S+ + D ++++ IVPV
Sbjct: 263 NLRQVLAAARLENCSVCGFDSLSPNDTTTPGKLSGASDFDRSEDDDECNKAMEIVPVNGS 322
Query: 287 EAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYL 346
E + S+TMLVR+LPE RPGWPLLRRA+ + KI VVQWAL+LP R
Sbjct: 323 EDSGGSVTMLVRKLPEPRPGWPLLRRAV---STLGQSVTPHKIPVVQWALKLPPR----- 374
Query: 347 ANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYS 406
D KQ+ YD ++ LN A+VP G +++ D+ +LP+ELEGL+E++S
Sbjct: 375 ---DTKQLGYDSSEDNLSTLN----ALVPFGINSITNKSIPDNSPRKLPEELEGLYERFS 427
Query: 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL 466
+TCR F Y++L+S TSNF A+N IGKGGSS+V++GCL +G+ +AVKILK +EDV+ +FV
Sbjct: 428 STCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRVVAVKILKQTEDVLNDFVA 487
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
EIEIITTLHHKNIISLLGFCFED+NLLLVY++LSRGSLEENLHGNKKDP AF WSERYKV
Sbjct: 488 EIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEENLHGNKKDPLAFCWSERYKV 547
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
A+GVAEAL+YLH+ ++Q VIHRDVKSSNILLSDDFEPQLSDFGLA+WAS S++HI C+DV
Sbjct: 548 AVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSDFGLARWASISTTHIICSDV 607
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS+ PKGQESLVM
Sbjct: 608 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISSGCPKGQESLVM 660
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1743 (618.6 bits), Expect = 1.5e-179, P = 1.5e-179
Identities = 368/642 (57%), Positives = 468/642 (72%)
Query: 7 EGDVISSGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS 66
E V++ G G TV+VGVK D S ELL WALVKVA+PGDTVIALHVL N IVDR SS
Sbjct: 3 ENGVVTGG-GHTVMVGVKFDESSNELLDWALVKVAEPGDTVIALHVLGNE-IVDRADNSS 60
Query: 67 LLSLVKAFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH 126
L+S+VK FDSVL VYEGFC LKQ++LKLK+ RG+S RKILV+EA+ SA+K +VG ++
Sbjct: 61 LVSIVKNFDSVLEVYEGFCKLKQLELKLKLSRGSSTRKILVKEAKMCSASKVVVGISRRF 120
Query: 127 HTIRSTTSLAKYCAKKLSKDCSVLAVNNGKVVFQKEGCPSTAGESKGTEDHRRNSLLDVI 186
HTI S+ S+AKY A+K++KDC VLAV+NGKV+FQK+G S SKG D RRN+L
Sbjct: 121 HTIHSSVSVAKYLARKVAKDCWVLAVDNGKVMFQKDGSSSIIHHSKGKSDARRNTL---- 176
Query: 187 HRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNC 246
S +T +KN+KVV S + + ++ + +L ++LV A C G NC
Sbjct: 177 -SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLVYA---CLG-----NC 225
Query: 247 SICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEAASTSITMLVRQLPES 303
S+ + +LP G+ S+S D A +++A+VP + E + ITMLV++LPE
Sbjct: 226 SV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPEDLTPFITMLVKELPEF 284
Query: 304 RPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDN 361
RPGWPLL R D AP SS RKI VVQW L+LP R S + +SD KQI +D ++
Sbjct: 285 RPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVVGSSDTKQIGFDSSES 344
Query: 362 ES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL 417
E + N + AIVP + IV L DH S P+ +EGL + S +C+ F Y++L
Sbjct: 345 EENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQARISTSCQFFTYKEL 402
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK 477
+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K+FV EI+IITTLHHK
Sbjct: 403 VSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKDFVAEIDIITTLHHK 462
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
N+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+ERYKVA+G+AEAL+YL
Sbjct: 463 NVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVGIAEALDYL 522
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I C+DVAGTFGYLAPEY
Sbjct: 523 HNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGTFGYLAPEY 582
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
FMYGK+N+KIDVYA+GVVLLELL+GRKP++++ PK Q+SLVM
Sbjct: 583 FMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVM 624
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1115 (397.6 bits), Expect = 2.3e-157, Sum P(2) = 2.3e-157
Identities = 239/423 (56%), Positives = 300/423 (70%)
Query: 221 GSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGS-CSQSEE-ESPSDGGAGDESL 278
G MN+ +LV D + AAK S P R + S+S +SP G D L
Sbjct: 169 GPQMNIP-SLVCGSPDIAIEAAKIGNSF-SPARTSSRWTRTSRSSSLQSPDSLGV-DNLL 225
Query: 279 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 338
A+VPVQ E S S+ ES PGW LR +R++ + S +K +V+QW RL
Sbjct: 226 ALVPVQTNETDSGSL--------ESGPGWHFLRGLYGNNRKSWTKVSAKK-AVLQWVSRL 276
Query: 339 PTRQPSYLANSDVKQITYDPGDNE--SINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPK 396
R + D K+ D G +E S +++G+ +I G+E++ SPLS S +P+
Sbjct: 277 RGRHSETVIYLDRKRS--DSGCDEDCSSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPE 334
Query: 397 ELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
ELEGLHEKYS+TCRLF Y+++LS TSNF +ENL+G+GG+S VY+G LPDG+ELAVKILKP
Sbjct: 335 ELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRELAVKILKP 394
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
DV+KEF+LEIE+IT++HHKNI+SL GFCFE+NNL+LVYD+L RGSLEENLHGN+KD
Sbjct: 395 CLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAK 454
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
FGW ERYKVA+GVAEAL+YLH+ VIHRDVKSSN+LL+DDFEPQLSDFG A AS+
Sbjct: 455 KFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASS 514
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+S H+ D+AGTFGYLAPEYFM+GKV DKIDVYAFGVVLLEL++GRKPI D KGQES
Sbjct: 515 TSQHVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQES 574
Query: 637 LVM 639
LV+
Sbjct: 575 LVL 577
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 712 (255.7 bits), Expect = 4.9e-91, Sum P(2) = 4.9e-91
Identities = 141/231 (61%), Positives = 175/231 (75%)
Query: 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 468
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
TFGYLAPEYFMYGKV+DK+DVYAFGVVLLEL++GR IS+D P+GQESLVM
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVM 489
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 105/219 (47%), Positives = 144/219 (65%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVLEI 468
F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+ E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+A+
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKIAV 371
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627
TFGYLAPE M G +++K D+YAFG++LLE++TGR+P++
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN 470
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 2.3e-60, Sum P(2) = 2.3e-60
Identities = 128/302 (42%), Positives = 186/302 (61%)
Query: 341 RQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLST-DHDSTELPKELE 399
R+ +S + Y P N S+N G GN S+ S+ D +S PK
Sbjct: 284 RRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGR 343
Query: 400 GLHEK-YSATCRL-FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP- 456
G + T ++ F Y++L T F ++G+GG VYKG L +GK +A+K LK
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
S + +EF E+EII+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
WS R ++A+G A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT 521
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+ SHI+ T V GTFGYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ES
Sbjct: 522 AQSHIS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 637 LV 638
LV
Sbjct: 581 LV 582
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 614 (221.2 bits), Expect = 6.4e-60, P = 6.4e-60
Identities = 147/351 (41%), Positives = 202/351 (57%)
Query: 302 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 356
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 357 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 416
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 474
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 475 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 528
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
TFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI GQE+LV+
Sbjct: 384 TFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVV 434
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 4.6e-59, Sum P(2) = 4.6e-59
Identities = 114/237 (48%), Positives = 162/237 (68%)
Query: 405 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKE 463
++ + + F +++ AT+NF ++G+GG +VY+G DG ++AVK+LK + +E
Sbjct: 704 FTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSRE 763
Query: 464 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
F+ E+E+++ LHH+N+++L+G C ED N LVY+ + GS+E +LHG K + W R
Sbjct: 764 FLAEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDAR 823
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHI 581
K+A+G A L YLH S+ RVIHRD KSSNILL +DF P++SDFGLA+ A + HI
Sbjct: 824 LKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHI 883
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGRKP+ P GQE+LV
Sbjct: 884 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLV 939
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 1.7e-58, Sum P(3) = 1.7e-58
Identities = 104/236 (44%), Positives = 148/236 (62%)
Query: 404 KYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIK 462
K+ R F Y +L +AT F + + +GG V+ G LPDG+ +AVK K S +
Sbjct: 370 KFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQGDR 429
Query: 463 EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE 522
EF E+E+++ H+N++ L+G C ED LLVY+++ GSL +L+G ++P GWS
Sbjct: 430 EFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGREP--LGWSA 487
Query: 523 RYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
R K+A+G A L YLH ++HRD++ +NILL+ DFEP + DFGLA+W +
Sbjct: 488 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKGV 547
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
T V GTFGYLAPEY G++ +K DVY+FGVVL+EL+TGRK + PKGQ+ L
Sbjct: 548 E-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCL 602
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 3.6e-57, P = 3.6e-57
Identities = 112/228 (49%), Positives = 162/228 (71%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 470
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 643 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-22 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-22 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 79/219 (36%), Positives = 112/219 (51%), Gaps = 20/219 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 485
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFMYG 601
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+APE YG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
K+DV++ GV+L ELLTG+ P S ++ Q L+ +
Sbjct: 178 P---KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 72/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 547 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 604
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 605 DKIDVYAFGVVLLEL 619
+K D+++ GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-47
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 484
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 541
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+APE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+D+++ GV+L ELLTG+ P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-44
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDY 176
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHP 631
K D+++ G+ +EL G+ P S P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 73/204 (35%), Positives = 110/204 (53%), Gaps = 14/204 (6%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
K DV++FGV+L E+ T G +P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 9e-43
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 430 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKP 625
K K DV++FGV+L E+ T G +P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 1e-39
Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---------- 592
+ +HRD+ + N L++++ ++SDFGL++ D+ Y
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR------------DIYEDDYYRKRGGGKLPI 168
Query: 593 --LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+APE GK K DV++FGV+L E+ T G +P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 9e-39
Identities = 68/217 (31%), Positives = 110/217 (50%), Gaps = 18/217 (8%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L S ++ +HRD+ + N L+ +D ++SDFGL++ + T ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
G K DV++FGV+L E+ T G P +SN+
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE 214
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-38
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 428 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 484 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 537
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS ++HRD+K +NIL+ D +L+DFG AK + V GT ++APE
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
+ D+++ G ++E+ TG+ P S
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDK 606
D+ + N+L+S+D ++SDFGLAK AS +G + APE K + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTK 179
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 5e-32
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 477
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 538 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 592
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 593 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
+APE + + D+++ G+ L ELLTG P
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 489 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRD+KS NILLS D +L+DFG A A + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
K+D+++ G++ +E+ G P + P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 478
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S ++++HRD+K NI L+ + +L DFG++K S++ V GT YL+PE
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
N K D+++ G VL EL T + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 428 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 480
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPE 596
S QR IHRD+ + NIL+ + ++SDFGLAK + + + F Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639
K + DV++FGV L EL T G + P E L M
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPP-AEFLRM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q VIHRD+K++NIL + D +L+DFG+A + V GT ++APE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP-------------ISNDHP 631
+ D+++ G ++ELLTG P + +DHP
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 531
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD---VAG 588
+ YL ++Q +HRD+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 589 T----FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE MY K + DV++FGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 542
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGTFGYLAPEYFMY 600
IHRD+K+ NILL +D +++DFG++ + + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 601 GK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
+ K D+++FG+ +EL TG P S P + L++ Q
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQ 221
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ IHRD+K++NILLS++ + +L+DFG++ + ST S T GT ++APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVIK 171
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
++K D+++ G+ +EL G P+S+ HP
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++HRD+K +NI L + +L DFG A +T++ +AGT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 602 KVNDK---IDVYAFGVVLLELLTGRKPISN 628
K D+++ G V+LE+ TG++P S
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 430 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 481
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 482 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 537
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS +I+RD+K NILL D +L+DFGLAK S+ S GT YLAPE
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEV 164
Query: 598 FM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YGK +D ++ GV+L E+LTG+ P
Sbjct: 165 LLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 474
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 475 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 531
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA---- 587
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 588 --------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y++PE D++A G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 482
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ IHRD+K+ NILL+++ + +L+DFG++ + + + V GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEVIQEIG 175
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHP 631
N+K D+++ G+ +E+ G+ P S+ HP
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 479
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-----WASTSSSHITCTDVAGTFGYLA 594
Q IHRD+ + NIL+ +D +++DFGLA+ +S I + + A
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTA 172
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT 621
PE +G + K DV++FG++L E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-----AGTFGYLAPEYF- 598
+IHRD+K SN+L++ E +++DFG+ S + T GT Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 599 --MYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
Y D+++ G+ LLE G+ P
Sbjct: 174 GESYSY---AADIWSLGLTLLECALGKFPFLP 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 70/213 (32%), Positives = 111/213 (52%), Gaps = 22/213 (10%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 542
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
++IHRDVK SNIL++ + +L DFG++ S + T V GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGND 175
Query: 603 VNDKIDVYAFGVVLLELLTGRKPIS--NDHPKG 633
+ K D+++ G+ L+EL TGR P ND P G
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 22/220 (10%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 471
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGT 589
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
Y++PE N K D+++ G +L E+ + P D
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 488 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179
Query: 603 VND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
D K D+++ G+ L+EL P +P
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 430 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 483
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYG 601
+HRD+ + N+LL + + ++SDFG+++ S + T AG + + APE YG
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG 173
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKP 625
K + K DV+++GV L E + G KP
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 66/219 (30%), Positives = 112/219 (51%), Gaps = 22/219 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 590
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
Y++PE N K D+++ G +L E+ + P D
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 424 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 475
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 525
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 526 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++ ++ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ ++ PE +YGK + D+++FGVVL E+ + G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 477
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 533
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY+
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYM 166
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
APE + +D ++ GV E L G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 68/182 (37%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 446 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 501
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 562 EPQLSDFGLAKWASTSSSHITCTD--VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
+ ++ DFGL K T + T D + F Y APE + K DV++FGV L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 620 LT 621
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 70/205 (34%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 488
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 608
D+ + NIL+S+D ++SDFGLA+ + + V T APE + K + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 609 VYAFGVVLLELLT-GRKPISNDHPK 632
V+++GV+L E+ + GR P +PK
Sbjct: 180 VWSYGVLLWEVFSYGRAP----YPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 9e-23
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 483
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 484 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S ++HRD+K SNIL+++D +L+DFGLA+ T + T+ T Y PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELL 173
Query: 599 M----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ YG ++D+++ G +L EL G KPI
Sbjct: 174 LGATRYGP---EVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-23
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 450 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 508 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 568 FGLAKWASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
FGL + + H + F + APE + DV+ FGV L E+ T G +P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 533
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++ ++ + ++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE MY K + DV++ GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 607
+ + N+L+ ++ +++DFGLA+ I F + APE +Y + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR---VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 56/203 (27%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWA---STSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F + K + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 607 IDVYAFGVVLLELLT-GRKPISN 628
DV++FGV++ E+ + G+ P N
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 490 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 548
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 549 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDKI 607
D+ + N+L+S+D ++SDFGL K AS++ D + APE K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 68/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 599
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRK--PISNDHPKGQESLVMQ 640
YGK +DV+A G ++ ELL G P +D Q L+ +
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQK 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 487 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 534
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYL 593
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T GT ++
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 594 APEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
APE + D + DV++ G+ +EL G+ P+ + HP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 537
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT---FGYLA 594
+ IHRD+ + N L+ ++ +++DFGL++ + T T AG + A
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 173
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT 621
PE Y K + K DV+AFGV+L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 481
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 539
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF 598
VIHRD+K++NIL+++ +L DFG+ A SS T GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVI 173
Query: 599 MYGKVND-KIDVYAFGVVLLELLTGRKPISN 628
GK D K D+++ G+ + E+ TG P S+
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 6e-22
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 429 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYF 598
++R +HRD+ + NIL+ + ++ DFGL K + + + F Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 599 MYGKVNDKIDVYAFGVVLLELLT 621
K + DV++FGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 544
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF---MY 600
IHRD+K +NILL++D + +L+DFG+ A+ +T + + GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERK 178
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
G + K D++A G+ +EL + P+ + HP
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +HRD+K +NIL+ + +L+DFG+AK S G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKPIS 627
G D+++ G +LE+ TG+ P S
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 29/211 (13%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 480
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSSHITCTDVAGT---FGYL 593
IHRD+ + N L+ +D ++SDFGLA++ TSS GT +
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWA 168
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRK 624
PE F Y + + K DV++FGV++ E+ + K
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 62/214 (28%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 480
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHIT-CTDVAGTFGYLA 594
+ V+HRD+K +N++L + +L DFG A+ W +H + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
PE K D+++ G + E+ TG+ P+++
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 542
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF---- 598
++HRD+K N+L++ + +L+DFGLA+ S S T T Y APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGR 623
Y +D+++ G + ELL+ R
Sbjct: 175 GYST---PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 472
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 590
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
Y++PE N K D+++ G +L E+ + P D
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-21
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 539
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K DV+++GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 607
+ + NIL+ ++ +++DFGLA+ F + APE YG+ K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 608 DVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 475
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 534
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V T Y A
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 595 PEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
PE YG +D+++ G + ELL R P
Sbjct: 171 PELLFGARHYGV---GVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 480 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----YL 593
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF Y+
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYM 170
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
APE + DV++ G+ LLE+ R P +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 478
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 536
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS ++++HRD+KS N+ L ++ D G+AK S ++ + GT YL+PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
N+K DV+A GVVL E TG+ P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 430 IGKG--GSSQVYK----GCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481
+GKG G + +Y+ L KE+ + L E D + E I I++ L H NII+
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNE----IVILSLLQHPNIIA 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLHS 539
+DN LL+ ++ + G+L + + ++ F E + + A+ Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVLWYLFQIVSAVSYIHK 119
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
++HRD+K+ NI L+ +L DFG++K + S V GT Y++PE
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYYMSPELCQ 174
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
K N K D++A G VL ELLT ++ +P
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAK----WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
IHRD+ + N L+ ++ ++SDFG+++ T S + + T APE YG
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKPISN 628
+ + DV+++G++L E + G P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 607 IDVYAFGVVLLELLTGRKPISNDHP 631
D+++ G+ +EL G P S+ HP
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 18/216 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 482
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 530
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A + YL S Q +HRD+ + N L+ + ++ DFG+++ ++ +
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE MY K + DV++FGV+L E+ T G++P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 3e-20
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 13/205 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+K++N+LLS+ E +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 607 IDVYAFGVVLLELLTGRKPISNDHP 631
D+++ G+ +EL G P S HP
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---- 599
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 600 YGKVNDKIDVYAFGVVLLELLTG 622
YG+ +D++A G ++ E+LTG
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 476
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + ++HRD+K+ N+L+ D ++SDFG++K + + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 597 YF-MYGK-VNDKIDVYAFGVVLLELLTGRKPISND 629
Y + + K+D+++ G V+LE+ GR+P S++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 448 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 565 LSDFGLAKWA----STSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLE 618
+SDFGL+++ TSS V F + PE +Y K + K DV+AFGV++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 619 LLT-GRKP 625
+ + G+ P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------YLA 594
S +HRD+ + NIL++ + ++SDFGL++ S + T T G + A
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV++FG+V+ E+++ G +P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 9e-20
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 541
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
R++HRD+K NIL++ D +L+DFGLA+ A T T T Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGR 623
Y +D+++ G + E++TG+
Sbjct: 174 KHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 60/182 (32%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 446 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
++ DFGLAK + + + F Y A E K + DV++FGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 620 LT 621
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 480
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 481 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPEYF 598
++HRD+K +NIL +L DFG +K T S T V GT +++PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 599 M---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
YG+ K DV++ G ++E+LT + P +
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+ YL S +HRD+ + N L+ ++ DFG+ S I TD G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGG 182
Query: 592 -------YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++ PE +Y K + D+++FGVVL E+ T G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS N+LL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 10/204 (4%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 485
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 486 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 542
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 543 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V+HRD+K +NI L + +L DFGLAK SS GT Y++PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
++K D+++ G ++ EL P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 20/210 (9%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM--GVAEALEYLH 538
L G + +++ +++ G+L++ L + + +++ V M G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL- 123
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YLAPE 596
S +HRD+ + NIL++ + E ++SDFGL++ T T G + APE
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K DV++FG+V+ E+++ G +P
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
+HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 606 KIDVYAFGVVLLELLT-GRKP 625
K DV++FG++L EL T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 4e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 479
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 519
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
+ T+ ++APE + DV++FGV+L E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQ 167
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
S + GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
++++NIL+ D+ +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 610 YAFGVVLLELLT-GRKP 625
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHITCTDVAGTFGYLAPEYFMYGK 602
IHRD+ + N L+ ++ ++SDFG+++ SSS + + T APE YG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 603 VNDKIDVYAFGVVLLELLT 621
+ + DV+++G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-19
Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 33/212 (15%)
Query: 428 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 481
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 482 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 535
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------WASTSSSHITCTDVAGT 589
YL S ++ +HRD+ + N +L + F +++DFGLA+ + S + V
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-- 167
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++A E K K DV++FGV+L EL+T
Sbjct: 168 --WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 60/208 (28%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 543
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
+ IHRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ K D+++ G+ +EL G P S+ HP
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 401 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 459
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 460 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 510
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 511 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGR 623
G++ A +S+ + GT ++APE + D + DV++ G+ +EL G
Sbjct: 173 GVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 624 KPISNDHP 631
P+ + HP
Sbjct: 231 PPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 608 DVYAFGVVLLELLTGRKPISNDHP 631
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 430 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 484 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++IHRD+K+ N+LL+ D + +L+DFG++ A + GT ++APE M
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 601 GKVND-----KIDVYAFGVVLLEL 619
+ D K D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-18
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG---TFGYLAPEY 597
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K DV+++G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-18
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 26/236 (11%)
Query: 406 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 464
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
K+A+G+A+AL +LH + V+ ++ I++ EP L S + CT
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---------LSLPGLLCT 834
Query: 585 DVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
D Y+APE + +K D+Y FG++L+ELLTG+ P ++ S+V
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIV 889
|
Length = 968 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
++S+NIL+ D +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 610 YAFGVVLLELLT-GRKP 625
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 63/229 (27%), Positives = 115/229 (50%), Gaps = 27/229 (11%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILK--PSEDVIKEFVLEIEI 470
LSA F+ E +G+ ++YKG L + +A+K LK + EF E +
Sbjct: 4 LSAV-RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAA 517
+ LHH NI+ LLG ++ + +++++L++G L E L H G D ++
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 518 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
+ +A+ +A +EYL S+ +H+D+ + NIL+ + ++SD GL++ ++
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ ++ PE MYGK + D+++FGVVL E+ + G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 11/207 (5%)
Query: 423 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 478
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q+++HRD+KS+NILL + ++ D G++K ++ T + GT Y+APE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ K D+++ G +L E+ T P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 57/218 (26%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVN 604
IHRD++++N+L+S+ +++DFGLA+ + T + A + APE +G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 605 DKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641
K DV++FG++L E++T G+ P +P S VM +
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 24/194 (12%)
Query: 446 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLL 617
+++DFG AK T T + GT YLAPE + YGK +D +A G+++
Sbjct: 138 GYIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIY 189
Query: 618 ELLTGRKPISNDHP 631
E+L G P +D+P
Sbjct: 190 EMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 482
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 483 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 592
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 593 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+APE + + K +D ++ G +L E L G P + P
Sbjct: 168 IAPEVILGQGHSK---TVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 477
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 478 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V T Y
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 594 APEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
APE + ID++A G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 430 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 523
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ A ++ PE Y + + DV+A+GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 18/189 (9%)
Query: 448 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 505 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 553 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612
N+L+++D +++DFGLA+ + T+ ++APE + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 613 GVVLLELLT 621
GV+L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 32/222 (14%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 487 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 535
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLA 594
+LH A +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++A
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMA 189
Query: 595 PEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
PE + D + D+++ G+ +E+ G P+ + HP
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 428 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 478
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 535
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
YL IHRD+ + N L+S+ D ++ DFGLA+ S + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + GK + DV++FGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 427 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 589 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
T G ++A E Y K DV++FGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 64/233 (27%), Positives = 114/233 (48%), Gaps = 16/233 (6%)
Query: 402 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 459
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 460 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 518
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG A S
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK 168
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 474
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 535 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTD-----VAG 588
YLH ++IHRDVK +N+L+ S +++DFG A+ ++ T + G
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA---AARLAAKGTGAGEFQGQLLG 170
Query: 589 TFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 629
T ++APE YG+ DV++ G V++E+ T + P + +
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 485 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
++D+++ G++++E++ G P N+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 506 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+ N+L+++D +++DFGLA+ + T+ ++APE + DV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 612 FGVVLLELLT 621
FGV+L E+ T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-- 605
RD+K+ NIL + D + +L+DFG++ A + + GT ++APE M D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 606 ---KIDVYAFGVVLLEL 619
K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 428 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 536
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGY 592
L IHRD+ + N LL+ P ++DFG+A+ +S + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639
+ PE F+ G K DV++FGV+L E+ + G P QE +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 484
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 485 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
IHRDVK NIL++ + +L DFG A+ + TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 600 --YGKVNDKIDVYAFGVVLLELLTG 622
YG +DV+A G V ELLTG
Sbjct: 176 TQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 506 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 554 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFG 613
N+L+++D +++DFGLA+ + ++ ++APE + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 614 VVLLELLT 621
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 26/192 (13%)
Query: 449 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 506 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 549
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 609
+ + N+L++++ +++DFGLA+ + + T+ ++APE + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 610 YAFGVVLLELLT 621
++FGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 598
+HRD+ + N+LL + ++SDFGL+K S+ A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECI 170
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K + + DV+++G+ + E + G+KP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 10/206 (4%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
IHRD+ + N L+S ++SDFG+ ++ + + + + PE F + K
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 604 NDKIDVYAFGVVLLELLT-GRKPISN 628
+ K DV++FGV++ E+ T G+ P
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 486
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 487 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++APE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIA 184
Query: 600 YGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
+ D K D+++ G+ +E+ G P+ + HP
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 17/211 (8%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 489 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 607
RD+K SNIL++ + +L DFG++ S I T V GT Y++PE GK K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFV-GTSTYMSPERIQGGKYTVKS 183
Query: 608 DVYAFGVVLLELLTGRKPI--SNDHPKGQES 636
DV++ G+ ++EL G+ P SN GQ+
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDD 214
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 24/203 (11%)
Query: 449 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 507 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+ N L+ ++ +++DFG+++ + ++A E + GK DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 612 FGVVLLELLTGRKPISNDHPKGQ 634
FGV L E+L + + P G+
Sbjct: 226 FGVTLWEILM----LCKEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 428 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 481
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 529
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKT 169
Query: 590 FG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
G ++A E Y DV+++GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 430 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 483
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R+++RD+K N+LL D ++SD GLA AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 603 VNDKIDVYAFGVVLLELLTGRKP 625
+ +D +A G L E++ GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRDVK SN+L++ + +L DFG+ ST + GT Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 607 IDVYAFGVVLLELLTGRKP 625
DV++ G+ +EL GR P
Sbjct: 174 SDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 402 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 456
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 457 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 515
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQ 166
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
S + GT ++APE ++D+++ G++++E++ G P +D P
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 488 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 539
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF- 598
+ IHRDVK +NILL+ + +L DFG++ A +S+ + GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 599 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ + + DV++ G+ +EL G P+++ HP
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 429 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R +HRD+ + N+L+S +L DFGL+++ S+ + ++APE + +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
DV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y++PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPE----- 238
Query: 602 KVNDKI----------DVYAFGVVLLELLTGRKP 625
++N + D+++ GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 9e-16
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 22/204 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K T ++ T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 618 ELLTGRKPISN-DHPKGQESLVMQ 640
E++ GR P N DH K E ++M+
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 54/175 (30%), Positives = 86/175 (49%), Gaps = 6/175 (3%)
Query: 452 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
AK S T V GT Y PE +K DV+AFG +L ++ T + P
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 34/218 (15%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 528
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKK 180
Query: 589 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
T G ++A E Y DV+++GV+L E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 445 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 562 EPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
+L DFG+A+ ST TC GT YL+PE N+K D++A G VL E+
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 621 T 621
T
Sbjct: 196 T 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 601
IHRD+K+ NILL++ +L+DFG A S ++S + GT ++APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISN 628
+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ LLG C + LV + G L + +H +K + G + +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE 127
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLA+ ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K + DV+++GV + EL+T G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 528
L G CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+A L +LHS + +I+RD+K N++L + +++DFG+ K + T T G
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT-FCG 163
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 20/222 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 601
+HRD+K +NILL+D+ +L+DFG++ A +++ GT ++APE G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
N D++A G+ +EL + P+ + HP L+ +S F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 487 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 542
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ IHRD++++NIL+S +++DFGLA+ + + + APE +G
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
K DV++FG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 52/187 (27%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 505 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGV 614
L+ + + +++DFG+++ + + ++A E + GK DV+AFGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 615 VLLELLT 621
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 429 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 480
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 535
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+L S R +HRD+ + N L+S E ++S L+K S + + +LAP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT 621
E + K DV++FGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 422 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 473
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 530
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
A EYLHS + +I+RD+K N+LL + +++DFG AK + C GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTP 179
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
YLAPE +D + GV+L E + G P +D P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 484
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 485 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 539
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
G IHRD+K N L+ +L+DFGL+K + ++ V G+ Y+APE
Sbjct: 121 G----YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN----SVVGSPDYMAPEVLR 171
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ +D ++ G +L E L G P S P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 481
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 538
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
R++HR++ + NILL D Q++DFG+A ++ ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631
++G+ + DV+++GV + E+++ G +P + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 22/204 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K + + T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 618 ELLTGRKPISN-DHPKGQESLVMQ 640
E++ GR P N DH + E ++M+
Sbjct: 187 EMMCGRLPFYNQDHERLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 429 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 482
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+ +++RD+K NILL + +L+DFG AK T T + GT YLAPE
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT-LCGTPEYLAPEVIQSKG 174
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
N +D +A G+++ E+L G P +D+P G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 534
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
++LH + +I+RD+K N+LL + +++DFG+ K +T + GT Y+A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
PE Y +D +A GV+L E+L G+ P D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 51/215 (23%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-- 591
+ YL A++ +HRD+ + N ++++D ++ DFG+ + I TD G
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 592 -----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE G K DV++FGVVL E+ T
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 482
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 483 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 528
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
E L Y H + +HRD+K SNILL++ + +L+DFGLA+ ++ S V
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 589 TFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y PE YG IDV++ G +L EL T +KPI
Sbjct: 180 TLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 49/179 (27%), Positives = 94/179 (52%), Gaps = 12/179 (6%)
Query: 448 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 505 EENLHGNKKDPAAFG--WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562
L ++ S Y+VA G + +L S + IHRD+ + N+LL+
Sbjct: 127 LNFLRRKRESFLTLEDLLSFSYQVAKG----MAFLASKNC---IHRDLAARNVLLTHGKI 179
Query: 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++ DFGLA+ S+++ + ++APE + DV+++G++L E+ +
Sbjct: 180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 28/220 (12%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 484
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 485 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS + +++RD+K NILL D +++DFG+ K + TCT GT Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT-FCGTPDYIAPEI 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
+ K N +D ++FGV+L E+L G+ P H +E L
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 471
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD--------- 514
+ L H NI+ LLG ++ L +++ + S L E L H G+ D
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
PA F + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL +
Sbjct: 123 PADF-----VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ + + +++PE MYGK + D++++GVVL E+ + G +P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD+ + N L+++ ++SDFG+++ T + APE YG+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 607 IDVYAFGVVLLELLT-GRKPISN 628
DV++FG++L E + G P +N
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYAN 199
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 489
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 547
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDK 606
RD++++NIL+S+ +++DFGLA+ + T + A + APE YG K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 67/225 (29%), Positives = 109/225 (48%), Gaps = 26/225 (11%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 484
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 541
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY- 600
+HRD+K +NILL+D+ + +L+DFG+A A +++ GT ++APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 601 --GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
G N D++A G+ +EL + P+ + HP L+ +S F
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-15
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 449 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 616
L +L DFG +K S S S + GT YLAPE + + + K D+++ GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 617 LELLTGRKP 625
ELLT +P
Sbjct: 262 YELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 536
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS RV+HRD+K N+L++ + +L+DFGLA+ T T T Y APE
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 170
Query: 597 YFMYGKV-NDKIDVYAFGVVLLELLTGR 623
+ K + +D+++ G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 477
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 535
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT----DVAGTFG 591
YLH+ + +IHRD+K +NIL+ + ++SDFG++K +S + G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
++APE K D+++ G +++E+LTG+ P +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 484
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 485 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
EYLH+ + +I+RD+K N+LL + +L DFG AK S T T GT Y+
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYV 159
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
APE + + +D ++ G++L ELLTGR P D
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 479
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 535
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+LH Q +I+RD+K NILL +L+DFGL K S +T T GT Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
E M +D ++ G ++ ++LTG P + ++ K
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 430 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 483
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 598
+HRD+ + N+LL ++SDFGL+K ++ A T G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639
Y K + K DV++FGV++ E + G+KP KG E M
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 446 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 500
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 559
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
+L+DFGL++ + GT YLAPE + + D ++ G V+ E
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 620 LTGRKPISNDHPK 632
L G P + P
Sbjct: 187 LFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 21/213 (9%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL----KPSEDVIKEFVLEIEIITTLHHKN 478
F+ + IG G VY E+ AVK + K + + ++ + E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K+ NILL++ + +L+DFG A +S ++S + GT ++APE
Sbjct: 139 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 599 MY---GKVNDKIDVYAFGVVLLELLTGRKPISN 628
+ G+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 475
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLA 594
YL S +HRD+ + NIL++ + ++SDFGL++ + T + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV+++G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 2e-14
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 429 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 482
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 543 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 602 KVNDKIDVYAFGVVLLELLT 621
N K D++A G VL EL +
Sbjct: 177 PYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 429 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 481
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 482 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 533
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS----SHITCTDVAGT 589
+EYL S + IHRD+ + N +L +D ++DFGL+K + I V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++A E K DV+AFGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 43/224 (19%)
Query: 430 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 482
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 483 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 531
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA-KWASTSSSHITCTDV 586
YLHS V+HRD+K +NIL+ + + + D GLA + + V
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 587 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE + Y K ID++A G + ELLT PI
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 472
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 473 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 525
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 526 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
S++ + ++A E + DV++FGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG- 601
+RV+HRD+K N+L+ + +L+DFGLA+ T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPI 626
+ + +D+++ G + E+ T +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 482 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 529
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+A L +LHS + +I+RD+K N++L + +++DFG+ K +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
Y+APE Y +D +AFGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 68/238 (28%), Positives = 105/238 (44%), Gaps = 44/238 (18%)
Query: 423 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 464
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 465 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 581 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
GT Y+APE G + +D ++ GV+ ELLTG P + D + +S
Sbjct: 162 RA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 483
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +I+RD+K N+LL + +L+DFG+ K + T + GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
+D +A GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 479
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 480 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH +++RD+K NILL L DFGL+K A+ + + T T GT YLAPE
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLAPE 166
Query: 597 YFM----YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ Y K +D ++ GV++ E+ G P
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 70/235 (29%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 418 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 469
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 470 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 584
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY---- 166
Query: 585 DVAGTFGYLAPEYFMYGKVNDKI---------DVYAFGVVLLELLTGRKPISNDH 630
D GT Y +PE KI D +A GV+ ELLTG+ P D
Sbjct: 167 D--GTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 518 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISND----- 629
+ + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 169 NXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222
Query: 630 --HPKGQESLVMQS 641
H ES +QS
Sbjct: 223 LYHIAQNESPALQS 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 49/206 (23%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 495
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 496 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDVAGTFGYLAPEYFM----Y 600
IHRD+K SNIL++ + + ++ DFGLA+ T+ T Y APE + Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPI 626
K ID+++ G + ELLT RKP+
Sbjct: 185 TK---AIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 483
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 539
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+I+RD+K NILL L+DFGL K S T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLR 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPI-SNDH 630
+ +D + G VL E+L G P S D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 9e-14
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 475
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 532
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L +LH + +I+RD+K N++L + +++DFG+ K +T GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
+APE Y +D +A+GV+L E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 16/177 (9%)
Query: 455 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 514
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISN 628
S ++S + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 65/227 (28%), Positives = 117/227 (51%), Gaps = 28/227 (12%)
Query: 429 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 481
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHITCTDVAGTFGYLAP 595
HS +I+RD+K NILL ++ +L+DFGL+K + ++ C GT Y+AP
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAP 167
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
E D ++FGV++ E+LTG P K +++++++
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 480
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 481 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 533
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+++LHS R++HRD+K NIL++ D + +++DFGLA+ S + T V T Y
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYR 173
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
APE + +D+++ G + EL R+P+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 47/133 (35%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 554 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612
NILL + +L DFG +K +A+T S + T GT Y+APE + + K D+++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 613 GVVLLELLTGRKP 625
GV+L ELLT ++P
Sbjct: 232 GVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 484
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 485 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH + +I+RD+K N+LL D +++DFG+ K + GT Y+APE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
K N+ +D ++FGV+L E+L G+ P +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 35/165 (21%)
Query: 475 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 525
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHIT 582
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+ S + +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 583 CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
TD T Y APE + Y K +D+++ G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 484
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 485 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
YL VIHRDVK SNILL +L DFG++ S + T AG Y+A
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182
Query: 595 PEYFMYGKVNDKI----DVYAFGVVLLELLTGRKPISN 628
PE N K DV++ G+ L+EL TG+ P N
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KV 603
+HRD+K +N+L+S D +++DFGLA+ S + VA T Y APE +YG K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 604 NDKIDVYAFGVVLLELLTGR 623
+ +D++A G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 483
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 537
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC----TDVAGTFGYL 593
H HRD+K N+L+S +++DFGLA+ I TD T Y
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYR 165
Query: 594 APEYFMY-GKVNDKIDVYAFGVVLLELLTGR 623
APE + + +D++A G ++ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 430 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 484 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R+I+RD+K N+LL +D ++SD GLA AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 603 VNDKIDVYAFGVVLLELLTGRKP 625
+ +D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 55/250 (22%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 475
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 476 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 532
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 533 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 572
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 573 --------WASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT 621
+ GT Y+APE YG + D ++ GV+L E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL---ECDWWSLGVILYEMLY 225
Query: 622 GRKPISNDHP 631
G P +D
Sbjct: 226 GFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 28/207 (13%)
Query: 446 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGV 614
D +++DFGL K + + T GT YLAPE YG+ +D + GV
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV 183
Query: 615 VLLELLTGRKPISN-DHPKGQESLVMQ 640
V+ E++ GR P N DH K E ++M+
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 51/184 (27%), Positives = 92/184 (50%), Gaps = 16/184 (8%)
Query: 449 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 505 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
++ +++DFG+++ + + +++ E + GK DV+AFGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 618 ELLT 621
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 21/204 (10%)
Query: 446 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 500
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 501 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
D +++DFGL K + T GT YLAPE +D + GVV+
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 618 ELLTGRKPISN-DHPKGQESLVMQ 640
E++ GR P N DH K E ++M+
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNII 480
L+G+G +VY C + G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 481 SLLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
G C D L + +++ GS+++ L K A S K + E + YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFGYLAPE 596
HS ++HRD+K +NIL +L DFG +K T S V GT +++PE
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
K DV++ G ++E+LT + P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 430 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 542 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFM 599
++++HRD+KS NI LS + +L DFG+A+ + S TC GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQ 175
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
N+K D+++ G VL EL T + P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 444 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
E +L DFG++ S ++ GT Y++PE + + D+++ G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 620 LTGRKPISNDHPKGQESL 637
GR PI K E++
Sbjct: 196 AIGRYPIPPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 474
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-SHITCTDVAGTFG 591
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+++PE K D+++ G ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 36/213 (16%)
Query: 446 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 496
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 497 DFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDV 550
D L L +H ++ +E Y++ G L+Y+HS + VIHRD+
Sbjct: 88 D-LMESDLHHIIHSDQP------LTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDL 133
Query: 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKI 607
K SN+L+++D E ++ DFG+A+ S+S + T+ T Y APE + I
Sbjct: 134 KPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI 193
Query: 608 DVYAFGVVLLELLTGRKPI-SNDHPKGQESLVM 639
D+++ G + E+L GR+ + + Q L++
Sbjct: 194 DMWSVGCIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN 604
+HRD+K N+L+ + +L+DFGLA+ T V T Y APE + + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 605 DKIDVYAFGVVLLELLTGRKPI 626
+D+++ G + E++ R+P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 43/108 (39%), Positives = 65/108 (60%), Gaps = 9/108 (8%)
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++ + S + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 585 DVAGTFGYLAPEYF---MYGKVND-KIDVYAFGVVLLELLTGRKPISN 628
AG Y+APE + K D K DV++ G+ ++EL TGR P +
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 40/113 (35%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A++ + + + +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
APE K N K D+++ G+VL E+L I D P E V
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272
|
Length = 357 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEI 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+ +D +A GV++ E++ G+ P D+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 446 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDK-IDVYAFGVVLL 617
+ L+DFGL+K GT Y+AP+ G +DK +D ++ GV++
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 618 ELLTGRKPISNDHPKGQES 636
ELLTG P + D K ++
Sbjct: 200 ELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 485
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 486 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 539
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ HRD+K NIL+ DD +L+DFG + S T+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 600 Y-GKVNDKIDVYAFGVVLLELLT 621
G K+D++A G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 423 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 467
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 468 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 525 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSS 579
V A V L+YLH ++++RD+K N+LL + +++DFGL K +S
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
C GT +LAPE +D + GV++ E+L G P D
Sbjct: 160 TF-C----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 475
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 476 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFG 591
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+++PE K DV++ ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 598 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
G D D ++ G +L +LL G P K + +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 480
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 535
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA---------------STSSSH 580
YLH +++RD+K NILL + LSDF L+K + SS +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 581 ITCTDVA------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
++ GT Y+APE +D + G++L E+L G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 482
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 483 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 533
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS-SSHITC-TDVAGTFG 591
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S +S T+ T
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 592 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+ T T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 593 LAPE-YFMYGKVNDKIDVYAFGVVLLELLTGR 623
APE + N +D+++ G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG E+ A+K L E + EI ++ L H+NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 487 FEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+N L+LV++++ L++ + HG + S Y++ G+A + H
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGTFGYLAPEYFM 599
RV+HRD+K N+L++ E +L+DFGLA+ +T S+ + T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWYRAPDVLL 173
Query: 600 YGKV-NDKIDVYAFGVVLLELLTGR 623
+ + ID+++ G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 446 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 499
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 558
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 559 DDFEP--QLSDFGLAKWAS----TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611
P ++ DFG+ + +T T+V GT Y APE V D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 612 FGVVLLELLTGR 623
+G++ LE LTG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 480
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 598 FMYGKVND-KIDVYAFGVVLLELLTGRKP 625
G D D ++ G +L +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 477 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 523
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 524 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH- 580
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
T+ T Y APE + K K ID+++ G +L E+L+ R Q +L++
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL 223
Query: 640 Q 640
Sbjct: 224 G 224
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 546 IHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYLAPEYF----- 598
+HRD+K N+L++ ++SDFG +K + + CT+ GT Y+APE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPR 186
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
YG D+++ G ++E+ TG+ P
Sbjct: 187 GYGA---PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 47/229 (20%)
Query: 424 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 475
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 476 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++ S
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-- 161
Query: 580 HITCTDVAGTFGYLAPEY---FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
I T AG Y+APE + + DV++ G+ L E+ TG+ P
Sbjct: 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 480
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++RD+K NILL L+DFGL K S T T GT YLAPE
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIR 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
++ +D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 430 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
++HRDVK SNIL++ E +L DFG++ S ++ GT Y++PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS 180
Query: 605 DKIDVYAFGVVLLELLTGRKPI 626
+ D+++ G+ L+E+ GR PI
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 424 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 476
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 477 KNIISLLGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 529
+NI+ +L C ED V Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+A + YLH + VIH+D+ + N ++ ++ + +++D L++ H +
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++A E + + + DV++FGV+L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 26/191 (13%)
Query: 454 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 569 GLAKWA--STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
G++ S ++S + GT Y++PE + D+++ G+ L+E+ GR PI
Sbjct: 145 GVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 627 SNDHPKGQESL 637
K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 430 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 591
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 592 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
+++PE G DV++FGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 49/206 (23%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
S +H+ + + +L++ D ++S F + + + + T + + + APE Y
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
+ DV++FG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)
Query: 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 482
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 483 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 534
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+A
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
PE K +D ++FGV+L E+L G+ P D
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVND 605
HRD+K N+L+SD E +L+DFGLA+ A + SH +V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 606 KIDVYAFGVVLLELLTG 622
+D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 31/233 (13%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 473
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 474 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 529
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ ALE+LH +++RD+K NILL + L+DFGL+K + T + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 590 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
Y+APE +GK +D ++ G+++ ELLTG P + + + +S V
Sbjct: 170 IEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 484
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 485 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++HRD+K N+L+S + +L DFG A+ S S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 602 KVNDKIDVYAFGVVLLELLTGR 623
+D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 474
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
YL +R++HRD+ + N+L+ +++DFGLAK ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E ++ + DV+++GV + EL+T G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 450 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 507
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 508 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 558
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGT----FGYLAPEYFMYGKVNDKIDVYAFGV 614
++ +++DFG+++ +S + V G ++A E + GK K DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 615 VLLELLT 621
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 429 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 481
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
R++HRD+ + N+L+ +++DFGLA+ + ++A E ++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKP 625
+ + DV+++GV + EL+T G KP
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 19/172 (11%)
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 513
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
++ ++ CT V GT Y+ PE + N+K D+++ G +L EL T + P
Sbjct: 150 LTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 479
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 480 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 533
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L +LH +I+RD+K N+LL + +L+D+G+ K T + GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYI 163
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI----SNDHP 631
APE +D +A GV++ E++ GR P +D+P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 446 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 501
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 620
+ ++ DFGLA+ + T T Y APE + + K + ++D+++ G + E+L
Sbjct: 146 DLKICDFGLAR---IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 621 TGRKPI--SNDH 630
G KP+ DH
Sbjct: 201 EG-KPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+LL D +L+D+G+ K T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 605 DKIDVYAFGVVLLELLTGRKP--ISNDHP 631
+D +A GV++ E++ GR P I D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNP 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 42/201 (20%)
Query: 446 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 495
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 496 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 549
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVND 605
+K SN+LL+ + + ++ DFGLA+ +TS T+ T Y APE + Y
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA-- 189
Query: 606 KIDVYAFGVVLLELLTGRKPI 626
IDV++ G + ELL GRKP+
Sbjct: 190 -IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 486 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+LL + +L+D+G+ K T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174
Query: 605 DKIDVYAFGVVLLELLTGRKPI----SNDHP 631
+D +A GV++ E++ GR P S+D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 56/189 (29%), Positives = 91/189 (48%), Gaps = 26/189 (13%)
Query: 446 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 497
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555
L L + K D F Y++ G L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF---LIYQILRG----LKYIHSAD---IIHRDLKPSNL 151
Query: 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGV 614
+++D E ++ DFGLA+ T T Y APE + + N +D+++ G
Sbjct: 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 615 VLLELLTGR 623
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKV 603
V+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDY 182
Query: 604 NDKIDVYAFGVVLLELLTGR 623
+ +ID++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 64/253 (25%), Positives = 103/253 (40%), Gaps = 52/253 (20%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 477 KNIISLLGFC-FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETI 111
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL----------------AKWASTSS 578
+ S IHRD+K N+LL +LSDFGL + ++
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 579 SHITCT--------------------DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 618
GT Y+APE F+ N + D ++ GV++ E
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231
Query: 619 LLTGRKPISNDHP 631
+L G P +D+P
Sbjct: 232 MLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 480 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEY 597
S IHRDVK N+LL +L+DFG K + C GT Y++PE
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR--CDTAVGTPDYISPEV 214
Query: 598 FM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ EYL S +++RD+K N+LL D +++DFG AK T ++ C
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLC--- 189
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
GT Y+APE + D + G+ + E+L G P + P
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 423 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 476
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 477 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 596 EYF---------MYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
E YG + D ++ GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 591
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 592 YLAPEY--FMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + K ID+++ G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 486
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
HRDVK +N+L++ + + +L DFG++ AS + ++I C Y+APE G N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMAPERIKSGGPN 179
Query: 605 DKI------DVYAFGVVLLELLTGRKP 625
DV++ G+ +LE+ GR P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 430 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+++RD+K N+LL D +LSD GLA T T AGT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP 170
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
+ +D +A G + E++ GR P + K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 541 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 595
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 596 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILK--PSED-----VIKEFVLEIEIITTLHHKNIIS 481
IG G VYK P G +A+K ++ +ED ++E L ++ + H NI+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66
Query: 482 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 535
L+ C + + LV++ + + L L K P +E K M L+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 123 FLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAP 176
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
E + +D+++ G + E+ RKP+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 545
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 604
+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 605 DKIDVYAFGVVLLELLTGR 623
+ID++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 25/124 (20%)
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 579
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K S +
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 580 -HITC-------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISN 628
HI V GT Y+APE + YGK +D +A G++L E L G P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFG 218
Query: 629 DHPK 632
D P+
Sbjct: 219 DTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 30/222 (13%)
Query: 429 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 481
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 482 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----Y 592
HS + IHR VK+S+ILLS D + LS + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 593 LAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
L+PE + G N+K D+Y+ G+ EL G P +
Sbjct: 175 LSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 543
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY------ 597
IH D+ N L+ D ++ D+GLA +IT A +LAPE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 598 -FMYGKVNDKIDVYAFGVVLLELLT-GRKPISN 628
+ K ++++ GV + EL T +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 486 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
D L LV+++ + L+ ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
V+HRD+K N+L++ + E +L+DFGLA+ + V T Y P+ K
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175
Query: 603 VND-KIDVYAFGVVLLELLTGRKPI 626
+ ID+++ G + EL +P+
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS----SSHITCTDVAG 588
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+ S + + + T+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 589 TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE + + IDV++ G +L ELL GRKP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 428 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 471
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 529
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG- 588
+ L LH +HRD+ +NI ++ +++DFGLA+ T +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 589 -----------TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE M K + +D+++ G + ELLTG KP+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
GT GY+APE + D +A G +L E++ G+ P K
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 481
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 482 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 535
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
E + +D+++ G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 504
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 505 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 557
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 558 SDDFE-----------------PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
S ++ DFGL+K S +C GT Y +PE ++
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 601 --GKVNDKIDVYAFGVVLLELLTGRKP 625
+DK D++A G ++ EL +G+ P
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 34/219 (15%)
Query: 430 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 478
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 539 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFG 591
++++H +V NIL+ + LSD G+ + +
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE---RVERI---P 169
Query: 592 YLAPEYFMYGKVNDKI--DVYAFGVVLLELLT-GRKPIS 627
++APE G+ + I D ++FG LLE+ + G +P+S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 485
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 486 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ NKK P + + + + YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 541 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 595
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 596 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 626
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 430 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 540
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+RV+HRD+K N+L+S+ E +L+DFGLA+ A + S +V T Y P+ +
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLL- 176
Query: 601 GKVN--DKIDVYAFGVVLLELLTGR 623
G +D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 69/260 (26%), Positives = 109/260 (41%), Gaps = 28/260 (10%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 453
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 454 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 509
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 510 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 570 LAKWASTSSSHITCTDVAGTFGYLAPEYF-------MYGKVNDKIDVYAFGVVLLELLTG 622
+ C GT Y++PE YG+ + D ++ GV L E+L G
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
Query: 623 RKPISNDHPKGQESLVMQSQ 642
P D G S +M +
Sbjct: 244 DTPFYADSLVGTYSKIMNHK 263
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 465 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 525 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S + T
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160
Query: 584 TDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
++ T Y P+ + + + ID++ G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 480
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 537
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS +I+RD+K NILL L+DFGL K T + GT YLAPE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEV 167
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ +D + G VL E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 430 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 481
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 535
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 591
YL +A++ +HRD+ + N +++ DF ++ DFG+ + I TD G
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 592 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE G D+++FGVVL E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 8/146 (5%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHV-LANNAIVDRDGKSSLLSLVKA--- 73
+V V V D S+ L WAL +A G T++ +HV +I GK + S K
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 74 --FDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS 131
+L Y FC+ K V + + + K +V + TK ++G + ++H
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 132 T--TSLAKYCAKKLSKDCSVLAVNNG 155
+ +A K+ C+V V+ G
Sbjct: 121 FKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-10
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 429 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 481
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 529
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW---------------- 573
+ EY+HS + V+HRD+K NILL E + D+G A +
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
SS + GT Y+APE + ++ D+YA GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 476
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S + V T Y P+
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 597 YFMYG-KVNDKIDVYAFGVVLLELLTGR 623
+ + +D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 429 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 480
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 481 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 532
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+EYL S++ IHRD+ + N +L+++ ++DFGL+K + + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
LA E DV+AFGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 447 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619
DFG+++ S T GT Y++PE + + K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 521
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+ +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 582 TCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPI 626
T V T Y APE + K + ID+++ G + ELLT +KP+
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNI--------I 480
IGKG +V + D + + A+K ++ + V + E+ TL + + I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 481 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEY 536
L F F+ L LV F++ G L +L G + + AE ALE
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALEN 108
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLA 594
LH + VI+RD+K NILL L DFGL K ++ C GT YLA
Sbjct: 109 LHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPEYLA 161
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE + +D + GV+L E+LTG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 47/256 (18%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTD--- 585
+ S IHRD+K N+LL +LSDFGL K A + +H +D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 586 ----------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 624 KPISNDHPKGQESLVM 639
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 462 KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKD 514
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 64 RELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD- 116
Query: 515 PAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFG
Sbjct: 117 ------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
LA+ A TS T T Y APE + + +D+++ G ++ E++ G
Sbjct: 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 483 LGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHS 539
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYLHS 114
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++RD+K NILL L+DFGL K + T + GT YLAPE
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLH 169
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ +D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 477
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 478 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTDVA- 587
+ + IHRD+K N+LL +LSDFGL K A + +H +D +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 588 ------------------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 624 KPISNDHPKGQESLVM 639
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 471
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 472 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 527 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA------- 571
+ E + YLH ++HRD+K++NIL+ + +++DFGLA
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 572 ---KWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRK 624
K + T++ T Y PE + Y +D++ G V E+ T R+
Sbjct: 170 PNPKGGGGGGTR-KYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFT-RR 224
Query: 625 PI 626
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 54/165 (32%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 485 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYF--- 598
+IHRDVK N+LL +L+DFG K T C GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYISPEVLKSQ 218
Query: 599 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 430 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 475
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 536 YLHSGSAQRVIHRDVKSSNILLS-----DDFEP--QLSDFGLAKWASTSSSHITCTDVAG 588
YL + ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---PITVLSRQECVE--- 170
Query: 589 TFGYLAPEYFMYGKV-NDKIDVYAFGVVLLEL-LTGRKPISN 628
++APE K + D ++FG L E+ G P+ +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 430 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 480
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 481 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH---ITCTDV 586
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH ++ V
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 587 AGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641
T Y +P + ID++A G + E+LTG+ + H Q L+++S
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 70/239 (29%)
Query: 447 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 500
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 501 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 520
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 521 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLT 621
++ DFGLA+ ++ D ++APE ++ KV + DV++FGV+L E+ +
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 29/167 (17%)
Query: 467 EIEIITTLHHKNIISLLGFCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 520
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 521 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 171
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
T+ ++ T T Y APE + + +D+++ G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 17/192 (8%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 501
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF L
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
+ +L G + + + L+Y+H+ +IHRD+K N+ +++D
Sbjct: 100 PFMGTDL-GKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDC 155
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 620
E ++ DFGLA+ + T T Y APE + + +D+++ G ++ E+L
Sbjct: 156 ELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210
Query: 621 TGRKPI--SNDH 630
TG KP+ +DH
Sbjct: 211 TG-KPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 11/181 (6%)
Query: 445 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 500
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
++ D G+A+ + + + GT Y++PE F N K DV+A G + E+
Sbjct: 139 NIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 621 T 621
T
Sbjct: 197 T 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-- 581
V A + LE LH +R+++RD+K NILL D ++SD GLA I
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPE 154
Query: 582 --TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T GT GY+APE + D + G ++ E++ G+ P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 445 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 494
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 553
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 554 NILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYA 611
N+L++ + ++ DFGLA S H+T V T Y APE M + +D+++
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWS 190
Query: 612 FGVVLLELLTGR 623
G + ELL R
Sbjct: 191 VGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182
Query: 594 APEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
APE + + N +D+++ G ++ ELL G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 430 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 539
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 540 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
RV+HRD+K N+L+ +L+DFGLA+ T V T Y APE
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEIL 175
Query: 599 MYGK-VNDKIDVYAFGVVLLELLTGRKPI 626
+ + + +D+++ G + E++ +KP+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ A + LE LH + ++RD+K NILL D ++SD GLA S
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 525
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 526 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ A + LE L +R+++RD+K NILL D ++SD GLA T
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT GY+APE K D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 430 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 484 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 535
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
YL S++ IHRD+ + N +L+++ ++DFGL+K + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E K DV++FGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 471 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+AE + +HS +HRD+K N+LL + +L+DFG + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 590 FGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y++PE GK + D ++ GV + E+L G P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 430 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 484
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 538
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+ IH D+ N LL+ D ++ D+GL+ ++T + ++APE
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 599 --MYGK--VNDKI---DVYAFGVVLLELLT-GRKP 625
++G V D+ +V++ GV + EL G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 446 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 501
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 558
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLL 617
+D E ++ DFGLA+ A T T Y APE + + N +D+++ G ++
Sbjct: 152 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 618 ELLTGR 623
E+LTG+
Sbjct: 207 EMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 521
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
C +GT +PE K D+++ G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 61/262 (23%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 476
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA--------------------- 571
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 572 ------KWASTSSS------------HITCT--DVAGTFGYLAPEYFMYGKVNDKIDVYA 611
+W+ H C + GT Y+APE + D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 612 FGVVLLELLTGRKPISNDHPKG 633
GV+L E+L G+ P D P
Sbjct: 230 VGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++ D
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV++FGV+L E+ + G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 465 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A+ I
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINA 237
Query: 584 TDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
AGT APE +D+++ G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 467 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 522
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 174
Query: 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620
T T Y APE + + +D+++ G ++ E++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 430 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 482
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 539
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+ S+++ +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV+++G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-07
Identities = 27/137 (19%), Positives = 47/137 (34%), Gaps = 9/137 (6%)
Query: 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSV 77
++V V S L WA + G ++ LHV+ + L +A +
Sbjct: 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARA---L 57
Query: 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST--TSL 135
L V ++ + G IL A+ A ++G+ +R S+
Sbjct: 58 LEALREALAEAGVKVETVVLEGDPAEAIL-EAAEELGADLIVMGSRG-RSGLRRLLLGSV 115
Query: 136 AKYCAKKLSKDCSVLAV 152
A+ + C VL V
Sbjct: 116 AERVLRHAP--CPVLVV 130
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 191
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
APE + + +D+++ G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 431 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 488
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 489 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+H D+ N L+ D ++ D+G+ T D +LAPE + G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGE 175
Query: 603 VNDKI---------DVYAFGVVLLELL-TGRKPISN 628
+ + +V+A GV L EL +P S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
N++ L + ++++ LV G L ++ P +R+ M VA L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA--LDAL 101
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + ++ RD+ +NILL D QL+ F +W+ S C A Y APE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEV 153
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
+ + D ++ G +L ELLTG K + HP G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/173 (29%), Positives = 75/173 (43%), Gaps = 46/173 (26%)
Query: 471 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL-------EENLHGNKKDPAAFGWSE 522
IT LH + F+D NNL LV D+ G L E+ L +D A F
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARF---- 106
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG----LAKWASTSS 578
Y +AE + + S +HRD+K N+LL + +L+DFG L + S
Sbjct: 107 -Y-----LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160
Query: 579 SHITCTDVA-GTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ VA GT Y++PE G+ + D ++ GV + E+L G P
Sbjct: 161 N------VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKPSEDVIKE----FVLEIEIITTLHHK 477
+F +IG+G +V L + K A+KIL E + + F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSL-------EENLHGNKKDPAAFGWSERYKVAMGV 530
I +L ++NNL LV D+ G L E+ L +D A F +E +A+
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL---PEDMARFYLAEMV-IAIDS 117
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
L Y +HRD+K NIL+ + +L+DFG + + + GT
Sbjct: 118 VHQLHY---------VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 591 GYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKP 625
Y++PE GK + D ++ GV + E+L G P
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV++FGV+L E+ + G P
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 618
+AGT APE +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 484
LI + + +YKG + KE+ ++ K + +I EI+ + + NI+ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 485 FCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
F + + L L+ ++ +RG L E L K + + +A+ + L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF-- 598
+ + ++++ S + L++++++ ++ GL K S+ +V Y + +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLND 194
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISN 628
++ + K D+Y+ GVVL E+ TG+ P N
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 63/255 (24%), Positives = 102/255 (40%), Gaps = 59/255 (23%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHH 476
S F+ +G G +V C D L A+K L+ + + + E +I+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 477 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
+ ++ L + F+D +NL V D++ G + L + P R+ +A + A+E
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAE-LTLAIE 115
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHI------ 581
+H IHRD+K NIL+ D +L+DFGL +W S SHI
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 582 -----------TCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVY 610
C D + GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 611 AFGVVLLELLTGRKP 625
+ GV+L E+L G+ P
Sbjct: 233 SVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S+++ +
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV+++G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S + +HRD+ + N+L+ + ++ DFGLA+ S++I+
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE DV++FG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 477
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 538 HSGSAQRVIHRDVKSSNILL 557
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-05
Identities = 23/138 (16%), Positives = 48/138 (34%), Gaps = 4/138 (2%)
Query: 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDS 76
+ ++V V S L WAL + G +I LHV+ + +
Sbjct: 3 KRILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 77 VLAVYEGFCNLKQVDLKLK-ICRGTSIRKILVREAQSYSATKFIVGT-AKNHHTIRSTTS 134
+ + ++ + RG + ++ A+ A ++G+ ++ S
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMGSRGRSGLRRLLLGS 122
Query: 135 LAKYCAKKLSKDCSVLAV 152
+A+ + C VL V
Sbjct: 123 VAEKVLRHAP--CPVLVV 138
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 59/209 (28%)
Query: 483 LGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
L + F+D +NL V D++ G SL + +D A F +E + A+E +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-------LTCAVESVH 118
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTS------------------ 577
IHRD+K NIL+ D +L+DFGL +W S
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 578 ----SSHITCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFG 613
++ C D + GT Y+APE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 614 VVLLELLTGRKPISNDHPKGQESLVMQSQ 642
V+L E+L G+ P P + V+ Q
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQ 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 517 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS GL
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
Query: 575 STSSS-------HITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKP 625
S + H +L+PE + K D+Y+ G+ EL G P
Sbjct: 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 626 ISNDHPKGQ 634
D P Q
Sbjct: 210 F-KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 484
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 485 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 534
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ H V+HRD+K N+L+ +++D GL + S T V T Y
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 594 APEYFMYGK-VNDKIDVYAFGVVLLELLTG 622
APE + + +D+++ G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 486
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWA 574
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 69/265 (26%)
Query: 423 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 475
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 476 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 531
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 572
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 573 ----------------WASTSSSHITCT----------DVAGTFGYLAPEYFMYGKVNDK 606
+ SS T GT Y+APE F+ +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 607 IDVYAFGVVLLELLTGRKPISNDHP 631
D ++ G ++ E L G P +++
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 444 PDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500
P G + V+I +E+ +K E+ + H NI++ + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 501 RGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558
GS L K G SE + G L YLH IHR++K+S+IL+S
Sbjct: 83 YGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 559 DDFEPQLSDFG-LAKWASTSSSHITCTDV----AGTFGYLAPEYF---MYGKVNDKIDVY 610
D LS L D +L+PE +YG N K D+Y
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIY 194
Query: 611 AFGVVLLELLTGRKPISNDHPKGQ 634
+ G+ EL TGR P D + Q
Sbjct: 195 SVGITACELATGRVPFQ-DMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
VA +E+L S + +HRD+ + N+LL+ ++ DFGLA+ S++++
Sbjct: 246 VARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 590 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++APE DV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 444 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 500
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 501 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--GTFGYLAPEYFMYGKVNDKIDVYAF 612
I L+ D + L DFG A D GT +PE + D+++
Sbjct: 298 IFLNCDGKIVLGDFGT---AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 613 GVVLLELLT 621
G++LL++L+
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 21/59 (35%), Positives = 36/59 (61%), Gaps = 3/59 (5%)
Query: 449 LAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
+AVK+LK S D + + E++I++ L HKNI++LLG C +L++ ++ G L
Sbjct: 71 VAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 7/70 (10%)
Query: 437 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496
QV++ L DG+E+AVK+ +P V K +++++ K + +L F +L +
Sbjct: 26 QVHRAVLKDGEEVAVKVQRP--GVKKRIRSDLKLL-----KFLAKILKKFFPGFDLDWLV 78
Query: 497 DFLSRGSLEE 506
D + +E
Sbjct: 79 DEFRKSLPQE 88
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 643 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.7 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.65 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.64 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.63 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.44 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.35 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.33 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.0 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.93 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.76 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.52 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.5 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.38 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.11 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.07 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.86 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.51 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.45 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.23 | |
| PLN02236 | 344 | choline kinase | 97.18 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.03 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.61 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=408.47 Aligned_cols=230 Identities=51% Similarity=0.892 Sum_probs=206.9
Q ss_pred cccccChHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhH-HHHHHHHHHHHHhcCCCceeEEEeEE
Q 006480 408 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 486 (643)
Q Consensus 408 ~~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~ 486 (643)
..+.|++.++..+|++|...+.||+|+||.||+|.+++|+.||||.+...... .++|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 57789999999999999999999999999999999999999999998876544 67799999999999999999999999
Q ss_pred EeCC-eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 487 ~~~~-~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
.+.+ +.+||||||++|+|.++|+..... +++|..|++|+.++|+||+|||..+..+||||||||+|||||+++.+||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999976543 7899999999999999999999987678999999999999999999999
Q ss_pred eecCccccccC-CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 566 SDFGLAKWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 566 ~DFGla~~~~~-~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
+|||+|+..+. ...... ...||.+|+|||++..+..+.|+|||||||+|+||+||+.|++...+.+...++.|.
T Consensus 219 sDFGLa~~~~~~~~~~~~--~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVST--TVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred cCccCcccCCccccceee--ecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 99999977665 222111 117999999999999999999999999999999999999999987766777777774
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=375.36 Aligned_cols=213 Identities=29% Similarity=0.445 Sum_probs=192.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.++||+|+||+||.+.. ++++.||+|++++.. ...+....|..||..++||+||+++-.|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45789999999999999999975 478899999998754 3456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
+||+.||.|...|+..+ .|++..+..++.+|+.||.|||+ ++||||||||+|||||++|+++|+||||++..-
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999997654 59999999999999999999999 999999999999999999999999999998544
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.... ...+++||+.|||||++.+..|+..+|+|||||++|||++|.+||.+.+.+.....|.+++
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 4322 2334799999999999999999999999999999999999999999999999999888765
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=374.81 Aligned_cols=212 Identities=29% Similarity=0.511 Sum_probs=191.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..+|.+.+.||+|+|++||+|.+. ++..||||.+... ....+.+..||.||+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 457888888999999999999865 7899999998654 355677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC------CcEEEeecCc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFGL 570 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~------~~vkL~DFGl 570 (643)
|||.||+|.++|+..+ .+++..++.++.||+.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998764 58999999999999999999999 999999999999999865 5689999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
|+.+.... ...+.+|++.|||||+++.++|+.|+|+||+|+|||||++|++||...+++++...+.++.
T Consensus 162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~ 230 (429)
T KOG0595|consen 162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN 230 (429)
T ss_pred hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc
Confidence 99888543 3345799999999999999999999999999999999999999999999998888777664
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=349.82 Aligned_cols=210 Identities=28% Similarity=0.423 Sum_probs=193.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.....||.|+||.|.++..+ +|..||+|++++.. .......+|..+|+.+.||+++++++.|.+.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999855 78899999998764 34556788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||.+||.|..+|+..+ .|++..++.++.||+.||.|||+ ++|++|||||+|||||.+|++||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 9999999999997654 58999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
. +.+.||||.|+|||++....|+..+|+|||||++|||+.|.+||.+.++-.+.+.|..|++
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence 3 3457999999999999999999999999999999999999999999999999999998864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=372.79 Aligned_cols=213 Identities=29% Similarity=0.482 Sum_probs=195.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..|...+.||+|||..||.+.. .+|..||+|++.+ .....+.+.+||+|.+.|+|||||+++++|.+.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999987 7999999999976 4566788999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|+|.+++|.++++.. .++++.+++.++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999743 469999999999999999999999 9999999999999999999999999999987765
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
.... -.++||||.|+|||++.....+..+||||+|||||.||.|++||...+-++..+.|..+.|
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y 235 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY 235 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc
Confidence 4222 2347999999999999999999999999999999999999999999999999999988765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=353.76 Aligned_cols=220 Identities=28% Similarity=0.409 Sum_probs=196.1
Q ss_pred cCcccceeeeecCceEEEEEE-eCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEe-EEEeCCe-EEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g-~~~~~~~-~~LV 495 (643)
.+|.+.+.||+|.||.||++. +.+|..+|.|.++-. .....++..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 458889999999999999995 669999999998743 345678999999999999999999999 4555555 8999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCC-CCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
|||+.+|+|...++..++....+++..+|+++.|++.||..+|+.-+ .-|+||||||.||+|+.+|.+||.||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999999887778899999999999999999999998432 34899999999999999999999999999988
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
..... .....+|||+||+||.++..+|+.|+|||||||++|||+.-++||.+++-..+...|.++.|
T Consensus 179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 76543 34457999999999999999999999999999999999999999999988888888888765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=364.16 Aligned_cols=213 Identities=29% Similarity=0.472 Sum_probs=185.2
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh--------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.. .......+|++||++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 45688899999999999999974 589999999997532 122345699999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeec
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDF 568 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DF 568 (643)
.|+||||+.||+|.+.+-.++ .+.+..-..++.||+.|+.|||+ +||+||||||+||||..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999997765 46677778899999999999999 999999999999999866 88999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCChhh-HHHhhhccCC
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMQSQF 643 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~-~~~li~~~~f 643 (643)
|+|+...... .+.+.|||+.|.|||++.... +..++||||||||||-+|+|.+||....-.- +...|.+|+|
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 9999887433 455689999999999998664 3348899999999999999999999876444 8899999887
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.81 Aligned_cols=217 Identities=24% Similarity=0.349 Sum_probs=190.9
Q ss_pred HHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 418 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 418 ~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
....++|.++..||+|+||.||++.. .+|..+|+|++++++ ...+....|-+||...++|+||+|+-.|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44678899999999999999999975 489999999999875 3456788899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
||||||++||++..+|... ..|+++.+++++.+++.|+.-||+ +|+|||||||+|+|||..|++||+||||+.
T Consensus 217 YLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999755 469999999999999999999999 999999999999999999999999999984
Q ss_pred cccC--------------------CCCCcc-------------------------ccCCCCCCCccCcccccCCCCCchh
Q 006480 573 WAST--------------------SSSHIT-------------------------CTDVAGTFGYLAPEYFMYGKVNDKI 607 (643)
Q Consensus 573 ~~~~--------------------~~~~~~-------------------------~~~~~gt~~Y~APE~l~~~~~s~ks 607 (643)
-+.. ...... ....+|||.|||||+|++..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 2211 000000 1124799999999999999999999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 608 DVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 608 DIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
|+||||||+||||.|.+||.+++|.+....|+.-
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999999999999887653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.80 Aligned_cols=217 Identities=29% Similarity=0.423 Sum_probs=194.2
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 493 (643)
...+|.+.+.||+|+|++||+|.. .+++.||||++.+. +...+.+..|-++|.+| .||.|++|+-.|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 456788999999999999999975 48899999999763 34456677899999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+|+||+++|+|.++|+..+ .|++.-.+.++.+|+.||+|||+ +|||||||||+||||+.|+++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999998764 58999999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCC-----------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSH-----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~-----------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
+...... ..+..++||..|.+||++..+..++.+|||+||||||+|+.|++||.+.+..-..+.|+.-+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 7654322 11245899999999999999999999999999999999999999999999999999888765
Q ss_pred C
Q 006480 643 F 643 (643)
Q Consensus 643 f 643 (643)
|
T Consensus 304 y 304 (604)
T KOG0592|consen 304 Y 304 (604)
T ss_pred c
Confidence 4
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=348.68 Aligned_cols=195 Identities=28% Similarity=0.467 Sum_probs=178.3
Q ss_pred ccceeeeecCceEEEEEEeC-CCCEEEEEEe--CCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-eEEEEEeeCC
Q 006480 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLS 500 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~ 500 (643)
...+.||+|+.|+||++.++ +++.+|+|++ ..+....+++.+|++|++..+|||||.+||+|+.++ .+.++||||.
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 35678999999999999865 7889999999 345677899999999999999999999999999998 4999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|++++... ..+++...-.|+.+|++||.|||+ .++||||||||+|||++..|++||||||.++.+..+
T Consensus 162 gGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 162 GGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999765 358999999999999999999995 288999999999999999999999999999877664
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.+..++||..|||||.+++..|+.++||||||++++||.+|+.||...
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 456689999999999999999999999999999999999999999885
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.66 Aligned_cols=203 Identities=35% Similarity=0.588 Sum_probs=178.0
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-eEEEEEeeCCC
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSR 501 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~LV~E~~~~ 501 (643)
+.+.||.|+||+||+|.+.....||||++.... ...++|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999544449999998643 23679999999999999999999999999877 79999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCEEEcCCC-cEEEeecCccccccCCCC
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~~ 579 (643)
|+|.++++.. ....+++..++.++.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 125 GSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999874 23579999999999999999999999 66 99999999999999998 99999999998776532
Q ss_pred CccccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 580 HITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+..+-...
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~ 255 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA 255 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 2333468999999999999 669999999999999999999999999999874333
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.02 Aligned_cols=212 Identities=25% Similarity=0.412 Sum_probs=188.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 492 (643)
...++|.+.++||+|.||+|+++..+ +++.||||++++. .+.....+.|.+|+...+ ||+++.|+..|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34568999999999999999999865 7789999999985 356677888999998885 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|+||||+.||++..+.+. ..|++..+..|+++|+.||+|||+ ++|||||||.+|||||.+|++||+||||++
T Consensus 445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 999999999994444332 469999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
...... ....+++|||.|||||++.+..|+..+|+|||||+|||||.|+.||.+++.++....|+.
T Consensus 517 e~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred ccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 654322 244568999999999999999999999999999999999999999999999988887764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=345.30 Aligned_cols=215 Identities=27% Similarity=0.400 Sum_probs=191.7
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC-----h-hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-----E-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~-----~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 491 (643)
..++|.+.+.||+|+||+|++|.. .+|..||+|++... . ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999975 47899999987653 1 24556678999999999 9999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGL 570 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGl 570 (643)
+++||||+.||+|.+++... ..+.+.++..++.|++.|++|||+ ++|+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999863 368889999999999999999999 999999999999999999 9999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
+.... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+...|..++|
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF 240 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence 98774 1223445679999999999999887 86 789999999999999999999999999999999998876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=327.72 Aligned_cols=209 Identities=28% Similarity=0.378 Sum_probs=185.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.|....++|+|+||.||++.++ +|+.||||.+..++ ...+-.++||++|++++|||+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667789999999999999865 79999999997654 3566788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+...-| +-|.. .+..++.+.+.+++.|+++|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+...
T Consensus 83 ~dhTvL-~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 83 CDHTVL-HELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred cchHHH-HHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 987444 44443 33568899999999999999999999 89999999999999999999999999999988752
Q ss_pred CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
...+++.+.|..|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+.++-+|..+|++
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 235567889999999999987 7899999999999999999999999999999999888875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=340.93 Aligned_cols=211 Identities=29% Similarity=0.427 Sum_probs=187.0
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV 495 (643)
+.|..++.||+|.||.||+|.+ .+|+.||+|.++.+ +.......+||.||++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3466678999999999999974 58999999998754 34566788999999999999999999998876 689999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
+|||++ +|.-++.... ..|++.++..++.|++.||.|+|. ++|+|||||.+|||||++|.+||+|||||+++.
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999987 8988886433 579999999999999999999999 999999999999999999999999999999877
Q ss_pred CCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
..... .++..+-|..|+|||++.+. .|+..+|+||.||||.||++|++.|.+.+.-+|..+|.+
T Consensus 270 ~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk 334 (560)
T KOG0600|consen 270 PSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK 334 (560)
T ss_pred CCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH
Confidence 65433 36677889999999999865 799999999999999999999999999999888888764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=344.95 Aligned_cols=212 Identities=29% Similarity=0.490 Sum_probs=189.1
Q ss_pred ccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
..++.||+|-||.||.|.++....||+|.++........|.+|+++|++|+|+|||+++++|..++.+|||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 35678999999999999997777999999998877778999999999999999999999999998899999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.++|... ....+...+.+.++.|||+|++||++ +++|||||..+|||++++..+||+|||||+....+ .+....
T Consensus 289 l~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~ 362 (468)
T KOG0197|consen 289 LDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASE 362 (468)
T ss_pred HHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCC-ceeecC
Confidence 9999862 23578899999999999999999999 99999999999999999999999999999944332 222222
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
..--...|.|||.+..++++.|+|||||||+||||+| |+.||.+.+..+....|.+|.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~Gy 421 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGY 421 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccC
Confidence 2334567999999999999999999999999999999 999999999999999988874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.20 Aligned_cols=208 Identities=29% Similarity=0.445 Sum_probs=187.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|.||.||||..+ +.+.||+|.+.+. +...+.+.+|++|++.++||||+.++++|....++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 47888999999999999999865 7788999999764 3556778999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.| +|..+|... ..++++.++.++.+++.||.|||+ .+|+|||+||.||||..++.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 999999754 468999999999999999999999 99999999999999999999999999999988763
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
. ...+.+.|||.|||||++.++.|+..+|+||||||+|||++|++||...+...+...|.
T Consensus 154 t--~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 154 T--SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred c--eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 3 23456789999999999999999999999999999999999999999987766666654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=337.80 Aligned_cols=212 Identities=26% Similarity=0.388 Sum_probs=183.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||++... +++.||+|+++... .....+..|++++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999754 68899999997532 34456788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999754 358999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCC---------------------------------CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC
Q 006480 577 SSS---------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623 (643)
Q Consensus 577 ~~~---------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~ 623 (643)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHhhhc
Q 006480 624 KPISNDHPKGQESLVMQ 640 (643)
Q Consensus 624 ~Pf~~~~~~~~~~li~~ 640 (643)
.||.+.++......|+.
T Consensus 234 ~Pf~~~~~~~~~~~i~~ 250 (363)
T cd05628 234 PPFCSETPQETYKKVMN 250 (363)
T ss_pred CCCCCCCHHHHHHHHHc
Confidence 99999888776666653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=308.83 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=187.2
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+|...+.||+|.||.||+|++ .+|+.||||.++..+ ......++||..|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3577788999999999999985 489999999998643 235678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
||+. +|+..++... ..++...+..++.++++||+|||. +.|+||||||.|+||+.+|.+||+|||+|+.....
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9976 9999997543 678999999999999999999999 99999999999999999999999999999988765
Q ss_pred CCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
..... ..+-|..|+|||.+.+. .|+..+|+||.|||+.||+-|.+.|.++++-+|...|.++
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 44332 23789999999998855 6999999999999999999999999999998888888653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.39 Aligned_cols=208 Identities=27% Similarity=0.380 Sum_probs=183.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999865 78999999996532 34566889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997543 58899999999999999999999 9999999999999999999999999999986643
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+..+
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 21 2346999999999999999999999999999999999999999998877766666544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.17 Aligned_cols=208 Identities=27% Similarity=0.411 Sum_probs=184.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++.+++.+++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57889999999999999999865 68899999997542 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+.+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999754 357889999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+..+
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 230 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Confidence 22 2347999999999999999999999999999999999999999998877666666544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.01 Aligned_cols=211 Identities=26% Similarity=0.391 Sum_probs=182.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +|+.||||+++.. ......+.+|++++..++||||++++++|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999865 7899999999753 234566788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999754 258999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCc------------------------------------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 006480 577 SSSHI------------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (643)
Q Consensus 577 ~~~~~------------------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLl 620 (643)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11100 111246999999999999999999999999999999999
Q ss_pred cCCCCCCCCChhhHHHhhh
Q 006480 621 TGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 621 tG~~Pf~~~~~~~~~~li~ 639 (643)
+|+.||.+.++......++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~ 252 (364)
T cd05599 234 VGYPPFCSDNPQETYRKII 252 (364)
T ss_pred cCCCCCCCCCHHHHHHHHH
Confidence 9999999888766555443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.38 Aligned_cols=213 Identities=28% Similarity=0.349 Sum_probs=184.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||.|.-|+||++.+. ++..+|+|++.+.. +...+...|-+||+.++||++..||..|..+...||+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 45677889999999999999876 45889999998753 45677888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|||+||+|..+++.+.. ..|++..++.++.+++.||+|||. .|||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999986554 679999999999999999999999 9999999999999999999999999998743211
Q ss_pred C---------------------------------CC---------------------CccccCCCCCCCccCcccccCCC
Q 006480 577 S---------------------------------SS---------------------HITCTDVAGTFGYLAPEYFMYGK 602 (643)
Q Consensus 577 ~---------------------------------~~---------------------~~~~~~~~gt~~Y~APE~l~~~~ 602 (643)
. .. ......++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 00 01112367999999999999999
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 603 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 603 ~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.+.++|+|+|||+|||||.|..||.+.+.+....-|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv 348 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV 348 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh
Confidence 9999999999999999999999999998877665554
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=334.58 Aligned_cols=211 Identities=26% Similarity=0.363 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+++++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999754 78999999986532 34567888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999654 358899999999999999999999 9999999999999999999999999999863221
Q ss_pred CCCC---------------------------------------------ccccCCCCCCCccCcccccCCCCCchhHHHH
Q 006480 577 SSSH---------------------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 611 (643)
Q Consensus 577 ~~~~---------------------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 611 (643)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 612 FGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 612 lGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|||++|||++|++||.+.++......+.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999887765554443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=333.87 Aligned_cols=207 Identities=24% Similarity=0.361 Sum_probs=177.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.|...+.||+|+||+||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6888999999999999999754 78899999997532 345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999997543 58889999999999999999999 99999999999999999999999999997543110
Q ss_pred CC---------------------------------------------CccccCCCCCCCccCcccccCCCCCchhHHHHH
Q 006480 578 SS---------------------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612 (643)
Q Consensus 578 ~~---------------------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSl 612 (643)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChhhHHH
Q 006480 613 GVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 613 Gvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
||++|||++|+.||...++.....
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~ 258 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQL 258 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHH
Confidence 999999999999999877655433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=319.95 Aligned_cols=216 Identities=28% Similarity=0.443 Sum_probs=186.9
Q ss_pred hcCcccceeeeecCceEEEEEE-eCCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+.|.+.+.||.|..++||+|. .+.+..||||++.-+ ....+.+.+|+..++.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578899999999999999996 568899999999754 3457889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
||.+|++.+++...-. ..|.+..+..|++++++||.|||+ +|.||||||+.||||+.+|.+||+|||..-.+...
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986543 559999999999999999999999 99999999999999999999999999987655443
Q ss_pred CCC-c-cccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 578 SSH-I-TCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 578 ~~~-~-~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
... . ...+++||++|||||+++ ...|+.|+||||||++.+||.+|+.||....|-.+.-+-+++
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn 247 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN 247 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 221 1 114579999999999976 447999999999999999999999999998875544443333
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=327.37 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=182.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|.+. +++.||+|+++... .....+..|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999875 68899999997532 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999654 358899999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...++......+.
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 211 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHH
Confidence 2234579999999999999999999999999999999999999999888766555443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.72 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.|...+.||+|+||.||++.. .+|+.||+|.+.... .....+.+|++++.+++|+||++++++|.+++.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999975 478999999986532 223467889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+.+..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988864322 358999999999999999999999 99999999999999999999999999999865432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 2 12335799999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.40 Aligned_cols=209 Identities=24% Similarity=0.338 Sum_probs=178.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
+|...+.||+|+||.||+|... +++.||+|++.... .....+.+|++++++++||||+++++.|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999864 78899999997542 345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999999654 257889999999999999999999 89999999999999999999999999997532110
Q ss_pred C---------------------------------------------CCccccCCCCCCCccCcccccCCCCCchhHHHHH
Q 006480 578 S---------------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 612 (643)
Q Consensus 578 ~---------------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSl 612 (643)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123479999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 613 GVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 613 Gvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
||+||||++|++||.+.++......+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i 260 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKV 260 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999999988776554443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=327.67 Aligned_cols=209 Identities=25% Similarity=0.370 Sum_probs=183.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. ++..||+|++... ......+.+|++++..++||||+++++++.+.+.+++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356889999999999999999754 3368999998643 2345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997543 58899999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+..+
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 432 12357999999999999999999999999999999999999999998877666666554
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.87 Aligned_cols=210 Identities=25% Similarity=0.343 Sum_probs=179.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+++|+.++||||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 68999999997532 23456889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|.....
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999654 357888999999999999999999 9999999999999999999999999999753210
Q ss_pred CC-----------------------------------------CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 006480 577 SS-----------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 615 (643)
Q Consensus 577 ~~-----------------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvv 615 (643)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113579999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChhhHHHhh
Q 006480 616 LLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 616 l~eLltG~~Pf~~~~~~~~~~li 638 (643)
+|||++|+.||.+.++......+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i 256 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKV 256 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHH
Confidence 99999999999988776554433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.48 Aligned_cols=204 Identities=28% Similarity=0.395 Sum_probs=177.1
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
+.||+|+||.||++... +|+.||+|+++.. ......+..|+++++.++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999764 7899999999753 234457888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 999998654 358899999999999999999999 899999999999999999999999999987543221 12
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 2335799999999999999999999999999999999999999998876665555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=332.17 Aligned_cols=216 Identities=25% Similarity=0.343 Sum_probs=185.5
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
.+....++|.+.+.||+|+||.||++... +++.+|+|++.+.. .....+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999865 68899999986422 23456788999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+|+||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998643 37888999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
+....... ...+....||+.|+|||++... .++.++|||||||+||||++|+.||.+.+..+....|+.
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~ 261 (370)
T cd05621 189 CMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261 (370)
T ss_pred ceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 98664322 2233456799999999999754 378999999999999999999999999887777666654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.75 Aligned_cols=208 Identities=26% Similarity=0.461 Sum_probs=185.3
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhH-HHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.|..-..||+|+.|.||.+.. .+++.||||.+...... ..-+++|+.+|+.++|+|||.+++.|...+.+|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 466668899999999999974 47889999999765543 4457799999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
||+|.+.+... .+++.++..|+++++.||.|||. ++|||||||.+|||++.+|.+||+|||++..+.....
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999998654 38999999999999999999999 9999999999999999999999999999987765443
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.-...+||++|||||++....|++|+||||||++++||+-|++||-+++|-.-..||..
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ 483 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 483 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence 33457899999999999999999999999999999999999999999988776666643
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.88 Aligned_cols=212 Identities=24% Similarity=0.415 Sum_probs=192.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
-+|.+.+.||+|.||.|-+|.. ..|+.||||.++++ +...-.+.+||+||..|+||||++++++|...+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577888999999999999975 68999999999864 345567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||..+|.|.+++...+ .+++.+++.+++||..|+.|+|+ ++++|||||.+|||||+++.+||+||||+.++..
T Consensus 133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999997654 59999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
.. ...++||.+-|.+||++.+..|. +.+|-|||||+||.|+.|..||++.+.+.+...|..|-|
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY 270 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY 270 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc
Confidence 43 33457999999999999999884 789999999999999999999999999999988888765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=321.19 Aligned_cols=208 Identities=27% Similarity=0.398 Sum_probs=178.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----eEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~LV~ 496 (643)
.|...+++|.|+||.||+|... +++.+|||..-++....+ +|+.+|+.++|||||+|+-+|.... .+.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4667899999999999999864 678999998876654333 5999999999999999999987532 456899
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCcccccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 575 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~~~ 575 (643)
|||+. +|.+.++........++...+.-+..||++||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99976 9999998544444567888889999999999999999 999999999999999976 999999999999887
Q ss_pred CCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
....... ..-|..|+|||.+.+. .|+.++||||.|||+.||+-|++-|.+++..+|..+|.+
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 7655443 3568899999998855 799999999999999999999999999999999888864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.13 Aligned_cols=208 Identities=25% Similarity=0.449 Sum_probs=175.1
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC-C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 490 (643)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|++++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46789999999999999999963 24567999999753 23456789999999999 899999999998764 4
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCC--------------------------------------------------------
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 514 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 514 (643)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998753210
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCc
Q 006480 515 --PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592 (643)
Q Consensus 515 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y 592 (643)
...+++.++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1358889999999999999999999 89999999999999999999999999999865443332222334567889
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 593 ~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 99999999999999999999999999997 9999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=329.72 Aligned_cols=209 Identities=24% Similarity=0.366 Sum_probs=185.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHH--HHHHHHHHhcC-CCceeEEEeEEEeCC-eEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~--~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~LV 495 (643)
-++|.+.+.||.|.||.||+|.. .+|..||||.++..-....+. ++|+..|++|+ ||||++|.+++.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45788999999999999999984 488999999998754444443 47999999999 999999999999988 99999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
||||+. +|.++++.+ ...|++..++.|+.||++||+|+|+ +|++||||||+|||+.....+||+|||||+...
T Consensus 89 fE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999955 999999865 3689999999999999999999999 999999999999999988899999999999776
Q ss_pred CCCCCccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
... .+++.+.|..|+|||++. .+-|+.++||||+|||++|+.+-++-|.+.+.-++...|-
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc 223 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC 223 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH
Confidence 554 345578999999999876 6689999999999999999999999999999888877663
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.44 Aligned_cols=204 Identities=28% Similarity=0.409 Sum_probs=176.8
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
+.||+|+||.||++... +|+.||+|+++.. ......+..|+++++.++||||++++++|...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 234556788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 999988654 358999999999999999999999 899999999999999999999999999987532221 12
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~ 209 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 2345799999999999999999999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.09 Aligned_cols=218 Identities=26% Similarity=0.337 Sum_probs=187.4
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
+.++....++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999865 78899999986422 234567889999999999999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
++.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998643 37888899999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|++........ .......||+.|+|||++... .++.++|||||||++|||++|+.||.+.+.......|+.
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 261 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99986643221 223346799999999998754 388999999999999999999999999888777776654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=328.41 Aligned_cols=211 Identities=26% Similarity=0.387 Sum_probs=182.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.||+|+++.. ......+..|++++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 7899999999753 234567888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999654 358899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCC---------------------------------CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCC
Q 006480 577 SSS---------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623 (643)
Q Consensus 577 ~~~---------------------------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~ 623 (643)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHhhh
Q 006480 624 KPISNDHPKGQESLVM 639 (643)
Q Consensus 624 ~Pf~~~~~~~~~~li~ 639 (643)
+||.+.++......++
T Consensus 234 ~Pf~~~~~~~~~~~i~ 249 (360)
T cd05627 234 PPFCSETPQETYRKVM 249 (360)
T ss_pred CCCCCCCHHHHHHHHH
Confidence 9999988776655554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.81 Aligned_cols=203 Identities=28% Similarity=0.373 Sum_probs=177.0
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||+|+||.||++... +++.||+|+++.. ......+..|++++.+++||||++++++|...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999865 6889999999753 23456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 9999754 358899999999999999999999 9999999999999999999999999999975433221 223
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 208 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 457999999999999999999999999999999999999999988776666555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.14 Aligned_cols=204 Identities=29% Similarity=0.418 Sum_probs=177.7
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
+.||+|+||.||++... +|+.||+|+++.. ......+.+|+++++.++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999864 7899999999753 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 999988654 358899999999999999999999 899999999999999999999999999987543221 12
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~ 209 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc
Confidence 2345799999999999999999999999999999999999999998877666655544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=335.36 Aligned_cols=215 Identities=26% Similarity=0.370 Sum_probs=185.1
Q ss_pred cccceeeeecCceEEEEEEeC-C-CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~-g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
|.+.+.||+|+||.||+|... + +..||+|.+.... .....+..|+++|+.++||||++++++|..++.+||||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 788999999999999999754 3 6778888775443 444567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.++|........++++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999886543334578999999999999999999999 89999999999999999999999999999876543332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......++.+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~ 286 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 2334467999999999999999999999999999999999999999988776666655544
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.66 Aligned_cols=213 Identities=28% Similarity=0.447 Sum_probs=190.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|-||.||.|..+ ++..||+|++.+++ ....++.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 457889999999999999999855 67789999997754 3457888999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
+||..+|+|...|...+. ..|++.....+..|+|.||.|+|. ++||||||||+|+|++.++.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985443 468888899999999999999999 999999999999999999999999999987655
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.... .+.+||..|++||...+..++..+|+|++|++.||++.|.+||......+....|.+.+
T Consensus 176 ~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~ 238 (281)
T KOG0580|consen 176 SNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD 238 (281)
T ss_pred CCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc
Confidence 3222 23689999999999999999999999999999999999999999999888888887654
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=310.11 Aligned_cols=210 Identities=24% Similarity=0.345 Sum_probs=184.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh---HHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV 495 (643)
++|...+.|++|.||.||+|.++ +++.||+|.++-+.+ .--.-++||.+|.+.+|||||.+-++..- -+.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 46788899999999999999865 788899999986532 23456799999999999999999988753 4579999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
||||+. +|..++...+ .+|...++..+..|+++||.|||. +.|+||||||+|+|+++.|.+||+|||||+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999987 8999998654 579999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
... ..++..+-|..|+|||.+.+. .|++.+|+||+|||+.||+++++-|.+.+.-+|...|.+
T Consensus 229 sp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ 292 (419)
T KOG0663|consen 229 SPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK 292 (419)
T ss_pred CCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH
Confidence 643 345667889999999999865 699999999999999999999999999998888887754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.86 Aligned_cols=210 Identities=25% Similarity=0.377 Sum_probs=180.7
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
+|.+.+.||+|+||.||+|... +++.||+|++++.. .....+..|..++..+ +||+|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999865 67899999997532 3345677788888877 5899999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999986543 58899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~ 216 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 22 1223457999999999999999999999999999999999999999998877776666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=333.37 Aligned_cols=207 Identities=29% Similarity=0.438 Sum_probs=188.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-C-----CceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~~LV 495 (643)
+|.+++.||+|.||+|.++.+. +++.||||+++.......+...|+.||..|+ | -|||+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7899999999999999999854 7899999999999999999999999999997 4 3899999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEeecCcccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 573 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~~ 573 (643)
+|.+ .-+|.++|+.++. ..|+...++.++.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.+..
T Consensus 267 fELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999 4599999987765 458999999999999999999999 999999999999999743 4699999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
...... ..+.+..|+|||+|.+..|+.++||||||||+.||++|.+.|.+++..+|..+|+.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e 402 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIE 402 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHH
Confidence 665322 45789999999999999999999999999999999999999999999999999875
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.36 Aligned_cols=209 Identities=25% Similarity=0.382 Sum_probs=179.5
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCC-ceeEEEeEEEeCCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~LV~ 496 (643)
+|.+.+.||+|+||.||+|... +++.||||+++.. ......+..|++++..++|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999865 6788999999753 23456788899999999765 6888999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999986543 57899999999999999999999 8999999999999999999999999999874322
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 111 22235799999999999999999999999999999999999999998887766665544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.88 Aligned_cols=212 Identities=25% Similarity=0.360 Sum_probs=190.6
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.-|.+.+.||.|+.|.|-+|.+ .+|+..|||++.+. ......+.+||-||+.+.|||+++||+++....++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3477889999999999999975 48999999999764 234556788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|.|.++|-.++ +|++.++.+++.||+.|+.|+|. .+|+||||||+|+||+..+.+||+|||+|-.-..
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999997664 68999999999999999999999 8999999999999999999999999999975544
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
+.. ..+-||.|.|.|||++++.+|+ .++||||-|||||.||||+.||++++...+...|.+|+|
T Consensus 165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF 229 (786)
T ss_pred Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc
Confidence 332 2345899999999999999986 689999999999999999999999999999999999998
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=328.49 Aligned_cols=215 Identities=26% Similarity=0.329 Sum_probs=183.9
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 418 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 418 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
....++|.+.+.||+|+||.||++... +++.||+|+++... .....+..|+++++.++||||+++++++.+++.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999865 78899999996532 2345577899999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999998643 37788889999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
....... .......||+.|+|||++... .++.++|||||||++|||++|+.||.+.+..+....|+.+
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 6543221 122345799999999998753 4889999999999999999999999998877766666543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.33 Aligned_cols=212 Identities=26% Similarity=0.382 Sum_probs=185.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999865 78999999997532 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999754 358899999999999999999999 9999999999999999999999999999986554
Q ss_pred CC---------------------------CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 577 SS---------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 577 ~~---------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 011223457999999999999999999999999999999999999999998
Q ss_pred ChhhHHHhhhc
Q 006480 630 HPKGQESLVMQ 640 (643)
Q Consensus 630 ~~~~~~~li~~ 640 (643)
+.......++.
T Consensus 234 ~~~~~~~~i~~ 244 (350)
T cd05573 234 TLQETYNKIIN 244 (350)
T ss_pred CHHHHHHHHhc
Confidence 87665555543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=317.61 Aligned_cols=201 Identities=29% Similarity=0.464 Sum_probs=172.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC--eEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~LV~E 497 (643)
.+|...+.||+|+||.||++.+. +|...|||.+.... ...+.+.+|+.+|.+++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677889999999999999875 48999999986542 22677899999999999999999999855444 6999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~ 576 (643)
|+++|+|.+++...+. .|++..+..++.||++||.|||+ +|||||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999986642 59999999999999999999999 99999999999999999 79999999999987664
Q ss_pred C-CCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 577 S-SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 577 ~-~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
. ..........||+.|||||++..+ ..+.++|||||||++.||+||++||..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 1 111223347899999999999964 344599999999999999999999997
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=318.57 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=176.9
Q ss_pred eeeeecCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.||+|+||.||++.. .+++.||+|+++... .....+..|+++++.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 367899999997532 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999986543 57888999999999999999999 899999999999999999999999999987543222
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~ 215 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG 215 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 1 223357999999999999999999999999999999999999999998877666666554
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.80 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=182.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+..|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999865 78999999997542 34567888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997542 368999999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCccccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......++.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 3221 222347999999999987 45688999999999999999999999998876665555543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.26 Aligned_cols=208 Identities=24% Similarity=0.428 Sum_probs=178.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||.|+||.||+|... +++.||+|+++... .....+.+|+++++.++||||+++++++...+.+++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56899999999999999999865 78899999987532 2345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 9999886432 357899999999999999999999 999999999999999999999999999997554322
Q ss_pred CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
.......+++.|+|||++.+ ..++.++|||||||++|||++|++||.+.+.......+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 12233568999999999875 56899999999999999999999999998876655544
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=316.14 Aligned_cols=208 Identities=24% Similarity=0.405 Sum_probs=177.4
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHH---HhcCCCceeEEEeEEEeCCeEEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
|.+.+.||+|+||.||++... +|+.||||+++... ...+.+..|++++ +.++||||+++++++...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567899999999999999864 78999999997532 3345666776665 466799999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|...+.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988853 258999999999999999999999 899999999999999999999999999987533
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.++
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~ 216 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 221 1223467999999999999999999999999999999999999999998877666655543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.25 Aligned_cols=209 Identities=26% Similarity=0.467 Sum_probs=176.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-----------------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l 482 (643)
++|.+.+.||+|+||.||++.+. ++..||+|+++.. .....+|.+|++++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57888999999999999999753 2346999999764 3456789999999999999999999
Q ss_pred EeEEEeCCeEEEEEeeCCCCCHHHHhccCCC---------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 006480 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547 (643)
Q Consensus 483 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH 547 (643)
+++|.+.+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999999864321 11357889999999999999999999 89999
Q ss_pred cCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCC
Q 006480 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKP 625 (643)
Q Consensus 548 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt--G~~P 625 (643)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644333222333456889999999999999999999999999999986 6788
Q ss_pred CCCCChhh
Q 006480 626 ISNDHPKG 633 (643)
Q Consensus 626 f~~~~~~~ 633 (643)
|...+...
T Consensus 242 ~~~~~~~~ 249 (304)
T cd05096 242 YGELTDEQ 249 (304)
T ss_pred CCcCCHHH
Confidence 88765544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.98 Aligned_cols=211 Identities=24% Similarity=0.324 Sum_probs=180.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.||+|++.+.. ...+.+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999864 68999999997532 33456888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999996432 358899999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+.......++
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 2221 1222469999999999873 457889999999999999999999999887665555443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=318.91 Aligned_cols=206 Identities=28% Similarity=0.400 Sum_probs=177.1
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
+.||+|+||.||++... +|+.||+|+++.. ......+..|++++..++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999854 7899999999753 234567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+|.+++... ..+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 999988644 358999999999999999999995 15899999999999999999999999999875432221 2
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~ 211 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC
Confidence 23357999999999999999999999999999999999999999988776666665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=318.89 Aligned_cols=211 Identities=24% Similarity=0.297 Sum_probs=181.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 77889999997532 23455788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 358899999999999999999999 9999999999999999999999999999976644
Q ss_pred CCCCccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.... ......||+.|+|||++.. +.++.++|||||||+||||++|+.||...+.......++
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~ 221 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH
Confidence 3221 1223569999999999875 568899999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=316.58 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=177.2
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +++.||+|+++.. ......+..|.+++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 6789999999753 23455678899999876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 99999986543 58899999999999999999999 899999999999999999999999999987543222 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~ 211 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 223457999999999999999999999999999999999999999998887776666544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=333.58 Aligned_cols=220 Identities=25% Similarity=0.361 Sum_probs=187.8
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 490 (643)
...++|.+.+.||+|+||.||++.. .+|+.||||++... ......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457899999999999999999975 47899999998653 345667889999999999999999998775432
Q ss_pred ----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 491 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 491 ----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 3789999999999999997655445679999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 999998765433333334467999999999999999999999999999999999999999988776665555443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.84 Aligned_cols=215 Identities=32% Similarity=0.425 Sum_probs=180.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---------------hHHHHHHHHHHHHHhcCCCceeEE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIISL 482 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l 482 (643)
...++|.+...||+|.||.|-+|... +++.||||++.+.+ ...+...+||.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999864 78999999996532 123578899999999999999999
Q ss_pred EeEEEe--CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 483 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 483 ~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
+++..+ .+.+|||+|||..|.+...= .....+++.++++|+..++.||.|||. +|||||||||+|+||+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCC
Confidence 999865 46899999999988776432 222339999999999999999999999 999999999999999999
Q ss_pred CcEEEeecCccccccCCC---CCccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 561 FEPQLSDFGLAKWASTSS---SHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
|++||+|||.+....... ........+|||.|+|||...++. -+.+.||||+||+||.|+.|+.||.++..-+
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 999999999987664431 112223468999999999988632 4568999999999999999999999998888
Q ss_pred HHHhhhc
Q 006480 634 QESLVMQ 640 (643)
Q Consensus 634 ~~~li~~ 640 (643)
++..|..
T Consensus 327 l~~KIvn 333 (576)
T KOG0585|consen 327 LFDKIVN 333 (576)
T ss_pred HHHHHhc
Confidence 8777754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.04 Aligned_cols=207 Identities=30% Similarity=0.527 Sum_probs=178.4
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
+...-.+++.+...||+|.||+||+|.+.. .||||+++- +....+.|.+|+.+|++-+|.||+-+.|+|...+.
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 333344566788999999999999998732 499999974 45688999999999999999999999999987665
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
.+|+-+|+|-+|..+|+-.+ ..|.....+.|+.||++|+.|||. ++|||||||..||+|.+++.|||+||||+.
T Consensus 463 AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence 99999999999999999665 579999999999999999999999 999999999999999999999999999986
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
...............|...|||||+++.+ .|++.+||||||||+|||++|..||....+
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 54443333344445688899999999744 699999999999999999999999995443
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.83 Aligned_cols=210 Identities=24% Similarity=0.381 Sum_probs=179.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~ 496 (643)
+|...+.||+|+||.||++... +|+.||+|+++.. ....+.+..|++++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999864 7899999999753 234456788999998885 577888999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998654 358999999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......++..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~ 216 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 211 222356999999999999999999999999999999999999999998877666665543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=351.22 Aligned_cols=220 Identities=25% Similarity=0.302 Sum_probs=197.4
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
..++....++|.+.++||+|+||.|..+... +++.||+|++++.+. ...-|..|-+||..-+.+.|++|+-.|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4567777889999999999999999999754 788899999987542 24568889999999999999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
++++|+|||||+||+|..+|.... .+++.-+++|+..|+.||+-||+ .|+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999997543 68899999999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCccccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFM----Y-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~----~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
|.+..+..+ +...+...+|||.|++||++. + +.|+..+|+||+||++|||+.|..||..++--+.+..||..
T Consensus 220 GsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h 296 (1317)
T KOG0612|consen 220 GSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH 296 (1317)
T ss_pred hhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence 999877653 445566679999999999996 3 57999999999999999999999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.77 Aligned_cols=205 Identities=27% Similarity=0.422 Sum_probs=177.2
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +++.||||++++. ......+..|++++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999865 6889999999753 23456778899998876 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 99999886543 58899999999999999999999 999999999999999999999999999987543221 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 211 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC
Confidence 223457999999999999999999999999999999999999999998877766666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=316.81 Aligned_cols=212 Identities=25% Similarity=0.324 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.+|+|++.+.. .....+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46889999999999999999865 67889999996422 23445788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 358899999999999999999999 9999999999999999999999999999875543
Q ss_pred CCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.......++.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~ 222 (332)
T cd05623 155 DGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (332)
T ss_pred CCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence 222 1222357999999999986 34689999999999999999999999998877666655543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.83 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=176.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||++... +++.||+|+++.. ......+.+|+++++.++||||++++++|..++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999875 6788999998754 2345678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|++++.|..+... ...+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655432 2358899999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.. .......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 21 12234578999999999999999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.69 Aligned_cols=203 Identities=26% Similarity=0.419 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +++.||+|+++... .....+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 67889999997532 3345566777777754 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 9999998654 358899999999999999999999 899999999999999999999999999997543322 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234579999999999999999999999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.90 Aligned_cols=211 Identities=28% Similarity=0.417 Sum_probs=182.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh---HHHHHHHHHHHHHhcCCCc-eeEEEeEEEeCC------e
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 491 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~---~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~------~ 491 (643)
.|...+.||+|+||+||+|... +|+.||+|.++-+.+ .....++|+.+|+.|+|+| |+.|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4556678999999999999854 889999999976533 5567789999999999999 999999999877 8
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+.. +|..++.........++...+..+..||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999965 9999998655322456668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+...-... .++.-++|..|+|||++.+. .|+...||||+|||++||+++++-|.+++...+...|.
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If 234 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIF 234 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHH
Confidence 86553222 24556789999999999877 79999999999999999999999999999877776664
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.01 Aligned_cols=204 Identities=25% Similarity=0.427 Sum_probs=172.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----CeEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 493 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~ 493 (643)
+|.+.+.||+|+||.||+|... +|+.||||.++.. ......+.+|+++++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788999999999999999864 7899999998742 23445788999999999999999999998643 3589
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6899988643 358999999999999999999999 8999999999999999999999999999975
Q ss_pred ccCCC-CCccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 574 ASTSS-SHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 574 ~~~~~-~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
..... .........||+.|+|||++.. ..++.++|||||||++|||++|++||.+.+...+
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 43322 1222344679999999999875 6899999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=311.74 Aligned_cols=207 Identities=26% Similarity=0.419 Sum_probs=181.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||++... +|..+|+|++... ......+.+|++++++++||||+++++++..++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999865 7888999998754 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997543 478999999999999999999971 35999999999999999999999999998765432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 213 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 2 2235799999999999999999999999999999999999999988766555443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.65 Aligned_cols=219 Identities=29% Similarity=0.517 Sum_probs=191.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
..+....+.||+|+||.||+|... +...||||.+|... ....+|.+|++++..++|||||+|+|.|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344566788999999999999743 34679999998753 4688999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCC---------C-CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 493 LLVYDFLSRGSLEENLHGNKK---------D-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~---------~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
|+|+|||..|+|.++|..... . +.+++..+.+.|+.|||.|+.||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 999999999999999975431 1 3448999999999999999999999 88999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
|||+||||++.......+.......-..+||+||.|+++++++++|||||||||||+++ |+.||.+.+.++....|..|
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999986655444433323345678999999999999999999999999999999 99999999999999999988
Q ss_pred C
Q 006480 642 Q 642 (643)
Q Consensus 642 ~ 642 (643)
+
T Consensus 722 ~ 722 (774)
T KOG1026|consen 722 Q 722 (774)
T ss_pred C
Confidence 6
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.92 Aligned_cols=215 Identities=26% Similarity=0.379 Sum_probs=194.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe-EEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~LV~ 496 (643)
++|...+.||+|+||.++....+ +++.|++|.+.- ++.......+|+.++++++|||||.+++.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999988654 678899999864 34555678899999999999999999999999888 99999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
+|++||+|.+.+...+ ...|++..++.|+.||+.|+.|||+ +.|+|||||+.||+++.++.+||.|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 4679999999999999999999998 8999999999999999999999999999998877
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
... .....+||+.|+.||.+.+..|+.|+|||||||++|||++=+++|.+.+..++...|.++.+
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~ 223 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLY 223 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccC
Confidence 542 22346899999999999999999999999999999999999999999999999999988763
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.28 Aligned_cols=210 Identities=28% Similarity=0.372 Sum_probs=187.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|...++||+|.||.|.++.-+ +++.||+|++++.- +....-+.|-++|+..+||++..|.-.|+..+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 46778899999999999998744 89999999998753 33344567889999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||..||.|.-.|... ..|++...+.+..+|+.||.|||+ ++||+||||.+|.|||.||++||+||||++.--.
T Consensus 248 eyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999888654 468999999999999999999999 9999999999999999999999999999985433
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
. ...+.+++|||.|+|||++....|+..+|+|.+|||+|||+.|+.||.+.+...+..||+-
T Consensus 321 ~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ 382 (516)
T KOG0690|consen 321 Y--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM 382 (516)
T ss_pred c--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh
Confidence 2 2345568999999999999999999999999999999999999999999999999998874
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=305.30 Aligned_cols=196 Identities=29% Similarity=0.414 Sum_probs=171.3
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||+|+||+||++... +|+.||+|.+.... .....+..|+++++.++||||+++++++...+.+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 78899999987532 2345678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 98886543344568999999999999999999999 8999999999999999999999999999976544322 123
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3578999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.72 Aligned_cols=200 Identities=26% Similarity=0.383 Sum_probs=172.3
Q ss_pred CcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
+|.+.+.||+|+||.||++.. .+++.||+|++++. ....+.+..|++++..+ +||||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999874 36889999999653 23345678899999999 599999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998654 358899999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 65432221 12235799999999999865 48899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.02 Aligned_cols=203 Identities=27% Similarity=0.399 Sum_probs=173.8
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|.+. +|+.||+|+++... .....+..|..++..+ +||||+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999865 78899999997532 3345667788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++...... .
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 9999998653 357899999999999999999999 899999999999999999999999999987432211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2234679999999999999999999999999999999999999999887765554443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.81 Aligned_cols=204 Identities=30% Similarity=0.409 Sum_probs=173.5
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +|+.||+|++.... .....+..|.. +++.++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999865 78999999997532 23345566655 45779999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 9999998653 358899999999999999999999 899999999999999999999999999987533221 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 210 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 22345799999999999999999999999999999999999999998877666655544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.60 Aligned_cols=203 Identities=27% Similarity=0.435 Sum_probs=173.7
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 6789999999754 23345677788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 9999998653 358899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~ 209 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2233579999999999999999999999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.42 Aligned_cols=204 Identities=29% Similarity=0.391 Sum_probs=172.3
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|... +++.||+|++.... .....+..|+. +++.++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 78899999997532 23345556654 57889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|...+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--E 151 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--C
Confidence 9999888643 357888999999999999999999 899999999999999999999999999987532221 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 22345799999999999999999999999999999999999999998876655555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.52 Aligned_cols=201 Identities=24% Similarity=0.425 Sum_probs=173.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 78899999997543 234567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+. ++|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 68888876432 358889999999999999999999 89999999999999999999999999998754332
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2 12233568999999999875 468999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.22 Aligned_cols=208 Identities=25% Similarity=0.411 Sum_probs=174.0
Q ss_pred cCcccceeeeecCceEEEEEEeC--CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc---CCCceeEEEeEEEe-----
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 488 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~----- 488 (643)
++|.+.+.||+|+||.||+|... +++.||+|+++.. ......+.+|+++++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999753 5688999998643 22345567788877766 69999999999863
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
...+++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 699999875432 358899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
|+++...... ......||+.|+|||++....++.++|||||||++|||++|++||.+.+..+....+
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i 221 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 9997654431 223457899999999999899999999999999999999999999988766555444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.82 Aligned_cols=194 Identities=33% Similarity=0.531 Sum_probs=171.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHH
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 506 (643)
.+-||.|+.|.||+|.+ .++.||||.++.- -..+|+.|++|+||||+.|.|+|.....+|||||||..|-|.+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 45699999999999998 5688999977532 1247889999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCC
Q 006480 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586 (643)
Q Consensus 507 ~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 586 (643)
.|+..+ .+.......|..+||.|+.|||. +.|||||||.-||||+.+..+||+|||-++......+ ...+
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSF 271 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSF 271 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhh
Confidence 997553 57778889999999999999999 8899999999999999999999999999987766532 3347
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 587 ~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
+||..|||||+|.+...+.|+|||||||||||||||..||.+-+. ..|+||
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG 322 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG 322 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe
Confidence 999999999999999999999999999999999999999998653 455554
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=313.03 Aligned_cols=204 Identities=31% Similarity=0.407 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHH-HHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +|+.+|+|++... ......+..|.. +++.++||||+++++.+...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999864 7899999999753 233455666665 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 151 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--D 151 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--C
Confidence 9999988643 358899999999999999999999 899999999999999999999999999987532211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......++.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~ 210 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc
Confidence 22345799999999999999999999999999999999999999998877666555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.74 Aligned_cols=203 Identities=29% Similarity=0.389 Sum_probs=171.5
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH-HHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +++.||+|++.... .....+..|.. +++.++||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999865 67889999997532 22334455544 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 9999999754 347888899999999999999999 8999999999999999999999999999875432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+.......+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 2234579999999999999999999999999999999999999999887766555544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=296.99 Aligned_cols=212 Identities=24% Similarity=0.426 Sum_probs=183.0
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|+||.||++...++..+|+|.++.......++.+|+++++.++||||++++++|.+.+.+++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46788899999999999999988888899999886655567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... .
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 99999987543 358899999999999999999999 8999999999999999999999999999876533211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+.......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~ 216 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 1122345678999999998899999999999999999999 9999998876665555543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=305.38 Aligned_cols=214 Identities=26% Similarity=0.421 Sum_probs=187.3
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-----C
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-----D 489 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-----~ 489 (643)
.....|...+.||+|+||.|+.+.+. +|+.||||.+.. .....++..+|+.+|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556777899999999999999864 889999998862 34567889999999999999999999999865 4
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
+.+|+|+|+| .-+|...++... .++...+..+..||++||.|+|+ .+|+||||||+|+|++.+..+||||||
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 5799999999 558999987543 48888999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
||+..........++..+.|..|+|||++. ...|+..+||||.||||.||++|++-|.+.+.-.|..+|+.
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 999887654444557788999999999876 56899999999999999999999999999999999988874
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.72 Aligned_cols=212 Identities=27% Similarity=0.414 Sum_probs=190.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~L 494 (643)
...|.+.+.||+|.||.||++..+ +|+.+|+|++++... ....+.+|+.||+++. ||||+.++++|.+.+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456788899999999999999866 599999999976432 3468899999999998 9999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEeecCc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGL 570 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGl 570 (643)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+ .||+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999755 28999999999999999999999 999999999999999633 5799999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
+..... ......++||++|+|||++....|+..+||||+||++|.|++|.+||.+++..+....|..++|
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC
Confidence 998776 2234457999999999999999999999999999999999999999999999888888888875
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=303.05 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=176.5
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
+|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999864 78999999997532 223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999999886432 2458999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||.+.+...
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~ 208 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV 208 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence 21 123468999999999999999999999999999999999999999876533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.25 Aligned_cols=208 Identities=27% Similarity=0.460 Sum_probs=175.5
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
++|.+.+.||+|+||.||+|.. .++..||+|+++.. ......+.+|+++++.+ +||||++++++|...+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688899999999999999863 23457999999753 34456788999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCC-----------------------------------------------------------
Q 006480 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 513 (643)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864321
Q ss_pred -------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCC
Q 006480 514 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586 (643)
Q Consensus 514 -------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 586 (643)
....+++..++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11357889999999999999999999 89999999999999999999999999999866543322222233
Q ss_pred CCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChh
Q 006480 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632 (643)
Q Consensus 587 ~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~ 632 (643)
.++..|+|||++....++.++|||||||++|||++ |+.||......
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~ 321 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc
Confidence 45678999999999999999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.52 Aligned_cols=205 Identities=28% Similarity=0.419 Sum_probs=177.7
Q ss_pred eeeeecCceEEEEEEe----CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 428 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
+.||+|+||.||++.. .+|+.||+|+++... .....+..|++++++++||||+++++++..++.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 368899999997533 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999998643 358999999999999999999999 8999999999999999999999999999876543221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 223457999999999999989999999999999999999999999988776666655543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=311.17 Aligned_cols=192 Identities=26% Similarity=0.406 Sum_probs=168.4
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +++.||+|+++.. ......+..|+.++..+ +||||++++++|.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999865 7889999999753 23456688899999988 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 9999988644 358999999999999999999999 999999999999999999999999999987432211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 22345799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.86 Aligned_cols=204 Identities=25% Similarity=0.427 Sum_probs=176.0
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +++.||||+++.. ......+..|++++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 6789999999753 23456678899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 9999988654 258999999999999999999999 8999999999999999999999999999875322211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~ 210 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 22335699999999999999999999999999999999999999998877666655543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.15 Aligned_cols=213 Identities=28% Similarity=0.447 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|++|.||+|.+.+++.||+|.++......+++.+|++++++++||||+++++++...+.++++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45688999999999999999998788899999998766556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999997543 2468999999999999999999999 89999999999999999999999999999876532211
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
.......+..|+|||++.+..++.++||||||+++|||++ |+.||.+.........+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 1111223457999999999999999999999999999999 999999877655554443
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.64 Aligned_cols=207 Identities=26% Similarity=0.428 Sum_probs=175.5
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
++|.+.+.||+|+||.||+|.. .++..||||+++... .....+.+|++++..+ +||||++++++|...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999863 246689999997643 3456788999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCC-----------------------------------------------------------
Q 006480 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 513 (643)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999865321
Q ss_pred ------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 514 ------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 514 ------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 11257899999999999999999999 899999999999999999999999999998665433222
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 2223345678999999999999999999999999999998 9999987643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=296.77 Aligned_cols=213 Identities=23% Similarity=0.453 Sum_probs=184.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|...+++.||+|.+.......+.+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35788999999999999999998888899999998766667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999997542 2468899999999999999999999 89999999999999999999999999999866442211
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++....++.++|||||||++|+|++ |+.||...........+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 1122346778999999998899999999999999999998 999998876655544443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.74 Aligned_cols=212 Identities=21% Similarity=0.392 Sum_probs=179.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++... .....|.+|+.++.+++||||+++++++..++.+++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356889999999999999999753 45689999998642 445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999997542 368999999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
..... .......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 32211 11112345678999999999999999999999999999875 999999887665555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.83 Aligned_cols=219 Identities=27% Similarity=0.497 Sum_probs=185.5
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..+|.+.+.||+|+||.||++.. .++..+|+|.+... ....+.+.+|++++.+++||||++++++|...+.++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788999999999999999974 23456899998754 345678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCC---------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 494 LVYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||+ ++++||||||+|||+++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999997543 122458999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |.+||...........+..++
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986654332222333456788999999999999999999999999999998 999998887766666665543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=299.96 Aligned_cols=218 Identities=28% Similarity=0.485 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++++.++||||+++++++...+.+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999753 34789999997643 3467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCC----------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 493 LLVYDFLSRGSLEENLHGNK----------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
++||||+++++|.+++.... .....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999997542 123457899999999999999999999 89999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
++|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543222222223356788999999999999999999999999999998 99999887766655555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=299.47 Aligned_cols=217 Identities=29% Similarity=0.514 Sum_probs=184.0
Q ss_pred cCcccceeeeecCceEEEEEEeCC------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
++|.+.+.||+|+||.||+|.... ...+++|.++... .....|.+|++++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999997532 2579999987543 45667899999999999999999999999989999
Q ss_pred EEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 494 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999975421 11458899999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.++|+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||.+.++......|..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986544332222334467889999999999999999999999999999998 9999998887777666654
Q ss_pred c
Q 006480 641 S 641 (643)
Q Consensus 641 ~ 641 (643)
+
T Consensus 242 ~ 242 (283)
T cd05048 242 R 242 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.28 Aligned_cols=211 Identities=24% Similarity=0.447 Sum_probs=178.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|.+.+.||+|+||.||+|.+. ++. .||+|+++.. .....++.+|+.+++.++||||++++|+|.. +..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCcee
Confidence 46889999999999999999753 343 4899998753 3456789999999999999999999999976 46789
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997543 358899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~ 225 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 65433333333345678999999999999999999999999999998 999999877655544443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.99 Aligned_cols=218 Identities=22% Similarity=0.405 Sum_probs=182.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
..++|.+.+.||+|+||.||+|... .+..+|+|.++... ....++.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998742 35679999986533 345678999999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 2346888999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+.+.......+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999876544332222222345788999999999999999999999999999999 7999998877665554443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.91 Aligned_cols=208 Identities=23% Similarity=0.353 Sum_probs=171.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--------Ce
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------NN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------~~ 491 (643)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||++++++|... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 467999999999999999999864 788999998865432 234699999999999999999987532 24
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGL 570 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGl 570 (643)
+++||||+++ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 7799999975 7877776443344578999999999999999999999 9999999999999998664 799999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
|+....... .....||+.|+|||++.+. .|+.++|||||||+||||++|++||.+.+...+...+
T Consensus 218 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 283 (440)
T PTZ00036 218 AKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283 (440)
T ss_pred chhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 986654322 1235789999999998754 6999999999999999999999999988766554444
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=295.27 Aligned_cols=212 Identities=31% Similarity=0.514 Sum_probs=186.4
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC------h---hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------E---DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~------~---~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
++|...+.||.|..+.|-+.+. .+|+++|+|++... + ...+.-..|++||+++ -||+|+++.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4567778899999999988875 48899999998521 1 3345566899999998 5999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++|+|.|+.|.|.|+|... ..+++.+.+.|..|+.+|+.|||. ++|+||||||+|||++++..+||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999654 469999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
|..+..+. ...+.||||+|+|||.+. ...|+..+|+||.|||+|.|+.|-+||....---+...||.|+|
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 98877654 345579999999999885 33688899999999999999999999999877778899999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.10 Aligned_cols=200 Identities=23% Similarity=0.382 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeEEEEEeeC
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDFL 499 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~LV~E~~ 499 (643)
..||+|+++.||+|.+ +|+.||||.++... ...+.|.+|+++|.+++||||++++|+|.+ ...+++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 78999999997643 225678899999999999999999999977 35789999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++... ..+++.....++.+++.||.|||+. .+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999754 3588999999999999999999972 378899999999999999999999999998654322
Q ss_pred CccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~ 235 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII 235 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 12368899999999976 689999999999999999999999999988777666553
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.19 Aligned_cols=205 Identities=25% Similarity=0.427 Sum_probs=179.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||++.+. ++..+|+|+++.. ......+.+|+++++.++||||++++++|.+++.+++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467999999999999999999865 7888999998753 3455679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999996532 478899999999999999999971 36999999999999999999999999998755432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 211 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE 211 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH
Confidence 1 12346899999999999989999999999999999999999999877655444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.91 Aligned_cols=191 Identities=25% Similarity=0.409 Sum_probs=167.1
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +++.||+|+++.. ......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6789999999753 23455678899988876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 9999988654 358899999999999999999999 899999999999999999999999999987533221 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 2234579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.29 Aligned_cols=203 Identities=30% Similarity=0.467 Sum_probs=181.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.|...+.||+|.||.||+|.+. +++.||+|++.-. ++...++.+|+.+|.+++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4556688999999999999864 7889999999754 466788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.||++.+.|.... .+.+..+..++.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997543 45778888899999999999999 8999999999999999999999999999987765443
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.. .+++||+.|||||+++...|+.|+||||||++.+||.+|.+|+...+|...
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv 219 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV 219 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE
Confidence 32 568999999999999988999999999999999999999999999888443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.41 Aligned_cols=213 Identities=29% Similarity=0.444 Sum_probs=187.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
+++|++.+.||+|.|+.||+... ++|+.+|+|+++.. ....+++.+|++|-+.|+||||++|++.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45788889999999999999764 58999999998643 345678889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~ 573 (643)
|+|.|++|..-+-.. ..+++..+-.+..||++||.|+|. ++|||||+||+|+||- ..--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766433 457888888999999999999999 9999999999999995 345599999999998
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
+... .....++|||+|||||++....|+..+|||+-|||||-|+.|++||.+++...+...|++|.|
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y 229 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY 229 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc
Confidence 8732 234457899999999999999999999999999999999999999999999999999999875
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.44 Aligned_cols=212 Identities=19% Similarity=0.287 Sum_probs=174.7
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC------CceeEEEeEEE
Q 006480 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFCF 487 (643)
Q Consensus 415 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g~~~ 487 (643)
+++...+++|.+.+.||+|+||+||+|.+. +++.||||+++.......++..|+.++..++| +++++++++|.
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344456788999999999999999999864 67889999997655555566778888777754 45899999887
Q ss_pred eC-CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----
Q 006480 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----- 561 (643)
Q Consensus 488 ~~-~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----- 561 (643)
.. +++|+|||++ +++|.+++... ..+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence 64 5789999988 77899988654 3589999999999999999999961 4899999999999998765
Q ss_pred -----------cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 562 -----------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 562 -----------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764322 2234679999999999999999999999999999999999999999887
Q ss_pred hhhHHHhh
Q 006480 631 PKGQESLV 638 (643)
Q Consensus 631 ~~~~~~li 638 (643)
...+..++
T Consensus 350 ~~~~~~~i 357 (467)
T PTZ00284 350 NLEHLHLM 357 (467)
T ss_pred hHHHHHHH
Confidence 65555444
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.07 Aligned_cols=192 Identities=25% Similarity=0.392 Sum_probs=168.2
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++... +++.||+|+++.. ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 6789999999753 23456688999999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 9999988644 258999999999999999999999 899999999999999999999999999987532211 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 22345799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=293.09 Aligned_cols=212 Identities=26% Similarity=0.444 Sum_probs=182.1
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|+||.||+|...++..+|+|.++........|.+|+.++..++||||++++++|.+.+.+++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45788899999999999999887777899999986655557899999999999999999999999998899999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||+++....... .
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 99999987543 258999999999999999999999 8999999999999999999999999999876543221 1
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.+
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc
Confidence 1112345678999999998899999999999999999999 9999988776555555544
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.93 Aligned_cols=202 Identities=26% Similarity=0.346 Sum_probs=176.0
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
|...+.||+|+||+||++... +++.+|+|.+.... .....+.+|+++++.++|+||+.+++.+..++.+++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999764 78999999987542 2344578899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998865332 368999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
. .....|+..|+|||++.+..++.++|+|||||++|||++|+.||.+.....
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 223578999999999999999999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=310.87 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=177.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----eEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 493 (643)
+|.+.+.||+|+||.||++... +|+.||||.+... ....+++.+|+++++.++||||+++++++...+ .+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 7899999998653 234567889999999999999999999998766 789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5888887543 358999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.++..+...|.
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 218 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 5433221 22334689999999999864 58999999999999999999999999888766655543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.53 Aligned_cols=194 Identities=22% Similarity=0.306 Sum_probs=169.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..+|.+.+.||+|+||.||++... +++.||+|.... ..+.+|+++++.++||||++++++|...+..++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 357999999999999999999864 788999997542 45678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
. ++|..++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 166 ~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 166 K-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred C-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 5 6898888654 357899999999999999999999 899999999999999999999999999997543221
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1122345799999999999999999999999999999999999988754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.85 Aligned_cols=194 Identities=28% Similarity=0.387 Sum_probs=168.4
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||+|+||.||++... +|+.||+|.+.... .....+..|+++++.++||||+++++++..+..+++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 78999999986432 2234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+.+..... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 998864432 458899999999999999999999 999999999999999999999999999987664422 223
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
...|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 35689999999999988999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.23 Aligned_cols=195 Identities=26% Similarity=0.470 Sum_probs=165.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+|...+.||+|+||.||++.+. +++.||||++... ......+.+|+++++.++|+||+++++++..++.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456788999999999999865 7899999999653 345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.+|+|.+.. .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986532 34567888999999999999999 8999999999999999999999999999986643221
Q ss_pred CccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.+....||..|+|||++.. ...+.++|||||||++|||++|+.||....
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234579999999998843 234568999999999999999999998543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.61 Aligned_cols=208 Identities=25% Similarity=0.441 Sum_probs=176.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|... .+..||||+++... .....+.+|+++|.++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457888999999999999999742 23579999997543 34567999999999996 9999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC----------------------------------------------------------
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 513 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 513 (643)
++|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999865321
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 006480 514 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (643)
Q Consensus 514 ----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~ 559 (643)
....+++..+..++.||+.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01347888999999999999999999 89999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 99999999999986654333333334467889999999999999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=300.16 Aligned_cols=208 Identities=23% Similarity=0.442 Sum_probs=176.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||.||+|... +++.+|+|.++... .....+.+|+++++.++||||+++++++..++.+++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999865 67889999987532 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888886443 357899999999999999999999 899999999999999999999999999987544322
Q ss_pred CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
. ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 1 1223468999999999864 56899999999999999999999999988765554444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=289.09 Aligned_cols=212 Identities=27% Similarity=0.401 Sum_probs=183.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|++|.||++... +++.|++|.+... ......+.+|+++++.++||||+++++++.+.+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999865 7899999998643 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.... ...+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 2468899999999999999999999 899999999999999999999999999988665432
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.++
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG 216 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 21 22346889999999999999999999999999999999999999988765554444433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=292.29 Aligned_cols=212 Identities=26% Similarity=0.456 Sum_probs=182.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.+|.+.+.||+|+||.||+|... +++.+++|+++.+.....++.+|+++++.++||||++++++|..++.++++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 45788899999999999999864 68889999998776667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ...+++..++.++.|+++||.|||+ ++++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999996543 2458999999999999999999999 89999999999999999999999999999766543221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+.
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 219 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 219 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 1112234668999999999999999999999999999998 999998877665555544
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=291.83 Aligned_cols=210 Identities=26% Similarity=0.459 Sum_probs=179.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
.+|.+.+.||+|+||.||++.+.++..+|+|++.........+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35778899999999999999887777899999876554556788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 99999997543 368999999999999999999999 89999999999999999999999999998765432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...++......+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 1111234567999999999999999999999999999999 89999877655544433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=294.79 Aligned_cols=214 Identities=27% Similarity=0.473 Sum_probs=179.1
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|.+.+.||+|+||.||+|.. .+++.+++|.++... .....+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 256789999997533 345678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 495 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853321 12357889999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.++......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999986644322222233456778999999998899999999999999999998 99999887665444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.09 Aligned_cols=202 Identities=27% Similarity=0.358 Sum_probs=172.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 490 (643)
..++|.+.+.||+|+||.||++... +|+.||+|++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 7899999999643 344567889999999999999999999986543
Q ss_pred -eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 491 -~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999965 67666642 37888999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~ 230 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 997543322 22345789999999999999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=309.30 Aligned_cols=203 Identities=29% Similarity=0.369 Sum_probs=171.0
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc---CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
||+|+||.||+|... +++.||||++.... .....+..|..++..+ +||||+++++.+.+.+.+++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999996432 2334556677777765 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 9999998643 358899999999999999999999 8999999999999999999999999999875432221
Q ss_pred cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 582 TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 22345799999999999755 4899999999999999999999999988776665555433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=289.26 Aligned_cols=205 Identities=26% Similarity=0.464 Sum_probs=173.1
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
+.||+|+||.||+|.+. +++.+|+|.+... ......+.+|+++++.++||||++++++|...+.+++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999864 7899999988643 34567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99996432 358899999999999999999999 899999999999999999999999999987654321111111
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
....+..|+|||++.++.++.++|||||||++|||++ |..||....+......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 1233567999999999999999999999999999998 99999877665544443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=317.42 Aligned_cols=210 Identities=32% Similarity=0.505 Sum_probs=181.6
Q ss_pred cCcccceeeeecCceEEEEEEeC--CC--CE-EEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--DG--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--~g--~~-vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
++-.+.+.||+|+||.||+|.+. ++ .. ||||..+. .....++|++|.+++++++|||||+++|++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455689999999999999864 22 23 89999984 256788999999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+||||+|.||+|.++|...+. .++..+++.++.+.|.||+|||+ +++|||||..+|+|++.++.+||+||||++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999986643 68999999999999999999999 999999999999999999999999999987
Q ss_pred cccCCCCCcccc-CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 573 WASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 573 ~~~~~~~~~~~~-~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.... ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........|..
T Consensus 311 ~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~ 377 (474)
T KOG0194|consen 311 AGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK 377 (474)
T ss_pred CCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence 5541 11111 1124578999999999999999999999999999999 8999999999888887744
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=295.57 Aligned_cols=216 Identities=26% Similarity=0.474 Sum_probs=183.0
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|.+.+.||+|+||.||++... ++..+++|.++... ...+.+.+|+++++.++||||+++++++...+.+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888899999999999999742 45568999987644 445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
||||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975431 12358999999999999999999999 89999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||...++......+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 99999999976544332223334567889999999999999999999999999999999 9999988777665554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=291.77 Aligned_cols=212 Identities=25% Similarity=0.453 Sum_probs=180.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|.+.++..+|+|+++......+++.+|+++++.++||||+++++.+. .+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3568999999999999999998877678999999875555678899999999999999999999874 466899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997532 2457899999999999999999999 89999999999999999999999999999766543221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+..+......+.
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~ 217 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Confidence 1122346778999999998999999999999999999999 899998887666555443
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=295.05 Aligned_cols=199 Identities=28% Similarity=0.388 Sum_probs=174.0
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
|...+.||+|+||.||++... +++.||+|.+.... .....+..|+.+++.++|+||+++++.+.+.+.+++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677889999999999999765 78899999986532 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++..... ..+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999865332 458899999999999999999999 999999999999999999999999999987654322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 2 123479999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=293.94 Aligned_cols=212 Identities=24% Similarity=0.451 Sum_probs=178.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC----EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|.+.+.||+|+||.||+|.+. +++ .+++|.+.... ....++..|+.++..++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999853 444 47778875432 34567888888999999999999999885 456789
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.............++..|+|||++.++.++.++|||||||++|||++ |+.||.+..+.....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 54433333344567889999999999999999999999999999998 9999998877666555543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.89 Aligned_cols=214 Identities=28% Similarity=0.483 Sum_probs=185.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++|.+.+.||+|+||.||+|.+.+++.++||.+.......+++.+|+.+++.++||||+++++++.....+++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34679999999999999999999888889999999877666788999999999999999999999999889999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++.... ...+++..+..++.+++.||.|||+ ++++|+||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997543 2468999999999999999999999 8999999999999999999999999999876653211
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
.......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+.+.......+.
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 11112234678999999999899999999999999999998 999998877665555543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=304.16 Aligned_cols=212 Identities=25% Similarity=0.387 Sum_probs=184.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
..+|....+||+|+||.|.++..+ +...||||+++++ .+..+--+.|-++|... +-|++++|+.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999765 4567999999875 23334445677787766 57899999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+.||+|...++..+ .|.+..+..++.+||-||-|||+ +|||+||||.+||||+.+|++||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999998765 47778889999999999999999 99999999999999999999999999999854
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
-.. ..+..+++|||.|+|||++.++.|+..+|+|||||+||||+.|++||++++..++...|+..
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 332 23445689999999999999999999999999999999999999999999999999888753
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=306.17 Aligned_cols=207 Identities=24% Similarity=0.334 Sum_probs=176.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 489 (643)
..++|.+.+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999864 6889999999753 34456788999999999999999999987543
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 78777742 37889999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......++
T Consensus 172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 238 (364)
T cd07875 172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238 (364)
T ss_pred CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 998654322 2233578999999999999999999999999999999999999999887665554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=292.63 Aligned_cols=217 Identities=21% Similarity=0.386 Sum_probs=183.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.++..++||||+++++++...+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457889999999999999999753 34689999987543 3456788999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCC------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 493 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999999754321 2347899999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |+.||...++......+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence 9999876544332222233457889999999998899999999999999999998 9999988777665555543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=292.44 Aligned_cols=210 Identities=38% Similarity=0.608 Sum_probs=176.0
Q ss_pred cceeeeecCceEEEEEEeC-----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 426 AENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~-----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.+.||.|.||.||+|.+. .+..|+||.++.. ....+.|.+|++++++++||||++++|+|...+.+++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999875 3567999999764 34578999999999999999999999999988889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.++|.... ...+++..++.|+.||++||.|||+ ++++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 2568999999999999999999999 899999999999999999999999999998763332
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.........+...|+|||.+....++.++||||||+++|||++ |+.||...+.......+.+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~ 220 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ 220 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2222233456788999999999999999999999999999999 7899998877665555544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.69 Aligned_cols=213 Identities=27% Similarity=0.470 Sum_probs=181.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. +...+|||.++.. .....+|..|+.++..++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357889999999999999999864 2457999998754 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997543 368999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 222 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE 222 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 53333222223345678999999999999999999999999999998 999998776555544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=295.19 Aligned_cols=218 Identities=25% Similarity=0.419 Sum_probs=183.4
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.+|.+.+.||+|+||.||+|... +++.||+|+++... .....+..|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34777889999999999999753 35789999997543 34567889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 494 LVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
+++||+.+++|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 112358889999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+....+....+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999886544332222333456789999999998899999999999999999998 9999998887777777665
Q ss_pred cC
Q 006480 641 SQ 642 (643)
Q Consensus 641 ~~ 642 (643)
++
T Consensus 242 ~~ 243 (283)
T cd05091 242 RQ 243 (283)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=310.35 Aligned_cols=198 Identities=23% Similarity=0.331 Sum_probs=173.4
Q ss_pred cCcccceeeeecCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.+|.+.+.||+|+||.||++... .++.|++|.+.... .+.+|+++|+.++||||++++++|...+.+++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46899999999999999998743 45789999887543 345799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. ++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 168 ~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 95 6898888432 468999999999999999999999 899999999999999999999999999998665544
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 33334456799999999999999999999999999999999999999987654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=288.94 Aligned_cols=213 Identities=23% Similarity=0.386 Sum_probs=174.5
Q ss_pred cccceeeeecCceEEEEEEeCC-CC--EEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------Ce
Q 006480 424 FLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 491 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~-g~--~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 491 (643)
|.+.+.||+|+||.||+|.+.+ +. .+|+|.++.. ......+..|+++++.++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998653 33 5899998753 34567889999999999999999999987542 24
Q ss_pred EEEEEeeCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 492 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
.+++|||+.+|+|.+++...+ .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999874322 223468999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9987654322111122346778999999999999999999999999999999 899998876655544444
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=328.86 Aligned_cols=207 Identities=26% Similarity=0.394 Sum_probs=177.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|.+. +|+.||+|+++.. ....+++.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999865 6899999999753 234668999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 497 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
||++||+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 12346778889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----------------CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 570 LAKWASTSSS----------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 570 la~~~~~~~~----------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9986621110 0111235799999999999999999999999999999999999999987543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.39 Aligned_cols=216 Identities=29% Similarity=0.470 Sum_probs=179.7
Q ss_pred cCcccceeeeecCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
++|.+.+.||+|+||.||++... ++..+|+|.++.. .....++..|++++..+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56899999999999999998642 2356999999864 34456788999999999 7999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.+++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999975432 12358999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l 637 (643)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999876543221111111234568999999999999999999999999999998 9999988776665555
Q ss_pred hhc
Q 006480 638 VMQ 640 (643)
Q Consensus 638 i~~ 640 (643)
+..
T Consensus 255 ~~~ 257 (307)
T cd05098 255 LKE 257 (307)
T ss_pred HHc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=312.78 Aligned_cols=216 Identities=26% Similarity=0.394 Sum_probs=182.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
..-|..++.||-|+||.|.+++. ++...||+|.|++.+ +.......|-+||...+++.||+||-.|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34577889999999999999974 456678999998754 2344567799999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc---
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--- 572 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~--- 572 (643)
|||++||++..+|-..+ .|.++.++.++.++..|+++.|+ .|+|||||||+|||||.+|++||+||||+.
T Consensus 708 MdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999987553 68999999999999999999999 999999999999999999999999999983
Q ss_pred cccCCC-----CC--------------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHH
Q 006480 573 WASTSS-----SH--------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 615 (643)
Q Consensus 573 ~~~~~~-----~~--------------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvv 615 (643)
|..... .+ ......+||+.|+|||++....|+.-+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 221110 00 00112479999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCChhhH-HHhhhccCC
Q 006480 616 LLELLTGRKPISNDHPKGQ-ESLVMQSQF 643 (643)
Q Consensus 616 l~eLltG~~Pf~~~~~~~~-~~li~~~~f 643 (643)
||||+.|++||.++.|-+. ...|.|..|
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~ 889 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNF 889 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhc
Confidence 9999999999999988664 445556543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.54 Aligned_cols=211 Identities=23% Similarity=0.417 Sum_probs=181.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|...+++.+|+|.+........++.+|+++++.++||||+++++++ ..+.++++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCC
Confidence 356888999999999999999988899999999987666667899999999999999999999987 4567899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ...+++.+++.++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999986543 2468999999999999999999999 89999999999999999999999999999766532211
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
......++..|+|||++....++.++||||||+++|||++ |++||.+.+.......+
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 1122346778999999998999999999999999999999 99999887765544433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.58 Aligned_cols=217 Identities=27% Similarity=0.445 Sum_probs=180.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
.+++|.+.+.||+|+||.||+|.+. .+..|++|.+... ......|..|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999864 3567899988643 3345678999999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 565 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL 565 (643)
.++||||+++++|.+++...+. ....+++..++.++.||+.||.|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976532 22468999999999999999999999 8999999999999998754 5999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999986643222111222334578999999999999999999999999999997 999999877666555443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.91 Aligned_cols=205 Identities=24% Similarity=0.408 Sum_probs=171.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhc---CCCceeEEEeEEEe-----CC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCFE-----DN 490 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~-----~~ 490 (643)
+|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+++++.+ +||||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788999999999999999865 78899999987532 2234566777777665 79999999999864 24
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.++++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 5899999997 489988865432 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+...
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~ 217 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence 98664322 2233568999999999999999999999999999999999999998876655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.21 Aligned_cols=214 Identities=26% Similarity=0.451 Sum_probs=179.6
Q ss_pred CcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
+|.+.+.||+|+||.||+|... ....+++|.+.... ....++.+|+.+++.++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999742 33578999887543 345678999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006480 495 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~N 554 (643)
+|||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999864321 12358899999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 555 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||.+..+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976544332222223346778999999998899999999999999999998 999999887766
Q ss_pred HHHhhh
Q 006480 634 QESLVM 639 (643)
Q Consensus 634 ~~~li~ 639 (643)
....+.
T Consensus 238 ~~~~~~ 243 (290)
T cd05045 238 LFNLLK 243 (290)
T ss_pred HHHHHh
Confidence 555543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.81 Aligned_cols=213 Identities=25% Similarity=0.473 Sum_probs=178.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~----~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++|.+.+.||+|+||.||+|.+ .+|+ .||+|+++.. ......+.+|+.++..++||||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 45688899999999999999974 3554 4899998753 3456788899999999999999999999975 4578
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997543 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
..............+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC
Confidence 754333222222345678999999999999999999999999999998 9999988766555554443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.68 Aligned_cols=207 Identities=29% Similarity=0.453 Sum_probs=182.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.+|+|+++... .....+.+|+++++.++||||+++++++...+.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999865 68999999987532 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999754 358899999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 212 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE 212 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 3 2234689999999999988899999999999999999999999988776554444443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=292.94 Aligned_cols=217 Identities=22% Similarity=0.386 Sum_probs=180.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
..++|.+.+.||+|+||.||+|... .+..||+|.++... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999998643 24579999987543 334568899999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
.++||||+++|+|.+++...... ...+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999753211 2345778889999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999986544322222222345778999999999999999999999999999998 899998877666555444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=303.99 Aligned_cols=203 Identities=25% Similarity=0.326 Sum_probs=173.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 489 (643)
..++|.+.+.||+|+||.||++... .++.+|||.+... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999999753 34456788999999999999999999998643
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..+++||||+.+ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999965 67777642 37889999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.....
T Consensus 165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 227 (355)
T cd07874 165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_pred ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 997654322 223357899999999999999999999999999999999999999987654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=286.03 Aligned_cols=205 Identities=29% Similarity=0.448 Sum_probs=177.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|.+.+.||+|++|.||++... +++.+++|.+.... .....+.+|++++++++||||+++++++.+.+.+++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 78999999986432 234578899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998754 247889999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 575 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 43221111 123468889999999999999999999999999999999999998765543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.45 Aligned_cols=211 Identities=28% Similarity=0.469 Sum_probs=179.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|+||.||+|...++..+|+|.++........+.+|++++++++||||+++++++. .+..+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 468889999999999999999888888999999876555677999999999999999999999885 4668999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++.... ...+++..++.++.+++.||.|||+ ++|+||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 85 GSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 99999997543 2458899999999999999999999 89999999999999999999999999999765442211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++.+..++.++||||||+++|||++ |++||.+.+.......+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 1112245678999999998899999999999999999999 999998877655544443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=303.58 Aligned_cols=207 Identities=26% Similarity=0.474 Sum_probs=174.6
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe-CCe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 491 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-~~~ 491 (643)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+..|++++.++ +||||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4788999999999999999853 23578999998753 23456788999999999 89999999998875 457
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC---------------------------------------------------------
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 514 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 514 (643)
++++|||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999998643210
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccC
Q 006480 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594 (643)
Q Consensus 515 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 594 (643)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999999 8999999999999999999999999999987654433333334456788999
Q ss_pred cccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 595 PE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
||++.+..++.++|||||||+||||++ |+.||.+...
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999999999998 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.75 Aligned_cols=204 Identities=29% Similarity=0.473 Sum_probs=178.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999854 789999998754 2344567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.........+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886543334568899999999999999999999 8999999999999999999999999999886643
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
... ......|++.|+|||++.+..++.++|+||||+++|||++|+.||....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 221 1223468899999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.12 Aligned_cols=211 Identities=27% Similarity=0.449 Sum_probs=178.7
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC------C
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------N 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~------~ 490 (643)
.+++.|.+.+.||+|+||.||+|... +++.+|+|++.........+..|+.++..+ +||||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888999999999999999864 688999999976655567788999999998 799999999998753 4
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.++++|||+.+|+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 68999999999999999875432 468899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.....
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~ 226 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 976543221 223357899999999986 3468899999999999999999999998766544443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=286.86 Aligned_cols=210 Identities=26% Similarity=0.472 Sum_probs=179.4
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|++|.||++.+..+..+++|.+.........+.+|+++++.++||||+++++++. .+..+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 458889999999999999999877778999998876656678899999999999999999999875 4678999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999997543 2458899999999999999999999 89999999999999999999999999999765432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+..+......+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 1122346778999999998999999999999999999999 99999987765544443
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.61 Aligned_cols=199 Identities=36% Similarity=0.568 Sum_probs=174.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHH---HHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~---~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
|.+.+.||+|+||+||++... +++.+|+|++....... ....+|+.++++++||||+++++++...+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999876 56689999998765332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.+++|.+++... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.++|+|||++..... .
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred cccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--c
Confidence 999999999732 358999999999999999999999 8999999999999999999999999999875422 2
Q ss_pred CccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 580 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
........++..|+|||++. +..++.++||||||+++|+|++|..||.....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~ 204 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS 204 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334567899999999998 88999999999999999999999999998743
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=285.53 Aligned_cols=212 Identities=23% Similarity=0.354 Sum_probs=183.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+|.+.+.||+|+||.||++... +++.+++|.++. .....+.+..|+.+++.++||||+++++.+...+.++++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788999999999999999865 788999999854 2345577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998864332 457899999999999999999999 8999999999999999999999999999876644222
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+.++
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC
Confidence 122356899999999999989999999999999999999999999988776665555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=289.11 Aligned_cols=212 Identities=28% Similarity=0.472 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChh-HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..+|.+.+.||.|+||.||+|...+++.+++|++..... ....+..|+.+++.++||||+++++++...+.+++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 356888999999999999999988899999999986654 5678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997543 2468999999999999999999999 8999999999999999999999999999976643221
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++....++.++||||||+++|+|++ |+.||...+.......+.
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 1123346778999999998899999999999999999998 899998877655555443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.21 Aligned_cols=218 Identities=28% Similarity=0.459 Sum_probs=183.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
..++|.+.+.||+|+||.||++... ....+|+|.+... .....++.+|++++..+ +||||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4457888999999999999999753 2367899998753 34456788999999999 7999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.++++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999997532 223568999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l 637 (643)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999986654332222233345678999999999999999999999999999998 9999998776665555
Q ss_pred hhc
Q 006480 638 VMQ 640 (643)
Q Consensus 638 i~~ 640 (643)
+..
T Consensus 247 ~~~ 249 (293)
T cd05053 247 LKE 249 (293)
T ss_pred HHc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.68 Aligned_cols=217 Identities=24% Similarity=0.419 Sum_probs=183.6
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC-----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 491 (643)
..++|.+.+.||+|+||.||+|...+ +..+++|.++.. ......+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35688999999999999999998754 688999998754 3456778899999999999999999999876 467
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC----CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 567 (643)
.+++++|+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754322 1468999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||...++......+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 999986644333222233456778999999998899999999999999999999 999999877666554443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.01 Aligned_cols=219 Identities=30% Similarity=0.451 Sum_probs=185.2
Q ss_pred ccChHHHHHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe
Q 006480 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE 488 (643)
Q Consensus 411 ~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 488 (643)
.+++.++..++++|.+.+.||+|+||.||++.. .+++.+|+|++.........+..|+.++.++ +||||++++++|..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 356667777889999999999999999999986 4788999999987655556788899999999 89999999999875
Q ss_pred C-----CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 489 D-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 489 ~-----~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
. +.+++||||+++|+|.++++........+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 3 35899999999999999987543344568999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....+...
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 9999999876543221 11234688999999998643 368999999999999999999999988765433
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.63 Aligned_cols=216 Identities=27% Similarity=0.435 Sum_probs=181.6
Q ss_pred ChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEE---
Q 006480 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF--- 487 (643)
Q Consensus 413 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~--- 487 (643)
.++.+..+.++|.+.+.||+|+||.||++... +++.+|+|+++.......++..|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34555667889999999999999999999764 688999999876555556788899999999 6999999999884
Q ss_pred --eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 488 --EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 488 --~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
.++.+++||||+++++|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEE
Confidence 3457899999999999999886443333568899999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||...++..
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 99999876543221 222346899999999985 3458899999999999999999999998776533
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.39 Aligned_cols=217 Identities=28% Similarity=0.465 Sum_probs=182.7
Q ss_pred hcCcccceeeeecCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 489 (643)
..+|.+.+.||+|+||.||++.. .++..+|+|.++.. .....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688889999999999999963 13457999998753 34567899999999999 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999975432 12357889999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..+...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987654333222223346778999999999999999999999999999998 899999887777666
Q ss_pred hhhc
Q 006480 637 LVMQ 640 (643)
Q Consensus 637 li~~ 640 (643)
.+..
T Consensus 251 ~~~~ 254 (304)
T cd05101 251 LLKE 254 (304)
T ss_pred HHHc
Confidence 5543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=287.80 Aligned_cols=213 Identities=26% Similarity=0.415 Sum_probs=176.7
Q ss_pred cccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe-----
Q 006480 424 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 491 (643)
|.+.+.||+|+||.||+|... .+..+|+|.++.. ......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999854 2367999998754 2345678999999999999999999999876554
Q ss_pred -EEEEEeeCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 492 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 492 -~~LV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
.+++|||+++|+|..++.... .....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999985432 223468999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||.+.........+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99986654332222222345678999999998899999999999999999999 999998877655544443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.75 Aligned_cols=219 Identities=25% Similarity=0.314 Sum_probs=187.0
Q ss_pred cccccccChHHHHHhhcCcccceeeeecCceEEEEEE-eCCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCcee
Q 006480 406 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNII 480 (643)
Q Consensus 406 ~~~~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv 480 (643)
...+++-.++-.....+.|..-++||+||||.||-+. ..+|+-||+|.+.+.. ....-.++|-.||.+++.++||
T Consensus 169 ~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiV 248 (591)
T KOG0986|consen 169 TRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIV 248 (591)
T ss_pred HHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEE
Confidence 3344444444444445668888999999999999876 4489999999886432 2334467899999999999999
Q ss_pred EEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 481 ~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
.+--+|...+.+|||+..|.||+|.-.|..... ..|++..+..++.+|+.||.+||+ .+||+|||||+|||||+.
T Consensus 249 slaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~ 323 (591)
T KOG0986|consen 249 SLAYAFETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDH 323 (591)
T ss_pred EEeeeecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccC
Confidence 999999999999999999999999998876654 579999999999999999999999 999999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
|++.|+|+|||..+...... ...+||.+|||||+++++.|+...|+|||||+||||+.|+-||.....+
T Consensus 324 GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 324 GHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred CCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99999999999877765433 2358999999999999999999999999999999999999999875543
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=294.35 Aligned_cols=203 Identities=25% Similarity=0.410 Sum_probs=177.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||.||++... ++..+|+|.++.. .....++.+|++++.+++||||++++++|.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999754 6788999998653 34556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++..+..++.|++.||.|||+. .+++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999754 3578999999999999999999961 479999999999999999999999999987554322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 206 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH
Confidence 1235789999999999888899999999999999999999999987664443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.97 Aligned_cols=216 Identities=25% Similarity=0.467 Sum_probs=181.0
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|...+.||+|+||.||++... ++..+++|.++.. ......+.+|+++++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999632 4567899988754 3556789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 495 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
+|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875431 11358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |++||...........+.+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 9999999976544332222233446788999999999999999999999999999998 9999987766555544433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=321.25 Aligned_cols=207 Identities=28% Similarity=0.375 Sum_probs=172.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCC-CEEEEEEeC-CChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEe----C---
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILK-PSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE----D--- 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g-~~vAVK~l~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~----~--- 489 (643)
...+..+++.|.+|||+.||.|.+..+ ++||+|++- .++...+.+.+||++|+.|. |+|||.+++.... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678899999999999999987765 999999875 45677889999999999997 9999999994321 1
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
-+++|+||||.||.|-+++..... ..|++.++++|+.++++|+.+||... -+|||||||-+||||+.++..||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 257899999999999999986654 34999999999999999999999844 579999999999999999999999999
Q ss_pred ccccccCCCCCc-c------ccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 570 LAKWASTSSSHI-T------CTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 570 la~~~~~~~~~~-~------~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.|.-........ . .-...-|+.|+|||++. +...+.|+|||||||+||-|+....||...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 985333222110 0 00124689999999875 668999999999999999999999999976
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=283.46 Aligned_cols=209 Identities=30% Similarity=0.509 Sum_probs=181.1
Q ss_pred eeeeecCceEEEEEEeCC----CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||++.... +..+++|+++.... ....+..|++++..++|+||+++++++.....+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998653 78899999987543 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC-----CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 502 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 502 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
++|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765221 3578999999999999999999999 9999999999999999999999999999987665
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
...........++..|+|||.+....++.++|||||||++|||++ |+.||...++......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 432223334567899999999998899999999999999999999 699999887766555544
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=311.08 Aligned_cols=195 Identities=24% Similarity=0.321 Sum_probs=169.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
...|.+.+.||+|+||.||++.+. .++.||||... ...+.+|+++|++++||||+++++++..++..++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 457999999999999999999865 57889999643 234678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 4 68988886432 368999999999999999999999 8999999999999999999999999999987654332
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
........||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 222234579999999999999999999999999999999999886654
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=285.54 Aligned_cols=212 Identities=24% Similarity=0.441 Sum_probs=182.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
..+|.+.+.||+|+||.||++...++..+++|.+.........+.+|+++++.++|+||+++++++.+ ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35788999999999999999988788889999998766666789999999999999999999999887 78899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999997543 2467899999999999999999999 89999999999999999999999999998765432211
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++....++.++|+|||||++|+|++ |+.||.+.+.......+.
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 217 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 1112345678999999998899999999999999999999 999999877665555443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.48 Aligned_cols=201 Identities=25% Similarity=0.381 Sum_probs=171.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 489 (643)
..++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++|+.++||||++++++|...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4568999999999999999999854 78899999997532 3345678999999999999999999987543
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..++++++++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 4578999988 7899888753 248999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 224 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ 224 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence 99865442 223468999999999876 5789999999999999999999999987655433
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.25 Aligned_cols=203 Identities=29% Similarity=0.432 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 347888899999999999999864 68899999987643 3445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999998654 358899999999999999999999 899999999999999999999999999987554321
Q ss_pred CCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
. ......|+..|+|||++. ...++.++|||||||++|+|++|+.||....+.
T Consensus 161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred c--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 1 122357899999999985 556899999999999999999999999766543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=328.11 Aligned_cols=211 Identities=26% Similarity=0.404 Sum_probs=175.5
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCe
Q 006480 418 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNN 491 (643)
Q Consensus 418 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 491 (643)
....++|.+.+.||+|+||.||++... ++..+|+|++... ......|..|+.+|..|+||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999865 6778999998743 3456778999999999999999999998865 357
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC----CCCeEecCCCCCCEEEcCC-------
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSDD------- 560 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----~~~iiHrDLKp~NILl~~~------- 560 (643)
+||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.. .++||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999999754333356899999999999999999999832 1459999999999999643
Q ss_pred ----------CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 561 ----------FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 561 ----------~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3489999999986643322 223579999999999864 4589999999999999999999999986
Q ss_pred CCh
Q 006480 629 DHP 631 (643)
Q Consensus 629 ~~~ 631 (643)
.+.
T Consensus 246 ~~~ 248 (1021)
T PTZ00266 246 ANN 248 (1021)
T ss_pred CCc
Confidence 554
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=291.95 Aligned_cols=212 Identities=28% Similarity=0.473 Sum_probs=176.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC--EEEEEEeCC--ChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vAVK~l~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||.||+|... ++. .+++|.++. .....+.+.+|++++.++ +||||+++++++...+.++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57889999999999999999864 343 478888874 234567799999999999 799999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 496 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975431 12358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |+.||...........+.
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 9999999864322111 111223567999999998899999999999999999997 999999887766555443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=295.75 Aligned_cols=199 Identities=26% Similarity=0.417 Sum_probs=163.7
Q ss_pred ceeeeecCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEEEeeCCC
Q 006480 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~ 501 (643)
.+.||+|+||.||+|... +++.+|+|.+..... ...+.+|+++++.++||||+++++++.. +..++++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 467999999999999854 567899999975432 3457789999999999999999999864 456899999985
Q ss_pred CCHHHHhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeecCccc
Q 006480 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (643)
Q Consensus 502 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla~ 572 (643)
++|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58888875322 122458999999999999999999999 899999999999999 456789999999998
Q ss_pred cccCCCCC-ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 122346789999999999864 58999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=286.67 Aligned_cols=202 Identities=28% Similarity=0.376 Sum_probs=165.7
Q ss_pred eeeecCceEEEEEEeCC---CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~~---g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.||+|+||.||+|...+ ...+++|.+... ......|.+|+++++.++||||+++++.|...+.+++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 346888877643 2345678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCC-CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 504 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 504 L~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
|.+++...... ...+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999765422 2345678889999999999999999 8999999999999999999999999999875433222222
Q ss_pred ccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 583 CTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
.....+++.|+|||++.. ..++.++|||||||++|||++ |+.||....+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ 217 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 223456778999998753 357889999999999999999 889998776544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.76 Aligned_cols=208 Identities=24% Similarity=0.428 Sum_probs=176.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 357889999999999999999865 68899999986432 334567889999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+. ++|.+++.... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 996 58999886542 357899999999999999999999 89999999999999999999999999998754432
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|++||...+..++...
T Consensus 158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~ 216 (301)
T cd07873 158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216 (301)
T ss_pred CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 21 1223457899999999875 4588999999999999999999999998876555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.18 Aligned_cols=207 Identities=25% Similarity=0.433 Sum_probs=176.8
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
++|.+.+.||+|+||.||++.. ..+..+|+|+++.. ......+.+|+++++++ +||||++++++|...+.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688899999999999999963 13457999998754 34456789999999999 799999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++..... ..+++.++..++.+|+.||.|||+ ++|+|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 348999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~ 251 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence 6654332222223356788999999999999999999999999999998 999998766543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.88 Aligned_cols=200 Identities=31% Similarity=0.464 Sum_probs=173.9
Q ss_pred cccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------CeEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLL 494 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~L 494 (643)
|...+.||+||||.||+|.+ .+|+.||||.+++.. .......+|+++|++++|||||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44567899999999999984 589999999998743 4456788999999999999999999985443 35789
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCc--EEEeecCc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFE--PQLSDFGL 570 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~--~~~~--vkL~DFGl 570 (643)
|||||.+|+|...|.... +...+++.+++.++..+..||.|||+ ++|+||||||.||++- .+|. -||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999998654 34579999999999999999999999 9999999999999995 3333 69999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
|+.+++.. .+..++||..|++||++.. +.|+.-+|.|||||++|+..||..||-...
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99887755 5667899999999999994 889999999999999999999999997653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=286.84 Aligned_cols=213 Identities=24% Similarity=0.460 Sum_probs=181.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC----EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|.+.+.||+|+||.||+|.+. +|. .+|+|.++... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999854 333 58999887653 345688899999999999999999999987 78999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
.............++..|+|||.+....++.++|||||||++|||++ |+.||....+......+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 54333222222234678999999998899999999999999999999 99999998877766665543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=286.12 Aligned_cols=203 Identities=29% Similarity=0.425 Sum_probs=174.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.++++++||||+++++.+..++.+++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688999999999999999986 478899999987543 3445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998643 358899999999999999999999 899999999999999999999999999997654322
Q ss_pred CCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
. ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+.
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 1 112346889999999884 445788999999999999999999999766543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=281.60 Aligned_cols=212 Identities=27% Similarity=0.399 Sum_probs=184.4
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|...+.||.|+||.||.+.. .+++.+++|.+... .....++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999998874 47889999987643 35567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2468999999999999999999999 899999999999999999999999999998664433
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||...++......+..+
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG 216 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 2 223456899999999999888999999999999999999999999988776666555544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=293.31 Aligned_cols=216 Identities=26% Similarity=0.472 Sum_probs=179.9
Q ss_pred cCcccceeeeecCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
.+|.+.+.||+|+||.||++... ....+|+|+++.. .....++..|+++++.+ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46888999999999999998631 3456899998753 34466788999999999 6999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.++++|||+++|+|.+++..... ....+++.++..++.||+.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999975421 12458999999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l 637 (643)
.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||.+....+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986654322221112234567999999999999999999999999999999 9999998877666555
Q ss_pred hhc
Q 006480 638 VMQ 640 (643)
Q Consensus 638 i~~ 640 (643)
+..
T Consensus 249 ~~~ 251 (314)
T cd05099 249 LRE 251 (314)
T ss_pred HHc
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=287.90 Aligned_cols=192 Identities=29% Similarity=0.455 Sum_probs=170.1
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+|.+.+.||+|+||.||+|.. .+++.||+|++... ......+.+|++++.+++||||++++++|...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999975 47889999998653 344567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997542 36788899999999999999999 999999999999999999999999999997654322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.....||..|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 22357899999999999999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=283.70 Aligned_cols=204 Identities=29% Similarity=0.467 Sum_probs=179.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|... +|+.+++|.++.. ......+.+|++++++++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999876 8899999988642 234678899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.........+++..++.++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987544444568999999999999999999999 8999999999999999999999999999876544
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 221 1123468899999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=285.60 Aligned_cols=211 Identities=28% Similarity=0.492 Sum_probs=177.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CC---CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g---~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
+.|.+.+.||+|+||.||+|.+. ++ ..||||+++.. .....+|..|+.+++.++||||+++++++..++.+++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45788999999999999999864 33 36999998753 45567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 358999999999999999999999 899999999999999999999999999988665
Q ss_pred CCCCCccccCCC---CCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 576 TSSSHITCTDVA---GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 576 ~~~~~~~~~~~~---gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
............ .+..|+|||++.+..++.++|||||||++|||++ |..||...+.......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 433221111111 2457999999999999999999999999999987 99999887665544433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=285.82 Aligned_cols=202 Identities=26% Similarity=0.362 Sum_probs=167.4
Q ss_pred eeeecCceEEEEEEeC---CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 429 LIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.||+|+||.||+|... ++..+++|.++... .....+.+|+.+++.++||||+++++++.+...+++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999754 34578999987643 334578899999999999999999999999899999999999999
Q ss_pred HHHHhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 504 LEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 504 L~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 22356778888999999999999999 8999999999999999999999999999875443322222
Q ss_pred ccCCCCCCCccCcccccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 583 CTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~-------~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
.....++..|+|||++... .++.++|||||||++|||++ |+.||....+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 217 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH
Confidence 2334678899999998642 36889999999999999996 999998765544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=283.15 Aligned_cols=205 Identities=26% Similarity=0.413 Sum_probs=174.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 492 (643)
.+|.+.+.||+|+||.||+|... +++.|++|.+... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999864 6899999988532 23356788999999999999999999998763 568
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999986432 47888999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 216 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA 216 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence 65432111 11223468999999999998899999999999999999999999998765433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=290.02 Aligned_cols=211 Identities=26% Similarity=0.387 Sum_probs=179.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++... +++.|++|.+.... .....+.+|+++++.++||||+++++.+..++.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46889999999999999999865 67899999987543 33567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++... ..+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999654 258899999999999999999999 8999999999999999999999999999864211
Q ss_pred CCC-------------CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 577 SSS-------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~-------------~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
... ........++..|+|||++.+..++.++|||||||++|||++|+.||.+.++......+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 100 001112457889999999999999999999999999999999999999877665554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=286.37 Aligned_cols=207 Identities=27% Similarity=0.440 Sum_probs=177.1
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
|.+.+.||+|+||.||+|... ++..+++|.+... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999865 5778899998654 35567889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99999886432 368999999999999999999999 8999999999999999999999999999875533211
Q ss_pred cccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 582 TCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
......+++.|+|||++. +..++.++|||||||++|||++|++||...++......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 220 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence 223356899999999984 446788999999999999999999999987765544443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=282.00 Aligned_cols=211 Identities=26% Similarity=0.508 Sum_probs=180.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
.+|.+.+.||+|+||.||++.+.++..+|+|.++........|.+|++++++++||||+++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 46788899999999999999887788999999986655556789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999987543 357899999999999999999999 89999999999999999999999999998755432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......++..|+|||++.++.++.++||||||+++|||++ |+.||...........+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence 1112235678999999998999999999999999999998 999998877655554443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=282.77 Aligned_cols=205 Identities=28% Similarity=0.471 Sum_probs=171.2
Q ss_pred eeeecCceEEEEEEeC---CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 429 LIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.++++++||||++++++|. .+.+++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 45679999997643 34567999999999999999999999885 467899999999999
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc-
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT- 582 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 582 (643)
|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987433 368999999999999999999999 8999999999999999999999999999986544322211
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||....+......+.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 111234578999999998899999999999999999996 9999998877665555443
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=280.08 Aligned_cols=204 Identities=27% Similarity=0.482 Sum_probs=173.4
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
++||+|+||.||+|...+++.+|+|.++.. ......+.+|+++++.++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888899999998754 234557889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccC
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (643)
+++.... ..+.+..++.++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++......... ....
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 9986443 357899999999999999999999 89999999999999999999999999998754332211 1112
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 586 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
..++..|+|||++..+.++.++||||||+++|+|++ |..||...........+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~ 207 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 234677999999999999999999999999999999 99999877655443333
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=282.76 Aligned_cols=204 Identities=25% Similarity=0.445 Sum_probs=176.3
Q ss_pred CcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
+|...+.||.|+||.||+|...+++.+|+|.++... .....+.+|+++++.++|+||++++++|.+.+.++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999988889999999986431 2345688999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999653 257899999999999999999999 899999999999999999999999999987653
Q ss_pred CCCC----CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 576 TSSS----HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 576 ~~~~----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 2111 111223568999999999999999999999999999999999999998765433
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=283.46 Aligned_cols=213 Identities=26% Similarity=0.495 Sum_probs=179.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCC---EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~---~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|...+.||+|+||.||+|.+. ++. .+++|.++.. ......+..|+++++.++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999864 333 6899998754 3446778999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999996532 468999999999999999999999 89999999999999999999999999998766
Q ss_pred cCCCCCccc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
......... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~ 224 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 543222111 11223457999999998899999999999999999997 999998877666555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=280.99 Aligned_cols=207 Identities=33% Similarity=0.536 Sum_probs=181.5
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||.|+||.||++.. .|+.+|+|.++......+++.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 35788899999999999999987 57899999998766667889999999999999999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 358999999999999999999999 8999999999999999999999999999987643221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
...++..|+|||++..+.++.++||||||+++|||++ |+.||...+.......+
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 2235678999999998899999999999999999997 99999888766554443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=288.67 Aligned_cols=217 Identities=26% Similarity=0.477 Sum_probs=180.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... ++..+|+|++.... ....++.+|+.+++.++||||++++++|..++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999753 46789999987542 4457799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCC------------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006480 493 LLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~N 554 (643)
+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999996432 112357889999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 555 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875543222111222345677999999998999999999999999999998 889998776655
Q ss_pred HHHhhhc
Q 006480 634 QESLVMQ 640 (643)
Q Consensus 634 ~~~li~~ 640 (643)
....+.+
T Consensus 241 ~~~~~~~ 247 (288)
T cd05050 241 VIYYVRD 247 (288)
T ss_pred HHHHHhc
Confidence 5444443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=285.48 Aligned_cols=205 Identities=29% Similarity=0.461 Sum_probs=178.4
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||++.. .+++.++||.+... .....++.+|+++++.++||||++++++|.+++.++++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999985 48899999988642 234568889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++.........+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987543334568999999999999999999999 8999999999999999999999999999876644
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+...
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 322 11234689999999999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=282.33 Aligned_cols=205 Identities=27% Similarity=0.438 Sum_probs=173.0
Q ss_pred eeeecCceEEEEEEe---CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~---~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
.||+|+||.||+|.+ .+++.+|+|+++.. ....+++..|+.+++.++||||+++++++. ++.+++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 36788999998753 234678999999999999999999999885 56789999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999643 358899999999999999999999 8999999999999999999999999999987654332211
Q ss_pred -ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 583 -CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 583 -~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
.....++..|+|||.+....++.++|||||||++|||++ |+.||.+.+.......+.++
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~ 214 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG 214 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC
Confidence 112234678999999998899999999999999999998 99999988776666665543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.96 Aligned_cols=208 Identities=27% Similarity=0.419 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
++|.+.+.||.|+||.||++... +++.+++|++.... ...+.+.+|+++++.++||||+++++.+...+.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57889999999999999999864 67889999987543 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999986542 358899999999999999999999 8999999999999999999999999999876543221
Q ss_pred CccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
......++..|+|||.+... .++.++|||||||++|||++|+.||...++......
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~ 215 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 12235688899999999876 899999999999999999999999988765554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.77 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=179.3
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV~E 497 (643)
.|.+.+.||+|++|.||++... +++.+++|.+... ....+.+.+|++++++++|||++++++.+.. ++.++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999865 6788999998643 2445678899999999999999999998764 446899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++++|.+++..... ..+++.++..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999975322 458999999999999999999999 89999999999999999999999999999866432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 216 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE 216 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 22 22235689999999999999999999999999999999999999998776555444433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.04 Aligned_cols=210 Identities=27% Similarity=0.363 Sum_probs=189.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCC-EEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~-~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++..+..||-||||.|-+++.+..+ .+|+|++++.. .....+..|-+||...+.|+||+||--|.+..++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566788999999999998865433 48999998643 44567888999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|-|-||.|+..|.... .|.......++.++++|++|||+ ++||+|||||+|.+|+.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999997553 58888999999999999999999 9999999999999999999999999999998876
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. ...+++|||.|.|||++.+...+..+|.||||+++|||++|.+||.+.+|-...++|++|
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG 634 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG 634 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh
Confidence 43 345689999999999999999999999999999999999999999999999999999987
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=284.37 Aligned_cols=213 Identities=26% Similarity=0.439 Sum_probs=179.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-C---CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~---g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
..+|.+.+.||+|+||.||+|... + +..+|+|.++.. ......+..|+.++..++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999753 2 336899998753 3456788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
........ .....++..|+|||++.+..++.++|+|||||++|||++ |+.||......+....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~ 223 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence 54332211 111233568999999999999999999999999999887 999998876655544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=280.99 Aligned_cols=202 Identities=29% Similarity=0.495 Sum_probs=179.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
++|.+.+.||+|+||.||+|... +++.+++|.++.... ..++.+|+++++.++||||+++++++.+...++++|||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888999999999999999876 478999999976544 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ..+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999986433 468999999999999999999999 8999999999999999999999999999986654322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
......++..|+|||++.+..++.++|||||||++|+|++|+.||...++.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~ 205 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh
Confidence 122345889999999999999999999999999999999999999876553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=303.02 Aligned_cols=209 Identities=26% Similarity=0.464 Sum_probs=175.8
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 492 (643)
++|.+.+.||+|+||.||+|.+. .++.||+|+++.. ......++.|+++|..+. ||||++++++|...+.+
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45778899999999999999753 3468999999754 233457889999999997 99999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCC-----------------------------------------------------------
Q 006480 493 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 513 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 513 (643)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred -----------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 514 -----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 514 -----------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
....+++..++.++.||+.||.|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11347888899999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
+++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||......+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 999999999999986543322222233457889999999998899999999999999999998 999998755433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.51 Aligned_cols=204 Identities=27% Similarity=0.440 Sum_probs=175.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+.|.+.+.||.|+||.||+|... +++.+++|++.... .....+..|+.+++.++||||+++++.+..++.+++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999865 68899999987543 55678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999998876432 358999999999999999999999 899999999999999999999999999986543321
Q ss_pred CccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.......+++.|+|||++. ...++.++|||||||++|||++|++||...++..
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 222 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH
Confidence 1222346889999999985 3457889999999999999999999998766443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=285.23 Aligned_cols=206 Identities=28% Similarity=0.433 Sum_probs=180.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||.|++|.||+|... +++.+++|++... ......+.+|+++++.++||||+++++++.++..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 7889999998754 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... .+++..++.++.|++.||.|||+ ++++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998743 68999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
. ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...++......
T Consensus 153 ~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~ 209 (274)
T cd06609 153 S--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL 209 (274)
T ss_pred c--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH
Confidence 1 22235688999999999988899999999999999999999999987765544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.01 Aligned_cols=213 Identities=21% Similarity=0.377 Sum_probs=187.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.-|.+++.||+|.|..|-+|.. -+|..||||++.+.. -....+++|++.|+.++|||||+||++......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3477788999999999988864 389999999997654 345679999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~ 576 (643)
+=.+|+|.++|.... ..+++....+++.||+.|+.|+|+ ..+|||||||+||++.+ -|-+||+|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999997654 468999999999999999999999 88999999999998865 58899999999876655
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
+. ..++.+|...|-|||++.+..|+ +++||||||||||-|+.|++||...++-+....||.-+|
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 43 34457899999999999999998 579999999999999999999999888888888886654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=325.88 Aligned_cols=215 Identities=27% Similarity=0.492 Sum_probs=184.0
Q ss_pred cCcccceeeeecCceEEEEEEeC--CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--~g~----~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.+-.....||+|+||.||+|... +|. .||||.++.. .....+|++|..+|++++||||++++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34566789999999999999854 343 4899999864 567789999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 494 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
+++|||++|+|..+|+..+. .+..++..+.+.++.+||+|+.||++ +++|||||..+|+||+....+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987632 24568899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
|+.+.....+.......-...|||||.|+.+.++.|+|||||||+|||++| |..||.+.+..+....++
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~ 918 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL 918 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH
Confidence 995544333332222233468999999999999999999999999999999 999999998777666443
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=288.07 Aligned_cols=210 Identities=26% Similarity=0.433 Sum_probs=178.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-----------------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIIS 481 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~ 481 (643)
.++|.+.+.||+|+||.||++.... +..+|+|++.... .....+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999987542 2458999987643 45678999999999999999999
Q ss_pred EEeEEEeCCeEEEEEeeCCCCCHHHHhccCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006480 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (643)
Q Consensus 482 l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~N 554 (643)
++++|..++.++++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999975431 12368999999999999999999999 899999999999
Q ss_pred EEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChh
Q 006480 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPK 632 (643)
Q Consensus 555 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt--G~~Pf~~~~~~ 632 (643)
|+++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...+..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876544332222233456789999999998899999999999999999998 78899876544
Q ss_pred h
Q 006480 633 G 633 (643)
Q Consensus 633 ~ 633 (643)
.
T Consensus 241 ~ 241 (296)
T cd05051 241 Q 241 (296)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=281.19 Aligned_cols=205 Identities=32% Similarity=0.517 Sum_probs=175.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEE-eCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~LV~E~~~ 500 (643)
.+|.+.+.||+|+||.||++.. .|+.+++|.++... ..+.+.+|+.+++.++|+|++++++++. .++..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4688899999999999999976 57889999987543 3567899999999999999999999865 4567899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999875432 358899999999999999999999 899999999999999999999999999987554322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 212 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 12345678999999999899999999999999999997 99999877665544433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=289.82 Aligned_cols=209 Identities=25% Similarity=0.422 Sum_probs=174.6
Q ss_pred cCcccceeeeecCceEEEEEEeCC---------------CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPD---------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~---------------g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
++|.+.+.||+|+||.||++.... ...||+|.++.. ......|.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999986532 234899998764 344567999999999999999999999
Q ss_pred EEEeCCeEEEEEeeCCCCCHHHHhccCCC--------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 006480 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (643)
Q Consensus 485 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 556 (643)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11247889999999999999999999 89999999999999
Q ss_pred EcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChhh
Q 006480 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 633 (643)
Q Consensus 557 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt--G~~Pf~~~~~~~ 633 (643)
+++++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||...+...
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999976543322222223345778999999999999999999999999999998 778988765544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=291.96 Aligned_cols=212 Identities=27% Similarity=0.462 Sum_probs=175.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. ++. .+++|.++.. ......+.+|++++.++ +||||+++++++.+++.+++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457889999999999999999864 454 3577777642 34556888999999999 89999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 495 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
||||+++|+|.+++..... ....+++..++.++.||+.||+|||+ ++++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12358899999999999999999999 89999999999999999999
Q ss_pred EEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...+.......+
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9999999986332111 1111234667999999998889999999999999999998 99999877655544433
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.16 Aligned_cols=214 Identities=27% Similarity=0.472 Sum_probs=190.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
....|.+...||+|.|+.|.+|... ++..||||++.++. .....+.+|++++..++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3567889999999999999999754 89999999998753 3345588999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+|.++++|..... ..+.++..++.|+..|++|||+ ++|+|||||.+||||+.+..+||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987653 4457888899999999999999 999999999999999999999999999998776
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
... ...+.+|++.|.|||++++..|+ +++|+||||++||.|+.|..||++.+-++....++.++|
T Consensus 207 ~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 207 YGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY 272 (596)
T ss_pred ccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee
Confidence 433 23447899999999999988775 789999999999999999999999999988888887775
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.50 Aligned_cols=203 Identities=28% Similarity=0.470 Sum_probs=177.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
..+|.+.+.||+|+||.||+|.. .+++.+++|.+.... .....+.+|+.+++.++||||+++++.|..++..++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788999999999999999985 478899999987543 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998532 47899999999999999999999 899999999999999999999999999987554322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~ 223 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 1 1123468899999999998889999999999999999999999998876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=293.79 Aligned_cols=216 Identities=29% Similarity=0.463 Sum_probs=180.8
Q ss_pred cCcccceeeeecCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
.+|.+.+.||+|+||.||++... .+..+|+|+++.. .....++.+|+++++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999642 1236899988753 34567899999999999 7999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.++++|||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999975421 12358899999999999999999999 8999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 637 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~l 637 (643)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986654322222222334567999999999999999999999999999998 9999998877776665
Q ss_pred hhc
Q 006480 638 VMQ 640 (643)
Q Consensus 638 i~~ 640 (643)
+..
T Consensus 249 ~~~ 251 (334)
T cd05100 249 LKE 251 (334)
T ss_pred HHc
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.18 Aligned_cols=202 Identities=26% Similarity=0.420 Sum_probs=172.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|++|.||+|... ++..||+|.++... ...+.+.+|+.+++.++||||+++++++.+++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999865 78999999986532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. ++|.+++..... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888865432 2468999999999999999999999 899999999999999999999999999987554322
Q ss_pred CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
. ......+++.|+|||++.+. .++.++|||||||++|+|++|++||.+...
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~ 207 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE 207 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 1 12223578999999998754 579999999999999999999999987754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.05 Aligned_cols=213 Identities=30% Similarity=0.406 Sum_probs=181.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|...+.||+|+||.||++... +++.+|+|.+.... ...+.+..|++++..++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999865 58999999997543 34567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987432 2468999999999999999999999 8999999999999999999999999999875433
Q ss_pred CCCC---------------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 577 SSSH---------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 577 ~~~~---------------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.... .......||..|+|||++.+..++.++||||||+++|+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2111 1112346889999999999889999999999999999999999999887
Q ss_pred ChhhHHHhhh
Q 006480 630 HPKGQESLVM 639 (643)
Q Consensus 630 ~~~~~~~li~ 639 (643)
+.......+.
T Consensus 236 ~~~~~~~~~~ 245 (316)
T cd05574 236 NRDETFSNIL 245 (316)
T ss_pred chHHHHHHHh
Confidence 7655544433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=288.55 Aligned_cols=209 Identities=24% Similarity=0.422 Sum_probs=175.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-----------------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 482 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l 482 (643)
++|.+.+.||+|+||.||++... ++..+|+|+++.. .....++.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56889999999999999997432 2346899999754 3456789999999999999999999
Q ss_pred EeEEEeCCeEEEEEeeCCCCCHHHHhccCCCC-------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 006480 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (643)
Q Consensus 483 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 555 (643)
++++..++..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998754321 1347888999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChhh
Q 006480 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 633 (643)
Q Consensus 556 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt--G~~Pf~~~~~~~ 633 (643)
|++.++.++|+|||++................+++.|+|||....+.++.++|||||||++|||++ |..||...++..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976544322222222345678999999988899999999999999999998 789998765443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.12 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=168.2
Q ss_pred cceeeeec--CceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 426 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 426 ~~~~LG~G--~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+.++||+| +|++||++.. .+|+.||+|.++.. ......+.+|+++++.++||||++++++|..++.+++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999975 48899999999754 344566778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865322 358899999999999999999999 8999999999999999999999999986543321111
Q ss_pred Cc-----cccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 580 HI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 580 ~~-----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 216 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 216 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh
Confidence 00 0112356788999999976 46899999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=290.57 Aligned_cols=199 Identities=27% Similarity=0.430 Sum_probs=163.1
Q ss_pred ceeeeecCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEEEeeCCC
Q 006480 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 501 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~ 501 (643)
...||+|+||.||+|... +++.||+|.+.... ....+.+|+++++.++||||+++++++.. +..+++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 357999999999999864 45789999987643 23467889999999999999999999854 5678999999864
Q ss_pred CCHHHHhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeecCccc
Q 006480 502 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 572 (643)
Q Consensus 502 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla~ 572 (643)
+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7888775321 123458899999999999999999999 899999999999999 566799999999998
Q ss_pred cccCCCCC-ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 66543221 12234578999999999976 458999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=283.90 Aligned_cols=211 Identities=29% Similarity=0.463 Sum_probs=179.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC------
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~------ 490 (643)
..+++|.+.+.||+|++|.||+|... +++.+++|++.........+.+|+++++++ +||||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35688999999999999999999875 678899999987766667899999999999 7999999999997644
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987644334578999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+...
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 226 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH
Confidence 876543221 1223568999999998853 3578899999999999999999999987654433
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=283.99 Aligned_cols=203 Identities=28% Similarity=0.385 Sum_probs=174.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+...||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++...+.+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999876 68999999986432 234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|++++.|..++... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888776432 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 22 1223467889999999876 468899999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=281.26 Aligned_cols=203 Identities=31% Similarity=0.499 Sum_probs=173.9
Q ss_pred eeeeecCceEEEEEEeC--CC--CEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP--DG--KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~--~g--~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|++|.||+|.+. ++ ..+|+|.+.... ...+.+..|+.++++++||||+++++.+.. +.+++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 36899999999999864 23 368999998654 456789999999999999999999999988 899999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 468999999999999999999999 899999999999999999999999999998765533222
Q ss_pred cc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 582 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 582 ~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||...+......
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 211 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 22 23457889999999999999999999999999999998 999998776554433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=286.01 Aligned_cols=206 Identities=28% Similarity=0.437 Sum_probs=177.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||.|+||.||++... ++..+|+|++.... .....+..|+++++.++||||+++++.+..++.+++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356889999999999999999864 68899999987543 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986533 368999999999999999999999 899999999999999999999999999986554322
Q ss_pred CCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 579 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
. ......+++.|+|||++. ...++.++|||||||++|||++|+.||...++...
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~ 216 (280)
T cd06611 158 Q--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV 216 (280)
T ss_pred c--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH
Confidence 1 122346899999999975 34578899999999999999999999988765443
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.21 Aligned_cols=214 Identities=29% Similarity=0.483 Sum_probs=180.9
Q ss_pred ChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe--
Q 006480 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 488 (643)
Q Consensus 413 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 488 (643)
++.++....+.|.+.+.||.|+||.||+|.+. +++.+|+|++........++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 45556667788999999999999999999864 788999999977666667788999999998 79999999999863
Q ss_pred ----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 489 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 489 ----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
.+.++++|||+++|+|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||+|+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4678999999999999999875432 357888899999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||....+..
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 999999875543211 122356899999999886 3568899999999999999999999998765543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=283.19 Aligned_cols=207 Identities=24% Similarity=0.330 Sum_probs=166.9
Q ss_pred eeeecCceEEEEEEeCCC---CEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 429 LIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~~g---~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.||+|+||.||+|...++ ..+++|.++... ...+.+.+|+++++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 346677766432 456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccc
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 583 (643)
|.+++.........+.+..++.++.||++||.|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333456777888999999999999999 89999999999999999999999999998643322111122
Q ss_pred cCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 584 TDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 584 ~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
....++..|+|||++.. ..++.++|||||||++|||++ |..||...++.+....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 221 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 23568899999998753 246789999999999999997 67899877665544443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=291.31 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=179.4
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
|.+.+.||+|+||.||++.++ +|..+|||.+..+ ....+++.||.|+++.+.|++|++||.|+....+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 667889999999999999754 8999999998654 34678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcc
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 582 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 582 (643)
+..+.++..+ .++++.++..++...+.||+|||. ..-||||||..||||+.+|..||+|||.|..+... ...
T Consensus 114 SiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK 185 (502)
T KOG0574|consen 114 SISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK 185 (502)
T ss_pred cHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence 9999998654 579999999999999999999999 77899999999999999999999999998655432 223
Q ss_pred ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 583 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 583 ~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
-.++.||+.|||||++..-.|+.++||||||++..||..|++||.+-.|
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 3457899999999999999999999999999999999999999998765
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=279.11 Aligned_cols=205 Identities=30% Similarity=0.480 Sum_probs=172.2
Q ss_pred eeeeecCceEEEEEEeC--C--CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~--~--g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|.+. + +..+|+|.+..... ..+++..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999743 2 36899999986553 5678999999999999999999999875 5678999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... .+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997543 58899999999999999999999 899999999999999999999999999998765433222
Q ss_pred cc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 582 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.. ....++..|+|||.+.+..++.++|||||||++|||++ |++||...+.......+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 11 11223567999999999999999999999999999998 9999988776655555443
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=278.28 Aligned_cols=216 Identities=27% Similarity=0.376 Sum_probs=182.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~ 496 (643)
+|.+.+.||.|+||.||++... +++.+++|+++.. ....+.+..|+++++.++||||+++++++.. +..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778899999999999999754 7889999998643 3445678899999999999999999998864 45689999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||+++++|.+++.........+++..++.++.||+.||.|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444567899999999999999999999321 289999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
..... ......+++.|+|||++....++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 54332 12335689999999999998999999999999999999999999998765555444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=279.80 Aligned_cols=205 Identities=27% Similarity=0.433 Sum_probs=174.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 492 (643)
.+|...+.||+|+||.||+|... +++.|++|.+... ......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999988642 1345678899999999999999999999875 3678
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 99999999999999996532 47899999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
........ .......++..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~ 216 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA 216 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence 65432111 11123468899999999999899999999999999999999999998765433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=285.65 Aligned_cols=206 Identities=28% Similarity=0.474 Sum_probs=179.5
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.+|.+.+.||.|++|.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999975 478999999886533 44567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++... .+++.++..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988532 48899999999999999999999 8999999999999999999999999999876543322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...++......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 11234688999999999998999999999999999999999999998776544333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=281.16 Aligned_cols=205 Identities=28% Similarity=0.481 Sum_probs=169.9
Q ss_pred eeeeecCceEEEEEEeC-CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||.||+|.+. ++. .+++|.++.. ......+..|++++.++ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999865 444 4688888743 34567889999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 502 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 502 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975431 12357899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
++....... .......+..|+|||++....++.++|||||||++|||++ |+.||.+.+.......+
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence 985322111 1111234567999999998999999999999999999997 99999887665555444
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=285.65 Aligned_cols=205 Identities=24% Similarity=0.436 Sum_probs=174.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||.||++... +++.||+|.++.. ......+.+|++++.+++||||+++++.+..++.+++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 7899999988653 34457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886532 22468999999999999999999996 1489999999999999999999999999987553322
Q ss_pred CCccccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
. ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 2 224688899999998544 35889999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=277.42 Aligned_cols=205 Identities=28% Similarity=0.505 Sum_probs=174.4
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
+.||+|+||.||++.+.+++.|++|.++... .....+.+|++++++++||||+++++++...+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 3689999999999998779999999987543 35678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccC
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (643)
+++.... ..+++..++.++.+++.||.|||+ ++++||||||+|||++.++.++|+|||++..............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9996542 357899999999999999999999 8999999999999999999999999999976543221111111
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 586 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
..++..|+|||++.++.++.++|||||||++|||++ |..||....+......+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 234667999999998999999999999999999999 89999887765544444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.55 Aligned_cols=193 Identities=25% Similarity=0.388 Sum_probs=165.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.+++.++||||+++++++...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999865 6678999986543 234689999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 94 68888886432 468999999999999999999999 899999999999999999999999999997543322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
. .....||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 223579999999999999999999999999999999998655543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.66 Aligned_cols=207 Identities=27% Similarity=0.462 Sum_probs=172.7
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC-Ce
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NN 491 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 491 (643)
++|.+.+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999963 35788999999753 33456788999999999 689999999988654 56
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC---------------------------------------------------------
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 514 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 514 (643)
+++||||+++|+|.+++......
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 88999999999999998653210
Q ss_pred ------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCC
Q 006480 515 ------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588 (643)
Q Consensus 515 ------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 588 (643)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1246888899999999999999999 8999999999999999999999999999986544332222223346
Q ss_pred CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 589 t~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 287 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc
Confidence 678999999999999999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.34 Aligned_cols=212 Identities=26% Similarity=0.498 Sum_probs=176.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC----EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|...+.||+|+||.||+|.+. +|. .+|+|.+.... ....++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778899999999999999753 444 57899887643 3345788999999999999999999999754 5689
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987543 358899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||.+........++..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 54433323333456788999999999999999999999999999997 9999988766555555443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.92 Aligned_cols=199 Identities=31% Similarity=0.448 Sum_probs=169.2
Q ss_pred cccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~L 494 (643)
|...+.||+|+||+||++.. .++..+|+|+++... .....+.+|+++++.++||||++++++|... ..+++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988652 367889999997643 3567788999999999999999999998753 46899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+|||+++|+|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999643 48999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 575 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 575 ~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
......... ....++..|+|||++....++.++||||||+++|||++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 543322111 12345677999999998899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=279.58 Aligned_cols=202 Identities=27% Similarity=0.500 Sum_probs=174.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
+|.+...||+|++|.||+|... +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4678889999999999999764 68899999886421 223568899999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999654 357889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 572 KWASTSSSH----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 572 ~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+........ .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 217 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH
Confidence 866532111 111234688999999999998999999999999999999999999987654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.89 Aligned_cols=197 Identities=29% Similarity=0.449 Sum_probs=174.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
|.-.+.||.|+||.||.+.+. +...||||.+.- +...+.+++.|+..|++++|||++.+.|+|..+.+.||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455678999999999999764 677899999864 346788999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
| -|+-.|++.-.+ .++-+.++..|+.+.+.||.|||+ ++.||||||..||||++.|.|||+|||.|-...+.
T Consensus 108 C-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 458888876554 478899999999999999999999 88999999999999999999999999998766553
Q ss_pred CCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
..++|||+|||||+|. .+.|+.|+||||||++..||...++|+.+.+.-.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 3468999999999985 7789999999999999999999999999887543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=280.54 Aligned_cols=211 Identities=29% Similarity=0.463 Sum_probs=178.1
Q ss_pred CcccceeeeecCceEEEEEEeCC--CCEEEEEEeCCC-----------hhHHHHHHHHHHHHHh-cCCCceeEEEeEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS-----------EDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 488 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vAVK~l~~~-----------~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 488 (643)
+|.+.+.||+|+||.||+|.... ++.+|+|.+... .....++..|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999998754 678999987532 2345668889998875 799999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++||||+|+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886543334568999999999999999999995 167999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
|++....... ......|+..|+|||++.+..++.++|+||||+++|||++|+.||...+.......+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 225 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI 225 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH
Confidence 9997655432 223456899999999999989999999999999999999999999877654444333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=279.00 Aligned_cols=206 Identities=33% Similarity=0.532 Sum_probs=176.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|+||.||++.. +++.+|+|.++... ....+.+|+.+++.++||||+++++++.. +..+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCC
Confidence 4588899999999999999875 77889999987543 34678899999999999999999999865 457999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 457899999999999999999999 899999999999999999999999999987543321
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.....+..|+|||++.++.++.++|+|||||++|||++ |+.||...+.......+.+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 212 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK 212 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC
Confidence 11234678999999998999999999999999999998 9999998877665555544
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=286.41 Aligned_cols=201 Identities=28% Similarity=0.477 Sum_probs=176.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
..+|.+.+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.+++.++||||++++++|..++.+++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36789999999999999999985 478999999987543 3446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999853 247889999999999999999999 899999999999999999999999999987654332
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
. ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2 12234688999999999999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=276.66 Aligned_cols=213 Identities=25% Similarity=0.391 Sum_probs=182.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.+|++... +|+.|++|.+... ....+++.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999754 7889999998642 34456889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+++|.+.+..... ..+++..++.++.|++.||.|||+ ++++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999875332 357899999999999999999999 899999999999999999999999999987554322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
. ......|++.|+|||++.++.++.++|+|||||++|+|++|+.||...+.......+..+.
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 1 1223468899999999999999999999999999999999999999887766655555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=282.92 Aligned_cols=206 Identities=29% Similarity=0.492 Sum_probs=171.9
Q ss_pred eeeeecCceEEEEEEeCC-------CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~-------g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.||+|+||.||+|...+ ++.+++|.+.... .....+.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999997542 2578999886543 4567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-----cEEEeecCc
Q 006480 499 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 570 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-----~vkL~DFGl 570 (643)
+++++|.+++..... ....+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22458899999999999999999999 8999999999999999887 899999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||...+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~ 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHH
Confidence 976543322222223356788999999999999999999999999999998 999998766544433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=276.14 Aligned_cols=211 Identities=32% Similarity=0.545 Sum_probs=179.9
Q ss_pred cccceeeeecCceEEEEEEeCC-----CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~-----g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
|.+.+.||.|+||.||++...+ +..+|+|+++.... ..+.+..|++++..++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3467889999999999998653 47899999976543 5778999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975432 128999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |++||...+.......+..
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~ 219 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK 219 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 422111 12337789999999988899999999999999999998 8999988776665555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=279.68 Aligned_cols=211 Identities=27% Similarity=0.430 Sum_probs=176.5
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
..+|.+.+.||+|+||.||+|.+.+ ...++||..... ....+.+.+|+.+++.++||||++++++|.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3468889999999999999998543 246899988754 3456789999999999999999999999865 56789
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+|||++.++.++|+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
...... ......++..|+|||.+....++.++|||||||++|||++ |+.||...+.......+.
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~ 222 (270)
T cd05056 158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE 222 (270)
T ss_pred ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 543221 2222345578999999998899999999999999999996 999998877655444443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=282.65 Aligned_cols=201 Identities=25% Similarity=0.444 Sum_probs=171.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|++|.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367889999999999999999865 78999999986532 223457789999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9975 9999887543 368899999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11 1122356889999999875 468999999999999999999999997665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=276.82 Aligned_cols=208 Identities=27% Similarity=0.422 Sum_probs=179.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||.|+||.||+|... ++..+++|++... ......+.+|+++++.++|+||+++++.+...+.+++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999854 7788999998653 23567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++..... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975322 2458899999999999999999999 999999999999999999999999999987665533
Q ss_pred CCc--cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHI--TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~--~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||...++..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~ 214 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh
Confidence 221 12234689999999999877 78999999999999999999999998876543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=280.96 Aligned_cols=206 Identities=23% Similarity=0.377 Sum_probs=177.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||+|.+. +|+.|++|++.... .....+.+|+.+++.++||||+++++++..++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999864 78999999987542 3457889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+ +++|.+++.... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986543 468999999999999999999999 899999999999999999999999999988665432
Q ss_pred CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
. .......|+..|+|||++.+. .++.++|||||||++|||++|++||.+..+.....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~ 211 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA 211 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH
Confidence 1 122234689999999998754 46899999999999999999999998876554443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=276.21 Aligned_cols=201 Identities=29% Similarity=0.456 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
+|...+.||+|+||.||+|... +++.|++|.+.... ...+.+.+|+++++.++||||+++++++..++.++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999876 78999999986432 3567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999643 247899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....+..
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 432 123356899999999998776 9999999999999999999999998765433
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=277.72 Aligned_cols=206 Identities=25% Similarity=0.410 Sum_probs=174.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 492 (643)
.+|.+.+.||+|+||.||+|.+. +++.+++|.+... ......+.+|+++++.++||||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999864 6899999987432 23456788999999999999999999998764 468
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 99999999999999986432 47889999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCC-CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 573 WASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 573 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
....... ........++..|+|||++.+..++.++|+|||||++|+|++|+.||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 6533211 1112235689999999999998999999999999999999999999987654443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=281.72 Aligned_cols=203 Identities=25% Similarity=0.427 Sum_probs=171.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++++|.+.+.||+|+||.||+|... +|+.|++|++.... .....+.+|+++++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999754 78899999986542 33346788999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 67877765432 357788899999999999999999 8999999999999999999999999999875433
Q ss_pred CCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...++
T Consensus 156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 211 12234578999999998754 588999999999999999999999987654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=282.22 Aligned_cols=200 Identities=28% Similarity=0.427 Sum_probs=169.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHH-HHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||++... +|+.||+|.++... ....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46889999999999999999865 78999999997642 334566677775 566789999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|++ |+|.+++.........+++..++.++.||+.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 68988886544444678999999999999999999998 6 899999999999999999999999999876543
Q ss_pred CCCCccccCCCCCCCccCcccccC----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~----~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 221 122468899999998864 4578999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=283.58 Aligned_cols=201 Identities=29% Similarity=0.460 Sum_probs=174.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.|...+.||+|+||.||+|.+. +++.||+|.++.. ....+.+.+|+++++.++||||++++++|..++.+++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666788999999999999764 6788999998743 345567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++.. ..+++..++.++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999998853 257899999999999999999999 8999999999999999999999999999876554221
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....+..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~ 208 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 208 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh
Confidence 2223468899999999999899999999999999999999999998665443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=281.00 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=170.3
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~ 493 (643)
.+|.+.+.||+|+||.||++.. .+++.||+|.++... ...+.+.+|+++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999874 367899999987643 456788999999999999999999998754 34689
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999996543 358999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 574 ASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 574 ~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
.......... ....++..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 6543322211 112345569999999998999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=280.08 Aligned_cols=213 Identities=25% Similarity=0.409 Sum_probs=179.0
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
++|.+...||+|+||.||+|... +.+.+++|.+.... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999853 34679999886543 24678999999999999999999999999989999
Q ss_pred EEEeeCCCCCHHHHhccCCCC-----CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 494 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755422 1268999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
|+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~ 231 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence 9987543322 112223456788999999998889999999999999999999 89999776554444433
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=279.65 Aligned_cols=205 Identities=28% Similarity=0.459 Sum_probs=177.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.|...+.||.|+||.||+|.+. ++..+|+|+++.. ......+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999865 6889999998753 345678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999863 247889999999999999999999 8999999999999999999999999999976544221
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
......++..|+|||++.+..++.++|+|||||++|||++|+.||....+......
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL 212 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh
Confidence 12234688899999999988999999999999999999999999987766544433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=279.53 Aligned_cols=204 Identities=26% Similarity=0.448 Sum_probs=175.2
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
+|...+.||+|++|.||++.. .+++.+|+|++.... ...+.+..|+++++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 478999999986432 245788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCcccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~ 573 (643)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999653 358899999999999999999999 8999999999999998776 599999999876
Q ss_pred ccCCCCC--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 574 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 574 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
....... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 215 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Confidence 6543111 11123468899999999998899999999999999999999999998665433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=277.23 Aligned_cols=194 Identities=26% Similarity=0.448 Sum_probs=166.0
Q ss_pred eeeeecCceEEEEEEeCCCC-----------EEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 428 NLIGKGGSSQVYKGCLPDGK-----------ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
+.||+|+||.||+|.+.+.. .+++|++.........|.+|+.+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999875332 57888887665447889999999999999999999999988 7789999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-------cEEEeecC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 569 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-------~vkL~DFG 569 (643)
||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999997543 268899999999999999999999 8999999999999999888 79999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQ 634 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~ 634 (643)
++...... ....++..|+|||++... .++.++|||||||++|||++ |..||...++...
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 98765431 123567889999999876 79999999999999999999 6888877754433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=274.70 Aligned_cols=209 Identities=25% Similarity=0.364 Sum_probs=179.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||++... +++.+|+|.+... ....+.+.+|+++++.++||||+++++.+...+.+++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788999999999999999764 7888999998653 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~~~~~ 577 (643)
+++++|.+++.... ...+++..+..++.+++.||.|||+ ++++||||+|+||+++++ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997543 2458999999999999999999999 899999999999999855 46899999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.. .....++..|+|||.+....++.++||||||+++|+|++|+.||...+.......+.
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 22 123468899999999998889999999999999999999999998877655544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=276.73 Aligned_cols=206 Identities=29% Similarity=0.461 Sum_probs=167.1
Q ss_pred eeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEEEEEeeCC
Q 006480 428 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 500 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV~E~~~ 500 (643)
+.||+|+||.||+|.+. ++..+|+|.+... ......+.+|+.+++.++||||+++++++.. ++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 3457999998542 3456788899999999999999999998764 556899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997543 346778889999999999999999 89999999999999999999999999998755332111
Q ss_pred --ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 581 --ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 581 --~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
.......++..|+|||++....++.++|||||||++|||++ |.+||...+.......+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 11122346778999999998999999999999999999999 577787766544444333
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.11 Aligned_cols=202 Identities=29% Similarity=0.423 Sum_probs=174.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++.++||||++++++|..++.+++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999875 68999999986532 245678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|++++.|.++.... ..+++.++..++.||+.||.|||+ .+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99998888876533 348999999999999999999999 89999999999999999999999999998765443
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|++||...+..
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~ 207 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI 207 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH
Confidence 22 2233568899999999875 45788999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=283.18 Aligned_cols=203 Identities=28% Similarity=0.410 Sum_probs=174.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
+|.+.+.||+|+||.||+|... +|+.|+||.++... .....+..|+++++.++|+||+++++++.+.+.+++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999865 78999999997543 2345677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+ +|+|.+++.... ..+++..++.++.||++||.|||+ ++|+||||+|+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997543 368999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+.++.+.
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~ 211 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH
Confidence 4322 1222356888999999864 4678999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=282.86 Aligned_cols=200 Identities=24% Similarity=0.379 Sum_probs=169.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||+|... +|+.+++|.++... .....+.+|+++++.++||||+++++++.+.+.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999865 78999999986532 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. ++|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 58888876432 358999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCC-CCCh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPIS-NDHP 631 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~-~~~~ 631 (643)
. ......+++.|+|||++.+. .++.++|||||||++|||++|..||. +.+.
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~ 206 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH
Confidence 1 12234678999999998765 47999999999999999999988854 4443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=274.98 Aligned_cols=212 Identities=25% Similarity=0.375 Sum_probs=179.6
Q ss_pred HHHhhcCcccceeeeecCceEEEEEE-eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 490 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 490 (643)
+....++|.+.+.||+|||+-||++. ..+++.||+|.+.... +..+..++|++..++++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 33456789999999999999999997 5588899999987654 77888999999999999999999999876544
Q ss_pred -eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 491 -~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..||+++|+..|+|.+.+...+..+..+++.+++.|+.+|++||.+||... .++.||||||.|||+++.+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 499999999999999999887777778999999999999999999999944 359999999999999999999999999
Q ss_pred ccccccCCCCC-------ccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 570 LAKWASTSSSH-------ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 570 la~~~~~~~~~-------~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.+....-.-.. .....-..|..|+|||.|. +...+.++|||||||+||+|+.|.-||+..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 98654321110 0011123588999999996 556889999999999999999999999754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=281.72 Aligned_cols=197 Identities=28% Similarity=0.466 Sum_probs=166.8
Q ss_pred ceeeeecCceEEEEEE-eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 427 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.+.||+|+|+.|--+. +.+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||.++..+|||||.|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3679999999998765 5699999999997654 67789999999999885 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeecCccccc--cCCC
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWA--STSS 578 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~~~--~~~~ 578 (643)
|...|+..+ .|++.++..+...|+.||+|||. +||.||||||+|||...-.. +|||||.|+--. ..+-
T Consensus 163 lLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999998764 59999999999999999999999 99999999999999975543 899999886321 1111
Q ss_pred C---CccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 579 S---HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 579 ~---~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+ .....+.+|...|||||+.. ...|+.++|.||||||||-||.|.+||.+.-
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 1 11122357889999999763 3369999999999999999999999998753
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=277.06 Aligned_cols=208 Identities=24% Similarity=0.359 Sum_probs=174.1
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++.+++++.....||+|+||.||+|.+. ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++.+++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999854 67889999887543 456788999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCcccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 573 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~ 573 (643)
||||+++++|.+++..... ....++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975321 1122788889999999999999999 89999999999999976 67999999999876
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
...... ......|++.|+|||++.... ++.++||||||+++|+|++|+.||....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 543221 122245889999999987543 8899999999999999999999997643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=278.73 Aligned_cols=208 Identities=25% Similarity=0.443 Sum_probs=176.7
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+|.+.+.||.|++|.||+|... +|+.||||+++... .....+.+|++++++++||||+++++++.+.+.+++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999875 68899999987543 23466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 89888865432 2468999999999999999999999 8999999999999999999999999999975543221
Q ss_pred CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
......++..|++||++.+. .++.++|||||||++|+|++|+.||.+.+..++...
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 212 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 11234578899999998754 578999999999999999999999998876554443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=285.01 Aligned_cols=206 Identities=28% Similarity=0.422 Sum_probs=173.0
Q ss_pred CcccceeeeecCceEEEEEEeC---CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 493 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 493 (643)
.|.+.+.||+|+||.||+|... +++.||+|.+... ......+.+|+.++..++||||++++++|.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999864 4789999999763 23446778899999999999999999999988 8899
Q ss_pred EEEeeCCCCCHHHHhccCCCC-CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEeec
Q 006480 494 LVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 568 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~DF 568 (643)
+||||+++ +|.+.+...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 777776543322 2368999999999999999999999 89999999999999999 999999999
Q ss_pred CccccccCCCC-CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 569 GLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 569 Gla~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
|++........ ........+++.|+|||++.+. .++.++|||||||++|+|++|++||.+...+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 99986644322 1222345789999999988764 5899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=282.05 Aligned_cols=200 Identities=34% Similarity=0.509 Sum_probs=171.0
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 492 (643)
..|.+.+.||+|+||.||++.+ .+++.||+|.++.. ......+.+|+++++.++||||+++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3577889999999999999873 36788999998754 34456899999999999999999999999875 578
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++++|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986432 358999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 573 ~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
.......... .....++..|+|||++.+..++.++|||||||++|||++++.|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 7654332211 123457778999999998899999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=279.98 Aligned_cols=203 Identities=29% Similarity=0.417 Sum_probs=175.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||+|... +++.|++|.++.. ....+.+.+|+++++.++|+||+++++++..++.+++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999865 6889999998753 2345788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|++++.|..++... ..+++..+..++.||+.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987666555432 348899999999999999999999 89999999999999999999999999998876554
Q ss_pred CCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
.. .......++..|+|||++... .++.++||||||+++|+|++|++||.+.+..
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 208 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI 208 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 32 122345688999999999888 8999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=277.78 Aligned_cols=202 Identities=30% Similarity=0.496 Sum_probs=173.7
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-----------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
+|...+.||.|+||.||+|... +|+.+|+|.++... ...+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999754 78999999875311 12356788999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999754 358899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
++...............|+..|+|||.+.... ++.++|+||||+++|||++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 217 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch
Confidence 97654433222233456889999999988654 89999999999999999999999976544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=283.00 Aligned_cols=201 Identities=28% Similarity=0.427 Sum_probs=175.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|+++++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999854 6889999988643 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++++|.+++... ..+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999988653 2589999999999999999999961 47999999999999999999999999998654332
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.. ....|+..|+|||++.+..++.++|||||||++|+|++|+.||....+
T Consensus 158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11 234689999999999988999999999999999999999999987654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=302.07 Aligned_cols=206 Identities=28% Similarity=0.487 Sum_probs=176.3
Q ss_pred cceeeeecCceEEEEEEeC-CCCEEEEEEeC-----CChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe--EEEEEe
Q 006480 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYD 497 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~-----~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~LV~E 497 (643)
...+||+|+|-+||+|.+. +|.+||--.++ .+.....+|..|+++|+.|+||||+++|+.+.+... +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3457999999999999875 67777743332 345567899999999999999999999999987654 889999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~ 576 (643)
.|..|+|..|++..+. .+...+..|++||++||.|||... -+|||||||-+||+|+ ..|.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999987753 677899999999999999999977 5999999999999997 569999999999988776
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~-~~~~~~~~li~~~ 641 (643)
... ..++|||.|||||++. ..|+..+||||||++++||+|+..||.- .++...+..|..|
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG 259 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG 259 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC
Confidence 432 2368999999999998 7899999999999999999999999975 4566666677665
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=279.70 Aligned_cols=199 Identities=29% Similarity=0.428 Sum_probs=177.7
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
+|.+.+.||.|+||.||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+++|.+++... ..+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999654 368899999999999999999999 89999999999999999999999999998765443
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2 12235688999999999988899999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=278.38 Aligned_cols=203 Identities=28% Similarity=0.472 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC---CCceeEEEeEEEeCCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.|...+.||+|+||.||+|.. .+++.+++|.++.. .....++.+|+.+++.++ |||+++++++|..++.+++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999985 47899999998653 345567889999999996 999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++... .+++..++.++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998542 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
... ......|+..|+|||++.++ .++.++|+|||||++|+|++|+.||.........
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 332 22335689999999998754 5789999999999999999999999887654433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=280.52 Aligned_cols=201 Identities=29% Similarity=0.427 Sum_probs=175.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV~ 496 (643)
++|...+.||.|++|.||++.+. +++.+|+|.+.... ....++.+|+++++.++||||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999874 67889999987543 3567799999999999999999999998653 4789999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++.........+++..+..++.||+.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876544444568999999999999999999999 8999999999999999999999999999875543
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 221 2346788999999999999999999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.49 Aligned_cols=208 Identities=26% Similarity=0.457 Sum_probs=183.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.+...+.+.||+|-||.|.++....+..||||.+++.. +..++|..|+++|.+|+||||+.|+|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34566789999999999999998788999999999864 5578999999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
|++|+|.+++...... .+.-.....|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+++-+....
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999876431 13444556699999999999999 899999999999999999999999999999776666
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt--G~~Pf~~~~~~~ 633 (643)
.+......+-...|||||.+..++++.++|+|+||+++||+++ ...||...+.+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 6666556667889999999999999999999999999999977 899998876544
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=277.02 Aligned_cols=213 Identities=25% Similarity=0.423 Sum_probs=175.0
Q ss_pred cccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC------
Q 006480 424 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 490 (643)
|.+.+.||+|+||.||+|.+. +++.+|||+++.. ....+++.+|+++++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999743 4688999998753 344667889999999999999999999886532
Q ss_pred eEEEEEeeCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 491 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
..+++++|+.+|+|.+++.... .....+++..+.+++.|++.||.|||+ ++|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875332 223457899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
|+++...............+++.|++||.+....++.++|||||||++|||++ |++||.+.+.......+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Confidence 99986644332222223345678999999999999999999999999999999 999998877655544443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=276.55 Aligned_cols=194 Identities=27% Similarity=0.465 Sum_probs=163.3
Q ss_pred eeeeecCceEEEEEEeCC-------------CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 428 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~-------------g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
+.||+|+||.||+|...+ ...+++|++.... .....|..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997431 2358899887644 44567889999999999999999999999989999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-------EEEe
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 566 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~-------vkL~ 566 (643)
+||||+++|+|..++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. ++|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886432 358999999999999999999999 89999999999999987664 8999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCChhh
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 633 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLl-tG~~Pf~~~~~~~ 633 (643)
|||++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.||.......
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 99998654321 2245788999999987 567999999999999999998 5999998765433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=279.62 Aligned_cols=202 Identities=29% Similarity=0.453 Sum_probs=172.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|...+.||.|++|.||+|... +|+.|+||.++... .....+.+|++++++++||||+++++++.+++.+++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788999999999999999865 78999999987532 2345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. ++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 689998865432 468999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
. ......+++.|+|||++.+.. ++.++|||||||++|||+||+.||...+..
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~ 207 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1 122335788999999887644 688999999999999999999999877643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=279.09 Aligned_cols=194 Identities=28% Similarity=0.386 Sum_probs=168.9
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||+|+||+||++... +|+.|++|.+.... .....+..|+++++.++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999754 78999999986532 2345677899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+++..... ..+++.+++.++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 999975433 468999999999999999999999 899999999999999999999999999987654321 122
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
...++..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 34678899999999988899999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-31 Score=275.51 Aligned_cols=204 Identities=30% Similarity=0.480 Sum_probs=176.7
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
|...+.||.|+||.||+|... +++.+|+|++.... .....+.+|++++..++||||+++++++..++.+++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667889999999999999754 78899999986432 445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999999863 247899999999999999999999 999999999999999999999999999987654322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.......++..|+|||++.+..++.++|+|||||++|+|++|..||....+......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 212 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL 212 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH
Confidence 122234688999999999988999999999999999999999999987665444433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.10 Aligned_cols=209 Identities=28% Similarity=0.433 Sum_probs=178.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCC-EEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~-~vAVK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+.|.++..||.|+||.||+|..++.. ..|.|++.. ++....+|+-||+||...+||+|++|++.|+.++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34778889999999999999876544 346788864 4577889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.||-....+-... ..+.+.++.-+++|++.||.|||+ ++|||||||..|||++-+|.++|+|||.+.... ..
T Consensus 112 ~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred CCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 9999888876543 479999999999999999999999 999999999999999999999999999864322 12
Q ss_pred CccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
...-..+.|||+|||||+.+ ...|++++||||||++|.||..+.+|-+..+|-...-.|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi 247 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 247 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence 22334578999999999876 558999999999999999999999999988875444333
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=274.61 Aligned_cols=212 Identities=27% Similarity=0.389 Sum_probs=184.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||++... +++.+++|.+... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999754 7889999998753 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987643334568999999999999999999999 899999999999999999999999999998765542
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
. ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...+.......+..+
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG 216 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 1 2245889999999999999999999999999999999999999988776655555443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=284.38 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=173.6
Q ss_pred cceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
....||+|+||.||++... ++..||||.+.... ...+.+.+|+.+++.++||||+++++.|...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3466999999999999864 78899999986533 445678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccc
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 583 (643)
|.+++.. ..+++.++..++.||+.||.|||+ ++|+||||||+||++++++.++|+|||++........ ..
T Consensus 106 L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 106 LTDIVTH-----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 9998853 247899999999999999999999 8999999999999999999999999999875543222 11
Q ss_pred cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 584 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
....|+..|+|||++....++.++|||||||++|||++|+.||...++.....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~ 228 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR 228 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23468999999999998899999999999999999999999998876654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=284.74 Aligned_cols=202 Identities=27% Similarity=0.432 Sum_probs=173.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
|.....||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..++||||++++++|..++.+++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 333457999999999999864 78999999986532 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|..++.. ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence 999998753 247899999999999999999999 8999999999999999999999999999875543221
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...++....
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 226 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 122356899999999999889999999999999999999999999877654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=307.20 Aligned_cols=201 Identities=20% Similarity=0.222 Sum_probs=161.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCCEEE------------------EEEeCCChhHHHHHHHHHHHHHhcCCCcee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--DGKELA------------------VKILKPSEDVIKEFVLEIEIITTLHHKNII 480 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vA------------------VK~l~~~~~~~~~~~~Ei~il~~l~HpnIv 480 (643)
.++|.+.+.||+|+||+||++... ++...+ .|.++........+.+|+++|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998643 221122 222223334456788999999999999999
Q ss_pred EEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 006480 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (643)
Q Consensus 481 ~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~ 559 (643)
++++++...+..|+|++++. ++|.+++..... .........+..|+.||+.||.|||+ ++||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999994 577777654321 11223456778899999999999999 89999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 006480 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626 (643)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf 626 (643)
++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|..|+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999876543221 122357999999999999999999999999999999999987544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-31 Score=268.07 Aligned_cols=202 Identities=34% Similarity=0.519 Sum_probs=179.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh-HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.|...+.||+|++|.||++... +++.+++|++..... ..+.+.+|+++++.++||||+++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3777899999999999999875 788999999977543 66789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ..+++..+..++.|++.||.|||+ ++++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987543 468999999999999999999999 8999999999999999999999999999876655332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.....++..|+|||++....++.++|+||||+++|+|++|+.||...++..
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 204 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK 204 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 233568999999999998889999999999999999999999998875433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=278.20 Aligned_cols=207 Identities=31% Similarity=0.472 Sum_probs=182.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.+++|...+.||+|++|.||+|.+. +++.+++|++.........+..|+++++.++|+||+++++.+...+..++|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999876 688999999987655667889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999997643 368999999999999999999999 999999999999999999999999999986554322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
. ......++..|+|||++.+..++.++|+|||||++|+|++|+.||...++...
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~ 224 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA 224 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 1 11224578899999999988999999999999999999999999998765443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=278.59 Aligned_cols=194 Identities=26% Similarity=0.444 Sum_probs=162.0
Q ss_pred eeeecCceEEEEEEeC-------------------------CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEE
Q 006480 429 LIGKGGSSQVYKGCLP-------------------------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 482 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~-------------------------~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 482 (643)
.||+|+||.||+|.+. ....+++|++.... .....|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999742 11358899987644 345678899999999999999999
Q ss_pred EeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-
Q 006480 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 561 (643)
Q Consensus 483 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~- 561 (643)
+++|.+.+..++||||+++|+|..++.... ..+++..+..++.||++||.|||+ ++|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986432 357899999999999999999999 8999999999999997643
Q ss_pred ------cEEEeecCccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCChhh
Q 006480 562 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 633 (643)
Q Consensus 562 ------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLl-tG~~Pf~~~~~~~ 633 (643)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3899999987543221 12357888999999875 56899999999999999995 7999998876544
Q ss_pred H
Q 006480 634 Q 634 (643)
Q Consensus 634 ~ 634 (643)
.
T Consensus 230 ~ 230 (274)
T cd05076 230 K 230 (274)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=274.15 Aligned_cols=191 Identities=28% Similarity=0.400 Sum_probs=170.3
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||.|++|.||++... +++.+++|++.... ...+.+.+|+.+++.++||||+++++.+.+++.++++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 58899999986532 3457799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+++.... .+++..+..++.||+.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 99997542 48899999999999999999999 899999999999999999999999999998765432 122
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
...+++.|+|||++....++.++|+||||+++|+|++|..||....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 3468999999999998899999999999999999999999998876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=279.85 Aligned_cols=207 Identities=25% Similarity=0.363 Sum_probs=175.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV 495 (643)
++|.+.+.||.|+||.||+|... +++.+++|.++... .....+.+|++++++++||||+++++++... +.+++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999875 68899999997532 2344677899999999999999999999877 899999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+. ++|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 49999887543 368999999999999999999999 899999999999999999999999999988665
Q ss_pred CCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.... ......+++.|+|||.+.+. .++.++||||||+++|+|++|++||...........
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK 218 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 4321 22334678999999998754 468999999999999999999999998766544433
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=278.48 Aligned_cols=205 Identities=21% Similarity=0.320 Sum_probs=171.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCe-----
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 491 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~----- 491 (643)
++|.+.+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999865 78999999886532 23467888999999995 6999999999987665
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC-CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecC
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 569 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFG 569 (643)
+|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888654332 3568999999999999999999999 89999999999999998 8999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.++.
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9876543222 1122357889999998875 45799999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=287.58 Aligned_cols=205 Identities=25% Similarity=0.340 Sum_probs=175.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 489 (643)
..++|.+.+.||+|+||.||++... +|+.||+|.+... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999864 7899999998642 34456788999999999999999999998643
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588888753 27888999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
+++....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~ 228 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9986644322 2234688999999999999999999999999999999999999998765544433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=277.84 Aligned_cols=192 Identities=28% Similarity=0.389 Sum_probs=160.1
Q ss_pred eeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHH---hcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~---~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.||+|+||.||++... +++.+|+|.+.... .....+.+|..++. ..+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999986532 12233445544443 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 99999988644 358999999999999999999999 8999999999999999999999999999875543221
Q ss_pred ccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 581 ITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
....||..|+|||.+. +..++.++|||||||++|||++|+.||.....
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 2246899999999987 45689999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=279.59 Aligned_cols=209 Identities=27% Similarity=0.402 Sum_probs=172.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 490 (643)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|++++++++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457899999999999999999865 7889999988543 223445678999999999999999999987654
Q ss_pred --eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 491 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 491 --~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
..++||||+. ++|.+.+.... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 48888886432 358999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC--ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 569 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 569 Gla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|++||.+.++.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~ 234 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999866443221 112234678899999988754 47899999999999999999999999877654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=272.19 Aligned_cols=201 Identities=30% Similarity=0.486 Sum_probs=175.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||+|... +++.+++|.++... ...+.+..|+++++.++|+||+++++++...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78899999987653 3677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999753 247889999999999999999999 899999999999999999999999999988665433
Q ss_pred CCcc--ccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 579 SHIT--CTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 579 ~~~~--~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.... .....++..|+|||++.... ++.++||||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 2211 11346889999999998766 8999999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=272.68 Aligned_cols=208 Identities=24% Similarity=0.390 Sum_probs=177.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|+||.||++... +|..+|+|.+... ....+.+.+|+++++.++||||+++++.+...+.+++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788999999999999999865 6889999998653 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~ 577 (643)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 457999999999999999999999 8999999999999999885 4699999998766442
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.. ......|++.|+|||++....++.++|+||||+++|||++|+.||...+.......
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 213 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 21 12234689999999999988999999999999999999999999988765544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=273.40 Aligned_cols=204 Identities=26% Similarity=0.431 Sum_probs=176.7
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||.|+||.||++... +|+.+++|++.... .....+.+|+++++.++||||+++++.+..++.++++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 58999999997643 3566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC-----
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 579 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~----- 579 (643)
.+++.... .+++..+..++.||++||.|||+ ++++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 58999999999999999999999 8999999999999999999999999999875543321
Q ss_pred -CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 580 -HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 580 -~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
........++..|+|||.+....++.++||||||+++|+|++|+.||....+......+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 1122335688899999999988899999999999999999999999998877666655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=276.66 Aligned_cols=205 Identities=24% Similarity=0.394 Sum_probs=171.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|++|.||+|... +|+.|++|.+.... .....+.+|+++++.++||||+++++++...+.+++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47889999999999999999865 78899999986532 344678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~ 576 (643)
|++ ++|.+.+..... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 588888754332 346788889999999999999999 89999999999999985 56799999999976543
Q ss_pred CCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
... ......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..+.
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~ 212 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 221 12234678999999998764 589999999999999999999999988765443
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=270.91 Aligned_cols=201 Identities=24% Similarity=0.432 Sum_probs=178.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|++|.||++... +++.+++|++.... .....+..|++++..++||||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999876 58999999987654 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 4589999999999999999999962 679999999999999999999999999988665433
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
... ....++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 23468899999999999999999999999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.66 Aligned_cols=202 Identities=29% Similarity=0.475 Sum_probs=176.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
++|.+.+.||+|+||.||++... +++.+++|.+.... .....+.+|+.+++.++||||+++++.|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57889999999999999999854 78899999986433 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++... .+++.++..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998642 47899999999999999999999 8999999999999999999999999999875544322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
......+++.|+|||++....++.++|+|||||++|+|++|+.||...++..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~ 222 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 1123468899999999998899999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=280.66 Aligned_cols=210 Identities=28% Similarity=0.412 Sum_probs=176.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.++... .....+.+|+.++++++|+||+++++++... +.+++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999865 68999999986432 2234567899999999999999999998764 56899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+.+ +|.+++.... ..+++.++..++.||+.||.|||+ .+++||||||+||++++++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999964 8988886543 468999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
..... ......+++.|+|||++.+ ..++.++|||||||++|||++|++||.+.++......+.
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 54321 1223346888999999875 568999999999999999999999999888776655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=268.76 Aligned_cols=211 Identities=29% Similarity=0.422 Sum_probs=184.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||.|+||.||++... +++.+++|++.... .....+..|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999865 68899999997542 4567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.........+++..+..++.+++.||.|||+ ++++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654334679999999999999999999999 899999999999999999999999999997665432
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
.......|++.|+|||.+....++.++|+||||+++|+|++|+.||...+.......+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 215 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 1223346899999999999889999999999999999999999999887665544443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=277.33 Aligned_cols=203 Identities=30% Similarity=0.447 Sum_probs=174.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-----CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-----~g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 492 (643)
..|.+.+.||+|+||.||++.+. +++.+|||+++.... ....|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999853 468899999986654 47789999999999999999999999887 5679
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+++|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccc-cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~~~~-~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........... ....++..|+|||.+....++.++||||||+++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 76533222211 12345677999999998899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=284.89 Aligned_cols=204 Identities=26% Similarity=0.440 Sum_probs=171.6
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
.+++|.+.+.||+|+||.||+|.. .+|+.||+|+++.. ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999975 47899999998753 23456788999999999999999999987653 35
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+.+ +|.+.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 8999999964 88887753 258999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 572 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 572 ~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
.......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7654322211 2233578999999998764 56899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=271.19 Aligned_cols=200 Identities=25% Similarity=0.353 Sum_probs=169.0
Q ss_pred eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHH-HhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII-TTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||.|+||.||+|... +|+.||+|++.... .....+..|..++ ...+||||+++++++..++.+++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68899999997543 2223445555544 455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999654 257899999999999999999999 8999999999999999999999999999875433
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 1234688999999999988899999999999999999999999998877665555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=277.90 Aligned_cols=200 Identities=29% Similarity=0.446 Sum_probs=172.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..|...+.||+|+||.||+|... +++.||+|++... .....++.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999865 7899999998642 234567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 57877775432 358999999999999999999999 8999999999999999999999999999875543
Q ss_pred CCCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
. ....+++.|+|||++. ...++.++||||||+++|||++|+.||.+.++...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 2 2246888999999884 45689999999999999999999999988765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=267.61 Aligned_cols=201 Identities=29% Similarity=0.433 Sum_probs=179.1
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV~ 496 (643)
+|...+.||+|++|.||+|... +++.+++|++.... .....+.+|++++++++||||+++++.+... +.++++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999876 78999999987654 4567889999999999999999999999988 8999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999997543 68999999999999999999999 8999999999999999999999999999887665
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
...........++..|+|||.+....++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 433212234578999999999998889999999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=276.45 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=171.0
Q ss_pred CcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
+|.+.+.||+|+||.||++.. .+|+.||+|+++... ...+.+..|++++..+ +|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 378999999997532 2346788899999999 599999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999654 357889999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........ ......|+..|+|||++... .++.++||||||+++|+|++|+.||....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 65432211 12235689999999998753 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=275.14 Aligned_cols=202 Identities=27% Similarity=0.431 Sum_probs=172.3
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
|.+.+.||.|++|.||+|... +|+.|++|++.... .....+.+|+++++.++||||+++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999864 79999999986542 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
+ ++|.+++..... ..+++..++.++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999875432 468999999999999999999999 8999999999999999999999999999875543221
Q ss_pred CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
......+++.|+|||++.+. .++.++||||||+++|+|++|++||...++..
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 207 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 11223568899999988754 57899999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=290.81 Aligned_cols=202 Identities=26% Similarity=0.390 Sum_probs=175.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV 495 (643)
....|.+++.||+||.+.||++...+.+.||+|.+.. +.....-|.+||++|.+|+ |.+|++|+++-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3457889999999999999999987778888876643 4567788999999999995 99999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||= ..+|..+|...... ...| .++.+..||+.|+.++|+ +||||-||||.|+|+- .|.+||+|||+|....
T Consensus 439 mE~G-d~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9986 45999999866542 2334 778899999999999999 9999999999999996 5689999999999998
Q ss_pred CCCCCccccCCCCCCCccCcccccCC-----------CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.+.+...-...+||+.||+||.+... +.++++||||||||||+|+.|++||..-
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 88877777778999999999998633 2668999999999999999999999753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=274.94 Aligned_cols=191 Identities=28% Similarity=0.408 Sum_probs=160.1
Q ss_pred eeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHH---HHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 429 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE---IITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~---il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.||+|+||.||++... +++.||+|++.... .....+..|.. +++...||||+++++++...+.+++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999764 68899999986532 11222344443 4445679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988643 358999999999999999999999 8999999999999999999999999999875543221
Q ss_pred ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 581 ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||....
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 234689999999999754 68999999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=274.46 Aligned_cols=206 Identities=27% Similarity=0.427 Sum_probs=176.5
Q ss_pred cccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
|...+.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999985 478899999886433 3456688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 999999865 247899999999999999999999 89999999999999999999999999988755432211
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.....|++.|+|||.+....++.++|||||||++|||++|+.||...++......+.
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 123468999999999998889999999999999999999999998877655444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=282.67 Aligned_cols=212 Identities=25% Similarity=0.367 Sum_probs=177.5
Q ss_pred ccChHHHHHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEE
Q 006480 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFC 486 (643)
Q Consensus 411 ~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 486 (643)
.....++-..+++|.+.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 334556667889999999999999999999975 478899999997532 2356788999999999999999999988
Q ss_pred EeC------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 487 FED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 487 ~~~------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
... +..+++++++ +++|.+++... .+++..++.++.|+++||.|||+ ++|+||||||+||+++.+
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 156 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence 643 3478888887 78998887532 48899999999999999999999 899999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
+.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999998754332 123468899999999876 578999999999999999999999998776544433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.19 Aligned_cols=208 Identities=31% Similarity=0.449 Sum_probs=180.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||.||++... +|+.+++|++... ......+..|++++.+++ ||||+++++++..++.+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999865 7899999998753 234567889999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997543 68999999999999999999999 899999999999999999999999999987665
Q ss_pred CCCCC------------------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 576 TSSSH------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 576 ~~~~~------------------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
..... .......++..|+|||++....++.++||||||+++++|++|+.||...+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 43321 12223567899999999998889999999999999999999999999876544333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.11 Aligned_cols=199 Identities=29% Similarity=0.465 Sum_probs=175.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|...+.||.|+||.||++... +++.+++|.+... .....++.+|+++++.++||||+++++.+...+.+++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999875 6889999998754 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.... ..+++..+..++.|++.||.|||+ ..+++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997543 468899999999999999999997 3689999999999999999999999999987654322
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.. ...++..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 11 156889999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=272.85 Aligned_cols=206 Identities=28% Similarity=0.421 Sum_probs=175.3
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEEEe
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 497 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV~E 497 (643)
|.+.+.||.|+||.||+|... +++.+|+|.+... ......+.+|+++++.++|||++++++++... +.+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999865 5889999999765 23456788999999999999999999999887 89999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++ +|.+++.... ..+++..++.++.||++||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886442 468999999999999999999999 89999999999999999999999999999866553
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 32 11233457889999998764 4689999999999999999999999988776544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=272.05 Aligned_cols=200 Identities=28% Similarity=0.386 Sum_probs=168.1
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeC--CeEEEEEe
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 497 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~LV~E 497 (643)
|.+.+.||+|+||.||+|... +++.+|+|.++.. .........|+.++.++. ||||+++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999854 7889999998753 222334567888999885 99999999999987 88999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+. |+|.+.+.... ..+++.+++.++.|++.||.|||+ .+++||||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 58888886533 368999999999999999999999 89999999999999999 99999999999866443
Q ss_pred CCCccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.. .....++..|+|||++. .+.++.++|||||||++|||++|.+||.+.++.+.
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~ 207 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH
Confidence 22 12346889999999775 45678999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=264.51 Aligned_cols=200 Identities=32% Similarity=0.505 Sum_probs=177.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+|++++++++|||++++++++.+.+.++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999765 67899999997654 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998654 358999999999999999999999 899999999999999999999999999998665433
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.. .....++..|+|||.+....++.++|||+||+++|+|++|+.||...++
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 21 2335689999999999888899999999999999999999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=274.06 Aligned_cols=195 Identities=25% Similarity=0.413 Sum_probs=163.6
Q ss_pred eeeeecCceEEEEEEeC-C-------CCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 428 NLIGKGGSSQVYKGCLP-D-------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~-~-------g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.||+|+||.||+|... . ...+++|.+.... ...+.+..|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 36899999999999753 2 2348888876543 3456788999999999999999999999998999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------EEEeecCc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 570 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~--------vkL~DFGl 570 (643)
+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. ++|+|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997543 368899999999999999999999 99999999999999987765 69999998
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQ 634 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~~ 634 (643)
+...... ....+++.|+|||++.+ ..++.++|||||||++|||++| ..||...++...
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 8654321 22468889999999986 4589999999999999999998 577776655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=282.79 Aligned_cols=208 Identities=27% Similarity=0.405 Sum_probs=173.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC--CeE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 492 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~~ 492 (643)
..++|.+.+.||+|+||.||+|.+. +|+.+|+|.+... ......+..|+.++.++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567889999999999999999865 6888999988542 23445677899999999 999999999998653 368
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+. ++|.+++... .+.+..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 5999888642 57889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 573 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 573 ~~~~~~~~---~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
........ .......||..|+|||++.. ..++.++|||||||++|+|++|+.||.+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 66543321 22234568999999998864 468899999999999999999999998876554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=276.47 Aligned_cols=202 Identities=18% Similarity=0.208 Sum_probs=156.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CCEEEEEEeCCChhH------------HHHHHHHHHHHHhcCCCceeEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~~~~------------~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
.++|.+.+.||+|+||.||+|...+ +..+++|+....... ......++..+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999998653 456677764322110 011223344556678999999999
Q ss_pred EEEeCC----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 485 ~~~~~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
++.... ..+++++++. .++.+.+... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 876543 3467888774 4677666533 235688899999999999999999 899999999999999999
Q ss_pred CcEEEeecCccccccCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 561 FEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+.++|+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999998664322111 1122469999999999999999999999999999999999999998874
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=275.09 Aligned_cols=208 Identities=28% Similarity=0.414 Sum_probs=173.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 490 (643)
..++|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578999999999999999999875 68899999996532 33456778999999999999999999987654
Q ss_pred -----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 491 -----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 491 -----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
.+++|+||+++ +|...+... ...+++..++.++.||+.||.|||+ .+|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 79999999976 777777643 2468999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++|++||...+.....
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~ 227 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999986654332 11122356788999998864 45789999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=275.37 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=171.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
|...+.||+|+||.||++... ++..+|+|.+... ......+..|+++++.++|||+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999854 7889999998643 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. |+|.+.+.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 58888775432 458999999999999999999999 89999999999999999999999999998654332
Q ss_pred CCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...+.......
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 235 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 235 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 2246889999999974 45789999999999999999999999988765443333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.51 Aligned_cols=197 Identities=26% Similarity=0.321 Sum_probs=164.8
Q ss_pred HHhhcCcccceee--eecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEE
Q 006480 418 LSATSNFLAENLI--GKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 418 ~~~~~~f~~~~~L--G~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 493 (643)
....++|.+.+.+ |+|+||.||++... ++..+|+|++....... .|+.+...+ +||||+++++.|...+.++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 3344566666665 99999999999854 78889999987543111 122222222 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAK 572 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~ 572 (643)
+||||+++++|.+++.... .+++.++..++.||+.||.|||+ .+++||||||+||+++.++ .++|+|||++.
T Consensus 86 iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999997542 68999999999999999999999 8999999999999999998 99999999987
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
...... ...++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 654322 23589999999999999999999999999999999999999986543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=282.96 Aligned_cols=206 Identities=26% Similarity=0.406 Sum_probs=174.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~ 492 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+++.++||||++++++|.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999854 78999999987542 345678889999999999999999998753 3578
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+. |+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 6899988643 348999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCC--ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 573 WASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 573 ~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
........ .......|+..|+|||++.. ..++.++|||||||++|||++|+.||.+.+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~ 220 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH
Confidence 65443221 11223578999999999865 5689999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=288.50 Aligned_cols=207 Identities=27% Similarity=0.437 Sum_probs=174.7
Q ss_pred cceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 426 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
.+++||+|-||+||-|.. ++|+.||||++.+- .....++.+|+.||++++||.||.|--.|...+..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 378999999999999975 58999999999653 24457788999999999999999999999999999999999966
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeecCccccccCCC
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~~~~~~ 578 (643)
.-|+-.|... ...+++..-..+..||+.||.|||. ++|+|.||||+||||... ..+||||||+|+......
T Consensus 648 DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 4444445432 2568888888999999999999999 999999999999999643 469999999999887754
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
-. ..++||+.|+|||+++.+.|+..-|+||.|||+|--++|..||..+ ++.-..|..+-|
T Consensus 722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaF 781 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAF 781 (888)
T ss_pred hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhcccc
Confidence 33 3478999999999999999999999999999999999999999876 334444554443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=265.82 Aligned_cols=209 Identities=27% Similarity=0.428 Sum_probs=173.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++......||.|..|+|++.... +|...|||.+..+. ...++++..++++...+ +|+||+.+|+|..+...++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34556788999999999999754 78899999997654 45678889998877764 8999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
.|.. -++.+|.... .++++..+-++...++.||.||.. .++|||||+||+|||+|+.|.+||||||++..+-.+
T Consensus 172 lMs~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9843 5666665433 468888888999999999999987 378999999999999999999999999999877665
Q ss_pred CCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-hhhHHHhhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDH-PKGQESLVM 639 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~-~~~~~~li~ 639 (643)
..+.. -+|.+.|||||.+. ..+|+-++||||||+.|+||.||+.||.+.+ .-+....|.
T Consensus 246 kAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl 308 (391)
T KOG0983|consen 246 KAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL 308 (391)
T ss_pred ccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence 44433 47999999999986 4479999999999999999999999999854 334444444
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=276.15 Aligned_cols=211 Identities=23% Similarity=0.387 Sum_probs=173.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 489 (643)
.++|.+.+.||+|+||.||+|... +++.+++|++.... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 68899999885432 2234677899999999999999999987543
Q ss_pred -CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 490 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
..+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+ ++|+||||||+|||+++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999965 7877776432 468999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC---------ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 569 GLAKWASTSSSH---------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 569 Gla~~~~~~~~~---------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
|++......... ...+...+++.|+|||++.+. .++.++|||||||++|||++|++||.+.++......+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 112234678899999988754 5899999999999999999999999987765544443
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.33 Aligned_cols=206 Identities=27% Similarity=0.427 Sum_probs=173.6
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc---CCCceeEEEeEEEeCCe-----
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 491 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 491 (643)
|.+.+.||+|+||.||+|... +++.+|+|.++.. ......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999976 5899999999743 22345667788877766 59999999999988776
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
++++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999996 489998865432 358999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
........ .....++..|+|||++.+..++.++|||||||++|||++|++||......+....+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~ 218 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI 218 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence 76644322 12235788999999999999999999999999999999999999988766554444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=280.44 Aligned_cols=201 Identities=25% Similarity=0.415 Sum_probs=169.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 490 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|.++.. ......+.+|+.+++.++||||++++++|... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999864 7899999998643 23456788999999999999999999998754 3
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++|+||+.. +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999964 7776652 248899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+......
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 87653321 23467889999999876 468999999999999999999999999876544433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=294.62 Aligned_cols=197 Identities=28% Similarity=0.435 Sum_probs=169.8
Q ss_pred eeeeecCceEEEEEEeCC-CCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 428 NLIGKGGSSQVYKGCLPD-GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~-g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
-+||+|.||+||-|.+.+ ...+|||-+... .....-+..||.+-++|+|.|||+++|.|.+++++-++||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999998654 456899988643 344566888999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeecCccccccCCCCCcccc
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+|... ..+..=.+..+-.+.+||++||.|||. +.|||||||-+|||++ ..|.+||+|||-++.+..... ...
T Consensus 661 sLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~TE 734 (1226)
T KOG4279|consen 661 SLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CTE 734 (1226)
T ss_pred HHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--ccc
Confidence 999754 333333788889999999999999999 8899999999999996 678999999999988766443 334
Q ss_pred CCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 585 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
++.||..|||||++..+ .|+..+|||||||++.||.||++||....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 57899999999999866 58999999999999999999999997653
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=278.58 Aligned_cols=202 Identities=24% Similarity=0.389 Sum_probs=172.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 490 (643)
..++|.+.+.||+|+||.||++... +|+.||||++... ......+.+|+++++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999754 7899999998642 234567889999999999999999999987653
Q ss_pred -eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 491 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 491 -~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
.+++||||+ +++|.+++.. ..+++..++.++.||++||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 468999999 7799988753 258899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
++....... ....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.....
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 987654321 23467899999999875 46889999999999999999999999987654443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=299.41 Aligned_cols=211 Identities=27% Similarity=0.492 Sum_probs=187.8
Q ss_pred cccceeeeecCceEEEEEEeC-C---CCEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~---g~~vAVK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
..++++||.|.||.||+|.++ . ...||||.+|. .+....+|+.|..||.+.+||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456799999999999999875 2 34699999996 46778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
||++|+|..+|+.+. ..|.+.+..-++++|+.|+.||-+ .++|||||..+|||++.+...|++||||++.+.++
T Consensus 711 yMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999998654 459999999999999999999999 89999999999999999999999999999988765
Q ss_pred CCCccccCCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 578 SSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 578 ~~~~~~~~~~g--t~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
. ...++...| ...|.|||.|.+.+++..+||||||||+||.++ |..||-+.+..+..+.|.+|
T Consensus 785 ~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 785 P-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred C-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 5 222222222 468999999999999999999999999999988 99999999999999988875
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.92 Aligned_cols=196 Identities=28% Similarity=0.456 Sum_probs=170.8
Q ss_pred eeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 428 NLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
..||+|+||.||++.. .++..+|||.+.... .....+.+|+.+++.++||||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5689999999999976 478999999986433 34567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccC
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (643)
+++... .+++..++.++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 987532 47899999999999999999999 8999999999999999999999999999876543321 1123
Q ss_pred CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 586 ~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
..|++.|+|||++....++.++|+|||||++|+|++|+.||.+.....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~ 223 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 223 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 468899999999988889999999999999999999999998776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=271.74 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=179.1
Q ss_pred hhcCcccc-eeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHH-HhcCCCceeEEEeEEEe----CCeE
Q 006480 420 ATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNL 492 (643)
Q Consensus 420 ~~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~ 492 (643)
.+++|.+- .+||-|-.|.|..+..+ +|..+|+|++..+... .+|+++- ..-.|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KA----RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKA----RREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHHH----HhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45566653 57999999999887654 8889999999876543 3466653 34479999999998753 3568
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecC
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFG 569 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFG 569 (643)
.+|||+|+||.|...++..+. ..|++.++-.|..||..|+.|||+ .+|.||||||+|+|.. .|..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987654 579999999999999999999999 9999999999999996 45679999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC----hhhHHHhhhccCC
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH----PKGQESLVMQSQF 643 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~----~~~~~~li~~~~f 643 (643)
+|+.... .....+.+-|++|.|||++...+|+..+|+|||||++|-||.|.+||.... ++++...|+.|||
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc
Confidence 9986553 223445688999999999999999999999999999999999999998765 5789999999987
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.75 Aligned_cols=209 Identities=24% Similarity=0.355 Sum_probs=172.7
Q ss_pred hcCcc-cceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhH---------------HHHHHHHHHHHHhcCCCceeEEE
Q 006480 421 TSNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLL 483 (643)
Q Consensus 421 ~~~f~-~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~---------------~~~~~~Ei~il~~l~HpnIv~l~ 483 (643)
.++|. +.+.||.|+||.||+|.+. +++.||||+++..... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4577999999999999865 7899999998653211 12578899999999999999999
Q ss_pred eEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 484 g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
+++...+..++||||+. |+|.+++... ..+++.....++.|++.||.|||+ .+|+||||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCE
Confidence 99999999999999996 6999998643 358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCC------------CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 564 QLSDFGLAKWASTSS------------SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 564 kL~DFGla~~~~~~~------------~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+|+|||++....... .........+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999997655111 01111223568899999998764 47999999999999999999999999887
Q ss_pred hhhHHHh
Q 006480 631 PKGQESL 637 (643)
Q Consensus 631 ~~~~~~l 637 (643)
+.++...
T Consensus 239 ~~~~~~~ 245 (335)
T PTZ00024 239 EIDQLGR 245 (335)
T ss_pred HHHHHHH
Confidence 6554443
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=272.84 Aligned_cols=202 Identities=26% Similarity=0.367 Sum_probs=166.6
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|...+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++. ||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556778999999999999864 68999999987542 44567889999999996 99999999999999999999999
Q ss_pred CCCCCHHHHhccC-CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
+.. +|.++.... ......+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.++|+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 665543211 11124689999999999999999999971 48999999999999999999999999999765432
Q ss_pred CCCccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.. .....|++.|+|||++... .++.++|||||||++|||++|+.||....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 21 1224689999999999866 68999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=269.40 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=175.4
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
|.+.+.||.|++|.||++... +++.+++|.++... .....+..|+++++.++||||+++++++...+.+++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999865 78899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++ +|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888886532 468999999999999999999999 899999999999999999999999999987665543
Q ss_pred CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..++.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~ 208 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 122334688899999999876 7899999999999999999999999887654443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.98 Aligned_cols=200 Identities=29% Similarity=0.404 Sum_probs=170.9
Q ss_pred CcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 423 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
+|.+.+.||+|++|.||++.. .+++.+|||+++... ...+.+..|++++.++ +||||+++++.+..++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999874 367889999987532 3346788999999999 599999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998643 358899999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
........ ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||....
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 212 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 65443221 112346899999999987665 7889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=275.92 Aligned_cols=202 Identities=25% Similarity=0.405 Sum_probs=172.7
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CC
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 490 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~ 490 (643)
++..++++|.+.+.||.|+||.||++... +++.||+|.+... ....+.+..|+++++.++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999755 8899999987542 2345678899999999999999999999876 56
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
..+++|||+ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||+|+|||+++++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 56898888632 47888889999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....+
T Consensus 155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8754321 122457889999998865 5789999999999999999999999987665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=278.86 Aligned_cols=203 Identities=24% Similarity=0.393 Sum_probs=172.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
.++|.+.+.||+|+||.||++... +++.||||.+... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457999999999999999999854 7899999998753 23456778899999999999999999988654 35
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999995 6898888643 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
....... .......++..|+|||.+.. ..++.++|||||||++|+|++|++||.+.+...
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 216 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 8664432 12223467889999998875 468999999999999999999999998775443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=287.10 Aligned_cols=211 Identities=29% Similarity=0.492 Sum_probs=182.2
Q ss_pred CcccceeeeecCceEEEEEEeC---CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP---DGK--ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~---~g~--~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
...+.+.||.|-||.||+|.+. .|. .||||..|.+ .+..+.|+.|.-++++++||||++|+|+|.+ ...++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 3445678999999999999854 233 4899999874 3567889999999999999999999999966 568999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
||.++-|.|..+|+.++ ..++......++.||..||.|||+ +.+|||||..+|||+....-+||+||||++++.
T Consensus 469 mEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 99999999999998665 468888999999999999999999 999999999999999999999999999999998
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....+... ...-..-|||||-+....++.++|||.|||++||++. |..||.+....+..-.|.+|
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG 608 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG 608 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC
Confidence 76554433 3345667999999999999999999999999999998 99999998776665555544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=299.47 Aligned_cols=145 Identities=31% Similarity=0.447 Sum_probs=131.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......+..|+.++..++||||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367899999999999999999875 7899999999753 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999996542 47889999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=277.34 Aligned_cols=209 Identities=26% Similarity=0.389 Sum_probs=178.9
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-----eEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 493 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 493 (643)
+|.+.+.||.|++|.||+|... +++.+++|.+... ....+.+..|+++++.++||||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999865 5899999998753 334578899999999999999999999998765 789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
++|||++ ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 58988886432 68999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
....... .......+++.|+|||++.+. .++.++||||||+++|+|++|++||.+.+...+...++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV 220 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 6554311 112334688999999999887 89999999999999999999999999887655544443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=269.76 Aligned_cols=198 Identities=29% Similarity=0.479 Sum_probs=169.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
|...+.||+|+||.||+|... +|+.+++|++... ......+..|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999864 7889999998642 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. |+|.+.+.... ..+++.++..++.||+.||.|||+ ++++||||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 58888776432 358999999999999999999999 8999999999999999999999999999864322
Q ss_pred CCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 579 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.....|+..|+|||++. ...++.++|||||||++|||++|++||...++...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~ 228 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 228 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 12346889999999984 46789999999999999999999999988765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=274.65 Aligned_cols=205 Identities=24% Similarity=0.342 Sum_probs=169.3
Q ss_pred CcccceeeeecCceEEEEEEeC-C--CCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC----Ce
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 491 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~--g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 491 (643)
+|.+.+.||+|+||.||++... + +..||+|.+... ....+.+.+|+++++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999864 4 778999998742 23456788999999999 599999999975432 45
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
++++++|+. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999885 6899988643 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 572 KWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 572 ~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~ 219 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHH
Confidence 865432211 11223568999999998765 46899999999999999999999999887654433
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=266.83 Aligned_cols=210 Identities=20% Similarity=0.328 Sum_probs=173.4
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC------ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
+|.+.+.||+|+||.||++... .+..+++|+++. ......++..|+.+++.++||||+++++++.+.+.+++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999764 344566666653 122344677899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++.........+++..++.++.|++.||.|||+ ++++|+||+|+||++++ +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999987544444578999999999999999999999 89999999999999975 569999999987654
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
.... ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 3221 122346889999999998888999999999999999999999999876554443333
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=277.99 Aligned_cols=193 Identities=32% Similarity=0.488 Sum_probs=164.0
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEEeEEEeCC----eEEEEEeeC
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NLLLVYDFL 499 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~LV~E~~ 499 (643)
+.++||+|.||.||+|.+ +++.||||++... ....|..|-+|+.. ++|+||+++++.-.... .++||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 456799999999999999 5599999999743 45678889888876 58999999999865544 799999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhC------CCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+.|+|.++|..+ .++|.+...++..|++||+|||.. ...+|+|||||++|||+.+|++..|+|||||..
T Consensus 291 ~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 291 PKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred cCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 999999999865 489999999999999999999972 336899999999999999999999999999998
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCC-CC-----chhHHHHHHHHHHHHHcCCCCC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-----DKIDVYAFGVVLLELLTGRKPI 626 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s-----~ksDIwSlGvvl~eLltG~~Pf 626 (643)
+...........-+||.+|||||++.+.. +. .+.||||+|.|||||++.-.-+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 87665554444578999999999997553 22 3699999999999999864443
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=269.97 Aligned_cols=205 Identities=28% Similarity=0.423 Sum_probs=173.9
Q ss_pred cCcccceeeeecCceEEEEEEeC---C--CCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~---~--g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 492 (643)
..|.....||+|.||.||+|... + .+.+|+|.++.+. -......+|+.+++.++|||++.|..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 45778899999999999999632 2 3478999998653 234567899999999999999999999987 7889
Q ss_pred EEEEeeCCCCCHHHHhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEee
Q 006480 493 LLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSD 567 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vkL~D 567 (643)
+|++||.+. +|...|+..+. ....++...+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 89998875432 22467888899999999999999999 889999999999999877 8999999
Q ss_pred cCccccccCCCCCc-cccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 568 FGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 568 FGla~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
||+++.+....... ....++-|+.|+|||.+.+. .|+.++||||.|||+.||+|-++-|.+..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999876644333 34456789999999999866 59999999999999999999999998764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.71 Aligned_cols=201 Identities=25% Similarity=0.278 Sum_probs=166.6
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
+.+.+|.|+++.||++.. +++.||||+++.. ......+..|+++++.++||||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344456666666666655 7899999998754 345678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC---
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 579 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~--- 579 (643)
+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 358899999999999999999999 8999999999999999999999999998865432211
Q ss_pred --CccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 580 --HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 580 --~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
........++..|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~ 216 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT 216 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 111123457888999999975 35889999999999999999999999876543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=260.59 Aligned_cols=201 Identities=32% Similarity=0.440 Sum_probs=174.5
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
||.|+||.||++... +++.+++|++.... .....+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 68899999987543 2456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCcccc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 584 (643)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 99997543 58899999999999999999999 899999999999999999999999999987654432 1223
Q ss_pred CCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 585 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 585 ~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 3568999999999998889999999999999999999999998876544444443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=273.34 Aligned_cols=201 Identities=24% Similarity=0.316 Sum_probs=165.5
Q ss_pred eeeeec--CceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G--~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
..||+| +||+||++.+. +|+.||+|++... ....+.+.+|+.+++.++||||++++++|..++.+++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999864 8899999998753 23457788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876432 358899999999999999999999 899999999999999999999999998654322211100
Q ss_pred --c---ccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 582 --T---CTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 582 --~---~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 0 0112356779999999764 57899999999999999999999998765433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.37 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=172.1
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
|.+.+.||.|++|.||+|... +++.++||.+..... ......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999875 578899999865422 2234557999999999 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887543 2468999999999999999999999 8999999999999999999999999999976644322
Q ss_pred CccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 580 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.....++..|+|||++. ...++.++|+||||+++|||++|++||......+.
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~ 207 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH
Confidence 22346889999999885 45689999999999999999999999987765444
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=267.91 Aligned_cols=198 Identities=23% Similarity=0.384 Sum_probs=174.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+..+||+|+|.+|..+.+. +.+.||+|++++. ++.......|-.+..+. +||++|-|+.+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467889999999999999998765 6678999999763 34456666787787765 79999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
|.||++||+|.-.++..+ .++++.++.+..+|..||.|||+ +|||+||||.+|+||+..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999988776554 58899999999999999999999 99999999999999999999999999999854
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
-... ....+++|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||+
T Consensus 402 l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 3321 23345899999999999999999999999999999999999999997
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=287.66 Aligned_cols=209 Identities=27% Similarity=0.445 Sum_probs=183.4
Q ss_pred cceeeeecCceEEEEEEeC--CCC--EEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 426 AENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~--~g~--~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++||+|.||.|++|.+. +|+ .||||+++... ....+|++|+.+|.+|+|||+++|||+..+ ..+.+|||++
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3567999999999999864 555 57999998764 367899999999999999999999999977 7789999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
+.|+|.+.|+.. ....|.......++.|||.|+.||.. +++|||||..+|+||...-.+||+||||.+.+.....
T Consensus 193 plGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 193 PLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred ccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999873 33678889999999999999999999 9999999999999999998999999999998887766
Q ss_pred CccccC-CCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 580 HITCTD-VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 580 ~~~~~~-~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
++.+.. ..-.+.|+|||.+...+++.++|+|+|||+||||+| |..||-+...-....+|-.
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~ 330 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA 330 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc
Confidence 665543 334677999999999999999999999999999999 8999999987766666543
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=268.69 Aligned_cols=200 Identities=29% Similarity=0.460 Sum_probs=167.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +++.||||.++... .....+..|+.++..+. ||||++++++|.+...++++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456888999999999999999876 48999999997542 34566777888777765 999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+. .+|+||||+|+||++++++.+||+|||++.....
T Consensus 94 e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9985 57777765432 3689999999999999999999961 4899999999999999999999999999876543
Q ss_pred CCCCccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.... ....++..|+|||++.... ++.++||||||+++|+|++|+.||...
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 3221 2235788999999987553 889999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=269.06 Aligned_cols=198 Identities=30% Similarity=0.450 Sum_probs=169.5
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.|...+.||+|+||.||+|... ++..+++|.+.. ......++.+|+++++.++|||++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999864 678899998863 23445678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 68888775432 358899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
....+++.|+|||++. ...++.++|||||||++|+|++|+.||...+...
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 221 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH
Confidence 2246889999999985 4568899999999999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=275.60 Aligned_cols=207 Identities=25% Similarity=0.412 Sum_probs=170.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC---------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED--------- 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------- 489 (643)
..+|.+.+.||.|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999864 78899999986543 4456788999999999999999999876543
Q ss_pred -----CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcE
Q 006480 490 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 563 (643)
Q Consensus 490 -----~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~v 563 (643)
..+++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35799999996 589888853 248899999999999999999999 8999999999999997 55678
Q ss_pred EEeecCccccccCCCCCc-cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 564 QLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
+|+|||++.......... ......++..|+|||++.. ..++.++|||||||++|+|++|+.||.+.++.....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999997654321111 1122357889999998754 568899999999999999999999998776544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=277.47 Aligned_cols=207 Identities=32% Similarity=0.522 Sum_probs=176.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--------hhHHHHHHHHHHHHHhcCCCceeEEEeEEE-eC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--------EDVIKEFVLEIEIITTLHHKNIISLLGFCF-ED 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~ 489 (643)
..++|...++||+|||+.||++.+ ...+.||||+-.-. +...+...+|.+|-+.|+||-||++|++|. +.
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345688999999999999999974 47789999986421 244567889999999999999999999986 45
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEe
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 566 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~ 566 (643)
+.+|-|.|||+|.+|.-+|+..+ .+++.+++.|++||+.||.||.... -+|||-||||.||||.+ -|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence 67999999999999999997664 5899999999999999999999865 68999999999999964 4789999
Q ss_pred ecCccccccCCCCCcc-----ccCCCCCCCccCcccccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 567 DFGLAKWASTSSSHIT-----CTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 567 DFGla~~~~~~~~~~~-----~~~~~gt~~Y~APE~l~~~----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
||||++.+..+..... ....+||..|++||.|.-+ +.+.|+||||.|||+|+.+.|+.||..+..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 9999998877654421 2236899999999998744 588999999999999999999999998754
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=266.01 Aligned_cols=202 Identities=27% Similarity=0.436 Sum_probs=174.3
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
|...+.||+|++|.||+|... +++.+++|++... ......+..|+++++.++||||+++++++.+.+.+++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999865 5899999999764 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
+ ++|.+++.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997543 358999999999999999999999 8999999999999999999999999999876544322
Q ss_pred CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
......++..|+|||.+... .++.++|||||||++|||++|++||.+.+..+.
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 207 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ 207 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 12223567889999999866 889999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=252.08 Aligned_cols=207 Identities=28% Similarity=0.389 Sum_probs=171.5
Q ss_pred cceeeeecCceEEEEEE-eCCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 426 AENLIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
....||+|++|.|-+-. ..+|+..|+|.++.. ....+++++|+++..+. .+|++|.++|.++.....++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 45679999999997665 458999999999753 45567888999987654 799999999999999999999999954
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
+|..+...--.....+++..+-+|+..+++||.|||+ ...+||||+||+||||+.+|++||||||++..+..+-.
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 8887766544555678999999999999999999998 37899999999999999999999999999987765432
Q ss_pred cccCCCCCCCccCccccc----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChhhHHHhh
Q 006480 582 TCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISND-HPKGQESLV 638 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~-~~~~~~~li 638 (643)
.+-..|...|||||.+. ...|+-|+||||||+.++||.+++.||..- +|-.|...|
T Consensus 205 -kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 205 -KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred -HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 22246889999999986 337999999999999999999999999875 444444443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=245.97 Aligned_cols=209 Identities=24% Similarity=0.377 Sum_probs=180.2
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+|.-.+.||+|.||+||+|.+. +++.||+|.++-++ .+....++||.+|+.++|.|||++++....++.+.||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999865 67889999987543 4567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
|. .+|..+..... ..+..+..+.+..|+++||.|+|+ +++.||||||.|.||+.+|++||+|||+++...-..
T Consensus 83 cd-qdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 95 48988887544 457888899999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
. .+..-+-|..|++|.++.+.+ |++..|+||.|||+.|+.. |++.|.+.+-.+|...|.|
T Consensus 156 r--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~ 217 (292)
T KOG0662|consen 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_pred E--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence 1 222345789999999998764 8999999999999999987 8999999998888888876
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=274.65 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=173.5
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe----
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 491 (643)
..++|.+.+.||+|++|.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 6789999998653 2345677889999999999999999998766554
Q ss_pred --EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 492 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 492 --~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
+++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+ .+|+||||||+||++++++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999999 6799998864 358999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
++...... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||.+........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~ 226 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK 226 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 98765432 223467889999999865 468899999999999999999999998876654433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=279.22 Aligned_cols=210 Identities=28% Similarity=0.488 Sum_probs=184.8
Q ss_pred CcccceeeeecCceEEEEEEeCC-CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+....++||.|-||.||.|.++. .-.||||.++.+.....+|+.|..+|+.++|||+|+|+|+|..+..+|||+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 34456889999999999998764 45699999998888889999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.++|..... ..++--..+.++.||..|+.||.. +++|||||..+|.|+.++..+|++||||++++..+..
T Consensus 348 GNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-- 420 (1157)
T KOG4278|consen 348 GNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-- 420 (1157)
T ss_pred ccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce--
Confidence 999999986543 446666778899999999999999 9999999999999999999999999999998876432
Q ss_pred cccCCCC---CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 582 TCTDVAG---TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 582 ~~~~~~g---t~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
+..+| ..-|.|||-+.+..++.|+|||+|||+|||+.| |--||.+-+--..+.|+.+|
T Consensus 421 --TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg 482 (1157)
T KOG4278|consen 421 --TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG 482 (1157)
T ss_pred --ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc
Confidence 22233 457999999999999999999999999999999 99999998877777777654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=281.01 Aligned_cols=207 Identities=29% Similarity=0.421 Sum_probs=173.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+..|.+...+|.|+|+.|-++.. .+++..++|++.... .+-.+|+.++... +||||+++.+.|.++.+.|+|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 55677778899999999977764 478899999997652 2334577665554 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE-cCCCcEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl-~~~~~vkL~DFGla~~~~~~ 577 (643)
+.++-|.+.+...+. +. .++..|+++|+.|+.|||. +|||||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999888865432 33 7788899999999999999 999999999999999 69999999999999877654
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh-hHHHhhhccCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMQSQF 643 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~-~~~~li~~~~f 643 (643)
+...+-|..|.|||++....|+.++||||||++||+||+|+.||..-... .....|..++|
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~ 531 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF 531 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc
Confidence 44457799999999999999999999999999999999999999886554 45555554443
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=267.61 Aligned_cols=211 Identities=27% Similarity=0.369 Sum_probs=169.8
Q ss_pred ccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 425 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
+-...||.|+||+|++-.. +.|+..|||.++.. +...++++.|.+...+. +.||||+++|+++.++..|+-||.|.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457799999999999764 58999999999764 35667899999876655 79999999999999999999999995
Q ss_pred CCCHHHHhccC-CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 501 RGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 501 ~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
- +|..+.+.- .-....+++..+-.|+...+.||.||.. ...||||||||+||||+..|.+||||||++..+..+
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 3 666544311 1122457888888999999999999987 478999999999999999999999999998766543
Q ss_pred CccccCCCCCCCccCccccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP-KGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~--~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~-~~~~~li~~~ 641 (643)
...+..+|...|||||.+. ...|+-++|+||||++|||+.||+.||..-+. -+|...|..|
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 2334458999999999996 33599999999999999999999999987654 3344444443
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=285.66 Aligned_cols=215 Identities=27% Similarity=0.468 Sum_probs=187.7
Q ss_pred cChHHHHHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe-
Q 006480 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE- 488 (643)
Q Consensus 412 f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 488 (643)
..++.+...++-|.+.++||.|.+|.||++.. ++++..|+|++....+.-.++..|.+||+.+ +|||++.++|+|..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34455556677899999999999999999974 4888999999998887778888899999988 69999999999975
Q ss_pred ----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 489 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 489 ----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
++.+|||||||.+|+..|+++... ...+.|..+..|+.++++||.+||+ ..+||||||-.|||++.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEE
Confidence 568999999999999999998766 5679999999999999999999999 8899999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
|+|||++..+.... ..-.+.+||+.|||||++... .|+.++|+||||++..||-.|.+|+.+..|.-
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 99999986554432 233456899999999999633 58889999999999999999999999988743
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=309.06 Aligned_cols=191 Identities=30% Similarity=0.566 Sum_probs=164.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
..|...+.||+|+||.||+|.. .+++.||||.++..... ...|++++++++||||++++|+|.+.+..++||||++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~ 766 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIE 766 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCC
Confidence 4567788999999999999986 58899999998754322 1246889999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.++++ .++|..+..++.||++||+|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 767 ~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 767 GKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 999999995 27899999999999999999996545899999999999999999998886 6665433221
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
....+|+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 1236889999999999999999999999999999999999999643
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=309.42 Aligned_cols=205 Identities=26% Similarity=0.386 Sum_probs=173.6
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.+-+|.-...||.|.||.||-+.+ ++|...|+|.++-.. ...+.+.+|+.+|..++|||+|+++|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 344677788999999999999985 478888999886543 3456678899999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
||||.+|+|.+.+...+ ..++.....+..|++.||.|||+ +|||||||||.||+|+.+|.+|+.|||.|....
T Consensus 1313 MEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999997543 34566667789999999999999 999999999999999999999999999998765
Q ss_pred CCCC--CccccCCCCCCCccCcccccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 576 TSSS--HITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 576 ~~~~--~~~~~~~~gt~~Y~APE~l~~~---~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.... ........||+-|||||+|.+. .-..+.||||||||++||+||+.||...+.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 5321 1122346899999999999854 456789999999999999999999987654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=253.79 Aligned_cols=181 Identities=24% Similarity=0.271 Sum_probs=155.7
Q ss_pred cCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccC
Q 006480 433 GGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511 (643)
Q Consensus 433 G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~ 511 (643)
|.+|.||++.+. +++.||+|.++.... +..|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999865 788999999976532 334555556667999999999999999999999999999999998654
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCC
Q 006480 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (643)
Q Consensus 512 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 591 (643)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++...... .....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 2 48899999999999999999999 89999999999999999999999999987655432 122356778
Q ss_pred ccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 592 Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 99999998888999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=294.23 Aligned_cols=195 Identities=30% Similarity=0.487 Sum_probs=160.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe---------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--------- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------- 488 (643)
..+|...++||+||||.||++.++ ||+.||||.+.-. ......+.+|+.+|.+|+|||||+++..+.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 456777889999999999999977 9999999998754 5667789999999999999999999732100
Q ss_pred ---------------------------------------------------------------------C----------
Q 006480 489 ---------------------------------------------------------------------D---------- 489 (643)
Q Consensus 489 ---------------------------------------------------------------------~---------- 489 (643)
+
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHH
Q 006480 490 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538 (643)
Q Consensus 490 -------------------------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH 538 (643)
-.+||-||||+.-.|.+++..+.... .....+.++++|++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHH
Confidence 13689999999988888887554211 36778999999999999999
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc----------------CCCCCccccCCCCCCCccCcccccCC-
Q 006480 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----------------TSSSHITCTDVAGTFGYLAPEYFMYG- 601 (643)
Q Consensus 539 ~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~Y~APE~l~~~- 601 (643)
+ +|||||||||.||+|+++..+||+|||+|.... .+......+..+||.-|+|||++...
T Consensus 715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 999999999999999999999999999997611 01111234457899999999999855
Q ss_pred --CCCchhHHHHHHHHHHHHHc
Q 006480 602 --KVNDKIDVYAFGVVLLELLT 621 (643)
Q Consensus 602 --~~s~ksDIwSlGvvl~eLlt 621 (643)
.|+.|+|+||||||||||+.
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999984
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=283.84 Aligned_cols=212 Identities=27% Similarity=0.478 Sum_probs=188.5
Q ss_pred cccceeeeecCceEEEEEEe-CCC----CEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCL-PDG----KELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~-~~g----~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
...+++||+|+||+||+|.+ +.| -+||+|++.... ....+++.|.-+|..++|||+++|+|+|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34468899999999999974 444 368999987543 45788999999999999999999999998754 89999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
+||+.|.|.++++..+ ..+.-...+.|..|||+||.|||. +.++||||-.+|||+..-.++||.|||+|+.+..
T Consensus 777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 9999999999998765 467888999999999999999998 9999999999999999999999999999999988
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
+...+......-.+.|||=|.+....|+.++|||||||++||++| |..|+.+...++...++..|.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge 917 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE 917 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence 777776655556778999999999999999999999999999999 999999999999988887763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=242.44 Aligned_cols=211 Identities=33% Similarity=0.462 Sum_probs=180.2
Q ss_pred cccceeeeecCceEEEEEEeCC-CCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 424 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
|.+.+.||.|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+..++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999998764 88999999986542 57789999999999999999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++..... .+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999975432 17899999999999999999999 89999999999999999999999999998876554211
Q ss_pred ccccCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC--CChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPISN--DHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~--~~~~~~~~li~~~ 641 (643)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+...+...+..+
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFG 217 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcC
Confidence 12234678899999999 677788899999999999999999999988 3344566666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=264.49 Aligned_cols=202 Identities=22% Similarity=0.351 Sum_probs=176.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC--CC----ceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH--HK----NIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~--Hp----nIv~l~g~~~~~~~~~ 493 (643)
+++|.+..++|+|.||.|....+. .+..||||+++.-.......+-|+++|.++. .| -++++.+||...++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678999999999999999998754 5688999999987777788889999999994 33 3889999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--------------
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 559 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-------------- 559 (643)
+|+|.+ |-++.++|..+.. .+|+...++.++.|+++++.|||+ .+++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 6699999987654 578999999999999999999999 89999999999999942
Q ss_pred ------CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 560 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
+..++|+|||.|..-.... ..++.|..|+|||+|.+-.|+.++||||+||||+||.||..-|..-+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999997655433 34679999999999999999999999999999999999999998766444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=270.53 Aligned_cols=199 Identities=24% Similarity=0.361 Sum_probs=171.6
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhH---------HHHHHHHHHHHHhcC---CCceeEEEeE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------IKEFVLEIEIITTLH---HKNIISLLGF 485 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~---------~~~~~~Ei~il~~l~---HpnIv~l~g~ 485 (643)
.....|.....+|+|+||.|+.+.++ +...|+||.+.++.-. .-.+-.||.||..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34456889999999999999999876 5667999999875422 123456999999997 9999999999
Q ss_pred EEeCCeEEEEEeeCC-CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 486 CFEDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 486 ~~~~~~~~LV~E~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
|.+++++||+||-.. +-+|.+++..+. .+++.++..|++||+-|+.+||+ ++|||||||.+|+.++.+|.+|
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~k 710 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVK 710 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEE
Confidence 999999999999874 459999997654 58999999999999999999999 9999999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCC
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
|+|||.|.+...++ ...+.||.+|.|||++.+.+|- ..-|||+||++||.++...-||.+
T Consensus 711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999987655443 2346899999999999998875 559999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=255.15 Aligned_cols=211 Identities=30% Similarity=0.461 Sum_probs=176.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--------C
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--------D 489 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 489 (643)
+.|.-..+||+|.||.||+|.. ++|+.||+|++-- .+-.-...++|+++|..|+|+|++.++++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455567899999999999974 4778888876522 22334567899999999999999999998853 2
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..+||||++|+. +|.-+|.... ..|+..++.++..++..||.|+|+ ..|+|||+|+.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence 358999999977 8888886432 578999999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCC--CccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 570 LAKWASTSSS--HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 570 la~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+++.++.... ...+++.+-|..|++||.+.+ ..|+++.|||+.|||+.||+||.+-|.+++...+..+|.
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 9987655322 223556678999999998874 579999999999999999999999999999888877775
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=257.17 Aligned_cols=205 Identities=32% Similarity=0.493 Sum_probs=168.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEEeEEEeCC----eE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NL 492 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~ 492 (643)
....+..+.+.||+|.||.||+|.+ .|..||||++...++ ..+.+|.+|++. |+|+||+.+++.=..++ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4456677889999999999999988 778899999986543 567789999987 49999999998754332 58
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHh-----CCCCCeEecCCCCCCEEEcCCCcEEEee
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~iiHrDLKp~NILl~~~~~vkL~D 567 (643)
+||.+|.+.|+|.|+|... .++....++++..+|.||++||. .+.-.|.|||||++|||+..++...|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999753 58889999999999999999996 2335699999999999999999999999
Q ss_pred cCccccccCCCCC--ccccCCCCCCCccCcccccCCCC-----C-chhHHHHHHHHHHHHHc----------CCCCCCCC
Q 006480 568 FGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYGKV-----N-DKIDVYAFGVVLLELLT----------GRKPISND 629 (643)
Q Consensus 568 FGla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~-----s-~ksDIwSlGvvl~eLlt----------G~~Pf~~~ 629 (643)
+|||-........ ......+||.+|||||++..... + ..+||||||.|+||+.- -++||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999876654322 33445789999999999875431 1 25999999999999964 25788764
Q ss_pred Ch
Q 006480 630 HP 631 (643)
Q Consensus 630 ~~ 631 (643)
-|
T Consensus 440 Vp 441 (513)
T KOG2052|consen 440 VP 441 (513)
T ss_pred CC
Confidence 43
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=278.18 Aligned_cols=216 Identities=28% Similarity=0.451 Sum_probs=179.7
Q ss_pred CcccceeeeecCceEEEEEEeC----C----CCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~----~----g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 491 (643)
+..+.+.||+|+||.|++|... . ...||||.++... ...+.+..|+++++.+ +||||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3445569999999999999732 1 3568999998643 4578899999999998 69999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCC---CCC---------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 006480 492 LLLVYDFLSRGSLEENLHGNK---KDP---------AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~---~~~---------~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~ 559 (643)
+++|+||+..|+|.++|...+ ... ..++..+.+.++.|||.|+.||++ .++|||||..+|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999998776 100 238889999999999999999999 89999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccCCCC--CCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC-hhhHH
Q 006480 560 DFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH-PKGQE 635 (643)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~-~~~~~ 635 (643)
+..+||+|||+|+........... .-.| ...|||||.+....|+.|+|||||||+||||+| |..||.+.. ..+..
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999999866554433211 1122 345999999999999999999999999999999 999999855 45555
Q ss_pred HhhhccC
Q 006480 636 SLVMQSQ 642 (643)
Q Consensus 636 ~li~~~~ 642 (643)
..+..|+
T Consensus 533 ~~l~~G~ 539 (609)
T KOG0200|consen 533 EFLKEGN 539 (609)
T ss_pred HHHhcCC
Confidence 5666553
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=255.82 Aligned_cols=207 Identities=24% Similarity=0.404 Sum_probs=175.6
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----CeEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLLL 494 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~L 494 (643)
...++.||-|+||.||.+.++ +|+.|+.|.+..- -...+.+.+|+.+|.-.+|.|++..+++.+-. .++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 456788999999999999876 8999999988642 24567899999999999999999999886543 35788
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++|.|.. +|...+-. +..++-+.+.-++.||++||.|||+ .+|.||||||.|.|++.+..+||||||+|+..
T Consensus 135 ~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 9999865 77777643 3568888888899999999999999 99999999999999999999999999999866
Q ss_pred cCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
..+... .++.-+-|.+|+|||++++. .|+..+||||.|||+.||+..+..|...+|-.+..+|.
T Consensus 207 e~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lIt 271 (449)
T KOG0664|consen 207 DQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMII 271 (449)
T ss_pred chhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHH
Confidence 554332 33444678999999999966 69999999999999999999999999999988888774
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=268.99 Aligned_cols=232 Identities=26% Similarity=0.316 Sum_probs=196.1
Q ss_pred HhHhhhhcccccccChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-
Q 006480 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH- 476 (643)
Q Consensus 399 ~~l~~~~~~~~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H- 476 (643)
..+.+.+...---|.+.-......+|.+....|+|-||+|.+|.+. .|..||||++...+.+.+.=+.|++||++|+.
T Consensus 409 ~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 409 PGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDA 488 (752)
T ss_pred CccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhcc
Confidence 3344444443334444444455678999999999999999999765 57899999999999999999999999999963
Q ss_pred -----CceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006480 477 -----KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (643)
Q Consensus 477 -----pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 551 (643)
-|+++|+-.|...+++|||+|.+ ..+|.+.|+..+.. ..|....+..++.|+..||..|.+ .+|+|.|||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIK 563 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIK 563 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh---cCeeecccC
Confidence 48999999999999999999998 56999999877543 568888999999999999999999 899999999
Q ss_pred CCCEEEcCC-CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 552 SSNILLSDD-FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 552 p~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
|+|||+++. ..+||||||.|...... ..+++.-...|.|||++.+..|+...|+||.||+||||.||+..|.+.+
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred ccceEeccCcceeeeccCccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999999865 56899999999766542 2233445677999999999999999999999999999999999999999
Q ss_pred hhhHHHhhh
Q 006480 631 PKGQESLVM 639 (643)
Q Consensus 631 ~~~~~~li~ 639 (643)
...+..+.|
T Consensus 640 NN~MLrl~m 648 (752)
T KOG0670|consen 640 NNQMLRLFM 648 (752)
T ss_pred cHHHHHHHH
Confidence 988887765
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=240.01 Aligned_cols=204 Identities=22% Similarity=0.406 Sum_probs=172.1
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeC--CeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~LV 495 (643)
..++|++.+.+|+|-++.||.|.. .++..++||++++-. .+.+.+|+.||..|. ||||++|+++..+. ....||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 356899999999999999999974 477889999998754 467889999999997 99999999998763 568899
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 574 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~~ 574 (643)
+||+.+.+...+. ..++...++.++.+++.||+|+|+ .||+|||+||.|++|+.. -.++|+|+|||.++
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998877665 347778899999999999999999 999999999999999854 56999999999988
Q ss_pred cCCCCCccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCC-CCChhhHHHhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPIS-NDHPKGQESLV 638 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~-~~~~~~~~~li 638 (643)
.+.... .-.+.+..|-.||.+. ...|+..-|+|||||+|..|+..+.||- +.+..+|...|
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkI 246 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKI 246 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHH
Confidence 765432 2346788999999886 6689999999999999999999887764 55555555544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=267.14 Aligned_cols=205 Identities=22% Similarity=0.340 Sum_probs=155.4
Q ss_pred hhcCcccceeeeecCceEEEEEEe-----------------CCCCEEEEEEeCCCh-hHHHHH--------------HHH
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSE-DVIKEF--------------VLE 467 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vAVK~l~~~~-~~~~~~--------------~~E 467 (643)
..++|.+.++||+|+||.||+|.+ ..++.||||.++... ....+| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999963 245679999987543 222233 346
Q ss_pred HHHHHhcCCCce-----eEEEeEEEe--------CCeEEEEEeeCCCCCHHHHhccCCC--------------------C
Q 006480 468 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 514 (643)
Q Consensus 468 i~il~~l~HpnI-----v~l~g~~~~--------~~~~~LV~E~~~~gsL~~~l~~~~~--------------------~ 514 (643)
+.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 677777753 3568999999999999999975321 0
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccC
Q 006480 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594 (643)
Q Consensus 515 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~A 594 (643)
...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 1235678899999999999999999 8999999999999999999999999999975543221 11112235889999
Q ss_pred cccccCCC--------------------C--CchhHHHHHHHHHHHHHcCCC-CCCC
Q 006480 595 PEYFMYGK--------------------V--NDKIDVYAFGVVLLELLTGRK-PISN 628 (643)
Q Consensus 595 PE~l~~~~--------------------~--s~ksDIwSlGvvl~eLltG~~-Pf~~ 628 (643)
||.+.... | ..+.||||+||++|+|++|.. ||.+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99886432 1 235799999999999999985 7764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=237.80 Aligned_cols=189 Identities=34% Similarity=0.515 Sum_probs=166.8
Q ss_pred CceEEEEEEeC-CCCEEEEEEeCCChh-H-HHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhcc
Q 006480 434 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 510 (643)
Q Consensus 434 ~~g~Vy~~~~~-~g~~vAVK~l~~~~~-~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~ 510 (643)
+||.||+|... +|+.+++|++..... . .+.+.+|++.++.++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999876 589999999976432 2 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCC
Q 006480 511 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590 (643)
Q Consensus 511 ~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~ 590 (643)
.. .+++..++.++.+++++|.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 43 28899999999999999999999 899999999999999999999999999998765532 223456889
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC-CChh
Q 006480 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPK 632 (643)
Q Consensus 591 ~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~-~~~~ 632 (643)
.|++||.+....++.++|||+||+++|+|++|..||.. .+..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~ 193 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL 193 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999988999999999999999999999999987 4433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=268.98 Aligned_cols=202 Identities=19% Similarity=0.264 Sum_probs=144.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-C----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeE------EEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 488 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~----g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~------~~~ 488 (643)
..++|.+.+.||+|+||.||+|.+. + +..||+|.++..... ..+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4578999999999999999999865 4 689999998653321 111111 1222222222222211 245
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCC----------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 552 (643)
+..+++||||+.+++|.+++...... ........+..++.||+.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 67899999999999999998743210 0111234466799999999999999 8999999999
Q ss_pred CCEEEcC-CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC----------------------CCCchhHH
Q 006480 553 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----------------------KVNDKIDV 609 (643)
Q Consensus 553 ~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----------------------~~s~ksDI 609 (643)
+|||++. ++.+||+|||+|+.+..... .......+|+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 58999999999986544322 223446789999999976422 24456799
Q ss_pred HHHHHHHHHHHcCCCCCCC
Q 006480 610 YAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 610 wSlGvvl~eLltG~~Pf~~ 628 (643)
|||||+||||+++..|+..
T Consensus 363 wSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHHHHhCcCCCch
Confidence 9999999999998777554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=245.26 Aligned_cols=145 Identities=20% Similarity=0.326 Sum_probs=121.6
Q ss_pred ccccccChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----C---C
Q 006480 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---K 477 (643)
Q Consensus 407 ~~~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-----H---p 477 (643)
..+..-...+.. ...+|.+.++||-|.|++||++.+. +.+.||+|+.+......+..+.||++|++++ | .
T Consensus 64 GGYHpV~IGD~F-~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVF-NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccc-cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 334433334432 2468999999999999999999864 6678999999998888899999999999984 3 3
Q ss_pred ceeEEEeEEEe----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006480 478 NIISLLGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (643)
Q Consensus 478 nIv~l~g~~~~----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~ 553 (643)
+||+|+++|.. +.++|+|+|++ |.+|..+|..... ..++...+.+|+.||+.||+|||.. .+|||-||||+
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPE 217 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPE 217 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcc
Confidence 69999999975 45899999999 7799999976544 4578899999999999999999985 58999999999
Q ss_pred CEEE
Q 006480 554 NILL 557 (643)
Q Consensus 554 NILl 557 (643)
||||
T Consensus 218 NvLl 221 (590)
T KOG1290|consen 218 NVLL 221 (590)
T ss_pred eeee
Confidence 9998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=238.38 Aligned_cols=205 Identities=25% Similarity=0.359 Sum_probs=173.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 490 (643)
..+|.....+|.|+- .|..+.+. .++.||+|.+... ....++..+|..++..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788899998 66666544 7889999887532 34567788999999999999999999998643 3
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
..|+|||+|. .+|...++. .++-..+..|+.|++.|+.|||+ .+|+||||||+||++..++.+||.|||+
T Consensus 95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 5799999994 589888862 35667888999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|+..... ..+++.+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+.-++..+|.
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~ 230 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKII 230 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHH
Confidence 9865543 45677899999999999998889999999999999999999999999988777776664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-27 Score=259.61 Aligned_cols=210 Identities=26% Similarity=0.440 Sum_probs=167.9
Q ss_pred cccceeeeecCceE-EEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 424 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 424 f~~~~~LG~G~~g~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
|...+.+|.|.-|+ ||+|.. +|+.||||.+-.+- ..-..+||..|+.. .||||+++++.-.+...+|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 34456789999987 499998 78999999885432 23456899999988 59999999999999999999999994
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---C--CcEEEeecCccccccC
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 576 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~--~~vkL~DFGla~~~~~ 576 (643)
.+|.+++.....+.....-...+.+..|++.||++||+ .+||||||||.||||+- + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 59999998742221222224557789999999999999 89999999999999975 3 4689999999998876
Q ss_pred CCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~~~~li~~~~ 642 (643)
+..... .....||-+|+|||++....-+..+||||||||+|+.++| .+||.+.. ..+.-|..++
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~ 729 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGN 729 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCc
Confidence 544332 3456899999999999998888999999999999999995 99998753 3444444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=233.64 Aligned_cols=226 Identities=23% Similarity=0.338 Sum_probs=189.1
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeE
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~ 485 (643)
.+++.....++....++-+|.||.||+|.+. +.+.+.+|.++.. ......++.|--++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3466666677888889999999999999643 3456778888754 3456788899999999999999999999
Q ss_pred EEe-CCeEEEEEeeCCCCCHHHHhccCC----CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 486 CFE-DNNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 486 ~~~-~~~~~LV~E~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
+.+ ....+++|.++.-|+|..+|...+ .....++..+...++.|++.|++|||+ ++|||.||..+|.+|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 876 467899999999999999998332 223456777888899999999999999 999999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
..+||+|=.|++.+-+...+.-...--....||+||.+.+..|+..+|+|||||+||||+| |+.||..-+|.+++..+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999986655443322222334667999999999999999999999999999999 999999999999999888
Q ss_pred ccC
Q 006480 640 QSQ 642 (643)
Q Consensus 640 ~~~ 642 (643)
.|.
T Consensus 513 dGy 515 (563)
T KOG1024|consen 513 DGY 515 (563)
T ss_pred ccc
Confidence 764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=210.74 Aligned_cols=182 Identities=37% Similarity=0.648 Sum_probs=160.5
Q ss_pred eeecCceEEEEEEeC-CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHH
Q 006480 430 IGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 506 (643)
||+|.+|.||++... +++.+++|++..... ....+.+|+++++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999875 489999999987654 36789999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccccCCCCCccccC
Q 006480 507 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 585 (643)
Q Consensus 507 ~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 585 (643)
++.... ..+++..++.++.+++.+|.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 358899999999999999999999 89999999999999999 89999999999976655321 1223
Q ss_pred CCCCCCccCcccccCC-CCCchhHHHHHHHHHHHH
Q 006480 586 VAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLEL 619 (643)
Q Consensus 586 ~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eL 619 (643)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4688899999999887 889999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=225.98 Aligned_cols=197 Identities=25% Similarity=0.414 Sum_probs=162.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeE-EEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGF-CFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~-~~~~~~~~LV~E~ 498 (643)
+.|.+.+.||+|-||.+.++.+. +.+.+++|.+.......++|.+|...--.| .|.||+.-|+. |+..+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 46888999999999999999765 677899999987777889999998765556 58999988764 6777889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEeecCccccccC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~~ 576 (643)
++.|+|...+... .+.+..-..++.|++.||.|+|+ +++||||||.+||||. +...+||||||+.+..+.
T Consensus 104 aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999988643 46777888999999999999999 9999999999999994 445799999999865443
Q ss_pred CCCCccccCCCCCCCccCcccccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-----~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.-. ...-+..|.+||..... ..++.+|||.||+++|..+||.+||.....
T Consensus 176 tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 176 TVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred eeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 222 12346679999976522 367789999999999999999999986544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=231.21 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=166.7
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 493 (643)
...+.|..+++||+|.|++||++.+. ..+.||+|.+..... ...+..|+++|..+. +.||+++.+++..++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34567888999999999999999743 467899999876543 245889999999995 899999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 572 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~ 572 (643)
+|+||++.....+++. .++..++..++..++.||.++|. +|||||||||+|+|.+. .+.-.|+|||||.
T Consensus 112 ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999885 36688999999999999999999 99999999999999974 4678899999996
Q ss_pred cccCCC--------------------------------CCccc----------cCCCCCCCccCccccc-CCCCCchhHH
Q 006480 573 WASTSS--------------------------------SHITC----------TDVAGTFGYLAPEYFM-YGKVNDKIDV 609 (643)
Q Consensus 573 ~~~~~~--------------------------------~~~~~----------~~~~gt~~Y~APE~l~-~~~~s~ksDI 609 (643)
+..... ..+.+ ...+||++|+|||++. ....++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 321100 00001 1247999999999886 5678999999
Q ss_pred HHHHHHHHHHHcCCCCCCCC
Q 006480 610 YAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 610 wSlGvvl~eLltG~~Pf~~~ 629 (643)
||.|||++-+++++.||-..
T Consensus 262 ws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeccceeehhhccccccccC
Confidence 99999999999999999754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=243.76 Aligned_cols=204 Identities=28% Similarity=0.432 Sum_probs=178.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.....+|.|.||.|||+.+. +++..|+|+++-.. +..+-+.+|+-+++..+||||+.++|.|...+.+++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 457888899999999999999864 78999999998654 5567778899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
|.+|+|++..+.. .++++.++..++++.++||.|||+ ++-+|||||-.|||+++.|.+||.|||.+-.+...-
T Consensus 94 cgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999988754 468999999999999999999999 889999999999999999999999999875443321
Q ss_pred CCccccCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 579 SHITCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l---~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
.....+.||++|||||+- ..+.|..++|||++|+...|+-.-++|.....|..
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr 222 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR 222 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH
Confidence 123347899999999976 46789999999999999999999999988876643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=223.28 Aligned_cols=165 Identities=19% Similarity=0.161 Sum_probs=129.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC--CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
...+|.+.+.||+|+||+||+|.+. +++.+|||++... ......|.+|+++|++++|+||++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3457889999999999999999764 5777899987532 2345678999999999999999853322 246
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEeecCc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~vkL~DFGl 570 (643)
.||||||++|++|.. +. . .. ...++.++++||.|||+ +||+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 799999999999973 21 1 01 13578899999999999 99999999 99999999999999999999
Q ss_pred cccccCCCCCcc------ccCCCCCCCccCcccccCC
Q 006480 571 AKWASTSSSHIT------CTDVAGTFGYLAPEYFMYG 601 (643)
Q Consensus 571 a~~~~~~~~~~~------~~~~~gt~~Y~APE~l~~~ 601 (643)
|+.......... .....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 987665432222 2356789999999998633
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.2e-23 Score=217.59 Aligned_cols=207 Identities=27% Similarity=0.306 Sum_probs=170.4
Q ss_pred CcccceeeeecCceEEEEEEeCCC--CEEEEEEeCCChh-HHHHHHHHHHHHHhcCC----CceeEEEeEE-EeCCeEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSED-VIKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 494 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~g--~~vAVK~l~~~~~-~~~~~~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~~L 494 (643)
+|.+.+.||+|+||.||++..... ..+|+|+...... ....+..|+.++..+.. +++..+++.. .....-++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987543 4789998876432 22267789999998873 6899999999 47778899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEeecC
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 569 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-----~~vkL~DFG 569 (643)
||+.+ |.+|.++..... ...|+..+.+.|+.|++.+|.+||+ .|++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999886554 4679999999999999999999999 999999999999999865 469999999
Q ss_pred ccc--cccCCCCC----c-c-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 570 LAK--WASTSSSH----I-T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 570 la~--~~~~~~~~----~-~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
+++ ........ . . ...+.||..|.++....+...+.+.|+||++.++.||+.|..||.+.......
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 998 32222211 1 1 12356999999999999999999999999999999999999999877654333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-22 Score=203.10 Aligned_cols=202 Identities=34% Similarity=0.545 Sum_probs=172.9
Q ss_pred cccceeeeecCceEEEEEEeCCCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCC-ceeEEEeEEEeCCeEEEEEee
Q 006480 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED----VIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~LV~E~ 498 (643)
|.+...||.|+|+.||++... ..+++|.+..... ....+.+|+.++..+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667889999999999999876 7889999976432 467899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~ 577 (643)
+.+++|.+++...... ..+.......+..|++.+|.|+|. .+++||||||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777543211 358889999999999999999999 8899999999999999988 7999999999855544
Q ss_pred CCCc----cccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 578 SSHI----TCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 578 ~~~~----~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.... ......||..|+|||.+.. ..++...|+|++|++++++++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 3221 2355789999999999987 6889999999999999999999999887763
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=8e-22 Score=184.74 Aligned_cols=138 Identities=24% Similarity=0.359 Sum_probs=114.7
Q ss_pred EEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCC--c----hhhhhHHHHHHHHHHHhhhhhcCCc
Q 006480 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS--S----LLSLVKAFDSVLAVYEGFCNLKQVD 91 (643)
Q Consensus 18 ~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~--~----~~~~~~~~~~ll~~~~~~C~~k~v~ 91 (643)
+|+||||+|++|++||+||++.+.+.|+.|++|||.++.......... . .....+...++++++...|...+++
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 599999999999999999999999999999999998764322211110 0 0122345568899999999889999
Q ss_pred EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-C-chHHHHhccCCCCcEEEEEeCC
Q 006480 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-T-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
++..++.|+++.+.|+++|++.+||+||||++|++.+.|.+ . ||++||++++|.+|||+||++|
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 99999998899999999999999999999999997655432 2 6999999999999999999997
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.2e-23 Score=243.69 Aligned_cols=149 Identities=22% Similarity=0.250 Sum_probs=115.2
Q ss_pred cCC-CceeEEEeEE-------EeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006480 474 LHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (643)
Q Consensus 474 l~H-pnIv~l~g~~-------~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 545 (643)
++| +||..++++| .....+++++||+ +++|.++|.... ..+++.+++.++.||++||.|||+ ++|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 345 5788888877 3345678889988 669999996432 458999999999999999999999 999
Q ss_pred EecCCCCCCEEEcCC-------------------CcEEEeecCccccccCCCC--------------CccccCCCCCCCc
Q 006480 546 IHRDVKSSNILLSDD-------------------FEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFGY 592 (643)
Q Consensus 546 iHrDLKp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y 592 (643)
+||||||+||||+.. +.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4456666666653211000 0001113588999
Q ss_pred cCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 593 ~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
||||++.+..|+.++|||||||+||||++|.+||...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999999999998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6e-22 Score=201.07 Aligned_cols=204 Identities=22% Similarity=0.278 Sum_probs=172.5
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.-+|.+.++||+|+||..+.|.+ -++.+||||.-... ...-++..|.+.++.|. .++|...+-|.+++-+-.||+|.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 44789999999999999999973 48899999976432 22356777888888885 79999999998888888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-----CcEEEeecCcccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKW 573 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-----~~vkL~DFGla~~ 573 (643)
+ |.+|+|++.-. ...|+..++..+|.||+.-++|+|. +.+|+|||||+|+||..- ..+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9 88999998743 3579999999999999999999999 899999999999999743 4589999999998
Q ss_pred ccCCCCCcc--c---cCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 574 ASTSSSHIT--C---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 574 ~~~~~~~~~--~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
+....+... + ....||..||+--...+...+.+.|+-|||=|+++.|-|..||.+....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~ 242 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD 242 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence 766433221 1 2357999999999999999999999999999999999999999986543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=195.33 Aligned_cols=208 Identities=23% Similarity=0.309 Sum_probs=173.4
Q ss_pred hhcCcccceeeeecCceEEEEEE-eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEEeEEEeCCeEEEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~LV~E 497 (643)
....|.+++.||.|+||.+|.|. ..+|..||||+-.... ...++..|-.+++.|++ ..|..+..+..+..+-.+|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 45689999999999999999997 5689999999876543 23457779999999975 677777777778888899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~~ 574 (643)
.+ |.+|++++.... ..|+..+++-++-||+.-+.|+|. +++|||||||+|+|+.-+ ..+.|+|||||+.+
T Consensus 92 LL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 889999987543 468899999999999999999999 999999999999999643 46899999999876
Q ss_pred cCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 575 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 575 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
....+.. ...+..||..|.+--...+...+.+.|+-|+|.+|.++.-|..||.+..+....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 5533221 223467999999988888888999999999999999999999999998765443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=193.98 Aligned_cols=169 Identities=14% Similarity=0.178 Sum_probs=133.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh----hHHHH------HHHHHHHHHhcCCCceeEEEeEEEeC-
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED- 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~----~~~~~------~~~Ei~il~~l~HpnIv~l~g~~~~~- 489 (643)
.++|...++||.|+||.||+... ++..+|+|++.+.. ..... +.+|++.+.+++||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999765 67789999997542 22222 57899999999999999999886643
Q ss_pred -------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 490 -------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 490 -------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
+..+|+|||++|.+|.++.. ++. ....+++.+|..||+ .|++||||||+||+++.++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 35899999999999988742 222 245689999999999 9999999999999999998
Q ss_pred EEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 006480 563 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (643)
Q Consensus 563 vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLl 620 (643)
++|+|||........... ..+++...|+.++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987544221110 11455666778999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=186.96 Aligned_cols=138 Identities=20% Similarity=0.223 Sum_probs=108.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChh---H------------------------HHHHHHHHHHHHhcCCCce
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V------------------------IKEFVLEIEIITTLHHKNI 479 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~---~------------------------~~~~~~Ei~il~~l~HpnI 479 (643)
...||+|+||.||+|...+|+.||||++++... . ......|++++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988999999999975421 0 1122349999999988776
Q ss_pred eEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCEEEc
Q 006480 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 480 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHrDLKp~NILl~ 558 (643)
.....+... ..+|||||+++++|...+... ..+++..+..++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 443333222 238999999988776543221 3588899999999999999999 67 8999999999999998
Q ss_pred CCCcEEEeecCccccc
Q 006480 559 DDFEPQLSDFGLAKWA 574 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~ 574 (643)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 578999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-20 Score=182.31 Aligned_cols=187 Identities=16% Similarity=0.101 Sum_probs=144.3
Q ss_pred ccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHH-----HHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEee
Q 006480 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~-----~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.+...|++|+||+||.+.. .+.+++.+.+........ .+.+|+++|++|. |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998766 778888888776543222 5789999999995 5889999886 456999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCEEEcCCCcEEEeecCccccccCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
+.|.+|...+.. ....++.|++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999988654321 113477899999999999 99999999 799999999999999999999855443
Q ss_pred CCC---ccc--------cCCCCCCCccCcccccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 578 SSH---ITC--------TDVAGTFGYLAPEYFMYG-KVN-DKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 578 ~~~---~~~--------~~~~gt~~Y~APE~l~~~-~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
... ... .-...++.|++|+...-- ..+ ...++++.|+.+|.++|++.|+-++.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 000 012368889998865422 333 57899999999999999999988765
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=181.45 Aligned_cols=109 Identities=28% Similarity=0.312 Sum_probs=96.0
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++...+ ..+++.+++.|+.||+.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997532 469999999999999999999999 55 999999999999999 99998665422
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~ 109 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE 109 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 2589999999999999999999999999999999999999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=178.65 Aligned_cols=141 Identities=23% Similarity=0.239 Sum_probs=111.1
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChh---------------------------HHHHHHHHHHHHHhcCCCce
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------------------VIKEFVLEIEIITTLHHKNI 479 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~---------------------------~~~~~~~Ei~il~~l~HpnI 479 (643)
...||+|+||.||+|.+.+|+.||||++++... ....+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 468999999999999987899999999976421 01224578999999999987
Q ss_pred eEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 006480 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (643)
Q Consensus 480 v~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~ 559 (643)
.....+.... .+|||||++++++....... ..++..+...++.+++.+|.+||+ ..||+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 5554444333 48999999988554432211 246778899999999999999997 26899999999999999
Q ss_pred CCcEEEeecCccccccC
Q 006480 560 DFEPQLSDFGLAKWAST 576 (643)
Q Consensus 560 ~~~vkL~DFGla~~~~~ 576 (643)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-21 Score=212.22 Aligned_cols=194 Identities=29% Similarity=0.360 Sum_probs=162.6
Q ss_pred eeeecCceEEEEEE----eCCCCEEEEEEeCCChh---HHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 429 LIGKGGSSQVYKGC----LPDGKELAVKILKPSED---VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~----~~~g~~vAVK~l~~~~~---~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.+|+|.||.|+++. .+.|+.+|+|++++... .......|..++...+ ||+++++...++.+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 36999999999764 33677899999876321 1124556778888887 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|...+... ..+.+.....+...++.+++++|+ .+|+|||+|++||+++.+|++++.|||+.+..-....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999888644 357777888889999999999999 9999999999999999999999999999986654322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.+||..|||||++. .....+|+||||++++||+||..||.. +....|++.
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 17999999999999 678899999999999999999999998 444555443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.3e-19 Score=207.09 Aligned_cols=201 Identities=21% Similarity=0.232 Sum_probs=161.5
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEEeEEEeCCeE
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNL 492 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~ 492 (643)
++......|.+.+.||+|+||+||+|...+|+.||+|+-++..... |.--.+++.+|+ -+-|+.+..++...+.-
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3444456789999999999999999998889999999998754211 111112333443 23455555556666778
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------CCcEEE
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------DFEPQL 565 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-------~~~vkL 565 (643)
+||+||.+.|+|.+++... ..++|...+.++.||++.+..||. .+|||+||||+|+||.. ..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999999844 468899999999999999999999 99999999999999952 345899
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P 625 (643)
+|||.+.-+..-.........++|-.|-.+|+..+..|++.+|.|.|+.+++-||.|+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999998766554444555667899999999999999999999999999999999999753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.7e-20 Score=208.43 Aligned_cols=199 Identities=24% Similarity=0.322 Sum_probs=162.0
Q ss_pred cceeeeecCceEEEEEEeC-CCCEEEEEEeC----CCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 426 AENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~----~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
...++|.|++|.|+..... ..+.++.|... +.+ .....+..|+.+-..+.|||++..+..+++.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977776532 33333333322 322 222236778888888999999998888887777777799
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++ +|..++... ..+...++..++.|++.|+.|||. .||.|||||++|++++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999998754 247788899999999999999999 99999999999999999999999999999876655
Q ss_pred CCC--ccccCCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSH--ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~--~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
... .....++|.-.|+|||.+....|++. .||||.|++++.|++|+.||......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 544 55567889999999999999999975 99999999999999999999876544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-18 Score=170.59 Aligned_cols=135 Identities=21% Similarity=0.281 Sum_probs=104.9
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCC-hhHHHHHHHHHHHHHhc-----CCCceeEEEeEEEeCC---eEE-EE
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---NLL-LV 495 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~~~-LV 495 (643)
-...||+|+||.||. ...++.. +||++... ....+.+.+|+.+++.+ +||||++++|++.++. .++ +|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 357899999999996 3334444 69988754 23456789999999999 5799999999998863 333 78
Q ss_pred Eee--CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEeec
Q 006480 496 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 568 (643)
Q Consensus 496 ~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~DF 568 (643)
+|| +.+|+|.+++... .+++. ..++.+++.++ .|||+ ++|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5579999999642 24444 35677888777 99999 99999999999999974 347999995
Q ss_pred -Cccc
Q 006480 569 -GLAK 572 (643)
Q Consensus 569 -Gla~ 572 (643)
|...
T Consensus 154 ~G~~~ 158 (210)
T PRK10345 154 IGEST 158 (210)
T ss_pred CCCcc
Confidence 5443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.3e-18 Score=167.88 Aligned_cols=134 Identities=23% Similarity=0.392 Sum_probs=114.5
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.||+|++|.||+|.. .|..+++|+..... .....+.+|++++..+.|++|.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77789999876421 1124678899999999999998888777777888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++|++|.+++.... + .+..++.+++.+|.+||+ .+++|||++|+|||++ ++.++|+|||++...
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999986321 2 788899999999999999 8999999999999999 789999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-17 Score=169.90 Aligned_cols=145 Identities=19% Similarity=0.180 Sum_probs=113.2
Q ss_pred hhcCcccceeeeecCceEEEEEE--eCCCCEEEEEEeCCChh-------------------------HHHHHHHHHHHHH
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIIT 472 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~--~~~g~~vAVK~l~~~~~-------------------------~~~~~~~Ei~il~ 472 (643)
...-|.+.+.||+|+||.||+|. ..+|+.||+|+++.... ....+..|++++.
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 33457889999999999999998 56899999999874320 1133568999999
Q ss_pred hcCCC--ceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEecC
Q 006480 473 TLHHK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRD 549 (643)
Q Consensus 473 ~l~Hp--nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-iiHrD 549 (643)
++.+. .+.+++++ ...+|||||+++++|...+... ..+...+...++.||+.+|.|||+ ++ |+|||
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~D 174 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK---EGELVHGD 174 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCC
Confidence 99753 34455543 2348999999998887654322 235556678899999999999999 88 99999
Q ss_pred CCCCCEEEcCCCcEEEeecCccccccC
Q 006480 550 VKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 550 LKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|||+||+++ ++.++|+|||++.....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccCC
Confidence 999999999 88999999999875443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-17 Score=163.75 Aligned_cols=131 Identities=21% Similarity=0.359 Sum_probs=108.1
Q ss_pred eeeecCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 429 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 429 ~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.||+|+||.||+|.. +|..+++|+..... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 12356788999999999887665555566667789999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|||++|+||+++ ++.++|+|||++....
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999999875321 0 689999999999999 9999999999999999 8899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.5e-19 Score=201.00 Aligned_cols=196 Identities=22% Similarity=0.274 Sum_probs=153.7
Q ss_pred CcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
+|...+.||.+.|=+|.++.++.|. |+||++-+.. ...++.+.|++ ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999998887 8899985432 22344444555 555689999999888777788899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc--cc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--AS 575 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~--~~ 575 (643)
|..+ +|.|.|... ..+...+...|+.|++.||..+|+ .||+|||||.+||||+.-.-+.|+||...+. ++
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 899998654 357788888999999999999999 9999999999999999999999999987653 22
Q ss_pred CCCCC---ccccCCCCCCCccCcccccCC----------C-CCchhHHHHHHHHHHHHHc-CCCCCCC
Q 006480 576 TSSSH---ITCTDVAGTFGYLAPEYFMYG----------K-VNDKIDVYAFGVVLLELLT-GRKPISN 628 (643)
Q Consensus 576 ~~~~~---~~~~~~~gt~~Y~APE~l~~~----------~-~s~ksDIwSlGvvl~eLlt-G~~Pf~~ 628 (643)
.++.. +...+-..-.+|+|||.|... . .+++.||||+||+++||++ |++||.-
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 22111 111122334579999988642 1 6789999999999999999 8999963
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=162.50 Aligned_cols=145 Identities=20% Similarity=0.204 Sum_probs=113.8
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChh-----------------------HHHHHHHHHHHH
Q 006480 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEII 471 (643)
Q Consensus 415 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~-----------------------~~~~~~~Ei~il 471 (643)
+++......|.+.+.||+|+||.||++...+|+.+|||++..... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444555888899999999999999988899999998764320 112367789999
Q ss_pred HhcCCC--ceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 006480 472 TTLHHK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549 (643)
Q Consensus 472 ~~l~Hp--nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrD 549 (643)
..+.|+ .+...++. ...++||||+++++|.+.... .....++.+++.++.++|+ .+|+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 999877 44555443 455899999999998765421 2345688999999999999 9999999
Q ss_pred CCCCCEEEcCCCcEEEeecCccccccC
Q 006480 550 VKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 550 LKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|||+||+++.++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999864433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=172.63 Aligned_cols=202 Identities=24% Similarity=0.351 Sum_probs=134.0
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCC----------CceeEEEeEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHH----------KNIISLLGFCF 487 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~H----------pnIv~l~g~~~ 487 (643)
++.....||.|+++.||.+.+. +|+++|+|+... .....+++.+|.-.+..+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3456789999999999999976 689999998742 22456677776644444322 12333333221
Q ss_pred ---------eC---C-----eEEEEEeeCCCCCHHHHhcc---CCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 006480 488 ---------ED---N-----NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547 (643)
Q Consensus 488 ---------~~---~-----~~~LV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiH 547 (643)
.. + +.+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 347888888 5588887542 22222334555667888999999999999 99999
Q ss_pred cCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHH
Q 006480 548 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLEL 619 (643)
Q Consensus 548 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSlGvvl~eL 619 (643)
+||+|+|+|++.+|.+.|+||+......... .+ ...+..|.+||.... -.++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 9999999999999999999998776444321 11 234578999997643 2588999999999999999
Q ss_pred HcCCCCCCCCChhh
Q 006480 620 LTGRKPISNDHPKG 633 (643)
Q Consensus 620 ltG~~Pf~~~~~~~ 633 (643)
.+|+.||....+..
T Consensus 244 WC~~lPf~~~~~~~ 257 (288)
T PF14531_consen 244 WCGRLPFGLSSPEA 257 (288)
T ss_dssp HHSS-STCCCGGGS
T ss_pred HHccCCCCCCCccc
Confidence 99999999775543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-18 Score=195.07 Aligned_cols=175 Identities=30% Similarity=0.434 Sum_probs=132.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.+|..+++|..|+||.||...++ +.+.+|+|+-+ .....+. |+....+|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~lilRn------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNLILRN------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cchhhhc------cccccCCccee--------------------
Confidence 46888999999999999999765 45668885433 3222221 44444455555
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC--
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-- 578 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~-- 578 (643)
|+-...++..+. ++. +++.++.|||+ .+|+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 136 -gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 455555544332 222 34789999999 999999999999999999999999999986432110
Q ss_pred -----------CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 579 -----------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 579 -----------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.......++||+.|+|||++..+.|+..+|+|++|+|+||.+-|..||.++.|+++...+.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 1111223689999999999999999999999999999999999999999999988876553
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-17 Score=184.11 Aligned_cols=141 Identities=19% Similarity=0.310 Sum_probs=114.5
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEe-CCC---h-----hHHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPS---E-----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 418 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l-~~~---~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
......|...+.||+|+||.||+|.+.... +++|+. .+. . ....++.+|++++..++|++|+.+..++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 334455677899999999999999875443 444432 211 1 123568899999999999999988888877
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
.+..++||||+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ .++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999884 346789999999999999 899999999999999 6789999999
Q ss_pred Ccccccc
Q 006480 569 GLAKWAS 575 (643)
Q Consensus 569 Gla~~~~ 575 (643)
|+++...
T Consensus 472 Gla~~~~ 478 (535)
T PRK09605 472 GLGKYSD 478 (535)
T ss_pred cccccCC
Confidence 9997653
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.3e-16 Score=149.13 Aligned_cols=132 Identities=18% Similarity=0.197 Sum_probs=97.2
Q ss_pred CEEEEEecCCc--chHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCC-CCch----hhhhHHHHHHHHHHHhhhhhcC
Q 006480 17 RTVVVGVKLDT--HSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KSSL----LSLVKAFDSVLAVYEGFCNLKQ 89 (643)
Q Consensus 17 r~I~VaVD~s~--~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~-~~~~----~~~~~~~~~ll~~~~~~C~~k~ 89 (643)
++|+||||+|+ .|.+||+||+.-. +.++.|++|||+++........ .... ....+..++.++.+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la-~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLA-QDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHH-hcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 68999999995 7999999999764 4467999999997653211110 0111 1222333455565555544456
Q ss_pred CcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEe
Q 006480 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 90 v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~ 153 (643)
++++.++..| ++.+.|+++|++++||+||||+||++ ..+.+ .|++.++++|++ |||++|+
T Consensus 82 ~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCccHHHHHHcCC--CCEEEeC
Confidence 7888888885 89999999999999999999999975 43322 299999999998 9999985
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-18 Score=167.96 Aligned_cols=193 Identities=23% Similarity=0.436 Sum_probs=156.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
..+|.+...|..|+|.+ .|..+++|+++.. ....++|..|.-.|+...||||+.++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34578888899999998 4566777888653 3455789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEec-CCCCCCEEEcCCCcEEEe--ecCccccccCCCCC
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR-DVKSSNILLSDDFEPQLS--DFGLAKWASTSSSH 580 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHr-DLKp~NILl~~~~~vkL~--DFGla~~~~~~~~~ 580 (643)
|...|++... ...+-.++.+++..|++|++|||+.. ++|-| -|.+..++||++.+.+|+ |--++
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs--------- 340 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS--------- 340 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee---------
Confidence 9999997643 45667788999999999999999954 34444 689999999999988876 22211
Q ss_pred ccccCCCCCCCccCcccccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s---~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
..+....-.|.||+||.++...-+ ..+|+|||+++||||.|...||...+|-+
T Consensus 341 fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 341 FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 112223457889999999876544 47999999999999999999999887754
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-16 Score=146.88 Aligned_cols=133 Identities=18% Similarity=0.201 Sum_probs=98.6
Q ss_pred CEEEEEecCCcc--hHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCC--CCc----hhhhhHHHHHHHHHHHhhhhhc
Q 006480 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG--KSS----LLSLVKAFDSVLAVYEGFCNLK 88 (643)
Q Consensus 17 r~I~VaVD~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~--~~~----~~~~~~~~~~ll~~~~~~C~~k 88 (643)
++|+||||+|++ +.+||+||++...+.|..|++|||+++........ ... .....+...+.++.+...+...
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 689999999998 58999999999989999999999997643211110 000 1112233334555555555555
Q ss_pred CCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEe
Q 006480 89 QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 89 ~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~ 153 (643)
+++++..+..| ++.+.|+++|+++++|+||||+++. ...+.. .|++.+|++|+| |||++|+
T Consensus 83 ~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~~~-~~~~~llGS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 83 TDRVHVHVEEG-SPKDRILELAKKIPADMIIIASHRP-DITTYLLGSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCCCC-CchheeecchHHHHHHhCC--CCEEEeC
Confidence 67788888775 8999999999999999999999854 333322 399999999998 9999985
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=147.30 Aligned_cols=135 Identities=13% Similarity=0.133 Sum_probs=95.5
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCC-CCCCCCchhhhh-HHHHHHHHHHHhhhhhcCCcEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DRDGKSSLLSLV-KAFDSVLAVYEGFCNLKQVDLK 93 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~~~~~~~~~~~-~~~~~ll~~~~~~C~~k~v~~~ 93 (643)
-++|+||+|+|+.|..||+||+......|..|++|||..+.... ............ ....+..+.+..++...++...
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 37899999999999999999999888889999999995332111 000000000001 1112222333444555677765
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeC
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
..++..|+|.+.|+++|+++++|+||||+|+. .++...||+.++++|++ |||++|+.
T Consensus 83 ~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~--~~~~lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 83 ETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQD--FWSKLMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred EEEEEecCHHHHHHHHHHHhCCCEEEEeCccc--HHHHHHHHHHHHHhhCC--CCEEEecC
Confidence 55555569999999999999999999999974 22223499999999998 99999974
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-15 Score=141.25 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=115.2
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| +++.++++++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 45789999999999998744 7899999876544 5678899999999976 589999998887788999999998876
Q ss_pred HHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 504 L~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+... +......++.+++++|.+||.....+++|+|++|+||+++..+.++|+|||++...
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 45666778999999999999854457999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.8e-16 Score=143.38 Aligned_cols=131 Identities=17% Similarity=0.107 Sum_probs=95.4
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCC-C-CCC--c-hhhhhHHHHHHHHHHHhhhhhcCCc
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR-D-GKS--S-LLSLVKAFDSVLAVYEGFCNLKQVD 91 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~-~-~~~--~-~~~~~~~~~~ll~~~~~~C~~k~v~ 91 (643)
++|+||||+|++|.+||+||+....+.+..|+++||.++...... . ... . .....+..++.++++...+. ...
T Consensus 4 k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~~ 81 (142)
T PRK09982 4 KHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WPK 81 (142)
T ss_pred eEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CCc
Confidence 689999999999999999999999899999999999875422111 0 000 0 11122233345555554332 245
Q ss_pred EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeC
Q 006480 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
++..+..| +|++.|+++|++.+||+||||++ ++...+.. +|+..+++|++ |||++|+-
T Consensus 82 ~~~~v~~G-~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~-~va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 82 TKLRIERG-EMPETLLEIMQKEQCDLLVCGHH-HSFINRLM-PAYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred ceEEEEec-CHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH-HHHHHHHhcCC--CCEEEecC
Confidence 66666675 99999999999999999999986 54333332 79999999998 99999974
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.4e-15 Score=136.81 Aligned_cols=122 Identities=15% Similarity=0.101 Sum_probs=99.5
Q ss_pred EEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 006480 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (643)
Q Consensus 18 ~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v~ 97 (643)
+|+||||+++.|++||+||.....+.+..|.+|||.++... .......+.++.+...++..+++ ..++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~----------~~~~~~~~~l~~~~~~~~~~~~~--~~~~ 68 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN----------RLSEAERRRLAEALRLAEELGAE--VVTL 68 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc----------cCCHHHHHHHHHHHHHHHHcCCE--EEEE
Confidence 59999999999999999999988888999999999875321 11234456777777777776665 4456
Q ss_pred EcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEE
Q 006480 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAV 152 (643)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV 152 (643)
.++++.++|+++|+++++|+||||+++++.+.+... |+++++++|+ ..|+|+||
T Consensus 69 ~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 69 PGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred eCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 678999999999999999999999999865555322 9999999999 35999987
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.8e-15 Score=138.03 Aligned_cols=136 Identities=15% Similarity=0.142 Sum_probs=98.3
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchh--hhhHHHHHHHHHHHhhhhhcCCcEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLL--SLVKAFDSVLAVYEGFCNLKQVDLK 93 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~--~~~~~~~~ll~~~~~~C~~k~v~~~ 93 (643)
-++|+|++|+++.+++||+||+......++.|++|||.+.............. ................+...+....
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVI 81 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEE
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhcccee
Confidence 37999999999999999999999999999999999999875321110000000 0000000111111134455566666
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEe
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~ 153 (643)
...+..+++.+.|++++++.++|+||||+++++.+.+... |++++|++++| |||++|+
T Consensus 82 ~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 82 EVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred EEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 6666667999999999999999999999999765555433 99999999998 9999985
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.8e-15 Score=134.57 Aligned_cols=131 Identities=19% Similarity=0.167 Sum_probs=108.0
Q ss_pred EEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 006480 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (643)
Q Consensus 18 ~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v~ 97 (643)
+|+|+||+++.+.+||+||..-....+..|+++||.+++..... .......+...+++..+..++...+++++..+.
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~ 77 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP---SQLEVNVQRARKLLRQAERIAASLGVPVHTIIR 77 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc---chhHHHHHHHHHHHHHHHHHhhhcCCceEEEEE
Confidence 59999999999999999999999888999999999986532211 111123345568888988999889999998888
Q ss_pred EcCChhhHHHHHHHhcCCCEEEEccCCCCccccC-CCchHHHHhccCCCCcEEEEEe
Q 006480 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~-~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
.++++.+.|++.|+++++|+||||+++.+...+. ..|++++++++++ |||++|+
T Consensus 78 ~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 78 IDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred ecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 7779999999999999999999999998654322 2299999999998 9999985
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-15 Score=147.64 Aligned_cols=136 Identities=21% Similarity=0.261 Sum_probs=98.9
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhH---HHH----------------------HHHHHHHHHhcCCC--ce
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---IKE----------------------FVLEIEIITTLHHK--NI 479 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~---~~~----------------------~~~Ei~il~~l~Hp--nI 479 (643)
.+.||+|+||+||+|...+|+.||||++++.... ... ...|.+.+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998754211 111 13566666666543 34
Q ss_pred eEEEeEEEeCCeEEEEEeeCCCCCHHHH-hccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 480 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 480 v~l~g~~~~~~~~~LV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.++++. ...++||||++++.+... +.... .. .++..++.+++.++.++|. ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 555543 245999999998544321 11110 11 5678899999999999997 26799999999999999
Q ss_pred CCCcEEEeecCcccccc
Q 006480 559 DDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~ 575 (643)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=135.39 Aligned_cols=136 Identities=12% Similarity=0.120 Sum_probs=98.3
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHH-HHHHHHHHhhhhhcCCcEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAF-DSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~-~~ll~~~~~~C~~k~v~~~~ 94 (643)
-++|+|++|+|+.|..||++|+.-..+.|..|+++|+.+++...............+.. .+....++.++...++..+.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 37899999999999999999999988889999999998654321111111111111111 12223334445556776654
Q ss_pred EEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeC
Q 006480 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
.+++.|++.+.|+++|++.++|+||||+++++...+. .||+.+|++|++ |||++|+-
T Consensus 83 ~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~-~s~a~~v~~~~~--~pVLvv~~ 139 (142)
T PRK10116 83 TFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRA-SCSAKRVIASSE--VDVLLVPL 139 (142)
T ss_pred EEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHH-HHHHHHHHhcCC--CCEEEEeC
Confidence 4555569999999999999999999999998655443 389999999998 99999973
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-16 Score=168.06 Aligned_cols=124 Identities=31% Similarity=0.505 Sum_probs=107.4
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
++|+.|+++...+|.++|...+. ....++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58999999999999999975432 3456888899999999999999 5789999999999999999999999999
Q ss_pred cccccCCC----CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc
Q 006480 571 AKWASTSS----SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621 (643)
Q Consensus 571 a~~~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt 621 (643)
........ .....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87665544 1222334579999999999999999999999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=146.14 Aligned_cols=135 Identities=14% Similarity=0.160 Sum_probs=104.9
Q ss_pred ceeee-ecCceEEEEEEeCCCCEEEEEEeCCCh--------------hHHHHHHHHHHHHHhcCCCce--eEEEeEEEeC
Q 006480 427 ENLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFED 489 (643)
Q Consensus 427 ~~~LG-~G~~g~Vy~~~~~~g~~vAVK~l~~~~--------------~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~ 489 (643)
...|| .||.|+||++.. .+..++||.+.... .....+.+|++++..|+|++| +.++++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 899999999877 46778998874311 223567889999999998775 6777765443
Q ss_pred Ce----EEEEEeeCCC-CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 490 NN----LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 490 ~~----~~LV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
.. .++||||+++ .+|.+++... .++.. .+.+|+.+|.+||+ +||+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 22 3599999997 6999888532 24443 35689999999999 9999999999999999999999
Q ss_pred EeecCccccc
Q 006480 565 LSDFGLAKWA 574 (643)
Q Consensus 565 L~DFGla~~~ 574 (643)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=7.9e-15 Score=152.48 Aligned_cols=146 Identities=28% Similarity=0.381 Sum_probs=111.8
Q ss_pred CCCceeEEEeEEEe---------------------------CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHH
Q 006480 475 HHKNIISLLGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 527 (643)
Q Consensus 475 ~HpnIv~l~g~~~~---------------------------~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 527 (643)
+|||||+++++|.+ ...+||||..++. +|.+++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 69999999887642 2368999998855 9999997543 4555667789
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCC--cEEEeecCccccccCC----CCCccccCCCCCCCccCccccc
Q 006480 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQLSDFGLAKWASTS----SSHITCTDVAGTFGYLAPEYFM 599 (643)
Q Consensus 528 ~qia~aL~yLH~~~~~~iiHrDLKp~NILl--~~~~--~vkL~DFGla~~~~~~----~~~~~~~~~~gt~~Y~APE~l~ 599 (643)
.|+++|+.|||+ +||.|||+|++|||| ++|+ .+.|+|||++-.-... .......+..|.-.-||||++.
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999998 3444 3678999987432221 1111223456888899999986
Q ss_pred CCC-----CC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 600 YGK-----VN-DKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 600 ~~~-----~s-~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
... .+ .|+|.|+.|.+.||+++..-||.+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r 460 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR 460 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc
Confidence 331 22 4899999999999999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.8e-15 Score=161.23 Aligned_cols=154 Identities=23% Similarity=0.454 Sum_probs=127.2
Q ss_pred HHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EecC
Q 006480 471 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV-IHRD 549 (643)
Q Consensus 471 l~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i-iHrD 549 (643)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.. ....++|--...+.+.|+.||.|||+ -+| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 4578999999999999999999999999999999999975 33578888899999999999999998 334 9999
Q ss_pred CCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCC-------CCchhHHHHHHHHHHHHHcC
Q 006480 550 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-------VNDKIDVYAFGVVLLELLTG 622 (643)
Q Consensus 550 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-------~s~ksDIwSlGvvl~eLltG 622 (643)
+++.|.+++..+.+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987664311111111122345699999997641 46679999999999999999
Q ss_pred CCCCCCCC
Q 006480 623 RKPISNDH 630 (643)
Q Consensus 623 ~~Pf~~~~ 630 (643)
+.||....
T Consensus 155 ~~~~~~~~ 162 (484)
T KOG1023|consen 155 SGPFDLRN 162 (484)
T ss_pred cCcccccc
Confidence 99998743
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=152.24 Aligned_cols=140 Identities=21% Similarity=0.297 Sum_probs=99.1
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChh--HH---------------------------------------HHHH
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VI---------------------------------------KEFV 465 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~--~~---------------------------------------~~~~ 465 (643)
.+.||.|++|+||+|.+.+|+.||||+.++.-. .. -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 468999999999999999999999999986410 00 0233
Q ss_pred HHHHHHHhc----C-CCceeEEEeEE-EeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHH-HHHHHH
Q 006480 466 LEIEIITTL----H-HKNIISLLGFC-FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLH 538 (643)
Q Consensus 466 ~Ei~il~~l----~-HpnIv~l~g~~-~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-aL~yLH 538 (643)
+|.+.+.++ + ++++. +-..| ......+|||||++|++|.+....... .+ .+..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHH
Confidence 444444444 2 33332 22222 223456999999999999887653211 11 23456666665 467888
Q ss_pred hCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 539 ~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
. .|++|+|+||.||+++.++.++|+|||++..+..
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 8999999999999999999999999999976654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.6e-15 Score=169.05 Aligned_cols=205 Identities=27% Similarity=0.345 Sum_probs=166.7
Q ss_pred CcccceeeeecCceEEEEEEeCC--CCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~--g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.|.+.+.||+|+|+.|-...... ...+|+|.+... .........|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 34556669999999998876543 344566666433 344555566877777776 999999999999999999999
Q ss_pred eeCCCCCHHHHh-ccCCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCEEEcCCC-cEEEeecCcccc
Q 006480 497 DFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~ 573 (643)
+|..++++.+.+ +.. ....+....-.++.|+..+|.|+| . .++.||||||+|.+++..+ .++++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 322 124556667789999999999999 7 8899999999999999999 999999999988
Q ss_pred ccC-CCCCccccCCCC-CCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 574 AST-SSSHITCTDVAG-TFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 574 ~~~-~~~~~~~~~~~g-t~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
+.. ..........+| ++.|+|||.+.+. ...+..|+||.|+++.-|++|..|+.....+.
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 877 555556666788 9999999999874 56778999999999999999999998765443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=154.19 Aligned_cols=144 Identities=19% Similarity=0.243 Sum_probs=92.5
Q ss_pred cCcccceeeeecCceEEEEEEeCC-CCEEEEEEeCCCh-----------------------------------hHHHHHH
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-----------------------------------DVIKEFV 465 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~-g~~vAVK~l~~~~-----------------------------------~~~~~~~ 465 (643)
..|.. +.||.|++|+||+|.+.+ |+.||||++++.- +..+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999876 9999999998641 0112222
Q ss_pred HHHH------HHHhc----CCCceeEEEeEEEe-CCeEEEEEeeCCCCCHHHH--hccCCCCCCCCChHHHHHHHHHHHH
Q 006480 466 LEIE------IITTL----HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAE 532 (643)
Q Consensus 466 ~Ei~------il~~l----~HpnIv~l~g~~~~-~~~~~LV~E~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~qia~ 532 (643)
+|++ .+.++ .+.+.+.+-.+|.+ ....+|||||+.|+.|.+. +...+.+...+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 3333 33333 13333332233322 3456899999999999874 32221111122222233333333
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeecCccccccC
Q 006480 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDFGLAKWAST 576 (643)
Q Consensus 533 aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGla~~~~~ 576 (643)
+. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33 7899999999999999988 999999999877655
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=9e-13 Score=138.76 Aligned_cols=138 Identities=9% Similarity=0.038 Sum_probs=105.4
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCC-CCCCCchh-----hhhHHHHHHHHHHHhhhhhcC
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVD-RDGKSSLL-----SLVKAFDSVLAVYEGFCNLKQ 89 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~-~~~~~~~~-----~~~~~~~~ll~~~~~~C~~k~ 89 (643)
-++|+|++|+|+.|..||+||+.-..+.+..|+++||.++..... ........ ...+...+.++.+...+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 368999999999999999999998888899999999985432111 10001110 112233456677776777778
Q ss_pred CcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeCC
Q 006480 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 90 v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
++++..+.+++++.++|+++|++.++|+||||+++.+...+... |++..+++++| |||++|+.+
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEeccc
Confidence 99998888767999999999999999999999999854444322 99999999998 999999864
|
|
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.3e-12 Score=115.07 Aligned_cols=129 Identities=19% Similarity=0.241 Sum_probs=104.7
Q ss_pred EEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEEE
Q 006480 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKIC 97 (643)
Q Consensus 18 ~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v~ 97 (643)
+|+|++|++..++.+|+||++.+...+..|.++||.++...... ..........++.+..+...|...++.++..+.
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~---~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 77 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAA---ELAELLEEEARALLEALREALAEAGVKVETVVL 77 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch---hHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 58999999999999999999999999999999999876432111 111223355668889999888888999998888
Q ss_pred EcCChhhHHHHHHHhcCCCEEEEccCCCCccccC-CCchHHHHhccCCCCcEEEEE
Q 006480 98 RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAV 152 (643)
Q Consensus 98 ~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~-~~sVs~yc~~~ap~~C~V~vV 152 (643)
.| ++.+.|++++++.++|+||||+++++.+.+. ..+++++++++++ |||++|
T Consensus 78 ~~-~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 78 EG-DPAEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred cC-CCHHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEeC
Confidence 76 5689999999999999999999988654332 2399999999987 999975
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.4e-12 Score=121.93 Aligned_cols=131 Identities=21% Similarity=0.193 Sum_probs=97.1
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
.+.|+.|.++.||++.. .+..|++|+..........+..|..++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46789999999999887 477899999876543334567899999988655544 455443 23458999999998775
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+.. . ....++.+++++|..||... +.+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 0 11235678999999999832 23469999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-11 Score=130.27 Aligned_cols=137 Identities=15% Similarity=0.125 Sum_probs=94.6
Q ss_pred CCEEEEEecCCcch-------HHHHHHHHhhccCC-CCEEEEEEEecCCCCCCCCC--CCchhhhhHHH-HHHHHHHHhh
Q 006480 16 GRTVVVGVKLDTHS-------RELLTWALVKVAQP-GDTVIALHVLANNAIVDRDG--KSSLLSLVKAF-DSVLAVYEGF 84 (643)
Q Consensus 16 ~r~I~VaVD~s~~S-------~~AL~WAl~~~~~~-gd~vvlvHV~~~~~~~~~~~--~~~~~~~~~~~-~~ll~~~~~~ 84 (643)
.++|+||+|+|+.+ ..||++|+.-.... +..|++|||++......... ........+.. .+....++.+
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 231 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKAL 231 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHHH
Confidence 57999999999763 68999999887776 88999999986543211100 00111111111 1223333444
Q ss_pred hhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeC
Q 006480 85 CNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 85 C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~ 154 (643)
.+..++..+...+..+++.+.|+++|++.+||+||||+++++...+.+. |++.++++|++ |||++|+.
T Consensus 232 ~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 232 RQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred HHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEcC
Confidence 4455666543334445899999999999999999999999875555433 99999999998 99999963
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=5e-11 Score=111.22 Aligned_cols=137 Identities=18% Similarity=0.196 Sum_probs=106.7
Q ss_pred CCEEEEEec-CCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCC--Cc------hhhhhHHHHHHHHHHHhhhh
Q 006480 16 GRTVVVGVK-LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK--SS------LLSLVKAFDSVLAVYEGFCN 86 (643)
Q Consensus 16 ~r~I~VaVD-~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~--~~------~~~~~~~~~~ll~~~~~~C~ 86 (643)
.++|++++| +++.+..|+.+|+......+..+.++||.+.......... .. .........+.++.......
T Consensus 5 ~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (154)
T COG0589 5 YKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALAE 84 (154)
T ss_pred cceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHHH
Confidence 478999999 9999999999999999999999999999876543221111 00 01123344577777777777
Q ss_pred hcCCcE-EEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeC
Q 006480 87 LKQVDL-KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 87 ~k~v~~-~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~ 154 (643)
..++.. +..+..|....+.|++.|.+.+||+||||++|+++..+... ||+++++++++ |||++|+-
T Consensus 85 ~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 85 AAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 788884 77778874448999999999999999999999866655322 99999999998 99999974
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=112.28 Aligned_cols=135 Identities=18% Similarity=0.203 Sum_probs=98.1
Q ss_pred ceeeeecCceEEEEEEeCC-------CCEEEEEEeCCC-------------h----------hHHHHHH----HHHHHHH
Q 006480 427 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 472 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~-------g~~vAVK~l~~~-------------~----------~~~~~~~----~Ei~il~ 472 (643)
...||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999997653 478999998632 0 0122233 7999999
Q ss_pred hcCC--CceeEEEeEEEeCCeEEEEEeeCCCCCHHH-HhccCCCCCCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEec
Q 006480 473 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 548 (643)
Q Consensus 473 ~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~iiHr 548 (643)
++.. -++.+++++ ..-+|||||+.++.+.. .+.. ..++..+...+..+++.+|..| |+ .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 8853 566677765 34599999997653322 2221 1244456677889999999999 88 899999
Q ss_pred CCCCCCEEEcCCCcEEEeecCccccc
Q 006480 549 DVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 549 DLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||++.|||+. ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-10 Score=115.24 Aligned_cols=141 Identities=20% Similarity=0.277 Sum_probs=111.2
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCC--CceeEEEeEEEeC---CeEEEEEeeCC
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 500 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~LV~E~~~ 500 (643)
+.|+.|..+.||++...+|+.+++|+...... ....+..|.+++..+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999876443 45678899999999975 4467777776653 36789999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (643)
|.+|.+.+.. ..++......++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888776531 24667777888889999999998621
Q ss_pred --------------CCCeEecCCCCCCEEEcC--CCcEEEeecCcccc
Q 006480 542 --------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKW 573 (643)
Q Consensus 542 --------------~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~ 573 (643)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.4e-10 Score=105.87 Aligned_cols=131 Identities=23% Similarity=0.331 Sum_probs=100.1
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCC---------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
..+++|+-+.+|.+.+ -|.++++|.-.+. .-...+-.+|.++|.+++--.|.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999866 3445777754332 11245677899999998766665555556677788999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
++|..|.+.+... ...++..+-..+.-||. .+|+|+||.++||++..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888644 13466667777778999 9999999999999998765 999999998743
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.9e-10 Score=122.61 Aligned_cols=165 Identities=24% Similarity=0.292 Sum_probs=125.1
Q ss_pred eCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChH
Q 006480 443 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 521 (643)
Q Consensus 443 ~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~ 521 (643)
..++.++.|...+... .......+.++-|+.++||||+++++.+...+.+|||+|.+. .|..++... ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 4478888888876543 344556678889999999999999999999999999999985 577777543 244
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC
Q 006480 522 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601 (643)
Q Consensus 522 ~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~ 601 (643)
.....+.||+.||.|||+. .+++|++|.-..|+++..|+.||.+|-++.......... ....---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCcc
Confidence 5566788999999999863 679999999999999999999999998875444332100 011122346666655432
Q ss_pred CCCchhHHHHHHHHHHHHHcC
Q 006480 602 KVNDKIDVYAFGVVLLELLTG 622 (643)
Q Consensus 602 ~~s~ksDIwSlGvvl~eLltG 622 (643)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-09 Score=102.90 Aligned_cols=142 Identities=22% Similarity=0.286 Sum_probs=106.8
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCC---------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
....|-+|+-+.|+++.. .|+.++||.-.+. .-..++..+|.++|.++.--.|.-..-++.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999987 7787777754321 224567889999999987556655555666767779999
Q ss_pred eeCCC-CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeecCccc
Q 006480 497 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAK 572 (643)
Q Consensus 497 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~ 572 (643)
||++| -++.+++...-.. .........++..|-+.+.-||. .+|||+||..+||+|..++. +.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 4788887654332 12222236788888899999999 88999999999999976543 5899999975
Q ss_pred c
Q 006480 573 W 573 (643)
Q Consensus 573 ~ 573 (643)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.7e-11 Score=139.49 Aligned_cols=215 Identities=22% Similarity=0.296 Sum_probs=153.9
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhH----HHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
..+.|.+.+-+-+|.++.++.+.-. .|...++|+....... .+....+-.++-..++|.++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455677778888999998876532 4444555555433221 1222223233333345666655544445667899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+++|+.+++|...|+... ..+..-.+.....+..++.|||. ..++|||++|.|+|+..+++.++.|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999998654 34555556677788999999998 67999999999999999999999999843221
Q ss_pred cCC----C--------------------CC-----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 006480 575 STS----S--------------------SH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (643)
Q Consensus 575 ~~~----~--------------------~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P 625 (643)
... . .. .......||+.|++||...+......+|+|++|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 0 00 011235699999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHhhhcc
Q 006480 626 ISNDHPKGQESLVMQS 641 (643)
Q Consensus 626 f~~~~~~~~~~li~~~ 641 (643)
|....+.....-|..+
T Consensus 1035 ~na~tpq~~f~ni~~~ 1050 (1205)
T KOG0606|consen 1035 FNAETPQQIFENILNR 1050 (1205)
T ss_pred CCCcchhhhhhccccC
Confidence 9999987776655443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-10 Score=124.61 Aligned_cols=199 Identities=24% Similarity=0.239 Sum_probs=154.3
Q ss_pred Ccccceeeee--cCceEEEEEEe---CCCCEEEEEEeCC--C-hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEE
Q 006480 423 NFLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP--S-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 423 ~f~~~~~LG~--G~~g~Vy~~~~---~~g~~vAVK~l~~--~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 493 (643)
.|-+...+|. |.+|.||.+.. .++..+|+|.-+. . ....+.=++|+....+++ |+|.++.+..+...+.++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3556778899 99999999865 4788899987432 2 233344456766666664 999999999998999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeec
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDF 568 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DF 568 (643)
+-.|++ +.+|..+.+.... .++....+.++.+... ||..+|. .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 999998 5788888775432 3566677777777777 9999999 899999999999999999 88999999
Q ss_pred CccccccCCCCCc---cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 569 GLAKWASTSSSHI---TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 569 Gla~~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|+...+....-.. ......|..-|++||... +-++...|||+||.++++-.+|-.+....
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 9988766543111 112236788899999876 47889999999999999999987665543
|
|
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.7e-09 Score=113.02 Aligned_cols=105 Identities=13% Similarity=0.156 Sum_probs=82.9
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCC--CCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhh------
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL------ 87 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~------ 87 (643)
-++|+||||+|+.|++|++.|++..... +..|++|||.+....... ........+++++..+..++.
T Consensus 5 ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-----~~~~~~~~eelle~~~~~~~~~l~~~~ 79 (357)
T PRK12652 5 ANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-----GQDELAAAEELLERVEVWATEDLGDDA 79 (357)
T ss_pred cCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-----hhHHHHHHHHHHHHHHHHHHHhhhccc
Confidence 3789999999999999999999988774 589999999875321111 112224455677777777765
Q ss_pred cCCcEEEEEEEc-------CChhhHHHHHHHhcCCCEEEEccCCC
Q 006480 88 KQVDLKLKICRG-------TSIRKILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 88 k~v~~~~~v~~g-------~~~~~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
.+|+++..++.+ |++.+.|+++|++++||+||||-.-.
T Consensus 80 ~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~~ 124 (357)
T PRK12652 80 SSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEYN 124 (357)
T ss_pred CCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCCC
Confidence 589999988874 69999999999999999999997644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.2e-10 Score=124.94 Aligned_cols=194 Identities=23% Similarity=0.184 Sum_probs=145.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC--CCCEEEEEEeCCChh-HH--HHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPSED-VI--KEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vAVK~l~~~~~-~~--~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 493 (643)
.+.+|..+..||.|.|+.|+....+ ++..|++|.+...-. .. ..-+.|+-+...+ .|.+++..+..+...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888999999999999987643 677889988764321 11 1123455555555 5889998888888888888
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 572 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~ 572 (643)
+--||+.++++...+.. ...+....++.+..|++.++.++|+ +.++|+|+||+||++..+ +.-++.|||.+.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence 99999999988877732 2357778889999999999999999 899999999999999886 888999999876
Q ss_pred cccCCCCCccccCCCCCCCcc--CcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 006480 573 WASTSSSHITCTDVAGTFGYL--APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~--APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P 625 (643)
.+.... .....+-.++ +|+......+-.+.|+++||.-+.+.++|.+-
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 422211 1122333444 44445566788999999999999999887643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.1e-08 Score=100.26 Aligned_cols=125 Identities=24% Similarity=0.322 Sum_probs=83.3
Q ss_pred EEEEEEeCCCCEEEEEEeCCC---------------------------hhHHHHHHHHHHHHHhcCCC--ceeEEEeEEE
Q 006480 437 QVYKGCLPDGKELAVKILKPS---------------------------EDVIKEFVLEIEIITTLHHK--NIISLLGFCF 487 (643)
Q Consensus 437 ~Vy~~~~~~g~~vAVK~l~~~---------------------------~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 487 (643)
.||.|...+|..+|||+.+.. ........+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999989999999998631 01134566899999999765 56667655
Q ss_pred eCCeEEEEEeeCC--CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 488 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 488 ~~~~~~LV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
..+ +|||||+. |..+..+.... ++..+...++.+++..+.. +|. .||+|+||.+.|||++++ .+.
T Consensus 79 ~~~--~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 NRN--VIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ETT--EEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred eCC--EEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 233 89999998 54454433211 1234455677778775555 567 899999999999999988 999
Q ss_pred EeecCcccccc
Q 006480 565 LSDFGLAKWAS 575 (643)
Q Consensus 565 L~DFGla~~~~ 575 (643)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999876443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-09 Score=112.24 Aligned_cols=155 Identities=21% Similarity=0.303 Sum_probs=118.9
Q ss_pred HHHHhcCCCceeEEEeEEEeC-----CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC
Q 006480 469 EIITTLHHKNIISLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543 (643)
Q Consensus 469 ~il~~l~HpnIv~l~g~~~~~-----~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 543 (643)
+-|-++.|.||++++.++.+. ....++.|||..|+|..+|+..+.....+......+|+-||+.||.|||+.. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566789999999887653 3478999999999999999987777777888888999999999999999965 6
Q ss_pred CeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC--c-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHH
Q 006480 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--I-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 620 (643)
Q Consensus 544 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLl 620 (643)
+|+|+++..+-|++..+|-+||.--.-.. ....... . ....-.+-++|.|||+=.....+..+|||+||...+||-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999888875321100 0000000 0 000113678999999887778888999999999999998
Q ss_pred cCCCC
Q 006480 621 TGRKP 625 (643)
Q Consensus 621 tG~~P 625 (643)
-+..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 87654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.1e-08 Score=100.96 Aligned_cols=140 Identities=18% Similarity=0.167 Sum_probs=101.1
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCCh--hHHH----------HHHHHHHHHHhcCCC--ceeEEEeEEEe-----
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHK--NIISLLGFCFE----- 488 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~--~~~~----------~~~~Ei~il~~l~Hp--nIv~l~g~~~~----- 488 (643)
+.+-......|++... +|+.|.||...... ...+ .+.+|.+.+..+..- ...+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455555555777665 77889999775433 1122 377899988888433 33344555432
Q ss_pred CCeEEEEEeeCCCC-CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------C
Q 006480 489 DNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------D 560 (643)
Q Consensus 489 ~~~~~LV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-------~ 560 (643)
...-+||||++++. +|.+++..... ...+......++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23468999999876 89998853221 234566778899999999999999 99999999999999975 5
Q ss_pred CcEEEeecCcccc
Q 006480 561 FEPQLSDFGLAKW 573 (643)
Q Consensus 561 ~~vkL~DFGla~~ 573 (643)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 7899999998853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.2e-08 Score=105.72 Aligned_cols=167 Identities=20% Similarity=0.288 Sum_probs=127.5
Q ss_pred eEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEE----eCCeEEEEEeeCCC-CCHHHHh
Q 006480 436 SQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----EDNNLLLVYDFLSR-GSLEENL 508 (643)
Q Consensus 436 g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~LV~E~~~~-gsL~~~l 508 (643)
.+.|++... ||..|++|++.... ........-+++++++.|+|+|++.++|. .+..++|||+|+++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467998744 89999999994322 12223345678999999999999999886 35679999999986 5888766
Q ss_pred ccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 509 HGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 509 ~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
..... .+...++..+|.++.|+..||.++|+ .|+..+-|.|.+||++.+.+++|+-.|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 53322 22456788999999999999999999 88999999999999998888999888876655543
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 624 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~ 624 (643)
.. |.+. --.+-|.=.||.+++.|.||..
T Consensus 447 ~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 31 1111 1236899999999999999953
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.4e-08 Score=111.68 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=90.5
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCCh-----------------------------------hHHHHHH------H
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------------------------DVIKEFV------L 466 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-----------------------------------~~~~~~~------~ 466 (643)
+.|+.++-|+||+|.+++|+.||||+.++.- +..+.+. +
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999998640 0111122 2
Q ss_pred HHHHHHhc-----CCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHH-HHHHHhC
Q 006480 467 EIEIITTL-----HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA-LEYLHSG 540 (643)
Q Consensus 467 Ei~il~~l-----~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~ 540 (643)
|..-+.++ +.|++.-..-+....+.-.|+|||++|-.+.+...... ..++... ++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~---ia~~~~~~f~~q~~~- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKE---LAELLVRAFLRQLLR- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHH---HHHHHHHHHHHHHHh-
Confidence 22222222 23444333333333455699999999988888743221 1233222 22222222 112222
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 541 ~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
.|++|.|.+|.||++..+|.+.+.|||+...++.
T Consensus 284 --dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 --DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 6899999999999999999999999999866554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.6e-07 Score=98.15 Aligned_cols=207 Identities=18% Similarity=0.228 Sum_probs=133.0
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCC-ChhHHHHHHHHHHHHHhc-CCCceeEEEeEE------EeCC-eEEEEE
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEIITTL-HHKNIISLLGFC------FEDN-NLLLVY 496 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~------~~~~-~~~LV~ 496 (643)
....||+|+.+.+|-.- .-...+.|+... ......+.. +.|... .||-+-.=+.|= .... ..-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45679999999998532 222234466543 222222222 223332 455433311111 1222 266788
Q ss_pred eeCCCC-CHHHHhc--cCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 497 DFLSRG-SLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~g-sL~~~l~--~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
..+++. ....++. ..++.-..+.|+-.+.+++.++.+..-||+ .|.+-+|++++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 888764 2222332 112223467999999999999999999999 8899999999999999999999998543322
Q ss_pred ccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCC-----ChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTG-RKPISND-----HPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~-----~~~~~~~li~~~~ 642 (643)
...+ . .....+|...|.+||... +...+...|.|.|||++|+|+.| ++||.+- -+.-.+..|-.|+
T Consensus 167 ~~ng-~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 NANG-T--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred ccCC-c--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2221 1 112247899999999765 44677889999999999999996 9999873 2333444555444
Q ss_pred C
Q 006480 643 F 643 (643)
Q Consensus 643 f 643 (643)
|
T Consensus 244 f 244 (637)
T COG4248 244 F 244 (637)
T ss_pred e
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=2.9e-07 Score=93.47 Aligned_cols=132 Identities=20% Similarity=0.220 Sum_probs=94.3
Q ss_pred cccceeeeecCceEEEEEEeCCCCEEEEEEeCCC-----------------------hhHHHHHHHHHHHHHhcCCC--c
Q 006480 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-----------------------EDVIKEFVLEIEIITTLHHK--N 478 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~-----------------------~~~~~~~~~Ei~il~~l~Hp--n 478 (643)
..+...||-|--|.||.|..+.|.++|||.-+-. .-......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999999999999976421 01233466799999999654 7
Q ss_pred eeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 479 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
+.+.+++ +..++||||+.|-.|...-- .....-.++..|++-+.-+-. .||||+|+.+=||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 7777776 55699999998865554321 111112223333333332334 7899999999999999
Q ss_pred CCCcEEEeecCcc
Q 006480 559 DDFEPQLSDFGLA 571 (643)
Q Consensus 559 ~~~~vkL~DFGla 571 (643)
+||.+.++||--+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=9.7e-07 Score=87.56 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=101.4
Q ss_pred eeecCceEEEEEEeCCCCEEEEEEeCCC-------hhHHHHHHHHHHHHHhcCC--CceeEEEeEEEe-----CCeEEEE
Q 006480 430 IGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHH--KNIISLLGFCFE-----DNNLLLV 495 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~~g~~vAVK~l~~~-------~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~-----~~~~~LV 495 (643)
-|+||.|.|++... +|+.+-+|..... ......|.+|+..|..|.. -.+.+++ ++.. .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47799999999776 4456888876421 2345789999999999853 2355555 3321 1236899
Q ss_pred EeeCCC-CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeecCccc
Q 006480 496 YDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAK 572 (643)
Q Consensus 496 ~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~ 572 (643)
+|-+.+ -+|.+++..... .+.+......++.+++.++.-||+ .|+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998864 489988854322 245677778999999999999999 99999999999999986666 9999997654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=7.4e-07 Score=99.62 Aligned_cols=174 Identities=20% Similarity=0.251 Sum_probs=108.9
Q ss_pred CCchhHHhHhhhhcccccccChHHHHHhhcC---------cc--cceeeeecCceEEEEEEeCCCCEEEEEEeCCC----
Q 006480 393 ELPKELEGLHEKYSATCRLFNYQDLLSATSN---------FL--AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---- 457 (643)
Q Consensus 393 ~~~~~~~~l~~~~~~~~~~f~~~el~~~~~~---------f~--~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---- 457 (643)
-+|++.-.........|+.|+++++...... |. ..+.||.-+.|+||+|.+++|+.||||+.++.
T Consensus 121 llP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~ 200 (538)
T KOG1235|consen 121 LLPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKL 200 (538)
T ss_pred cCcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHH
Confidence 3555555445556667777887776554432 22 24689999999999999999999999998764
Q ss_pred ----------------------------hhHHHHHHHHHH----------HHHhcCCCc------eeEEEeEEEeCCeEE
Q 006480 458 ----------------------------EDVIKEFVLEIE----------IITTLHHKN------IISLLGFCFEDNNLL 493 (643)
Q Consensus 458 ----------------------------~~~~~~~~~Ei~----------il~~l~Hpn------Iv~l~g~~~~~~~~~ 493 (643)
++..+.+..|++ +.+.+.|-+ |.+++-.+ .....
T Consensus 201 ~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RV 278 (538)
T KOG1235|consen 201 IMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRV 278 (538)
T ss_pred HHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceE
Confidence 111122222222 222233444 33333322 23569
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----CCcEEEeecC
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDFG 569 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~DFG 569 (643)
|+||||+|..+.|.-.-.. ..++...+...+.++ |+++.-..|++|.|-+|.||++.. ++++.|-|||
T Consensus 279 LtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~-----~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 279 LTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEA-----YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred EEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHH-----HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 9999999987766533211 234444433333332 333322268999999999999983 6789999999
Q ss_pred ccccccC
Q 006480 570 LAKWAST 576 (643)
Q Consensus 570 la~~~~~ 576 (643)
+...+..
T Consensus 351 l~~~is~ 357 (538)
T KOG1235|consen 351 LYAVISH 357 (538)
T ss_pred ccccccH
Confidence 9876654
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.4e-06 Score=105.02 Aligned_cols=126 Identities=17% Similarity=0.102 Sum_probs=100.3
Q ss_pred CCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 15 ~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
...+|+|+|++++++.+++++|.+-..+-+..+++|||..+.... .......-+..+..+|+..|.+ .
T Consensus 249 ~~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~----------~~~~~~~~l~~~~~lA~~lGa~--~ 316 (895)
T PRK10490 249 TRDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRLHR----------LPEKKRRAILSALRLAQELGAE--T 316 (895)
T ss_pred cCCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCcCc----------CCHHHHHHHHHHHHHHHHcCCE--E
Confidence 457899999999999999999999999999999999998652110 0012223334444588777766 5
Q ss_pred EEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccc-cCCCchHHHHhccCCCCcEEEEEeCC
Q 006480 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTI-RSTTSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~-r~~~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
..+.|+|+.++|+++|+.++|+.||||.+++++++ ++ ||++.+++.++ ...|.+|...
T Consensus 317 ~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~~~~~--s~~~~l~r~~~-~idi~iv~~~ 375 (895)
T PRK10490 317 ATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRWWRRE--SFADRLARLGP-DLDLVIVALD 375 (895)
T ss_pred EEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCCccCC--CHHHHHHHhCC-CCCEEEEeCC
Confidence 57788999999999999999999999999987653 33 99999999998 7899999643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-06 Score=87.86 Aligned_cols=108 Identities=19% Similarity=0.189 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHhcC--CCceeEEEeEEEeC----CeEEEEEeeCCCC-CHHHHhccCCCCCCCCChHHHHHHHHHHHHH
Q 006480 461 IKEFVLEIEIITTLH--HKNIISLLGFCFED----NNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533 (643)
Q Consensus 461 ~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~----~~~~LV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~a 533 (643)
.....+|.+.+..|. .-.+.+++++.... ...+||+|++++. +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 346778888888775 33455666665542 2358999999874 89999875322 4556678899999999
Q ss_pred HHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeecCcccccc
Q 006480 534 LEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWAS 575 (643)
Q Consensus 534 L~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~~ 575 (643)
+.-||. .||+|+|+++.|||++.+. .+.|+||+.++...
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 9999999999999999887 89999999876443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.9e-06 Score=82.84 Aligned_cols=146 Identities=21% Similarity=0.298 Sum_probs=88.4
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEEeEEEe---CCeEEEEEeeCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 501 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~---~~~~~LV~E~~~~ 501 (643)
++.|+.|..+.||+....+ ..+++|+.... .....+..|..++..+... .+.+++..+.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4678999999999998866 68999998766 5567788899998888533 35666664432 3457999999999
Q ss_pred CCHHH----------------Hh---ccCCCCCCCCChHHH---------HHH------------HHHHHH-HHHHHHh-
Q 006480 502 GSLEE----------------NL---HGNKKDPAAFGWSER---------YKV------------AMGVAE-ALEYLHS- 539 (643)
Q Consensus 502 gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~- 539 (643)
..+.. .+ +........+.+... ... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 111000011111110 000 111222 3334442
Q ss_pred ---CCCCCeEecCCCCCCEEEc-CCCcEEEeecCccccc
Q 006480 540 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWA 574 (643)
Q Consensus 540 ---~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~ 574 (643)
..+..++|+|+.|.|||++ .++.+-|+||+.+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2347799999999999999 6666789999887543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.38 E-value=5.8e-06 Score=83.66 Aligned_cols=139 Identities=17% Similarity=0.249 Sum_probs=86.3
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEEeEEEeCCeEEEEEeeCCCCC-H
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGS-L 504 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~~gs-L 504 (643)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999984 34567888876533 3345688999999886433 4677787777777889999998863 2
Q ss_pred HHH---------------------hccCCCCCCCCChHHHH-HHHH----------HHHH-HHHHHHhC-CCCCeEecCC
Q 006480 505 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHSG-SAQRVIHRDV 550 (643)
Q Consensus 505 ~~~---------------------l~~~~~~~~~l~~~~~~-~i~~----------qia~-aL~yLH~~-~~~~iiHrDL 550 (643)
... ||..... ........ .+.. .+.. ...+|... ....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 1111000 11111100 0000 0011 12222221 2246799999
Q ss_pred CCCCEEEcCCCcEEEeecCcccc
Q 006480 551 KSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 551 Kp~NILl~~~~~vkL~DFGla~~ 573 (643)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.3e-06 Score=82.73 Aligned_cols=135 Identities=16% Similarity=0.176 Sum_probs=89.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHH----H------HHHHHHHHhcCCC---ceeEEEe---
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----F------VLEIEIITTLHHK---NIISLLG--- 484 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~----~------~~Ei~il~~l~Hp---nIv~l~g--- 484 (643)
.++|...+++-......|.+... +|+.+++|..+.......+ | .+++..+..++.. .+..++-
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45788888888888777877666 6788999988764322111 1 1233333333221 2222221
Q ss_pred --EEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc
Q 006480 485 --FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 562 (643)
Q Consensus 485 --~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 562 (643)
.+......+|+|||++|..|.+... +.. .++..+++++.-||+ .|+.|+|.+|.|++++++ .
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-c
Confidence 2222345679999999988876542 222 245567788999999 999999999999999865 4
Q ss_pred EEEeecCccc
Q 006480 563 PQLSDFGLAK 572 (643)
Q Consensus 563 vkL~DFGla~ 572 (643)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.26 E-value=9e-08 Score=106.13 Aligned_cols=191 Identities=22% Similarity=0.169 Sum_probs=139.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~ 498 (643)
.+..+..-+.+++|++++++|....-.+....+.+... .....++++|.+++||| .+..++-+..++..++++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 34444455667999999999976544444456665543 34456889999999999 77777777778889999999
Q ss_pred CCCC-CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 499 LSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 499 ~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
+.++ +-..... .....|...+...+.+.-+++|+|||+ ..-+||| ||+..+ +..++.||+.+..+...
T Consensus 316 ~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 316 CSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hcCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9877 2111111 111234444556667778889999998 3348898 887765 68999999988766554
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
. ......+|+.++|||+.+...++.+.|.|++|+=-.+|--|-+|-..
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 3 33456899999999999999999999999999877777777776554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.7e-05 Score=80.68 Aligned_cols=142 Identities=18% Similarity=0.144 Sum_probs=87.1
Q ss_pred eeeecCc-eEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeCCCCCHHH
Q 006480 429 LIGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 506 (643)
Q Consensus 429 ~LG~G~~-g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~ 506 (643)
.|..|.. ..||+.... +..+.+|+..... ..++..|+++++.+. +--+.+++++....+..++||++++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3455555 788998764 4678889886543 345677998888874 3446678887776667899999999887764
Q ss_pred Hh-------------------ccCCCCCCCCCh--HHHHHHHH--------------------HHHHHHHHHHh----CC
Q 006480 507 NL-------------------HGNKKDPAAFGW--SERYKVAM--------------------GVAEALEYLHS----GS 541 (643)
Q Consensus 507 ~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------qia~aL~yLH~----~~ 541 (643)
.. +.......++.. ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 42 111110111110 00000000 01111222211 11
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 542 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
...++|+|+.|.|||++++..+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 24589999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.1e-05 Score=79.34 Aligned_cols=104 Identities=25% Similarity=0.266 Sum_probs=82.2
Q ss_pred HHHHHHHhcCC-CceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC
Q 006480 466 LEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544 (643)
Q Consensus 466 ~Ei~il~~l~H-pnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 544 (643)
.|.-+++.+++ +++.+++|+|-. ++|.||...+++...... -..-...+|..|.+|+.++++.+.+|++.....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47778888876 699999999943 789999987766432100 001123689999999999999999999876666
Q ss_pred eEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 545 iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+.-.|++++|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876433
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.4e-05 Score=88.25 Aligned_cols=135 Identities=18% Similarity=0.097 Sum_probs=107.1
Q ss_pred CCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 15 ~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
...+|+|+|+++..|.+.++||..-.-+-+....+|||-.|.... ..+.-...+.....+|++-+ .+.
T Consensus 247 ~~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~~~----------~~~~~~~~l~~~~~Lae~lG--ae~ 314 (890)
T COG2205 247 ARERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPELHR----------LSEKEARRLHENLRLAEELG--AEI 314 (890)
T ss_pred ccceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEecccccc----------ccHHHHHHHHHHHHHHHHhC--CeE
Confidence 457999999999999999999999999999999999998664321 11233345566666665544 456
Q ss_pred EEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEeCCeEEeeec
Q 006480 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVNNGKVVFQKE 162 (643)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~~gk~~~~r~ 162 (643)
+.+.|+|+.++|+++|+.+++..||||.+.++++.+.+ .|+.++++++++ ...|.+|..+.....|.
T Consensus 315 ~~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~l~~~L~~~~~-~idv~ii~~~~~~~~~~ 382 (890)
T COG2205 315 VTLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGSLADRLAREAP-GIDVHIVALDAPPDKRP 382 (890)
T ss_pred EEEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcccHHHHHHhcCC-CceEEEeeCCCCccccc
Confidence 77888999999999999999999999999987665542 399999999998 88999998765554443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=9.3e-07 Score=99.30 Aligned_cols=101 Identities=22% Similarity=0.463 Sum_probs=78.9
Q ss_pred HHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccC--------CCCCCCccCccc
Q 006480 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--------VAGTFGYLAPEY 597 (643)
Q Consensus 526 i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~--------~~gt~~Y~APE~ 597 (643)
=+.+++.||.|+|+. .++||++|.|++|.++.++..||+.|+++........ +.+.. ......|.|||+
T Consensus 104 nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~-~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE-YPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCc-cccccCCCCCChhhccCcccccchh
Confidence 345566999999983 6899999999999999999999999998764443211 11111 134567999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 006480 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISND 629 (643)
Q Consensus 598 l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~ 629 (643)
+.+...+.++|+|||||++|.+.. |+.-|.+.
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhcc
Confidence 999889999999999999999994 55555544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=6.5e-05 Score=75.89 Aligned_cols=150 Identities=23% Similarity=0.249 Sum_probs=96.2
Q ss_pred hHHHHHhhcCcccce---eeeecCceEEEEEEeCCCCEEEEEEeCCChh-------------------------HHHHHH
Q 006480 414 YQDLLSATSNFLAEN---LIGKGGSSQVYKGCLPDGKELAVKILKPSED-------------------------VIKEFV 465 (643)
Q Consensus 414 ~~el~~~~~~f~~~~---~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~-------------------------~~~~~~ 465 (643)
+..+....++..+.. .|+.|--+.||+|...++..+|||+.+.... ......
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444445555544 4566778889999888899999999974310 011233
Q ss_pred HHHHHHHhcC--CCceeEEEeEEEeCCeEEEEEeeCCCCCH-HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 006480 466 LEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSL-EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542 (643)
Q Consensus 466 ~Ei~il~~l~--HpnIv~l~g~~~~~~~~~LV~E~~~~gsL-~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 542 (643)
.|+.-|.++. +-.+.+.+++.. -.|||||+....+ .=.|. ...+...+...+..++++.+.-|-. .
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~--~ 185 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK--E 185 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH--h
Confidence 5666777763 445566666642 2899999965310 00111 1122233455666666666665554 2
Q ss_pred CCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 543 ~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
.++||+||..=|||+. ++.+.|+|||-|....
T Consensus 186 a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 6799999999999999 8899999999875443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.1e-05 Score=73.71 Aligned_cols=127 Identities=24% Similarity=0.411 Sum_probs=93.9
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-----------------hHHHHHHHHHHHHHhcC------CCceeEEE
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 483 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-----------------~~~~~~~~Ei~il~~l~------HpnIv~l~ 483 (643)
...||+|+.-.||. +++.....||+..+.. ...++..+|+..+..+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999995 5666678899987655 23567778887777666 78999999
Q ss_pred eEEEeCCeEEEEEeeCCC------CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 484 GFCFEDNNLLLVYDFLSR------GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 484 g~~~~~~~~~LV~E~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
|+..++-.+.+|+|.+.. .+|.+++... .++. ...+ .+-+-..||-. ..|+.+||+|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~---~L~~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQ---ALDEFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHH---HHHHHHHHHHH---cCCeecCCCcccEEE
Confidence 999999999999998743 2788888432 2444 3333 33444557777 789999999999999
Q ss_pred cCC---C-cEEEee
Q 006480 558 SDD---F-EPQLSD 567 (643)
Q Consensus 558 ~~~---~-~vkL~D 567 (643)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 633 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.7e-05 Score=76.26 Aligned_cols=142 Identities=20% Similarity=0.277 Sum_probs=83.2
Q ss_pred ceeeeecCceEEEEEEeCC--CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.+.|..|-...+|+....+ ++.|++|+.........+..+|+.++..+...+ ..++++.+ + + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-Q-N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-C-C--cEEEEeeCCCc
Confidence 3567788888999987654 678999987654322223347888888885433 34444433 2 2 47999998876
Q ss_pred HHHH-----------------hccCCCCC--------CCCChHHHHHHHH----------------------HHHHHHHH
Q 006480 504 LEEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVAEALEY 536 (643)
Q Consensus 504 L~~~-----------------l~~~~~~~--------~~l~~~~~~~i~~----------------------qia~aL~y 536 (643)
+... +|...... ....+..+..+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 11111110 1111222222211 11111112
Q ss_pred H----Hh-CCCCCeEecCCCCCCEEEcC-CCcEEEeecCccc
Q 006480 537 L----HS-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 572 (643)
Q Consensus 537 L----H~-~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~ 572 (643)
| -. ..+..++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 2 11 12357999999999999997 5789999998774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.4e-05 Score=88.65 Aligned_cols=148 Identities=15% Similarity=0.306 Sum_probs=92.4
Q ss_pred ceeeeecCceEEEEEEeCCC---CEEEEEEeCCCh--hHHHHHHHHHHHHHhcC-CCce--eEEEeEEEeC---CeEEEE
Q 006480 427 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 495 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g---~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~~~LV 495 (643)
...|+.|.++.+|+....++ ..+++|+..... .....+.+|.++|+.+. |+++ .+++.+|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999876543 467777765432 23356889999999995 6665 7888887654 467899
Q ss_pred EeeCCCCCHHH-----------------------HhccCCCC-------CCCCCh--HHHHHHH---------------H
Q 006480 496 YDFLSRGSLEE-----------------------NLHGNKKD-------PAAFGW--SERYKVA---------------M 528 (643)
Q Consensus 496 ~E~~~~gsL~~-----------------------~l~~~~~~-------~~~l~~--~~~~~i~---------------~ 528 (643)
|||++|..+.+ .||..... ..+..+ .++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998764321 12211100 001011 1111111 1
Q ss_pred HHHHHHHHHHhCCC--------CCeEecCCCCCCEEEcC-CCc-EEEeecCccccc
Q 006480 529 GVAEALEYLHSGSA--------QRVIHRDVKSSNILLSD-DFE-PQLSDFGLAKWA 574 (643)
Q Consensus 529 qia~aL~yLH~~~~--------~~iiHrDLKp~NILl~~-~~~-vkL~DFGla~~~ 574 (643)
.+...+.+|..+-+ ..+||+|+++.|||++. ++. .-|.||+++.+-
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754322 35999999999999985 334 579999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.1e-05 Score=76.40 Aligned_cols=74 Identities=15% Similarity=0.208 Sum_probs=47.5
Q ss_pred ceeeeecCceE-EEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC---ceeEEEeEEEeC---CeEEEEEeeC
Q 006480 427 ENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFL 499 (643)
Q Consensus 427 ~~~LG~G~~g~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~---~~~~LV~E~~ 499 (643)
++.|+.||... ||+. +..+++|+... ......+..|.++|..+... -+.++++..... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 35678777765 8875 23577787654 22345788899999887532 344455544322 2348899999
Q ss_pred CCCCHH
Q 006480 500 SRGSLE 505 (643)
Q Consensus 500 ~~gsL~ 505 (643)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00019 Score=70.87 Aligned_cols=124 Identities=22% Similarity=0.333 Sum_probs=91.9
Q ss_pred cCcccceeeeecCc-eEEEEEEeCCCCEEEEEEeCC---C------------h-------hHHHHHHHHHHHHHhcC---
Q 006480 422 SNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFVLEIEIITTLH--- 475 (643)
Q Consensus 422 ~~f~~~~~LG~G~~-g~Vy~~~~~~g~~vAVK~l~~---~------------~-------~~~~~~~~Ei~il~~l~--- 475 (643)
.++...+.||.|.. |.||++.. +|+.||+|+.+. . + ....-|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999988 778999999431 0 0 12335788998888774
Q ss_pred CCce--eEEEeEEEeC------------------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHH
Q 006480 476 HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535 (643)
Q Consensus 476 HpnI--v~l~g~~~~~------------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~ 535 (643)
+.++ ++.+||..-. ..+.||.||.+... .+... -+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence 4456 9999987432 12568888886643 12222 3456777788
Q ss_pred HHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 536 yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
.+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8999 99999999999987 3589999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00015 Score=69.64 Aligned_cols=130 Identities=22% Similarity=0.270 Sum_probs=92.6
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
..+.|++|.+|.||++.+ .|..+|+|+-+.+. ....+..|.++|..+.--++.+=+-++.+ -++.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds-~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS-PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCCc-chhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchh
Confidence 456799999999999987 55689999887543 35678889999999987777654444322 25669999988887
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC-CCCEEEcCCCcEEEeecCccccc
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK-SSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK-p~NILl~~~~~vkL~DFGla~~~ 574 (643)
++-... . .+-...++++---|-. .||-|+.|. |..++|..+..+.|+||..|...
T Consensus 101 ~~~~~~-------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGG-------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcc-------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 765421 1 1233445555444545 789999885 56666666669999999988743
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00014 Score=74.69 Aligned_cols=139 Identities=13% Similarity=0.142 Sum_probs=80.1
Q ss_pred eeecCceEEEEEEeCCCCEEEEEEeCCChhHH-HHHHHHHHHHHhcCCCce-eEEEeEEEeCCeEEEEEeeCCCCCHHH-
Q 006480 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEE- 506 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~-~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL~~- 506 (643)
+..|-.+.+|+... +++.+++|+........ -+...|.++++.+..-.+ .+++..+ .+ ++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~--~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH--WLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC--EEEEEeccCcccccc
Confidence 45677788998764 66778889865443221 245678899988864333 3444433 22 78999998866532
Q ss_pred ----------------HhccCCCCCCCCChHH-HHHHHHHH---------HHHHHHHHh-----CCCCCeEecCCCCCCE
Q 006480 507 ----------------NLHGNKKDPAAFGWSE-RYKVAMGV---------AEALEYLHS-----GSAQRVIHRDVKSSNI 555 (643)
Q Consensus 507 ----------------~l~~~~~~~~~l~~~~-~~~i~~qi---------a~aL~yLH~-----~~~~~iiHrDLKp~NI 555 (643)
.||.......+++... +..+..++ ...+..+-. ..+..++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1222211111222221 11211111 111222211 1124689999999999
Q ss_pred EEcCCCcEEEeecCccccc
Q 006480 556 LLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 556 Ll~~~~~vkL~DFGla~~~ 574 (643)
++++++ +.|+||..|...
T Consensus 159 l~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEeCCC-CEEEeccccCcC
Confidence 999877 789999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=75.32 Aligned_cols=143 Identities=24% Similarity=0.364 Sum_probs=87.0
Q ss_pred eeeeecCceEEEEEEeCC-------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEEeEEEeCCeEEEEEeeC
Q 006480 428 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E~~ 499 (643)
+.|..|-...+|+....+ ++.+++|+.........+...|.+++..+....+ .++++++. + .+|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence 456677777899987654 5789999987654444566788888888854333 35555543 2 4689999
Q ss_pred CCCCHHHH-----------------hccCCCC--C-----CCCChHHHHH--------------------------HHHH
Q 006480 500 SRGSLEEN-----------------LHGNKKD--P-----AAFGWSERYK--------------------------VAMG 529 (643)
Q Consensus 500 ~~gsL~~~-----------------l~~~~~~--~-----~~l~~~~~~~--------------------------i~~q 529 (643)
+|..+... +|..... . ...-|..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765431 1111111 0 0011111111 1112
Q ss_pred HHHHHHHHHh------CCCCCeEecCCCCCCEEEcCC----CcEEEeecCccccc
Q 006480 530 VAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 574 (643)
Q Consensus 530 ia~aL~yLH~------~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~~ 574 (643)
+...+.+|-. ..+..++|+|+.+.|||++.+ +.+.|+||..|...
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 2233344432 245789999999999999985 88999999988543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00069 Score=71.42 Aligned_cols=77 Identities=10% Similarity=0.013 Sum_probs=57.2
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC---CceeEEEeEEEe---CCeEEEEEeeC
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFL 499 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~---~~~~~LV~E~~ 499 (643)
-.+.||.|..+.||+....+++ +.+|..+. ......+..|.+.|+.|.. ..+.+++++|.. .+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 3567999999999998765664 66777543 1123567889999988853 467888888754 36689999999
Q ss_pred CCCCH
Q 006480 500 SRGSL 504 (643)
Q Consensus 500 ~~gsL 504 (643)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00097 Score=72.91 Aligned_cols=75 Identities=19% Similarity=0.233 Sum_probs=55.2
Q ss_pred ceeeeecCceEEEEEEeCCC-CEEEEEEeCCC--------hhHHHHHHHHHHHHHhcC---CCceeEEEeEEEeCCeEEE
Q 006480 427 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS--------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g-~~vAVK~l~~~--------~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~L 494 (643)
.+.||.|.+..||++...+| +.++||.-.+. .....++..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998777 48999985421 124566778888888763 3457777776 4455789
Q ss_pred EEeeCCCCC
Q 006480 495 VYDFLSRGS 503 (643)
Q Consensus 495 V~E~~~~gs 503 (643)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0011 Score=69.48 Aligned_cols=144 Identities=17% Similarity=0.180 Sum_probs=86.9
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEEeE------EEeCCeEEEEEee
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 498 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~LV~E~ 498 (643)
.+.|..|....+|+....+ ..+++|+... .....+..|++++..+.+- .+.+++.. ....+..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567888888999987644 4688898865 2234566788888877432 24444431 2234567899999
Q ss_pred CCCCCHHH--------------HhccCC-CCC------CCCChHHHH----------HHHHHHHHHHHHHHh----CCCC
Q 006480 499 LSRGSLEE--------------NLHGNK-KDP------AAFGWSERY----------KVAMGVAEALEYLHS----GSAQ 543 (643)
Q Consensus 499 ~~~gsL~~--------------~l~~~~-~~~------~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 543 (643)
++|..+.. .||... ... ....|.... .....+..++.++.+ ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98866422 111100 000 111222211 011123344455543 2236
Q ss_pred CeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 544 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987789999988753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=69.80 Aligned_cols=142 Identities=18% Similarity=0.209 Sum_probs=77.8
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEEe------EEEeCCeEEEEEeeC
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLG------FCFEDNNLLLVYDFL 499 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g------~~~~~~~~~LV~E~~ 499 (643)
+.|+.|....+|+....+| .+++|+... .....+..|++++..|... .+.+++. +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567788789999877665 588898752 1223344455666555311 1333332 122356689999999
Q ss_pred CCCCHH-----------HH---hccCCC-C------CCCCCh-HHHHHH------------H-HHHHHHHHHHHh----C
Q 006480 500 SRGSLE-----------EN---LHGNKK-D------PAAFGW-SERYKV------------A-MGVAEALEYLHS----G 540 (643)
Q Consensus 500 ~~gsL~-----------~~---l~~~~~-~------~~~l~~-~~~~~i------------~-~qia~aL~yLH~----~ 540 (643)
+|..+. +. +|.... . ...+.| ...+.- . ..+...+..+.. .
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 886431 11 111110 0 001111 111111 1 111122233321 1
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 541 ~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
-+.++||+|++|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 34689999999999999876556899999874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0017 Score=68.63 Aligned_cols=144 Identities=19% Similarity=0.206 Sum_probs=83.8
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEEeE------EEeCCeEEEEEee
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 498 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~------~~~~~~~~LV~E~ 498 (643)
...++.|....+|+....+| .+++|+..... ....+..|++++..|... .+.+++.. ....+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677787789999876555 57788875532 123455677777777422 23444432 1224567899999
Q ss_pred CCCCCHH-----------H---HhccCC-CCCC-------CCChHHHHH------------HHHHHHHHHHHHHh----C
Q 006480 499 LSRGSLE-----------E---NLHGNK-KDPA-------AFGWSERYK------------VAMGVAEALEYLHS----G 540 (643)
Q Consensus 499 ~~~gsL~-----------~---~l~~~~-~~~~-------~l~~~~~~~------------i~~qia~aL~yLH~----~ 540 (643)
++|..+. . .+|... ..+. .-.|..... ....+...+++|.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9885431 0 112110 0000 011211110 01123345555543 2
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 541 ~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
.+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 34789999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00039 Score=58.90 Aligned_cols=83 Identities=25% Similarity=0.223 Sum_probs=66.8
Q ss_pred EEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEEEE
Q 006480 19 VVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKICR 98 (643)
Q Consensus 19 I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v~~ 98 (643)
|+|++++...|..+|.||.... +.+..++++|+.
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH---------------------------------------------
Confidence 6899999999999999999976 556677888874
Q ss_pred cCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-C-chHHHHhccCCCCcEEEE
Q 006480 99 GTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-T-SLAKYCAKKLSKDCSVLA 151 (643)
Q Consensus 99 g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~-sVs~yc~~~ap~~C~V~v 151 (643)
...+.+.+.|+++++++|++|.++.....+.. . +++.++.++++ |||+.
T Consensus 35 --~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 --AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred --HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 45678889999999999999999874332221 2 78899999997 88863
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0022 Score=68.20 Aligned_cols=138 Identities=23% Similarity=0.272 Sum_probs=97.0
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeCCC---------------------------hhHHHHHHHHHHHHHhcCCCc
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------------------------EDVIKEFVLEIEIITTLHHKN 478 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---------------------------~~~~~~~~~Ei~il~~l~Hpn 478 (643)
+...|..|--..||.+...+|..+|||+++.+ ..+......|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45678889999999999999999999998742 112223446788888887655
Q ss_pred eeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 479 Iv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
|.-.--+.... ..|||+|+.+..- -. .+-....++...+..+-.+++.-+.-|.+. .++||.||.-=|+|+.
T Consensus 228 IP~PePIlLk~--hVLVM~FlGrdgw---~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILLKN--HVLVMEFLGRDGW---AA-PKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceeeec--ceEeeeeccCCCC---cC-cccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEE
Confidence 54333333332 3899999953211 11 011124567778888888888888888774 4699999999999995
Q ss_pred CCCcEEEeecCccc
Q 006480 559 DDFEPQLSDFGLAK 572 (643)
Q Consensus 559 ~~~~vkL~DFGla~ 572 (643)
+|.+.|+|.+-+.
T Consensus 300 -dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSV 312 (520)
T ss_pred -CCEEEEEEccccc
Confidence 6689999998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0025 Score=68.65 Aligned_cols=145 Identities=15% Similarity=0.240 Sum_probs=85.9
Q ss_pred ceeeeecCceEEEEEEeCC-----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEEeEEEeCCeEEEEEeeCC
Q 006480 427 ENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~ 500 (643)
...|..|-...+|+....+ ++.|++|+........-+-.+|..++..+..-++. ++++++ .++ .|++|++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~-~~g---~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF-PNG---RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE-CCc---eEEEeeC
Confidence 4566668888999986432 36799998876433222336788898888644443 455554 222 5899997
Q ss_pred CCCHHHH-----------------hccCCCC--CCCCChHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 006480 501 RGSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMGV-----------------AEALEYL----HS- 539 (643)
Q Consensus 501 ~gsL~~~-----------------l~~~~~~--~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~- 539 (643)
+.+|... +|..... .....|.++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 2221100 1122234443333221 1112222 21
Q ss_pred CCCCCeEecCCCCCCEEEcC-CCcEEEeecCcccccc
Q 006480 540 GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAS 575 (643)
Q Consensus 540 ~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~ 575 (643)
..+..++|+|+++.|||+++ ++.+.|+||..|....
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 22357899999999999986 4689999999886443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00067 Score=70.94 Aligned_cols=133 Identities=21% Similarity=0.203 Sum_probs=93.6
Q ss_pred CcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC----------h-------------hHHHHHHHHHHHHHhcCC--C
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----------E-------------DVIKEFVLEIEIITTLHH--K 477 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~----------~-------------~~~~~~~~Ei~il~~l~H--p 477 (643)
-+.+.+.||-|--+.||.+-+..|++.++|+-+-. . -..-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999999999999865311 0 012234567778887742 3
Q ss_pred ceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 478 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
-+.+.+++ +..++|||++.+-.|...-+- .....++.-+++ -+--|-+ +|+||+|.+-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~---~Iv~la~---~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMG---LIVRLAN---HGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHH---HHHHHHH---cCceecccchheeEE
Confidence 35555655 456999999988777654421 122333333333 3344555 899999999999999
Q ss_pred cCCCcEEEeecCccc
Q 006480 558 SDDFEPQLSDFGLAK 572 (643)
Q Consensus 558 ~~~~~vkL~DFGla~ 572 (643)
++++.++++||--+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0055 Score=63.91 Aligned_cols=70 Identities=19% Similarity=0.130 Sum_probs=41.5
Q ss_pred eeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-C-Cc-eeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 430 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-KN-IISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 430 LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-H-pn-Iv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
.++|-...||.....+|+.+++|.-+ .......+.+|.++|..+. + |- +.+++.. .. -+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~-~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~~--~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPR-RPDVSERAAAEKRVLALVRKHLPVQVPDWRVH--TP--ELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecC-CHHHHHHHHHHHHHHHHHHhcCCCCCCceeee--cC--ceEEEeccCCCcc
Confidence 34454556666555578889998875 3344567788999999885 2 21 1222221 22 2566777766543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.02 E-value=8.1e-05 Score=89.83 Aligned_cols=171 Identities=10% Similarity=-0.059 Sum_probs=120.9
Q ss_pred HHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHh--
Q 006480 464 FVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-- 539 (643)
Q Consensus 464 ~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-- 539 (643)
.+.|.+.++...|+++.....-... ....+..++|+.+|.+.+.|-........+...-+...-.+.+.+..-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445566677789988876654432 345689999999999999886554444444433333333333445555554
Q ss_pred CCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHH
Q 006480 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 619 (643)
Q Consensus 540 ~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eL 619 (643)
....-.+|++||+-|.+|..+..+++.++|+.+....... ..+...+++.|++|++...-+++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 2235579999999999999999999999999983332211 22335678899999999998999999999999999999
Q ss_pred HcCCCCCCCCChhhHHH
Q 006480 620 LTGRKPISNDHPKGQES 636 (643)
Q Consensus 620 ltG~~Pf~~~~~~~~~~ 636 (643)
..|..||-.........
T Consensus 1434 s~~n~~fi~flq~~Lkg 1450 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKG 1450 (2724)
T ss_pred hcccHHHHHHHHHHHcC
Confidence 99998886544333333
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0092 Score=63.90 Aligned_cols=144 Identities=18% Similarity=0.303 Sum_probs=82.9
Q ss_pred ceeeeecCceEEEEEEeCC----CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCcee-EEEeEEEeCCeEEEEEeeCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~LV~E~~~~ 501 (643)
.+.|..|=...+|+....+ +..|++|+........-+-.+|..+++.+..-++. ++++++ .++ +|.+|+++
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence 3556667778889886532 24789998865443333345788898888655543 555555 322 58999977
Q ss_pred CCHHH-----------------HhccCCCC--CCCCChHHHHHHHHHH----------------------HHHHHHHHh-
Q 006480 502 GSLEE-----------------NLHGNKKD--PAAFGWSERYKVAMGV----------------------AEALEYLHS- 539 (643)
Q Consensus 502 gsL~~-----------------~l~~~~~~--~~~l~~~~~~~i~~qi----------------------a~aL~yLH~- 539 (643)
..|.. .+|..... ..+-.|..+.++..++ ..-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 11211100 0111233333332221 111112211
Q ss_pred ----CCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccc
Q 006480 540 ----GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWA 574 (643)
Q Consensus 540 ----~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~ 574 (643)
..+.-++|.|+.+.|||+++ ++.++|+||..|...
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 12235899999999999975 578999999988543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.023 Score=60.31 Aligned_cols=139 Identities=19% Similarity=0.287 Sum_probs=84.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCC--CceeEEEeEEEeCC--eEEEEEeeC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN--NLLLVYDFL 499 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~--~~~LV~E~~ 499 (643)
.+.+..|.-..+|.... +++.+++. .... ........+|.++++.+.- .-+...++.|.++. ..+.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 34443333344455444 37888888 3321 2345566778888888753 33445566776655 679999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHH-HHHHHHHHHHHh---------------------------------------
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVA-MGVAEALEYLHS--------------------------------------- 539 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~-~qia~aL~yLH~--------------------------------------- 539 (643)
+|..+.+.+.... .. .+++ ..+++.|.-||+
T Consensus 108 eGe~~~~~~~~~~-----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 108 EGEVVWSALPPES-----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred cceeccCcCCccc-----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 8853333222110 00 1111 234444444443
Q ss_pred -----------C-----CCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 540 -----------G-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 540 -----------~-----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
+ ....++|+|+++.||+++++..+-+.||+++....+
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 1 114689999999999999999999999999865443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 643 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 6e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-109
Identities = 91/243 (37%), Positives = 142/243 (58%), Gaps = 3/243 (1%)
Query: 399 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 458
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 459 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+H+T T V GT G++APEY GK ++K DV+ +GV+LLEL+TG++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 637 LVM 639
+++
Sbjct: 246 VML 248
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 326 bits (839), Expect = e-107
Identities = 95/255 (37%), Positives = 147/255 (57%), Gaps = 6/255 (2%)
Query: 386 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 445
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 446 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 504
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 565 LSDFGLAKWA-STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
++DFG++K +H++ T V GT GY+ PEYF+ G++ +K DVY+FGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 624 KPISNDHPKGQESLV 638
I P+ +L
Sbjct: 239 SAIVQSLPREMVNLA 253
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 3e-96
Identities = 84/248 (33%), Positives = 137/248 (55%), Gaps = 21/248 (8%)
Query: 403 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 456
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 457 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 511
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 512 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 572 KWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+ + + + +T + + GT Y+APE + G++ K D+Y+FGVVLLE++TG + D
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 631 PKGQESLV 638
+ + L+
Sbjct: 237 HREPQLLL 244
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-70
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 22/251 (8%)
Query: 400 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 459
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 460 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 515
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 516 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 568
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGR 623
GLA S GT Y+APE +ID+YA G+VL EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 624 KPISNDHPKGQ 634
+
Sbjct: 236 TAADGPVDEYM 246
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-60
Identities = 62/200 (31%), Positives = 107/200 (53%), Gaps = 11/200 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 547 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
HRD+K N+LL ++ DFG A T T+ G+ ++APE F ++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 606 KIDVYAFGVVLLELLTGRKP 625
K DV+++G++L E++T RKP
Sbjct: 183 KCDVFSWGIILWEVITRRKP 202
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 3e-58
Identities = 72/209 (34%), Positives = 111/209 (53%), Gaps = 10/209 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
++HR++KS N+L+ + ++ DFGL++ AST S AGT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRDEP 215
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHP 631
N+K DVY+FGV+L EL T ++P N +P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-56
Identities = 69/212 (32%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 481
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWM 181
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
APE + DV+++GV+L ELLTG P
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 477
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 592
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
Query: 593 LAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKP 625
+APE +K D Y+F ++L +LTG P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 7e-55
Identities = 58/246 (23%), Positives = 91/246 (36%), Gaps = 34/246 (13%)
Query: 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 471
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 472 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 524
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 525 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 572
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 573 WASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y+APE ++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 626 ISNDHP 631
+
Sbjct: 235 LFPGES 240
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 42/213 (19%), Positives = 85/213 (39%), Gaps = 19/213 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 484 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
+ + S ++++ +D ++S + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
D+++F V+L EL+T P ++
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-50
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE---YFMYGKV 603
HRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ + DVYAFG+VL EL+TG+ P SN + + Q
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-50
Identities = 55/231 (23%), Positives = 106/231 (45%), Gaps = 20/231 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAK------------WASTSSSHITCTDVAGTFGY 592
+IHRD+ S N L+ ++ ++DFGLA+ + V G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+APE ++K+DV++FG+VL E++ + P+ + + F
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-50
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 24/220 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMY 600
++H+D+KS N+ D+ + ++DFGL G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 601 GKV---------NDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ DV+A G + EL P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-48
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 485 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 593
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
APE ++D++AFG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 485 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 593
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE + + D+Y+FG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 6e-47
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 484
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 485 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 541 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYL 593
+ HRD+KS NIL+ + ++D GLA +++ I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 594 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
APE + + + D+YA G+V E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 14/211 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 476
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE N K D+++ G +L E+ + P
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 480
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 481 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSHITCTDVA---GT 589
+H+ + HRD+K +NILL D+ +P L D G A S +T D A T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 590 FGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKP 625
Y APE F + ++++ DV++ G VL ++ G P
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 59/248 (23%), Positives = 108/248 (43%), Gaps = 15/248 (6%)
Query: 402 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 457
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 458 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 517
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 518 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
++ GT YL+PE N+K D++A G VL EL T + K
Sbjct: 177 STVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV 234
Query: 636 SLVMQSQF 643
++ F
Sbjct: 235 LKIISGSF 242
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 55/224 (24%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 481 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 523
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 524 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y++PE ++D+YA G++L ELL
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 430 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 604
HRD+ + N L+++ ++SDFG+++ + + APE YG+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 605 DKIDVYAFGVVLLELLT-GRKP 625
+ DV++FG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
IHRD+K++N+LLS+ E +L+DFG+ + T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ K D+++ G+ +EL G P S HP
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP 224
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 396 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 452
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 453 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 509
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 510 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 568 FGLAKWASTS-----SSHITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELL 620
+ H +L+PE + K D+Y+ G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 621 TGRKPISNDHP 631
G P +
Sbjct: 232 NGHVPFKDMPA 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 485 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 541 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +IHRD+K NI ++ ++ D GLA S V GT ++APE +
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
K ++ +DVYAFG+ +LE+ T P S Q
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 15/205 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGYLAPEYFMY 600
A HRDVK NIL+S D L DFG+A +T+ +T GT Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
+ D+YA VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 478
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 479 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK----------WAST 576
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++ T GT Y++PE + K+D+++ G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 15/209 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMYGK 602
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 603 VNDKIDVYAFGVVLLELLTGRKPISNDHP 631
++ D+Y+ G+VL E+L G P + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETA 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 542
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC---TDVAGTFGYLAPEYFM 599
IHRDVK+ NILL +D Q++DFG++ + +T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 600 YGKV-NDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ + K D+++FG+ +EL TG P P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 55/215 (25%), Positives = 87/215 (40%), Gaps = 10/215 (4%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 475 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H NI+ N L +V ++ G L + K+ +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 533 ALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTP 180
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
Y++PE N+K D+++ G +L EL P
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 482
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
++K+D+++ GV+ E L G+ P + +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 416 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 460
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 519
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 580 HITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ ++A E K K DV++FGV+L EL+T G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 421 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPE 596
H R IHRD+K+ NILL+ + +L+DFG+ + T + T V GT ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
N D+++ G+ +E+ G+ P ++ HP
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 483
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 484 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYF 598
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
V+ + DVY+ G VL E+LTG P + D P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 481 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 594
++++ +HRD+ + N +L + F +++DFGLA+ T L A
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 264
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E K K DV++FGV+L EL+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 482
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 483 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 594 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
PE K++ K DV++ G +L + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-32
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 603
+HRD+ + N+L+S+D ++SDFGL K + T G APE K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 604 NDKIDVYAFGVVLLELLT-GRKP 625
+ K DV++FG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-32
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHR++ + N L+ ++ +++DFGL++ T ++ + APE Y K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 606 KIDVYAFGVVLLELLT-GRKP 625
K DV+AFGV+L E+ T G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 35/238 (14%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 479
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 480 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 525
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-- 583
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK S +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 584 ----------TDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
T GT Y+A E G N+KID+Y+ G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERV 235
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ + DV+++GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 50/215 (23%), Positives = 84/215 (39%), Gaps = 16/215 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 476
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS Q ++H DVK +NI L +L DFGL T+ + G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
G DV++ G+ +LE+ +
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 19/213 (8%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYLAP 595
++HRD+K NIL+S +SDFGL K A S + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 596 EYF---MYGKVNDKIDVYAFGVVLLELLTGRKP 625
E +D+++ G V +++
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-32
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 383 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 442
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 443 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 560
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 561 FEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617
L DFG A S +T + GT ++APE M + K+D+++ ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 618 ELLTGRKPISNDHP 631
+L G P +
Sbjct: 248 HMLNGCHPWTQYFR 261
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 487 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 603
+HRD+ + N+L+S+D ++SDFGL K AS++ G APE K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKF 191
Query: 604 NDKIDVYAFGVVLLELLT-GRKP---ISN 628
+ K DV++FG++L E+ + GR P I
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL 220
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 481 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G + +L LV ++L G L + L ++ A S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG 144
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
S +R +HRD+ + NIL+ + +++DFGLAK + G
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWY 197
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
APE + + DV++FGVVL EL T K
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD+ + N L+ D ++SDFG+ ++ + + G APE F Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K DV+AFG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 478
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 479 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 530
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGT 589
L +LH +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGT 192
Query: 590 FGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
++APE + D K D+++ G+ +E+ G P+ + HP
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 21/212 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
IHRD+K+ N+L++ + + +L+DFG+ AK T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 605 D-----KIDVYAFGVVLLELLTGRKPISNDHP 631
D K D+++ G+ L+E+ P +P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 425 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 597
+ +HRD+ + N+LL + ++SDFGL+K S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K + + DV+++GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 32/221 (14%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 479
++G+G V +G L DG L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 480 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 532
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTF 590
+EYL S + +HRD+ + N +L DD ++DFGL+K I D G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-------IYSGDYYRQGRI 208
Query: 591 GYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ A E K DV+AFGV + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 535
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAGTFGYL 593
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-------IYETDYYRKGGKGLL 202
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
+PE G DV++FGVVL E+ T +P +SN
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 65/213 (30%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 430 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 483 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
Q IHRD+ + N+LL +D ++ DFGLAK + G AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKPIS 627
E K DV++FGV L ELLT S
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 430 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 483 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 534
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTFGY 592
EYL S++ IHRD+ + N +L++D ++DFGL++ I D G
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGCASK 200
Query: 593 L-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L A E DV+AFGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 481 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 597
+ Q+ +HRD+ + N +L + F +++DFGLA+ + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ K DV++FGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 539
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEY 597
++HRD+ SN+LL+ + +++DFGLA + C GT Y++PE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEI 183
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ DV++ G + LL GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS NILL D +L+DFG A + + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHP 631
K+D+++ G++ +E++ G P N++P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
+ +R IHRD+ + NIL+ ++ ++ DFGL K G
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWY 184
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLT 621
APE K + DV++FGVVL EL T
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 53/284 (18%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 369 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 422
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 423 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 473
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 532
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 581
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
T T G+ E N +ID + + +L G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 597 YFMYGKVND--------KIDVYAFGVVLLELLTGRKP 625
+ + +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 23/224 (10%)
Query: 427 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 480
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 481 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 593
+ +R IHRD+ + NIL+ ++ ++ DFGL K + G
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWY 215
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
APE K + DV++FGVVL EL T + + + +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 478
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPE 596
++R IHRD+ + N+LL+ ++ DFGL + + H + + APE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPE 194
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 604
HRD+ + N L+ ++ ++SDFG+ ++ + F +PE F + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 605 DKIDVYAFGVVLLELLT-GRKP 625
K DV++FGV++ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
S +HRD+ + N+L+ + ++SDFGL++ T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAP 223
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E + + DV++FGVV+ E+L G +P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-31
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L EL T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 427 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 480 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL---- 593
S ++ +HRD+ + N+L+ + + ++ DFGL K T + T
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFW 195
Query: 594 -APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPIS 627
APE M K DV++FGV L ELLT S
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 483
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 540
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++VIHRD+K N+L+ E +++DFG + A + C GT YL PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
++K+D++ GV+ E L G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 5e-31
Identities = 27/243 (11%), Positives = 58/243 (23%), Gaps = 43/243 (17%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 483
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 484 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 515
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 516 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 576 TSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
T + Y E+ ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 634 QES 636
+ S
Sbjct: 301 KGS 303
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD+ + N L++D ++SDFGL+++ + + + G PE MY
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K D++AFGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 425 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPE 596
+HRD+ + N+LL ++SDFGL+K ++ G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPE 190
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
Y K + K DV++FGV++ E + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 530
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAG 588
A + YL ++Q +HRD+ + N L+ + ++ DFG+++ + TD G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 589 TFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L PE MY K + DV++FGV+L E+ T G++P +SN
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSH----ITCTDVAGTFGYLAPEYF 598
HRD++++NIL+S +++DFGLA+ T+ I T APE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APEAI 357
Query: 599 MYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
+G K DV++FG++L+E++T GR P +SN
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 427 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----APEYFMY 600
IHRD+ + N L+ ++ +++DFGL++ + T A APE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAY 186
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP 625
K + K DV+AFGV+L E+ T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
++IHRD+K SNILL +L DFG++ S I T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSAS 202
Query: 604 ND----KIDVYAFGVVLLELLTGRKPISNDHP 631
+ DV++ G+ L EL TGR P +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 482
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 483 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 531
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGT 589
+ YL + +HRD+ + N L+ ++ DFG+++ I TD G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 590 FGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L PE +Y K + DV++FGVVL E+ T G++P +SN
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 427 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 478
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 526
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL + + D
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-------EVYAADY 183
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
L APE MYGK + D++++GVVL E+ + G +P SN
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 48/236 (20%), Positives = 85/236 (36%), Gaps = 34/236 (14%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 475
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 576
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 577 SSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHP 631
G +LA E + K D++A + ++ N
Sbjct: 187 PQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 17/218 (7%)
Query: 424 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 480
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+++HRDVK SNIL++ E +L DFG++ S GT Y++PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636
+ + D+++ G+ L+E+ GR PI K E
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 430 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 482
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 602
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 603 VNDKIDVYAFGVVLLELLT-GRKP 625
+ DV+++GV + EL+T G KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 607 IDVYAFGVVLLELLT-GRKP 625
DV++FG++L EL T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-30
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 389 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 447
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 448 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 503
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 504 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 564 QLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVNDKIDVYAFGVVLLELLT 621
++SDFGL+K S+ T AG + APE + K + + DV+++GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 622 -GRKP 625
G+KP
Sbjct: 535 YGQKP 539
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 487
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHP 631
++D+++ G++++E++ G P +D P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 547 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 600
HRD++++NIL+SD +++DFGLA+ I + G APE Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
G K DV++FG++L E++T GR P ++N
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 595
S +HRD+ + NIL++ + ++SDFGL + G + +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSP 219
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
E Y K DV+++G+VL E+++ G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 594
+ +HRD+ + NIL++ + ++SDFGL++ + G + A
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTA 218
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE Y K DV++FG+V+ E++T G +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-30
Identities = 43/214 (20%), Positives = 82/214 (38%), Gaps = 26/214 (12%)
Query: 429 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 484
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 485 FCFEDNNLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
F + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH- 199
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ +++ D+K NI+L+++ + +L D G S + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEIVR 250
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
D+Y G L L + + G
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 598
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 187
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ ++DV++ G ++ LL G+ P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 9e-30
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRDVK SNILL + + +L DFG++ AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 604 ND-----KIDVYAFGVVLLELLTGRKPISNDHP 631
+ DV++ G+ L+EL TG+ P N
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 486 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 597 YFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YG +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGA---TVDLWSIGVTFYHAATGSLP 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------A 594
++R +HRD+ + N+L+S + +L DFGL+++ + + A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 185
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ FGV + E+L G KP
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 593
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE FM G K D ++FGV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 484 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 598
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 213
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ ++DV++ G ++ LL G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 485
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
VIHRDVK SN+L++ + ++ DFG++ + + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 604 ND----KIDVYAFGVVLLELLTGRKPISN-DHP 631
K D+++ G+ ++EL R P + P
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 479
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
++HR++ + N+LL + Q++DFG+A + ++ ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 600 YGKVNDKIDVYAFGVVLLELLT-GRKP 625
+GK + DV+++GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
++HRD+K N+L+ + ++SDFG +K + + GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 604 --NDKIDVYAFGVVLLELLTGRKPISN-DHP 631
D+++ G ++E+ TG+ P P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 475
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
L YLHS +IHRDVK+ NILLS+ +L DFG AS + + GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANS---FVGTPYWM 217
Query: 594 APEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHP 631
APE + + K+DV++ G+ +EL + P+ N +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 471
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 472 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 526
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 587 AGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDH 630
GT+ ++ PE+F K+D+++ G+ L + P S
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 22/226 (9%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
++HRD+K N+LL D ++ DFGL+ + GT Y+APE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
K ++K DV++ GV+L LL G P + V + ++
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 538
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 593
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKGGCAML 248
Query: 594 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE FM G K D ++FGV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 477
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGT 589
+IH +V + NILL + + + LSD G++ V
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPK 174
Query: 590 FGY------LAPEYFMYGKV-NDKIDVYAFGVVLLELLT-GRKP 625
+ PE K N D ++FG L E+ + G KP
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 484
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 542
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 543 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH 201
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
G ++K DV++ GV+L LL+G P + + V + ++
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 427 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 528
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--V 586
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 587 AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
T G L A E Y DV+++GV+L E+++ G P ++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 524
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 525 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ +I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NI 224
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
D A + PE Y + + DV+A+GVVL E+ + G +P +++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYL-----A 594
+ +HRD+ NIL++ +L DFGL+++ I D + L +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMS 182
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 481
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 529
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------V 200
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 628
D V + G + A E + DV++FGV+L E++T G P I
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 427 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYL-----A 594
++R +HRD+ + N+L+S + +L DFGL+++ + + + G L A
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 560
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
PE + + DV+ FGV + E+L G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 483
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 484 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------- 587
+H +IHRD+K N+LLS+ +L DFG A S +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 588 -GTFGYLAPEYF-MYGK--VNDKIDVYAFGVVLLELLTGRKP 625
T Y PE +Y + +K D++A G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 53/230 (23%), Positives = 96/230 (41%), Gaps = 32/230 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 480
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 582
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 583 CTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 625
+ +GT G+ APE ++ ID+++ G V +L+ K
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 482
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 541 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
G ++K DV++ GV+L LL+G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 482
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 540
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE- 596
+IHRDVK +LL+ L FG+A S GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEV 204
Query: 597 --YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
YGK +DV+ GV+L LL+G P
Sbjct: 205 VKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 477
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 527
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-- 585
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA+ I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMNDSNY 220
Query: 586 VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
+ L APE + DV+++G++L E+ + G P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-28
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 408 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 457
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 458 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 564
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 565 -LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------YFMYGKVNDKIDVYAFGVVLL 617
++DFG +K +S + GT YLAPE Y + +D ++ GV+L
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLGVILF 335
Query: 618 ELLTGRKPISNDH 630
L+G P S
Sbjct: 336 ICLSGYPPFSEHR 348
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 471
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 529
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
GT Y+APE K N+K DV++ GV++ LL G P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 33/252 (13%), Positives = 74/252 (29%), Gaps = 43/252 (17%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 479
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 480 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 514
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISND 629
S+ A + + D + G+ + + P ++D
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 630 HPKGQESLVMQS 641
G + +S
Sbjct: 321 AALGGSEWIFRS 332
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-------DINNIDY 212
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 63/234 (26%), Positives = 108/234 (46%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 526
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-------INNIDY 258
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV++ E+ T G P I +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 34/258 (13%), Positives = 77/258 (29%), Gaps = 54/258 (20%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 463
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 464 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 514
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 515 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 575 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGR 623
+ + G+ PE + D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 624 KPISNDHPKGQESLVMQS 641
PI+ D G + +S
Sbjct: 311 LPITKDAALGGSEWIFRS 328
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 479
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 480 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 531
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAG 588
AL YLH R+IHRD+K NI+L + + D G AK CT+ G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 589 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
T YLAPE K +D ++FG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 545
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 546 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
+HRD+K SNIL D+ + DFG AK + T ++APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y D+++ GV+L +LTG P
Sbjct: 196 GYDA---ACDIWSLGVLLYTMLTGYTP 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 53/229 (23%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 425 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 482
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 483 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 536 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641
+APE K + D+++ GV++ LL G P ++ + + +
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 44/234 (18%)
Query: 430 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 478
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 528
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 529 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 585
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+ I D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHIDY 246
Query: 586 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 629
T G L APE + DV++FGV+L E+ T G P + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 9e-27
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 482
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 483 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 508
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 509 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 564
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 565 LSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPE-----YFMYGKVNDKIDVYAFGVVLL 617
L DFGL+K + + T AGT ++APE YG K D ++ GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP---KCDAWSAGVLLH 267
Query: 618 ELLTGRKP 625
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 527
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV- 586
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ I
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-------IYKDPDY 204
Query: 587 -AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L APE + DV++FGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 427 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 484
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 485 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 591 GYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
GY+APE Y K +D ++ GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+APE F
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-R 200
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
V K D+++ GVV+ LLTG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 487 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 544 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++H D+K NI+ + DFGLA + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE 225
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
V D++A GV+ LL+G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 419 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 471
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 472 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 527
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 579
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 580 HITCTDVAGTFGYLAPE--------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
G+ Y+APE +Y K + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSGYPP 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y + K DV++ GV+L LL+G P
Sbjct: 198 TYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 425 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 540 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPE 179
Query: 597 YFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y + D+++ GV+L +L+G+ P
Sbjct: 180 LLNQNGYDE---SCDLWSLGVILYTMLSGQVP 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 54/230 (23%), Positives = 103/230 (44%), Gaps = 27/230 (11%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 591
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641
Y+APE K + D+++ GV++ LL G P ++H +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 278
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 477
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 535
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
LH ++HRD+K NILL DD +L+DFG + +V GT YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192
Query: 596 EYFM---------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
E YGK ++D+++ GV++ LL G P +
Sbjct: 193 EIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 430 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 530 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA+ I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIKNDSN 200
Query: 587 --AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
L APE + DV+++G+ L EL + G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 430 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 529
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 530 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+ I
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-------DI 222
Query: 582 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
V L APE G K DV+++G++L E+ + G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
V HRD+K N L S D +L DFGLA GT Y++P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
YG + D ++ GV++ LL G P
Sbjct: 184 YGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 479
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 537
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
H +IHRD+K N+LLS E ++DFG +K +S + GT YLA
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLA 184
Query: 595 PE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
PE Y + +D ++ GV+L L+G P S
Sbjct: 185 PEVLVSVGTAGYNR---AVDCWSLGVILFICLSGYPPFSEHR 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 543 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+ H D++ NI+ + +FG A+ + + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKP 625
V+ D+++ G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y K +D++A GV+L LL G P
Sbjct: 182 DPYSK---PVDIWACGVILYILLVGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 487 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 542 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+H D+K NI+ + +L DFGL S GT + APE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKP 625
V D+++ GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 423 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 479
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 480 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+H ++H D+K NIL + Q+ DFGLA+ GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y V+ D+++ GV+ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 402 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 454
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 455 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 510
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 511 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 565
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
DFG+++ + ++ GT YLAPE Y + D++ G++ LLT P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-25
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 544 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
V+HR++K N+LL +L+DFGLA AGT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRK 187
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
YGK +D++A GV+L LL G P
Sbjct: 188 DPYGK---PVDLWACGVILYILLVGYPP 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 543
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 544 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 599
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 204
Query: 600 --YGKVNDKIDVYAFGVVLLELLTGRKP 625
Y K +D++A GV+L LL G P
Sbjct: 205 DPYSK---PVDIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 478
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 536
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GYLAPE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
Query: 597 ---------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ YGK ++D++A GV+L LL G P
Sbjct: 270 ILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPP 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 479
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 480 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 535
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
YLH + +IHRD+K NILL++D Q++DFG AK S S GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 596 EYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
E K D++A G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS---SDLWALGCIIYQLVAGLPP 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 488 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 544
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 545 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 599
++HRD+K N+L + D +++DFGL+K V GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC 225
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGRKP 625
YG ++D+++ G++ LL G +P
Sbjct: 226 AYGP---EVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 539
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+R+ H D+K NI+L D P L DFG+A + ++ GT ++AP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E Y + + D+++ GV+ LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 14/182 (7%)
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 577 SSSHITC----------TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
T T GT Y++PE + K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 627 SN 628
Sbjct: 277 ME 278
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 538
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 595 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 430 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 480
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 481 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 529
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 585
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ GT ++APE Y + + D+++ GV+ LL+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 483
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 484 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 536
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAPE 184
Query: 597 YFM------YGKVNDKIDVYAFGVVLLELLTGRKP 625
F Y +D ++ GV ELL GR+P
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 7e-22
Identities = 32/219 (14%), Positives = 66/219 (30%), Gaps = 47/219 (21%)
Query: 429 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
V S + +S D G +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD------ 178
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
N + D+ G L LL R P+ + + +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 56/267 (20%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 382 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 441
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 442 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 491
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 492 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 541 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
V+HRD+K NIL+ + E +L DFG + GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 600 YGKVN-DKIDVYAFGVVLLELLTGRKP 625
Y + + V++ G++L +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 480
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 481 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 525
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 585
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 586 VAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESL 637
GT GY+APE G D D ++ G +L +LL G P K + +
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 476
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 477 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 525
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 584
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 585 DVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKP 625
GT Y PE+ + + V++ G++L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 537
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + +I+RD+K N+LL DD ++SD GLA + T AGT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPEL 360
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+ + + +D +A GV L E++ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 472
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 473 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 522
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 523 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HI 581
Y + A+ YL + +IHRD+K NI++++DF +L DFG A + +
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 582 TCTDVAGTFGYLAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
C GT Y APE M G ++++++ GV L L+ P
Sbjct: 189 FC----GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 475
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 476 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 531
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
EYLHS +I+RD+K N+L+ Q++DFG AK T T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPE 203
Query: 592 YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
LAPE + Y K +D +A GV++ E+ G P D P
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 56/229 (24%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 478
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 479 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 526
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 527 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 584 TDVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
A +F G Y+APE + + D ++FGV++ E+LTG P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 385 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 439
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 440 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 492
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 493 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------- 596
IHRDVK N+LL +L+DFG + T V GT Y++PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
YG+ D ++ GV L E+L G P D G
Sbjct: 247 DGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 482
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 483 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 532
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 593 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
PE K+D+++ GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYGK 602
R++HRD+K+ N+LL D +++DFG + + C G Y APE F GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQ-GK 188
Query: 603 VND--KIDVYAFGVVLLELLTGRKP 625
D ++DV++ GV+L L++G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 589 TF----GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMQ 640
TF YLAPE +D + GVV+ E++ GR P + DH K E ++M+
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 429 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 481
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 535
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
LH +R+++RD+K NILL D ++SD GLA V GT GY+AP
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGYMAP 354
Query: 596 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E + D +A G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 430 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 487 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 540
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWAST---SSSHITCTDVAGTFGYL 593
V+HRD+K +NIL+ + + ++D G A+ ++ + + V TF Y
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 202
Query: 594 APEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
APE + Y K ID++A G + ELLT +PI
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLT-SEPI 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 474
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+ L + H +++HRD+K N+L++ + +L DFGLA+ + + V T
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 592 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
Y AP+ M Y ID+++ G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYST---SIDIWSCGCILAEMITGK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 481 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 589 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 629
TF G YLAPE YG+ +D + GVV+ E++ GR P N
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 476
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS + V+HRD+K N+L++ + E +L++FGLA+ + V T Y P+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPD 171
Query: 597 YFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y ID+++ G + EL +P+
Sbjct: 172 VLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 48/229 (20%)
Query: 424 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 481
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 482 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 534
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 535 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
+YLHS + HRDVK N+L + +L+DFG AK + G
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-- 173
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
Y K D+++ GV++ LL G P ++H +
Sbjct: 174 -------KYDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 8e-19
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 472
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 473 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 528
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
V ALEYLHS + +I+RD+K NILL + +++DFG AK DV
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTY 161
Query: 589 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633
T G Y+APE Y K ID ++FG+++ E+L G P + +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-19
Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 53/244 (21%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 471
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 472 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 528 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 584
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 585 DVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQES 636
V TF G Y+APE M + + +D ++ G ++ ++LTG P + K +
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDK 232
Query: 637 LVMQ 640
++
Sbjct: 233 ILKC 236
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 9e-19
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YG 601
IHRDVK NIL++ +L DFG A+ + D T Y +PE + YG
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 602 KVNDKIDVYAFGVVLLELLTGR 623
+DV+A G V ELL+G
Sbjct: 182 P---PVDVWAIGCVFAELLSGV 200
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 460
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 461 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 513
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKP 625
S + ++ T GT ++APE + +DV+A GV L + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 429 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 480
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 481 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 535
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
+H +HRD+K NILL +L+DFG + + V GT YL+P
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 596 E----------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
E YG D +A GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 536
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 196
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 422 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITT 473
+F +IG+G +V K K A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 474 LHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAM 528
K I +L + F+D NNL LV D+ G L L + + A F +E
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ A++ +H +HRD+K NIL+ + +L+DFG + + V G
Sbjct: 184 -MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 238
Query: 589 TFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKP 625
T Y++PE YG D ++ GV + E+L G P
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETP 280
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV+L E+L G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAP 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 65/225 (28%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G YLAPE Y + +D + G VL E+L G P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPP 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 483
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 599
+IHRD+K NIL+S +L DFG A+ + ++ D T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 600 -YGKVNDKIDVYAFGVVLLELLTGR 623
YGK +DV+A G ++ E+ G
Sbjct: 201 KYGK---AVDVWAIGCLVTEMFMGE 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 588 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
TF G Y+APE + K N +D ++FGV+L E+L G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 26/223 (11%)
Query: 416 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 468
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+++ L H NII LL +N+ LV+DF+ LE + K + S K M
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSH-IKAYM 118
Query: 529 G-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK + + T V
Sbjct: 119 LMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV- 174
Query: 588 GTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
T Y APE YG +D++A G +L ELL R P
Sbjct: 175 -TRWYRAPELLFGARMYGV---GVDMWAVGCILAELLL-RVPF 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 60/243 (24%), Positives = 103/243 (42%), Gaps = 46/243 (18%)
Query: 423 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 476
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 477 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 523
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 524 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 581 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
GT Y+AP+ G + +D ++ GV++ ELLTG P + D K ++ +
Sbjct: 216 RAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 639 MQS 641
+
Sbjct: 275 SRR 277
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 3e-18
Identities = 86/435 (19%), Positives = 154/435 (35%), Gaps = 56/435 (12%)
Query: 224 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 283
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 284 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 341
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 342 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 400
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 401 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 455
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 456 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 504
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 505 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 562 EPQLSDFGLAKWASTSSSHITCTDVAGTF-G---YLAPE---YFMYGKVNDKIDVYAFGV 614
+++DFG+ K +I TF G Y+APE Y YGK +D +AFGV
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGV 530
Query: 615 VLLELLTGRKPISND 629
+L E+L G+ P +
Sbjct: 531 LLYEMLAGQAPFEGE 545
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 4e-18
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 538
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 235
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGR 623
+ + +D+++ G ++ E++ +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 588 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 252
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 5e-18
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 473
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 593
+ + H R++HRD+K N+L++ D +L+DFGLA+ T V T Y
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 594 APEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
AP+ M Y +D+++ G + E++TG+
Sbjct: 187 APDVLMGSKKYST---SVDIWSIGCIFAEMITGK 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 480
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 481 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 527
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 588 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
TF G Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 487 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 545 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG 601
+ HRD+K N LL P+L DFG +K + S T GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLL-R 191
Query: 602 KVND--KIDVYAFGVVLLELLTGRKP 625
+ D DV++ GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 479
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 538
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
Q+V+HRD+K N+L+++ E +L+DFGLA+ S + V T Y P+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 599 M----YGKVNDKIDVYAFGVVLLELLTGR 623
+ Y +ID++ G + E+ TGR
Sbjct: 173 LGSTDYST---QIDMWGVGCIFYEMATGR 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 484 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 537
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPE 596
H V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPE 180
Query: 597 YFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDH 630
G++ ++D+++ GV+L LL G P ++H
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 477 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 529
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 589
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ A T T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVT 186
Query: 590 FGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + + N +D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 600 YGKVND--KIDVYAFGVVLLELLTGRKP 625
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 478
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 479 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 523
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT 582
+++ + LH S V HRD+K N+L+ D +L DFG AK S S ++
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 583 --CTDVAGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
C+ Y APE Y +D+++ G + E++ G +PI
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLG-EPI 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 477
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H +RV+HRD+K N+L++ + E +++DFGLA+ T V T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDV 171
Query: 598 FM----YGKVNDKIDVYAFGVVLLELLTGR 623
M Y ID+++ G + E++ G
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 475
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTF 590
+ HS +R +HRD+K N+LLS + + DFGLA+ T + T
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 591 GYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
Y PE + Y +D+++ + E+L
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEMLMKT 235
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 479 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 524
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT- 582
++ +A Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 583 -CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
C+ Y APE Y IDV++ G VL ELL G+ PI
Sbjct: 217 ICSRY-----YRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ-PI 256
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 486 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 600 YGKVND--KIDVYAFGVVLLELLTGRKP 625
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 487
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 488 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 545 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 599
++HRDVK N+++ + + +L D+GLA++ + + + PE Y M
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 207
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y +D+++ G +L ++ ++P
Sbjct: 208 YDY---SLDMWSLGCMLASMIFRKEPF 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 484 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYL 593
EY H +++HRD+K N+LL D+ +++DFGL+ + + +C G+ Y
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYA 174
Query: 594 APEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 625
APE GK+ ++DV++ G+VL +L GR P
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 479
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 480 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 525
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 526 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 584
+ +A Y+HS + HRD+K N+LL +L DFG AK +
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNV 199
Query: 585 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPI 626
+ Y APE ++G ID+++ G V+ EL+ G +P+
Sbjct: 200 SYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 528
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 529 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDV 586
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H T+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 587 AGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
T Y APE Y K ID+++ G +L E+L+ R
Sbjct: 192 VATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 483
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 484 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGT 589
L Y+H +++HRD+K++N+L++ D +L+DFGLA+ ++ + T V T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 590 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWT-RSPI 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 484 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 535
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 595
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ A + T T Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 194
Query: 596 E----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
E + Y + +D+++ G ++ E++TG+
Sbjct: 195 EVILNWMRYTQ---TVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 483
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 484 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 534
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ + T T Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 595 PEYFM-YGKVNDKIDVYAFGVVLLELLTGR 623
PE + + N +D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 483
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+++ +V +++S G L + + +G + + R ++ ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYCHR-- 134
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMY 600
V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 188
Query: 601 GKVND--KIDVYAFGVVLLELLTGRKP 625
G++ ++D+++ GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 36/216 (16%)
Query: 430 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 477
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 478 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 531
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
L LH V+HRD+ NILL+D+ + + DF LA+ + ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRW 198
Query: 592 YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE + + K +D+++ G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTK---LVDMWSAGCVMAEMFNRK 231
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 480
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 481 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
R+IH D+K NILL + DFG + T + F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + ID+++ G +L ELLTG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 483
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 484 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 536
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----- 591
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + +
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 592 ---YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 623
Y APE Y + +DV++ G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSR---AMDVWSCGCILAELFLRR 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 41/218 (18%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 475
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 476 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWASTSSSHITCTD 585
L+Y+H +IH D+K N+L+ P+ ++D G A W T+
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHYTN 194
Query: 586 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 623
T Y +PE + D+++ ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 471
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 471
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 472 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 521
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 522 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/250 (21%), Positives = 87/250 (34%), Gaps = 58/250 (23%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 478
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 523
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 524 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 560
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 561 FEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVN--DKIDVYAFGVVL 616
+L DFG AK S + C+ Y APE M G ID+++ G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTPSIDLWSIGCVF 232
Query: 617 LELLTGRKPI 626
EL+ G KP+
Sbjct: 233 GELILG-KPL 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 428 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 479
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 480 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
+ +IH D+K NILL + + DFG +S + F Y +PE
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRF-YRSPE 228
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGR 623
+ + ID+++ G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 5e-14
Identities = 98/616 (15%), Positives = 166/616 (26%), Gaps = 186/616 (30%)
Query: 125 NHHTIRSTTSLAKYCAKKL--------SKDCSVLAVNNG-KVVFQKEGCPSTAGESKGTE 175
+HH + T +Y K + + V + K + KE
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 176 DHRRNSLLDVIHRSIS------------------MSKITGQKNSK------------VVT 205
R L + MS I ++ +
Sbjct: 63 GTLR--LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLY 120
Query: 206 DDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEE 265
+D V L + L QAL++ R +N I G
Sbjct: 121 NDNQVFAKYNVSRL-QPYLKLRQALLELRPA-------KNVLIDG--------------- 157
Query: 266 ESPSDGGAGDESLAIVPVQNVEAASTS------ITMLVRQLPES--RPGWPLLRRAIFPD 317
G+G +A+ + + + + PE+ LL +
Sbjct: 158 ----VLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 318 RRAPDRSS---LRKISVVQWALRLPTRQP---SYLANSDVKQITYDPGDNESINLN---- 367
D SS LR S+ RL +P L +V + + NL+
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKIL 269
Query: 368 ---GDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATS 422
+ + H T P E++ L KY CR QDL T+
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTT 325
Query: 423 NFLAENLIG---KGGSS--QVYKGCLPDGK----ELAVKILKPSE-------------DV 460
N ++I + G + +K D E ++ +L+P+E
Sbjct: 326 NPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 461 -IKEFVLEI-----------EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 508
I +L + ++ LH SL+ + + +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKY---SLV---EKQPKESTIS-----------I 428
Query: 509 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD-VKSSNILL---SDDFEPQ 564
Y LE + +HR V NI SDD P
Sbjct: 429 PS------------IY---------LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
Query: 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY----FMYGKV-NDKIDVYAFGVV---L 616
D + S H+ + + F+ K+ +D A G + L
Sbjct: 468 YLD---QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 617 LELLTGRKPISNDHPK 632
+L + I ++ PK
Sbjct: 525 QQLKFYKPYICDNDPK 540
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 83/516 (16%), Positives = 153/516 (29%), Gaps = 158/516 (30%)
Query: 44 GDTVIALHVLANNAIVDR-DGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL--KICRGT 100
G T +AL V + + + D K L+L CN + L++ K+
Sbjct: 162 GKTWVALDVCLSYKVQCKMDFKIFWLNL------------KNCNSPETVLEMLQKLLY-- 207
Query: 101 SIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDC-SVLA-VNNGKVV 158
I + S K + + + L + K ++C VL V N K
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAE--------LRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 159 --FQKEGCP---STAGESKGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGS---- 209
F C +T R + D + + + + I+ +S +T D
Sbjct: 260 NAF-NLSCKILLTT----------RFKQVTDFL-SAATTTHISLDHHSMTLTPDEVKSLL 307
Query: 210 -SITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESP 268
DL R + + R SI ++ DG +
Sbjct: 308 LKYLDCRPQDL-------------PREVLTTNP--RRLSIIA--ESIRDGLATW------ 344
Query: 269 SDGGAGDESLAIVPVQNVEAASTSITMLVRQL--PESRPGWPLLRRAIFPDRRAPDRSSL 326
D + N + +T I + L E R + L ++FP
Sbjct: 345 ------DNWKHV----NCDKLTTIIESSLNVLEPAEYRKMFDRL--SVFPP----S---- 384
Query: 327 RKIS----VVQWALRLPTRQPSYLANSDVKQ--ITYDPGDNESINLNG---DSGAIVPVG 377
I + W + + N K + P +I++ + V +
Sbjct: 385 AHIPTILLSLIWF-DVIKSDVMVVVNKLHKYSLVEKQP-KESTISIPSIYLEL--KVKLE 440
Query: 378 NE------IVSS---PLSTDHDSTELPKELE------GLH-------EKYSATCRLFN-- 413
NE IV P + D D P + G H E+ + LF
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT----LFRMV 496
Query: 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAV--KILKPSEDV-------IKEF 464
+ D FL + + + L ++L + ++ I +F
Sbjct: 497 FLDF-----RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 465 VLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYD 497
+ +IE L + +++ + ED +++
Sbjct: 552 LPKIE--ENLICSKYTDLLR-IALMAEDEA---IFE 581
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 58/245 (23%), Positives = 95/245 (38%), Gaps = 46/245 (18%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 476
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 477 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 530
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 591 G--------------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y APE Y K ID+++ G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK---SIDIWSTGCIFAELLNMLQSH 252
Query: 627 SNDHP 631
ND
Sbjct: 253 INDPT 257
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 483
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 484 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 528
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC-TDV 586
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH ++
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 587 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 623
T Y +P + Y K ID++A G + E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 64/315 (20%)
Query: 359 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 418
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 474
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 475 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 528
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 588
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA+ + + ++
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 589 TFG-------------------------YLAPEYFM----YGKVNDKIDVYAFGVVLLEL 619
Y APE + Y + IDV++ G + EL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDVWSIGCIFAEL 277
Query: 620 LTGRKPISNDHPKGQ 634
L K H
Sbjct: 278 LNMIKENVAYHADRG 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 625
++APE + DV++FGV+L E+ + G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 430 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 480
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 481 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 518
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 53/232 (22%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 484
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 485 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 537
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
HSG ++HRD+K SNILL+ + +++DFGL++ ++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 592 -------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 626
Y APE Y K ID+++ G +L E+L KPI
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTK---GIDMWSLGCILGEIL-CGKPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
S ++ H D+K NIL D+ + + + I D FG
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y APE + + DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 429 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 479
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 480 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 591
++ H D+K NIL + +FE ++ + S ++ I D FG
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD----FGSATFDH 193
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y PE + DV++ G +L E G
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 480
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 481 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 536 YLHSGSAQRVIHRDVKSSNILL-------------------------------------- 557
YLH+ R+IH D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 558 -----------SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 606
++ + +++D G A W + T Y + E + N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 607 IDVYAFGVVLLELLTGR 623
D+++ + EL TG
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 429 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 481
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 482 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------GTFG- 591
+ H D+K NILL D + + TF
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 592 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 622
Y APE + + D+++FG VL EL TG
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 480
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 546 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 591
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 6e-09
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 71/273 (26%)
Query: 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 468
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 469 EIITTLH---------HKNIISLLGFC------------------------------FED 489
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 549
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 550 VKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTD-----------VAGTFGYLAPE 596
+ N+LL +L K ++ + ++ D V + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 597 YFMYGKVNDKIDVY-AFGVVLLELLTGRKPISN 628
F G + + D+Y P SN
Sbjct: 248 LFT-GDGDYQFDIYRLMKKENNNRWGEYHPYSN 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 423 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 465
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 466 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 519
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 577
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 578 SSHI 581
H+
Sbjct: 215 GKHV 218
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 487
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 546 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 591
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 429 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 476
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 477 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 581
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 429 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 470
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 471 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 524
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 525 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 572
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 42/218 (19%)
Query: 430 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 487
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 488 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 546 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHI---TCTDVAGTFGYLAPEY 597
+HRD+K N L+ + DFGLAK +++ HI ++ GT Y +
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--- 181
Query: 598 FMYGKVN----------DKIDVYAFGVVLLELLTGRKP 625
VN D D+ + G VL+ L G P
Sbjct: 182 -----VNTHLGIEQSRRD--DLESLGYVLMYFLRGSLP 212
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 643 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.74 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.74 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.73 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.72 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.71 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.71 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.71 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.69 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.69 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.68 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.68 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.62 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.6 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.51 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.5 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.5 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.49 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.47 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.45 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.45 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.44 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.37 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.71 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.89 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.56 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.46 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 91.34 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 90.84 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 87.57 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.54 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 86.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.68 | |
| 2nz2_A | 413 | Argininosuccinate synthase; amino-acid biosynthesi | 82.37 | |
| 3bl5_A | 219 | Queuosine biosynthesis protein QUEC; PREQ1 biosynt | 81.14 | |
| 2pg3_A | 232 | Queuosine biosynthesis protein QUEC; YP_049261.1, | 80.34 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=418.88 Aligned_cols=215 Identities=26% Similarity=0.409 Sum_probs=195.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||+|... +|+.||||++.+. ....+.+.+|+++|+.++||||++++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999864 7999999999753 234678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||++||+|.++|...+ .+++.++..|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997543 58999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
..........+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+...+...|..+++
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 5555555678999999999999999999999999999999999999999999998888888877654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=420.31 Aligned_cols=215 Identities=26% Similarity=0.386 Sum_probs=186.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.|.+|+++|++++|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999864 7999999999753 3456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|++||+|.++|...+. ..+++.+++.|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 457899999999999999999999 99999999999999999999999999999866432
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
. ......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+...+...|..+.|
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~ 242 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 1 122346799999999999999999999999999999999999999999998888888877654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=412.62 Aligned_cols=218 Identities=27% Similarity=0.491 Sum_probs=191.6
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888999999999999999753 4788999999864 4567889999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCC---------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 495 VYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
|||||++|+|.++|+... .....++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 234579999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.++......|.+++
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99999987655444434444679999999999999999999999999999999999 999999999888888877764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=410.35 Aligned_cols=218 Identities=26% Similarity=0.473 Sum_probs=183.5
Q ss_pred cCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|.+.+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+.+.+||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46788899999999999999753 57889999998654 556789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 495 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
|||||++|+|.++|+.... ...+++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976532 23469999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.......|.+++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999997765544444455789999999999999999999999999999999999 999999998888777777653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=412.85 Aligned_cols=210 Identities=27% Similarity=0.422 Sum_probs=188.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46889999999999999999865 79999999996433 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
+||+|.+++... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999743 48999999999999999999999 9999999999999999999999999999987755332
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.++......|..+
T Consensus 226 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 285 (346)
T 4fih_A 226 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 285 (346)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 234578999999999999999999999999999999999999999999888777776543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=406.62 Aligned_cols=218 Identities=27% Similarity=0.437 Sum_probs=190.4
Q ss_pred cCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++.+.+.||+|+||+||+|.+ .+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 3466788999999999999985 25678999999753 345678999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 494 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
||||||++|+|.++|..... ....++|.+++.|+.||+.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999975431 12468999999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.+.......|..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987765444444456789999999999999999999999999999999999 8999999998888887776
Q ss_pred cC
Q 006480 641 SQ 642 (643)
Q Consensus 641 ~~ 642 (643)
++
T Consensus 263 ~~ 264 (308)
T 4gt4_A 263 RQ 264 (308)
T ss_dssp TC
T ss_pred CC
Confidence 54
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=402.27 Aligned_cols=207 Identities=32% Similarity=0.523 Sum_probs=174.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||+||+|.+.+ .||||+++. +....+.|.+|+++|++++|||||+++|+|. ++.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence 4567889999999999999998743 599999974 3456788999999999999999999999885 467899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
||++|+|.++|+... ..++|.+++.|+.||+.||.|||+ ++||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997543 469999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
.........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+.++.....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~ 247 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII 247 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 44444556789999999999963 469999999999999999999999999876554433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=415.17 Aligned_cols=211 Identities=27% Similarity=0.419 Sum_probs=189.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.+.|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+++|+.++|||||+++++|.+.+.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999865 79999999996543 3446688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
|+||+|.+++... .+++.++..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999643 48999999999999999999999 999999999999999999999999999998765533
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
. .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.++......|..+
T Consensus 302 ~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~ 362 (423)
T 4fie_A 302 P--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 362 (423)
T ss_dssp C--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred c--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC
Confidence 2 234578999999999999999999999999999999999999999999888777776543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=405.67 Aligned_cols=212 Identities=28% Similarity=0.396 Sum_probs=181.9
Q ss_pred cCcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
++|.+.+.||+|+||+||+|.. .+++.||||++++.. .....+.+|+++|++++||||++++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999975 257899999997532 233468889999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||++||+|.++|.... .+++.++..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997643 58999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... .....+||+.|||||++.+..|+.++|||||||+||||+||++||.+.+...+...|..+.
T Consensus 177 ~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 242 (304)
T 3ubd_A 177 IDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK 242 (304)
T ss_dssp ----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 44322 2345689999999999999999999999999999999999999999999888888887664
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=392.14 Aligned_cols=210 Identities=22% Similarity=0.392 Sum_probs=174.3
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||+|... +|+.||||++++. ......+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999864 7999999999753 234567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+ +|+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 689999997543 59999999999999999999999 9999999999999999999999999999986654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.. .....+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+.......|..+.
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~ 228 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV 228 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 32 2234689999999999998876 579999999999999999999999998888777776654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=404.46 Aligned_cols=209 Identities=25% Similarity=0.290 Sum_probs=180.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
+.|.+.+.||+|+||.||+|.+. +|+.||||+++.... +.+|+.+++.++|||||+++++|.+++.+||||||++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 46788899999999999999864 799999999976432 2469999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccccccCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~~ 579 (643)
||+|.++|+..+ .+++.++..|+.||+.||.|||+ ++||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 134 gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 999999997543 58999999999999999999999 9999999999999999987 699999999987754322
Q ss_pred C---ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 580 H---ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
. .....++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+...+...|..+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 271 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE 271 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC
Confidence 1 1223468999999999999999999999999999999999999999998877666665543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=387.69 Aligned_cols=195 Identities=28% Similarity=0.437 Sum_probs=170.8
Q ss_pred ccceeeeecCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeEEEEE
Q 006480 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVY 496 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~LV~ 496 (643)
.+.+.||+|+||.||+|.+. +++.||+|++.. .....+.|.+|+++|++++|||||+++++|.+ .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56788999999999999865 789999999964 33456789999999999999999999999875 35689999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEc-CCCcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~-~~~~vkL~DFGla~~ 573 (643)
|||++|+|.++|... ..+++..+..|+.||+.||.|||+ ++ ||||||||+||||+ .++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999754 358999999999999999999999 66 99999999999998 479999999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
.... .....+||+.|||||++.+ .|+.++|||||||+||||+||++||.+.+.
T Consensus 182 ~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~ 234 (290)
T 3fpq_A 182 KRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred CCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 5432 2334689999999998875 699999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=393.86 Aligned_cols=218 Identities=25% Similarity=0.389 Sum_probs=187.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCC-CceeEEEeEEEeC
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLGFCFED 489 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~ 489 (643)
...++|.+.+.||+|+||.||+|.+. .++.||||+++.. ....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 34578999999999999999999753 2468999999764 3456789999999999965 9999999999764
Q ss_pred -CeEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 006480 490 -NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (643)
Q Consensus 490 -~~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 556 (643)
+.++||||||++|+|.++|+.... ....++|.+++.++.|||+||.|||+ ++||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 568999999999999999975432 13458999999999999999999999 99999999999999
Q ss_pred EcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh-H
Q 006480 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG-Q 634 (643)
Q Consensus 557 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~-~ 634 (643)
|++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.+... .
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~ 297 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998766655555566789999999999999999999999999999999998 999999876433 3
Q ss_pred HHhhh
Q 006480 635 ESLVM 639 (643)
Q Consensus 635 ~~li~ 639 (643)
...+.
T Consensus 298 ~~~i~ 302 (353)
T 4ase_A 298 CRRLK 302 (353)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 33443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=383.30 Aligned_cols=201 Identities=30% Similarity=0.387 Sum_probs=165.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----eEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~LV~E 497 (643)
++|.+.+.||+|+||.||+|.+ +|+.||||+++........+..|+..+..++||||++++|+|.+++ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4578899999999999999988 6899999999765443333344556667889999999999998754 5899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|+++|+|.++|+.. .++|..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999753 4899999999999999999999731 2389999999999999999999999999998
Q ss_pred cccCCCCCc--cccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 573 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 573 ~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
......... .....+||+.|||||++.+. .|+.++|||||||+||||+||++||..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 775543322 22345799999999999754 478899999999999999999876643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=379.62 Aligned_cols=201 Identities=26% Similarity=0.439 Sum_probs=163.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC--------
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-------- 490 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 490 (643)
++|.+.+.||+|+||.||+|... +|+.||||+++.. +...+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46899999999999999999864 7899999998643 345678999999999999999999999997654
Q ss_pred ----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 491 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 491 ----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
.+|+||||+++|+|.+++..... .....+..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999976532 2235667789999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCC----------ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 567 DFGLAKWASTSSSH----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 567 DFGla~~~~~~~~~----------~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||.+.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 99999876543221 12234679999999999999999999999999999999996 88754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=387.93 Aligned_cols=212 Identities=25% Similarity=0.392 Sum_probs=183.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe------CC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 490 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 467999999999999999999864 8999999999754 2456778999999999999999999999764 36
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+|||||||. |+|.+++... ..+++..+..|+.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7999999995 6899999654 369999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCC--CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 571 AKWASTSS--SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 571 a~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|+.+.... ........+||+.|||||++.+. .|+.++|||||||++|||++|++||.+.+...+..+|+.
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~ 277 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 98764432 22234557899999999998875 579999999999999999999999999998888877764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=375.92 Aligned_cols=208 Identities=25% Similarity=0.395 Sum_probs=175.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
..++|.+.+.||+|+||+||+|..+ +++.||||++.+... ..++.+|+++|+.+ +||||++++++|.+.+++|+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4578999999999999999999753 567899999876543 35678999999998 69999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCcccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 573 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~ 573 (643)
||||+++|+|.+++. .+++.++..++.||+.||.|||+ +|||||||||+||||+.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999983 38899999999999999999999 999999999999999876 8999999999986
Q ss_pred ccCCCCC--------------------------ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCC
Q 006480 574 ASTSSSH--------------------------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPI 626 (643)
Q Consensus 574 ~~~~~~~--------------------------~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf 626 (643)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432111 122345899999999999875 5899999999999999999999999
Q ss_pred CCCC-hhhHHHhh
Q 006480 627 SNDH-PKGQESLV 638 (643)
Q Consensus 627 ~~~~-~~~~~~li 638 (643)
...+ ...+...|
T Consensus 248 ~~~~~~~~~l~~I 260 (361)
T 4f9c_A 248 YKASDDLTALAQI 260 (361)
T ss_dssp SCCSSHHHHHHHH
T ss_pred CCCCCHHHHHHHH
Confidence 6543 33333333
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=398.08 Aligned_cols=202 Identities=26% Similarity=0.402 Sum_probs=175.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.++||+|+||.||+|... +|+.||||++++.. ........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999865 79999999996432 1222333446677778999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
||||||++||+|.++|.... .|++..+..|+.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997543 58999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
....... ...+||+.|||||++.. ..|+.++|||||||+||||++|++||.+.+...
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~ 398 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 7755432 34689999999999975 579999999999999999999999998765443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=394.02 Aligned_cols=213 Identities=23% Similarity=0.344 Sum_probs=191.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|+++|+.++||||++++++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 357999999999999999999865 79999999987643 4567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEeecCccccccC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 576 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~~~~~ 576 (643)
|+||+|.++|.... ..|++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999996432 468999999999999999999999 999999999999999854 8999999999997765
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+...+...|..+.
T Consensus 310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 32 2334689999999999999999999999999999999999999999999888888887664
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=363.17 Aligned_cols=222 Identities=24% Similarity=0.303 Sum_probs=193.6
Q ss_pred cChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCCceeEEEeEE
Q 006480 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFC 486 (643)
Q Consensus 412 f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~ 486 (643)
+.+.++....++|.+.+.||+|+||.||+|.+. +++.||+|++++... ....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345667777899999999999999999999876 578899999975321 223488899999999999999999999
Q ss_pred EeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 487 ~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
.+.+.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997532 468999999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|||+|+....... ......+||+.|+|||++. ...|+.++|||||||++|||++|++||.+.+.......|+.
T Consensus 218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~ 295 (437)
T 4aw2_A 218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295 (437)
T ss_dssp CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhh
Confidence 9999986654332 2233468999999999997 56799999999999999999999999999988887777754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.08 Aligned_cols=214 Identities=26% Similarity=0.472 Sum_probs=191.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+.+++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999986 58999999999653 34567889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997543 48999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
... .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.+.......+..+++
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 231 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY 231 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 432 23456899999999999988875 799999999999999999999999998888887776653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.64 Aligned_cols=221 Identities=41% Similarity=0.747 Sum_probs=193.8
Q ss_pred ccChHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC
Q 006480 411 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (643)
Q Consensus 411 ~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 489 (643)
.+++.++...+++|.+.+.||+|+||.||+|.+.+|+.||||++.... ...+.+.+|+++++.++||||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344556666789999999999999999999998889999999987643 4567899999999999999999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
+.+++||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997665545579999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 99865543333333445689999999999999999999999999999999999999987765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.56 Aligned_cols=212 Identities=28% Similarity=0.403 Sum_probs=187.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||+|++++. ......+.+|+++|+.++||||++++++|...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999865 7899999999753 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998543
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......|..+
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 220 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 3221 233468999999999999999999999999999999999999999998887777666544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.47 Aligned_cols=220 Identities=25% Similarity=0.331 Sum_probs=192.3
Q ss_pred ChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcCCCceeEEEeEEE
Q 006480 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCF 487 (643)
Q Consensus 413 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~~ 487 (643)
.+.++....++|.+.+.||+|+||.||+|... +++.||+|++++... ....+.+|++++..++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566667889999999999999999999865 688999999975321 2234788999999999999999999999
Q ss_pred eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 006480 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (643)
Q Consensus 488 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 567 (643)
+.+.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999753 48899999999999999999999 9999999999999999999999999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCcccccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
||+|+...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+...+...|+.+
T Consensus 212 FG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 288 (410)
T 3v8s_A 212 FGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288 (410)
T ss_dssp CTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred cceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc
Confidence 99998765432 22334568999999999998665 889999999999999999999999999988888777654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.26 Aligned_cols=213 Identities=26% Similarity=0.415 Sum_probs=185.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|... +|+.||||++++. ......+..|.+++..+ +||||++++++|.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999865 7899999999753 23456788999999988 79999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999997543 58999999999999999999999 89999999999999999999999999999754
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...|..++
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 240 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 240 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 3322 22344689999999999999899999999999999999999999999999888888777654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.97 Aligned_cols=213 Identities=21% Similarity=0.301 Sum_probs=190.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||.||++... +++.+|+|+++........+.+|+++++.++||||++++++|.+.+.+++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 568999999999999999999865 6889999999877766778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeecCccccccCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~ 577 (643)
++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++......
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999996532 468999999999999999999999 89999999999999987 789999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......++.+.
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 219 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCC
Confidence 2 2234579999999999999899999999999999999999999999988877777766554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=358.42 Aligned_cols=222 Identities=23% Similarity=0.298 Sum_probs=193.3
Q ss_pred cChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEE
Q 006480 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 486 (643)
Q Consensus 412 f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 486 (643)
+.+++.....++|.+.+.||+|+||.||++... +|+.||||++++.. .....+.+|.+++..++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445666677889999999999999999999875 79999999997532 2234578899999999999999999999
Q ss_pred EeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 487 ~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
.+.+.+||||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997542 358999999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCccccc-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|||+++....... ......+||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.+...+...|+
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999987654322 2223468999999999997 4579999999999999999999999999998887776665
Q ss_pred c
Q 006480 640 Q 640 (643)
Q Consensus 640 ~ 640 (643)
.
T Consensus 284 ~ 284 (412)
T 2vd5_A 284 H 284 (412)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.54 Aligned_cols=209 Identities=27% Similarity=0.416 Sum_probs=187.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||+|++++.. .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999865 78999999997542 2356788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997643 58999999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......|..+
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 42 23457999999999999999999999999999999999999999998887777666654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=334.05 Aligned_cols=208 Identities=28% Similarity=0.462 Sum_probs=184.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+|+.+++.++||||++++++|...+.+++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 478999999986433 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999753 48899999999999999999999 899999999999999999999999999998765433
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+
T Consensus 171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 228 (297)
T 3fxz_A 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (297)
T ss_dssp C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 233467999999999999999999999999999999999999999988766554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=344.08 Aligned_cols=212 Identities=25% Similarity=0.380 Sum_probs=188.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh-------HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-------VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... +|+.||+|+++.... ....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999865 789999999975321 357889999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeec
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DF 568 (643)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999643 368999999999999999999999 8999999999999998877 7999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
|++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......|..+.
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 9998765432 2234679999999999999999999999999999999999999999998887777776654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=344.40 Aligned_cols=214 Identities=25% Similarity=0.426 Sum_probs=187.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 492 (643)
...++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|.+++..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34678999999999999999999875 78899999997542 3456788899999987 899999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997542 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......|..+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 233 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 5433222 234568999999999999999999999999999999999999999998887777666544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=344.52 Aligned_cols=218 Identities=28% Similarity=0.460 Sum_probs=189.4
Q ss_pred hcCcccceeeeecCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 489 (643)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.. ......+.+|+++++.+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36789999999999999999975 24567999999764 34567899999999999 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+.+|+||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999986542 12458999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987665443333344567899999999999999999999999999999999 999999988777766
Q ss_pred hhhcc
Q 006480 637 LVMQS 641 (643)
Q Consensus 637 li~~~ 641 (643)
.+..+
T Consensus 317 ~~~~~ 321 (370)
T 2psq_A 317 LLKEG 321 (370)
T ss_dssp HHHTT
T ss_pred HHhcC
Confidence 66544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.68 Aligned_cols=210 Identities=25% Similarity=0.354 Sum_probs=188.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||+|++++.. .....+.+|+++++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999865 78999999997542 3456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997543 48999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......|..++
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 42 234579999999999999999999999999999999999999999998887777776554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.12 Aligned_cols=220 Identities=40% Similarity=0.739 Sum_probs=194.3
Q ss_pred ccccccChHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEe
Q 006480 407 ATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 407 ~~~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
...+.|++.++...+++|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456789999999999999999999999999999998889999999997643 22336889999999999999999999
Q ss_pred EEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 485 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
+|...+..++||||+.+|+|.+++.........+++..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987766666799999999999999999999992222999999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
|+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 175 l~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp ECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred eccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 9999999876543332 2334569999999999999999999999999999999999999996
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=331.44 Aligned_cols=206 Identities=26% Similarity=0.442 Sum_probs=177.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++.+. +++.||+|++.. .....+.+.+|+.++..++||||+++++++.+.+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999864 789999999843 345567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~ 220 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 4322 222345799999999999999999999999999999999999999998876544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=344.08 Aligned_cols=214 Identities=25% Similarity=0.363 Sum_probs=188.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+|+||.||+|... +|+.||||++++.. .....+..|.+++..+ +||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3568999999999999999999875 57889999997532 3456788999999988 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997543 58999999999999999999999 8999999999999999999999999999985
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...|+.++
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 237 (353)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 43222 12344689999999999999999999999999999999999999999998887777776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.39 Aligned_cols=219 Identities=25% Similarity=0.392 Sum_probs=189.6
Q ss_pred cccChHHHHHhhcC----------cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCC
Q 006480 410 RLFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK 477 (643)
Q Consensus 410 ~~f~~~el~~~~~~----------f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~Hp 477 (643)
..|+++++..+++. |...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34666666666653 777889999999999999876 79999999997543 4467789999999999999
Q ss_pred ceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 478 nIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
||++++++|...+.+++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998642 48999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...++......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999999987654322 22346799999999999999999999999999999999999999998876555444
Q ss_pred h
Q 006480 638 V 638 (643)
Q Consensus 638 i 638 (643)
+
T Consensus 253 ~ 253 (321)
T 2c30_A 253 L 253 (321)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.25 Aligned_cols=212 Identities=28% Similarity=0.440 Sum_probs=186.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||++... +|+.||+|+++.. ......+.+|+++++.++||||++++++|.+.+.+++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999865 7899999999753 345677899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~ 573 (643)
||+.+|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999654 358999999999999999999999 899999999999999865 4599999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+..+.
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~ 246 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA 246 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 654322 234679999999999999999999999999999999999999999988777766665543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=343.49 Aligned_cols=205 Identities=20% Similarity=0.274 Sum_probs=179.1
Q ss_pred hhcCcccceeeeecCceEEEEEE------eCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEEeEEEeCC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~ 490 (643)
..++|.+.+.||+|+||.||+|. ..+++.||||+++... ..++..|++++..++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45679999999999999999994 4478899999998653 356778888888886 999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC----------
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 559 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---------- 559 (643)
..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974322 23569999999999999999999999 89999999999999998
Q ss_pred -CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 560 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 560 -~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
++.+||+|||+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999998765444444555678999999999999999999999999999999999999999654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.75 Aligned_cols=212 Identities=27% Similarity=0.413 Sum_probs=177.5
Q ss_pred hcCcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+++++.++||||++++++|...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45799999999999999999986 478999999997642 334567889999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997543 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 236 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 75433221 223457999999999999999999999999999999999999999998877776666544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=337.51 Aligned_cols=199 Identities=24% Similarity=0.395 Sum_probs=177.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||++... +++.||+|++++. ......+.+|+.++.++ +||||++++++|.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999865 6889999999753 34566788999999988 89999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997542 58999999999999999999999 89999999999999999999999999999854
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 161 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 161 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 3222 123446899999999999999999999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.03 Aligned_cols=214 Identities=26% Similarity=0.353 Sum_probs=182.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++|.+.+.||+|+||.||++... +|+.||||++.... ...+.+.+|+++++.++||||++++++|.+.+.++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346899999999999999999864 78999999986422 23577899999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeecCc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGL 570 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGl 570 (643)
+||||+++|+|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886543334568999999999999999999999 89999999999999986655 99999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... .....+..
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~ 246 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIK 246 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHH
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHc
Confidence 987654322 23346799999999999999999999999999999999999999988543 33344433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=336.66 Aligned_cols=220 Identities=25% Similarity=0.344 Sum_probs=194.0
Q ss_pred ccccChHHHHHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----CCceeEE
Q 006480 409 CRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISL 482 (643)
Q Consensus 409 ~~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l 482 (643)
...|++++.....++|.+.+.||+|+||.||+|.. .+++.||||+++........+..|+++++.+. ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34566666667788999999999999999999986 47899999999887777788889999999996 9999999
Q ss_pred EeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---
Q 006480 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--- 559 (643)
Q Consensus 483 ~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~--- 559 (643)
++++...+.+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 99999999999999999 9999999986543 358999999999999999999999 99999999999999975
Q ss_pred ----------------------CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHH
Q 006480 560 ----------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 617 (643)
Q Consensus 560 ----------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~ 617 (643)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 8899999999998654422 2357999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCChhhHHHhhh
Q 006480 618 ELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 618 eLltG~~Pf~~~~~~~~~~li~ 639 (643)
||++|+.||...+.......+.
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~ 272 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMME 272 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHH
T ss_pred HHHHCCCCCCCCcHHHHHHHHH
Confidence 9999999999887766555543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=332.16 Aligned_cols=210 Identities=24% Similarity=0.365 Sum_probs=185.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... +|+.||+|+++... .....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356899999999999999999865 78999999986532 1367899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeec
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DF 568 (643)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 9999999999999999643 358999999999999999999999 9999999999999999887 8999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 99987654322 2345799999999999999999999999999999999999999998877666555543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.97 Aligned_cols=213 Identities=25% Similarity=0.476 Sum_probs=188.5
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|.+.+++.||+|++.......+++.+|++++++++||||+++++++.+.+.+++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 46789999999999999999998888999999998776666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... .
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 161 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 161 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc-c
Confidence 999999997543 468999999999999999999999 899999999999999999999999999998654421 1
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.......+..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~ 222 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 222 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhc
Confidence 12223457888999999999999999999999999999999 9999999887766655543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.44 Aligned_cols=200 Identities=24% Similarity=0.378 Sum_probs=176.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||++... +++.||+|++++.. .....+..|..++.++ +||||++++++|.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 457999999999999999999865 67889999997532 3345678899999887 89999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997543 58999999999999999999999 89999999999999999999999999999853
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3222 2234568999999999999999999999999999999999999999743
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.71 Aligned_cols=203 Identities=29% Similarity=0.428 Sum_probs=179.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+++|+.++||||++++++|.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999865 68899999997532 3456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 9999999999999754 358999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
... .....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 432 2344689999999999974 468999999999999999999999998655433
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=329.58 Aligned_cols=209 Identities=26% Similarity=0.429 Sum_probs=181.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|.+.+|+.||+|+++... .....+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999998889999999997542 345778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++ +|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9975 8888887543 458999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 232 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI 232 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 22 2234578999999999986 56899999999999999999999999988776665554
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.63 Aligned_cols=212 Identities=28% Similarity=0.381 Sum_probs=178.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHH-HHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||++... +++.||||++++.. .....+..|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999865 68899999997542 334566777776 567899999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997543 58899999999999999999999 99999999999999999999999999999864
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...|+..
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 33221 234468999999999999999999999999999999999999999998888777776654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.98 Aligned_cols=205 Identities=25% Similarity=0.397 Sum_probs=179.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999865 78999999986543 334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999999644 358999999999999999999999 99999999999999999999999999999866544
Q ss_pred CCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 33333445689999999999987776 77899999999999999999999876653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=326.72 Aligned_cols=205 Identities=27% Similarity=0.514 Sum_probs=179.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.. .....+.|.+|+++++.++||||++++++|.+++.+++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999865 789999998865 446678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999998643 468999999999999999999999 899999999999999999999999999998664432
Q ss_pred CCc------------cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 579 SHI------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 579 ~~~------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||....+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 211 11145799999999999999999999999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=334.91 Aligned_cols=220 Identities=25% Similarity=0.454 Sum_probs=189.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
...++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......+.+|+++++.++||||++++++|.+.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34678999999999999999999864 3478999999764 345678999999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL 550 (643)
.+++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||+ ++|+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 999999999999999999764321 2568999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 006480 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISND 629 (643)
Q Consensus 551 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~ 629 (643)
||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999986654333233334578999999999999999999999999999999999 99999998
Q ss_pred ChhhHHHhhhcc
Q 006480 630 HPKGQESLVMQS 641 (643)
Q Consensus 630 ~~~~~~~li~~~ 641 (643)
+.......+..+
T Consensus 281 ~~~~~~~~~~~~ 292 (343)
T 1luf_A 281 AHEEVIYYVRDG 292 (343)
T ss_dssp CHHHHHHHHHTT
T ss_pred ChHHHHHHHhCC
Confidence 877766666554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=332.77 Aligned_cols=215 Identities=28% Similarity=0.450 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.|.+|+++++.++||||++++++|.+.+.+++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457899999999999999999864 3456999999863 4556789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999996543 468999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 553322 22223456788999999999999999999999999999999 99999998877766665543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=346.45 Aligned_cols=214 Identities=26% Similarity=0.377 Sum_probs=187.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
..++|.+.+.||+|+||.||++... +|+.+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+.+++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3567999999999999999999764 78999999997543 3456789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecCccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAK 572 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~ 572 (643)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999997643 58999999999999999999999 8999999999999998 56889999999997
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+..+.
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 229 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA 229 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC
Confidence 6654322 2334689999999999999999999999999999999999999999998887777776654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.16 Aligned_cols=215 Identities=25% Similarity=0.416 Sum_probs=189.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++|.+.+.||+|+||.||+|...++..||+|+++.......++.+|++++..++||||++++++|.+.+.+++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35679999999999999999999888889999999877666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997542 358999999999999999999999 8999999999999999999999999999986654322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+.......+..+
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 221 (268)
T 3sxs_A 160 -VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221 (268)
T ss_dssp -EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred -hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC
Confidence 22233456788999999999899999999999999999999 99999988776665555443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.90 Aligned_cols=202 Identities=29% Similarity=0.415 Sum_probs=177.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----eEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~LV 495 (643)
..++|.+.+.||+|+||.||+|.+ .++.||||+++........+..|+.++..++||||+++++++.... .+++|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred chhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 356899999999999999999987 4799999999876666667778999999999999999999998744 47999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC----------CeEecCCCCCCEEEcCCCcEEE
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~----------~iiHrDLKp~NILl~~~~~vkL 565 (643)
|||+++|+|.+++... .+++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+||
T Consensus 101 ~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred EecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 9999999999999753 48999999999999999999998 7 9999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+|||+++...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999987765544334444679999999999986 356778999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.20 Aligned_cols=219 Identities=26% Similarity=0.450 Sum_probs=190.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
..++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456899999999999999999975 24578999999754 3556789999999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 551 (643)
+++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 9999999999999999986543 12348999999999999999999999 899999999
Q ss_pred CCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 006480 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 630 (643)
Q Consensus 552 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~ 630 (643)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655444333344567889999999999999999999999999999999 999999988
Q ss_pred hhhHHHhhhcc
Q 006480 631 PKGQESLVMQS 641 (643)
Q Consensus 631 ~~~~~~li~~~ 641 (643)
.......+..+
T Consensus 258 ~~~~~~~~~~~ 268 (314)
T 2ivs_A 258 PERLFNLLKTG 268 (314)
T ss_dssp GGGHHHHHHTT
T ss_pred HHHHHHHhhcC
Confidence 87777666544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=332.68 Aligned_cols=213 Identities=32% Similarity=0.537 Sum_probs=177.2
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
...++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+.+|++++++++||||+++++++...+.+++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999977 6889999999754 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999975421 1248999999999999999999999 78 99999999999999999999999999975
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......+
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~ 251 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 54322 1223457999999999999999999999999999999999999999998876655544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=337.31 Aligned_cols=219 Identities=25% Similarity=0.430 Sum_probs=186.6
Q ss_pred cChHHHHHhhcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEE
Q 006480 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISL 482 (643)
Q Consensus 412 f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l 482 (643)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555678999999999999999999973 25688999999764 34557899999999999 79999999
Q ss_pred EeEEEeCCe-EEEEEeeCCCCCHHHHhccCCCC-----------------------------------------------
Q 006480 483 LGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 514 (643)
Q Consensus 483 ~g~~~~~~~-~~LV~E~~~~gsL~~~l~~~~~~----------------------------------------------- 514 (643)
+++|.+.+. +++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999865421
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 515 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 515 ---------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1238999999999999999999999 8999999999999999999999999999987655544
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 303 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH
Confidence 444555678999999999999999999999999999999998 999998876433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=325.00 Aligned_cols=219 Identities=36% Similarity=0.657 Sum_probs=192.1
Q ss_pred ccccccChHHHHHhhcCcccc------eeeeecCceEEEEEEeCCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhcC
Q 006480 407 ATCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLH 475 (643)
Q Consensus 407 ~~~~~f~~~el~~~~~~f~~~------~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~-----~~~~~~~~~Ei~il~~l~ 475 (643)
.....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+++++.++
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 345778999999999998877 8999999999999987 6889999998642 345678999999999999
Q ss_pred CCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 006480 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (643)
Q Consensus 476 HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 555 (643)
||||+++++++.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence 99999999999999999999999999999999974322 2468999999999999999999999 8999999999999
Q ss_pred EEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 556 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 556 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
|++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 999999999999999987665443333445679999999998875 589999999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=336.54 Aligned_cols=211 Identities=22% Similarity=0.295 Sum_probs=185.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|... +|+.+|+|++.... .....+.+|+++|+.++||||++++++|.+.+.+++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457999999999999999999865 78999999997653 4456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeecCccccccC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 576 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~ 576 (643)
+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999997432 468999999999999999999999 89999999999999974 57899999999987654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 322 2234799999999999999999999999999999999999999999877666555544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.87 Aligned_cols=208 Identities=25% Similarity=0.409 Sum_probs=178.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||.||+|...+|+.||+|+++... .....+.+|+++++.++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998889999999997543 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 9999987543 468999999999999999999999 899999999999999999999999999998664322
Q ss_pred CCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+...+...+
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 213 (288)
T 1ob3_A 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred c--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 2 22335789999999999764 6899999999999999999999999988766655444
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=324.03 Aligned_cols=209 Identities=25% Similarity=0.414 Sum_probs=176.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh---------------------------HHHHHHHHHHHHH
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---------------------------VIKEFVLEIEIIT 472 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~---------------------------~~~~~~~Ei~il~ 472 (643)
.++|.+.+.||+|+||.||+|.+. +++.||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999999999999864 788999999965421 2356889999999
Q ss_pred hcCCCceeEEEeEEEe--CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006480 473 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (643)
Q Consensus 473 ~l~HpnIv~l~g~~~~--~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL 550 (643)
.++||||+++++++.+ .+.+++||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5689999999999999886532 358999999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 551 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654322 233457999999999998665 4789999999999999999999999
Q ss_pred CCChhhHHHhhh
Q 006480 628 NDHPKGQESLVM 639 (643)
Q Consensus 628 ~~~~~~~~~li~ 639 (643)
..........+.
T Consensus 242 ~~~~~~~~~~~~ 253 (298)
T 2zv2_A 242 DERIMCLHSKIK 253 (298)
T ss_dssp CSSHHHHHHHHH
T ss_pred CccHHHHHHHHh
Confidence 877655555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=351.42 Aligned_cols=205 Identities=27% Similarity=0.422 Sum_probs=183.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||+|++++.. .....+..|+++++.++||||++++++|.+.+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999875 79999999997532 2346788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999998665445679999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 4332 2234589999999999999999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=323.64 Aligned_cols=215 Identities=24% Similarity=0.452 Sum_probs=186.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++|.+.+.||+|+||.||++.+.++..||+|+++......+++.+|++++..++||||++++++|.+.+.+++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 35678999999999999999999888889999999877666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 9999999997532 358999999999999999999999 899999999999999999999999999998664321
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+.......+..+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 111223457788999999999999999999999999999998 99999988877666655543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.79 Aligned_cols=218 Identities=28% Similarity=0.460 Sum_probs=190.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC--------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 489 (643)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ......+.+|+++++.+ +||||++++++|...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467899999999999999999752 3457999999764 34567899999999999 999999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+.+++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 999999999999999999986542 12458999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+......
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987665443333444568899999999999999999999999999999999 999999988777766
Q ss_pred hhhcc
Q 006480 637 LVMQS 641 (643)
Q Consensus 637 li~~~ 641 (643)
.+..+
T Consensus 305 ~~~~~ 309 (382)
T 3tt0_A 305 LLKEG 309 (382)
T ss_dssp HHHTT
T ss_pred HHHcC
Confidence 66554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=330.67 Aligned_cols=210 Identities=27% Similarity=0.429 Sum_probs=174.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----e
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----N 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 491 (643)
.++|.+.+.||+|+||.||++.+ .+++.||||+++.. ......+.+|++++..++||||+++++++...+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46799999999999999999986 57899999999753 244668899999999999999999999987654 3
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+++|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 499999999999999997543 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 572 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 572 ~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~ 230 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 230 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 866543222 222345799999999999999999999999999999999999999998877655433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.58 Aligned_cols=218 Identities=25% Similarity=0.414 Sum_probs=186.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|... +++.||||+++.. .....++.+|+.+++.++||||++++++|...+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357889999999999999999842 5678999999753 45566899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEe
Q 006480 493 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 566 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL~ 566 (643)
++||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999976442 23468999999999999999999999 8999999999999999555 59999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999986543332223334568999999999999999999999999999999998 99999998887776666543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.79 Aligned_cols=215 Identities=22% Similarity=0.281 Sum_probs=184.5
Q ss_pred hhcCcccceeeeec--CceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G--~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+| +||.||+|... +|+.||||+++.. ......+.+|+++++.++||||++++++|.+.+.++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999876 7999999999753 355677889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999976532 358999999999999999999999 8999999999999999999999999999865
Q ss_pred ccCCCC-----CccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSSS-----HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~~-----~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 432111 111122478999999999987 679999999999999999999999999877665554443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=330.58 Aligned_cols=206 Identities=22% Similarity=0.264 Sum_probs=179.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+++++.+ +||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46899999999999999999985 5889999999875432 34688899999999 999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEeecCcccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFGla~~ 573 (643)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 999999998642 469999999999999999999999 89999999999999998887 99999999987
Q ss_pred ccCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 574 ASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 574 ~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 65433211 12346899999999999999999999999999999999999999998654433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=328.18 Aligned_cols=213 Identities=26% Similarity=0.448 Sum_probs=169.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|+++... .....+.+|+++++.++||||+++++++..++.+++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999865 78999999997542 334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 498 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|+. |+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999886432 223458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 222 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF 222 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 3322 2234578999999999986 468999999999999999999999999988776665553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=346.83 Aligned_cols=213 Identities=27% Similarity=0.393 Sum_probs=177.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||||+++.. ......+.+|+++++.++||||++++++|...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 457999999999999999999864 7899999999742 23456788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997543 58999999999999999999995 1679999999999999999999999999997543
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......+...
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 3222 234468999999999999999999999999999999999999999998887777766544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=334.76 Aligned_cols=205 Identities=23% Similarity=0.411 Sum_probs=179.2
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+ .+++.||||++.... .....+.+|+++++.++||||+++++++...+.+++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999986 588999999996432 2245788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+ +|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 789999886543 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+........
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~ 218 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK 218 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 432 2234579999999999998876 789999999999999999999998875544433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.03 Aligned_cols=214 Identities=24% Similarity=0.446 Sum_probs=178.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCE----EEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++|.+.+.||+|+||.||+|.+. +++. ||+|.++... ...+.|.+|+.++++++||||++++++|.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357899999999999999999854 4443 5888876432 4567899999999999999999999999875 578
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||+|+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999997643 468999999999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC
Confidence 766554444444567889999999999999999999999999999999 99999998877776666544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.61 Aligned_cols=216 Identities=25% Similarity=0.443 Sum_probs=185.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|+++++.++||||++++++|...+.+++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3567899999999999999999876 7899999999764 344567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999997542 358999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
...........+++.|+|||++.++.++.++|||||||++|||++ |+.||.+.+.......+..+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 331 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG 331 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 211111112235678999999999999999999999999999998 99999998776666555443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=335.23 Aligned_cols=208 Identities=26% Similarity=0.369 Sum_probs=177.5
Q ss_pred ccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCCC
Q 006480 425 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 502 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~g 502 (643)
...+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|++++++++||||++++++|.+.+.++|||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999864 78999999998654 45678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE--cCCCcEEEeecCccccccCCCCC
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl--~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 9999986543 358999999999999999999999 899999999999999 5678999999999987654322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 22357999999999999999999999999999999999999999998877666665543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=328.51 Aligned_cols=223 Identities=24% Similarity=0.407 Sum_probs=172.7
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeCC-C---CEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLPD-G---KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~-g---~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
++....++|.+.+.||+|+||.||+|.+.. + ..||||+++.. ....+.+.+|+++++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334456789999999999999999998653 3 27999999763 3456789999999999999999999999987
Q ss_pred CCeE------EEEEeeCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 489 DNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 489 ~~~~------~LV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
.+.. ++||||+.+|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCC
Confidence 6655 99999999999999986432 223468999999999999999999999 899999999999999999
Q ss_pred CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhh
Q 006480 561 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 639 (643)
Q Consensus 561 ~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~ 639 (643)
+.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999999987655433333334567889999999999999999999999999999999 999999988777666555
Q ss_pred cc
Q 006480 640 QS 641 (643)
Q Consensus 640 ~~ 641 (643)
.+
T Consensus 254 ~~ 255 (323)
T 3qup_A 254 GG 255 (323)
T ss_dssp TT
T ss_pred cC
Confidence 43
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.96 Aligned_cols=211 Identities=28% Similarity=0.427 Sum_probs=173.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCC--eE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 492 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~~ 492 (643)
..++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.++..+. ||||++++++|...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3578999999999999999999864 7899999998643 455677889999999997 999999999998644 78
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|+||||+. |+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5899998753 58899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCC-------------------CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 573 WASTSS-------------------SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 573 ~~~~~~-------------------~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311 1122344689999999999986 67999999999999999999999999999887
Q ss_pred hHHHhhh
Q 006480 633 GQESLVM 639 (643)
Q Consensus 633 ~~~~li~ 639 (643)
.+...|.
T Consensus 238 ~~~~~i~ 244 (388)
T 3oz6_A 238 NQLERII 244 (388)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7766664
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=330.93 Aligned_cols=223 Identities=27% Similarity=0.336 Sum_probs=183.5
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC------hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
++....++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+++++.++||||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 44556778999999999999999999864 7889999998642 3456789999999999999999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCC------------------------------------CCCCChHHHHHHHHHHHH
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAE 532 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qia~ 532 (643)
.+.+++||||+++|+|.+++...... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998631110 123467788899999999
Q ss_pred HHHHHHhCCCCCeEecCCCCCCEEEcCCC--cEEEeecCccccccCCCC--CccccCCCCCCCccCcccccC--CCCCch
Q 006480 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYFMY--GKVNDK 606 (643)
Q Consensus 533 aL~yLH~~~~~~iiHrDLKp~NILl~~~~--~vkL~DFGla~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~--~~~s~k 606 (643)
||.|||+ ++|+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 899999999986543222 122344679999999999975 679999
Q ss_pred hHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 607 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 607 sDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
+|||||||++|||++|+.||.+.+.......+...
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 291 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 99999999999999999999988776666555443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.43 Aligned_cols=212 Identities=24% Similarity=0.437 Sum_probs=182.0
Q ss_pred hhcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
..++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++..+ +||||++++++|...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 356899999999999999999985 245689999997542 3457899999999999 8999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 551 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLK 551 (643)
.+++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999765321 1348999999999999999999999 899999999
Q ss_pred CCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 006480 552 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 630 (643)
Q Consensus 552 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~ 630 (643)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987765544444445568899999999999999999999999999999998 999998876
Q ss_pred hhhH
Q 006480 631 PKGQ 634 (643)
Q Consensus 631 ~~~~ 634 (643)
....
T Consensus 280 ~~~~ 283 (344)
T 1rjb_A 280 VDAN 283 (344)
T ss_dssp CSHH
T ss_pred cHHH
Confidence 5443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=360.32 Aligned_cols=214 Identities=25% Similarity=0.364 Sum_probs=189.6
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+|+||.||+|... +++.||||++++. ......+..|.++|..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999865 7889999999753 23456788899999987 7999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
|||||+++|+|.+++.... .+++..++.|+.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999997643 58999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+...+...|+.++
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 558 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 558 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC
Confidence 433222 2345689999999999999999999999999999999999999999999888888887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.24 Aligned_cols=203 Identities=25% Similarity=0.411 Sum_probs=177.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC--eEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|+++++.++||||+++++++...+ .+++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999875 68999999997543 34577889999999999999999999998755 78999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeecCcc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 571 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla 571 (643)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999975432 2348999999999999999999999 899999999999999 78888999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCccccc--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~--------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 87655432 23357999999999986 5789999999999999999999999997544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=323.29 Aligned_cols=211 Identities=25% Similarity=0.376 Sum_probs=185.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... +|+.||+|+++... .....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456899999999999999999865 78999999986532 1367899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeec
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DF 568 (643)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999753 358999999999999999999999 8999999999999999888 7999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 99987654322 23457999999999999999999999999999999999999999988776666555443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.08 Aligned_cols=208 Identities=24% Similarity=0.378 Sum_probs=177.2
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|++++++++||||+++++++.+++.+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999865 7899999999643 3456788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+ +|.+.+.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 6666665432 468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCC-CCCCChhhHHHhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLV 638 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLltG~~P-f~~~~~~~~~~li 638 (643)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+...+...+
T Consensus 155 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i 215 (292)
T 3o0g_A 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred cc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence 22 223457899999999998766 89999999999999999988777 5555555554444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=324.48 Aligned_cols=203 Identities=24% Similarity=0.385 Sum_probs=173.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------- 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------- 490 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+++++.++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999876 8999999999743 345678999999999999999999999987643
Q ss_pred --------------------------------------------------eEEEEEeeCCCCCHHHHhccCCCCCCCCCh
Q 006480 491 --------------------------------------------------NLLLVYDFLSRGSLEENLHGNKKDPAAFGW 520 (643)
Q Consensus 491 --------------------------------------------------~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~ 520 (643)
.+++||||+++|+|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 38999999999999999986543 234577
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC----------ccccCCCCCC
Q 006480 521 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 590 (643)
Q Consensus 521 ~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~gt~ 590 (643)
..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7899999999999999999 89999999999999999999999999999876654221 1223457999
Q ss_pred CccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 591 ~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 9999999999999999999999999999999988764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=314.30 Aligned_cols=211 Identities=28% Similarity=0.444 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999865 6899999998643 345677889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~~ 573 (643)
||+.+++|.+.+... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988754 358999999999999999999999 89999999999999986655 99999999976
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..+
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence 654322 23457999999999999999999999999999999999999999998877766666554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.36 Aligned_cols=211 Identities=24% Similarity=0.390 Sum_probs=178.2
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC------hhHHHHHHHHHHHHHhc---CCCceeEEEeEEEeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTL---HHKNIISLLGFCFED 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~------~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~ 489 (643)
..++|.+.+.||+|+||.||+|.+ .+|+.||||+++.. ......+.+|+++++.+ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999986 47899999998632 12234566777777766 499999999999876
Q ss_pred C-----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 490 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 490 ~-----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
. .+++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999996 599999976543 348999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+...+...+.
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999986654322 234579999999999999999999999999999999999999999988777665554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.33 Aligned_cols=214 Identities=26% Similarity=0.450 Sum_probs=173.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. ....++|.+|++++.+++||||++++++|.+.+.+++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 5778999999754 4556789999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 468999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 575 STSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 575 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~ 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 543221 11122345788999999999999999999999999999998 9999998877666555543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.86 Aligned_cols=213 Identities=25% Similarity=0.466 Sum_probs=187.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||++...+++.||+|+++......+.+.+|+++++.++||||+++++++.+.+.+++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46789999999999999999998888899999998876666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....... .
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-Y 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-H
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc-c
Confidence 999999997643 368999999999999999999999 899999999999999999999999999998654321 1
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~ 220 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc
Confidence 11223457889999999998999999999999999999999 9999998877666555543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.69 Aligned_cols=202 Identities=28% Similarity=0.438 Sum_probs=164.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
..++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+++++.++||||++++++|...+.+++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567999999999999999999876 68899999998653 346688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCcccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAS 575 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~~~ 575 (643)
+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999654 358999999999999999999999 89999999999999975 8999999999998664
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 422 223457999999999999999999999999999999999999999876544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.61 Aligned_cols=211 Identities=27% Similarity=0.355 Sum_probs=184.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|... ++..+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+.+++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999865 67789999986532 4467889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCcccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~~ 575 (643)
+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999987543 58999999999999999999999 899999999999999 788999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
... ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...+.......+..+.
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 223 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT 223 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC
Confidence 432 22335799999999998754 9999999999999999999999999988777666665543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.92 Aligned_cols=204 Identities=27% Similarity=0.380 Sum_probs=181.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
..++|.+.+.||+|+||.||++... +|+.||||++.... .....+.+|+++|..++||||++++++|.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4567999999999999999999865 79999999996532 234568899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999975432 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 54322 2345899999999999999999999999999999999999999998643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=322.43 Aligned_cols=210 Identities=25% Similarity=0.420 Sum_probs=184.3
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|++++.++ +||||++++++|...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999974 356789999998653 4567899999999999 99999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCC--------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999865421 2358999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhh
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 633 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~ 633 (643)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999987766554444445567889999999999999999999999999999999 999998876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.85 Aligned_cols=217 Identities=28% Similarity=0.465 Sum_probs=186.2
Q ss_pred hcCcccceeeeecCceEEEEEEe--------CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~--------~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 489 (643)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.. ......+.+|+++++.+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46799999999999999999985 35678999999764 34567899999999999 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCC------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+.+++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999865421 2348999999999999999999999 899999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987665433333334567889999999999999999999999999999999 999999887776665
Q ss_pred hhhc
Q 006480 637 LVMQ 640 (643)
Q Consensus 637 li~~ 640 (643)
.+..
T Consensus 271 ~~~~ 274 (334)
T 2pvf_A 271 LLKE 274 (334)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 5544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=328.73 Aligned_cols=214 Identities=24% Similarity=0.455 Sum_probs=181.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCE----EEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++|.+.+.||+|+||.||+|.+. +++. +|+|.+.... .....+.+|+.++..++||||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357899999999999999999854 4543 7888875432 33456788999999999999999999985 56789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997542 468999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 233 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG 233 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence 766554444455678899999999999999999999999999999999 99999998877776666554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=347.41 Aligned_cols=215 Identities=23% Similarity=0.434 Sum_probs=186.8
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|+.++||||+++++++. .+.+++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 345678999999999999999999988899999999987667789999999999999999999999986 6678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999974321 357889999999999999999999 899999999999999999999999999998664321
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
........+|+.|+|||++....++.++|||||||+||||++ |+.||.+.+.......+..
T Consensus 339 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~ 400 (454)
T 1qcf_A 339 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400 (454)
T ss_dssp -HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred -eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 111122356788999999999999999999999999999999 9999999887766665544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=333.76 Aligned_cols=199 Identities=26% Similarity=0.407 Sum_probs=165.0
Q ss_pred hcCcccc-eeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHH-hcCCCceeEEEeEEEe----CCeEE
Q 006480 421 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFE----DNNLL 493 (643)
Q Consensus 421 ~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~----~~~~~ 493 (643)
.++|.+. +.||+|+||.||++.+. +|+.||||+++.. ..+.+|++++. ..+||||++++++|.. .+.+|
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 3456665 78999999999999865 7899999999754 34667888874 4589999999999875 56799
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 570 (643)
|||||+.+|+|.+++..... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999976432 468999999999999999999999 89999999999999997 78999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 98654322 22346799999999999999999999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.72 Aligned_cols=212 Identities=25% Similarity=0.441 Sum_probs=187.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999875 89999999997532 2356789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 9999999999999643 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+.......|..+.
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 232 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 432 2234579999999999998776 789999999999999999999999988777777766554
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.60 Aligned_cols=201 Identities=24% Similarity=0.334 Sum_probs=168.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||.||++... +++.||||++.........+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999876 7899999999876655577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeecCccccccCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 577 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~~~~~ 577 (643)
.+|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999996543 58999999999999999999999 99999999999999987765 999999999744332
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 2 2233579999999999998888766 9999999999999999999987554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.18 Aligned_cols=216 Identities=26% Similarity=0.453 Sum_probs=191.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
...++|.+.+.||+|+||.||+|.+. ++..||+|+++......+.+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678999999999999999999876 58889999998877778899999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999976433 468999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.. .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.......+..
T Consensus 165 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~ 227 (288)
T 3kfa_A 165 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227 (288)
T ss_dssp SS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 32 22333457889999999999999999999999999999999 9999998877666555543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.11 Aligned_cols=214 Identities=24% Similarity=0.419 Sum_probs=185.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++|.+.+.||+|+||.||+|...+++.||+|+++......+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 45689999999999999999999888889999999877666788999999999999999999999986 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999964321 258999999999999999999999 8999999999999999999999999999987654321
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+.+.......+..
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 225 (279)
T 1qpc_A 165 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225 (279)
T ss_dssp -ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT
T ss_pred -ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc
Confidence 22233457889999999998999999999999999999999 9999998877665555543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.10 Aligned_cols=225 Identities=22% Similarity=0.379 Sum_probs=191.1
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeE
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGF 485 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~ 485 (643)
.++.....++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3344456678999999999999999999753 46789999997543 445678999999999999999999999
Q ss_pred EEeCCeEEEEEeeCCCCCHHHHhccCC------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC
Q 006480 486 CFEDNNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 559 (643)
Q Consensus 486 ~~~~~~~~LV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~ 559 (643)
+.+.+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcC
Confidence 999999999999999999999987532 112357899999999999999999999 89999999999999999
Q ss_pred CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhh
Q 006480 560 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 638 (643)
Q Consensus 560 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li 638 (643)
++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 99999999999986654433333344567899999999999999999999999999999999 89999988777666665
Q ss_pred hcc
Q 006480 639 MQS 641 (643)
Q Consensus 639 ~~~ 641 (643)
..+
T Consensus 254 ~~~ 256 (322)
T 1p4o_A 254 MEG 256 (322)
T ss_dssp HTT
T ss_pred HcC
Confidence 543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=315.99 Aligned_cols=211 Identities=30% Similarity=0.477 Sum_probs=182.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
+.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++.++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3567999999999999999999865 67899999986532 235678899999999999999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999997543 58999999999999999999999 89999999999999999999999999998654
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+...
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (279)
T 3fdn_A 160 PSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred Cccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC
Confidence 4322 23357999999999999999999999999999999999999999998877666655443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=342.36 Aligned_cols=207 Identities=25% Similarity=0.331 Sum_probs=175.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 490 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.. .....+++.+|+.+|+.++||||++++++|... +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999864 789999999975 345567889999999999999999999999654 4
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+||||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999976 57777642 38899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|+...... .....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+...+...|+.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~ 277 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 277 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 98665432 23346899999999999999999999999999999999999999999887777666643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.96 Aligned_cols=215 Identities=26% Similarity=0.453 Sum_probs=188.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...+|.+.+.||+|+||.||+|.+. ++..||||+++......++|.+|+++|++++||||++++++|...+.+++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567889999999999999999876 488999999987766678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999976432 458999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
........+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+.......+..
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 434 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 122223456789999999999999999999999999999999 9999999887666655543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=316.06 Aligned_cols=214 Identities=24% Similarity=0.405 Sum_probs=173.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+|+||.||+|.+. .+..||+|+++.. ......+.+|+.+++.++||||+++++++ .++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 3467999999999999999999864 3457999998763 34567899999999999999999999998 456789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999997543 368999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....... ......+|+.|+|||++....++.++|||||||++|||++ |+.||.+.........+..+
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~ 233 (281)
T 1mp8_A 166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 233 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC
Confidence 6543221 2223457889999999999999999999999999999997 99999988877766666543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.68 Aligned_cols=210 Identities=31% Similarity=0.506 Sum_probs=182.6
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC-eEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~LV~E~ 498 (643)
..++|.+.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++||||+++++++.+.+ .+++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456789999999999999999988 47899999998754 4578999999999999999999999988765 79999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999986432 347899999999999999999999 899999999999999999999999999998543321
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....+++.|+|||++.+..++.++|||||||+||||++ |+.||.+.+.......+.++
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 402 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 12357889999999999999999999999999999998 99999988777766666544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.01 Aligned_cols=209 Identities=29% Similarity=0.423 Sum_probs=177.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||++... +|+.||||+++.... .+.+|++++.++ +||||++++++|.+.+.+|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457999999999999999999865 788999999976542 245688888888 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC----CcEEEeecCccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 574 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~~ 574 (643)
+.+|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999754 358999999999999999999999 899999999999998543 35999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC---ChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND---HPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~---~~~~~~~li~~~ 641 (643)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+. +.......|..+
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 238 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC
Confidence 54332 223467999999999999888999999999999999999999999863 334444444443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.58 Aligned_cols=212 Identities=26% Similarity=0.419 Sum_probs=186.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++.+. +++.+|+|++... ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999875 6789999998643 34567889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998654 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.++
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 230 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Confidence 3322 223357999999999999999999999999999999999999999988776665555443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.49 Aligned_cols=212 Identities=28% Similarity=0.401 Sum_probs=178.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+++++.++||||++++++|.+.+.+++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 356899999999999999999864 78999999987543 346788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~ 574 (643)
|+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986543333568999999999999999999999 899999999999999 45688999999999765
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
..... .....||+.|+|||++. +.++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~ 238 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc
Confidence 54322 23457999999999886 578999999999999999999999999887666554443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.31 Aligned_cols=193 Identities=25% Similarity=0.421 Sum_probs=152.6
Q ss_pred ceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
.+.||+|+||.||++.+. +|+.||||++... ....+.+|+.+++.+. ||||++++++|.+.+..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 378999999999999875 7899999999643 3467788999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---cEEEeecCccccccCCCCCc
Q 006480 505 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 505 ~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~~~~~~~~ 581 (643)
.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.......
T Consensus 94 ~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 94 FERIKKK----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 9999764 358999999999999999999999 8999999999999998765 899999999986654322
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 2234578999999999999999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.29 Aligned_cols=209 Identities=27% Similarity=0.354 Sum_probs=177.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ...+.+.+|+++++.++||||++++++|...+.+++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999875 68999999986543 346778899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988644 358999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22 2234578999999999976 678999999999999999999999999988766655443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.85 Aligned_cols=206 Identities=33% Similarity=0.524 Sum_probs=169.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+ .|+.+|||+++... ...+.+.+|+++++.++||||++++++|.+.+.+++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 58899999987542 3357789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC---eEecCCCCCCEEEcC--------CCcEE
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR---VIHRDVKSSNILLSD--------DFEPQ 564 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~---iiHrDLKp~NILl~~--------~~~vk 564 (643)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999853 358999999999999999999999 66 999999999999986 77899
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+.
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred EccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh
Confidence 999999976554322 23479999999999999999999999999999999999999999877655544433
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.34 Aligned_cols=212 Identities=26% Similarity=0.419 Sum_probs=186.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++.+. +++.+|+|++... ......+.+|+.+++.++||||++++++|.+.+.+++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999875 6789999998643 34567889999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998754 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.++
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 256 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence 3322 223457999999999999999999999999999999999999999988766665555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=326.10 Aligned_cols=216 Identities=30% Similarity=0.490 Sum_probs=187.1
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhc-CCCceeEEEeE
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLGF 485 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l-~HpnIv~l~g~ 485 (643)
.....++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|++++..+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445678999999999999999999875 79999999986532 2356788999999999 79999999999
Q ss_pred EEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 486 ~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
+...+.+++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999753 358999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+.
T Consensus 242 ~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999987654322 234679999999999863 368999999999999999999999999887766666655
Q ss_pred ccC
Q 006480 640 QSQ 642 (643)
Q Consensus 640 ~~~ 642 (643)
.++
T Consensus 319 ~~~ 321 (365)
T 2y7j_A 319 EGQ 321 (365)
T ss_dssp HTC
T ss_pred hCC
Confidence 543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=321.04 Aligned_cols=197 Identities=24% Similarity=0.265 Sum_probs=167.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+..|+..+..+ +||||++++++|.+.+.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999876 7999999998653 23445566666666655 8999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 779999887543 469999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+.
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 322 233569999999999876 7999999999999999999997776653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=326.33 Aligned_cols=202 Identities=24% Similarity=0.377 Sum_probs=170.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCC--CceeEEEeEEEeCCeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~L 494 (643)
..++|.+.+.||+|+||.||++...+++.||||++... ......+.+|+++|..++| |||+++++++...+.+++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999889999999998653 3456789999999999986 999999999999999999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
|||+ .+|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++..
T Consensus 87 v~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9994 588999999764 358999999999999999999999 8999999999999997 678999999999877
Q ss_pred cCCCCCccccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 65444334445689999999999865 678999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.01 Aligned_cols=212 Identities=28% Similarity=0.448 Sum_probs=184.6
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--------------hHHHHHHHHHHHHHhcCCCceeEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
..++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568999999999999999999865 68899999997542 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC---
Q 006480 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF--- 561 (643)
Q Consensus 485 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~--- 561 (643)
+|.+.+.+++||||+++|+|.+.+.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999987543 58999999999999999999999 8999999999999998776
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|++||.+.+.......+..+
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 69999999998765432 233457999999999987 46999999999999999999999999999888888777766
Q ss_pred C
Q 006480 642 Q 642 (643)
Q Consensus 642 ~ 642 (643)
+
T Consensus 263 ~ 263 (504)
T 3q5i_A 263 K 263 (504)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.25 Aligned_cols=210 Identities=26% Similarity=0.408 Sum_probs=181.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.+++.++||||+++++++...+.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356899999999999999999876 78999999986532 1367899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeec
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DF 568 (643)
++||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 9999999999999999653 358999999999999999999999 8999999999999998877 8999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 99986654322 2335799999999999999999999999999999999999999998877665555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=314.12 Aligned_cols=203 Identities=20% Similarity=0.267 Sum_probs=178.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|++++..+ +|+||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46799999999999999999985 588999999986543 234578899999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-----EEEeecCcccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 573 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFGla~~ 573 (643)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 999999997643 358999999999999999999999 89999999999999987776 99999999987
Q ss_pred ccCCCCC-----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 574 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 574 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 6554322 122346799999999999999999999999999999999999999998543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=316.47 Aligned_cols=217 Identities=25% Similarity=0.356 Sum_probs=184.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~L 494 (643)
.++|.+.+.||+|+||.||++... +|+.||+|++... ....+.+.+|+++++.++||||+++++++.. .+.+++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999865 7899999999753 3456789999999999999999999998864 578999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCEEEcCCCcEEEeecC
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~-----iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997654444568999999999999999999999 67 9999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..++
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc
Confidence 9986654321 1223468999999999999999999999999999999999999999988766666655543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=324.25 Aligned_cols=209 Identities=24% Similarity=0.435 Sum_probs=174.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh--HHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+++++.++||||+++++++...+.+++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999875 789999999975432 222456799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+. |+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 59999987543 468999999999999999999999 899999999999999999999999999997654332
Q ss_pred CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 155 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 214 (324)
T 3mtl_A 155 K--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF 214 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred c--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 2233578999999999986 578999999999999999999999999988777666554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=313.69 Aligned_cols=206 Identities=27% Similarity=0.481 Sum_probs=159.8
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45799999999999999999986 488999999996532 2346789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997542 468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 3222 12235799999999999999999999999999999999999999987765443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.86 Aligned_cols=214 Identities=27% Similarity=0.462 Sum_probs=183.4
Q ss_pred hcCcccce-eeeecCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+++++.++||||+++++++ ..+.+++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999753 6788999999863 35677899999999999999999999999 5677999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996432 468999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~ 229 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC
Confidence 54332221 223457899999999998899999999999999999998 99999988776666655543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.14 Aligned_cols=208 Identities=26% Similarity=0.369 Sum_probs=184.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc------CCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~~~~~~~ 493 (643)
..+|.+.+.||+|+||.||+|.+. +++.||||+++........+.+|+++++.+ +|+||++++++|...+.++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999765 688999999998877778888999998887 5779999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--EEEeecCcc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 571 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla 571 (643)
+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 699999976543 358999999999999999999999 89999999999999999987 999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
...... .....||+.|+|||++.+..++.++|||||||+||||++|++||.+.+...+...++
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~ 312 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI 312 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 765432 223579999999999999999999999999999999999999999988776665554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=331.24 Aligned_cols=204 Identities=20% Similarity=0.287 Sum_probs=170.2
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC------CCEEEEEEeCCChhH------------HHHHHHHHHHHHhcCCCceeE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 481 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~------g~~vAVK~l~~~~~~------------~~~~~~Ei~il~~l~HpnIv~ 481 (643)
..++|.+.+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998765321 112445566677788999999
Q ss_pred EEeEEEeC----CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 482 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 482 l~g~~~~~----~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+++++... ..++|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999874 4589999999 999999997642 469999999999999999999999 899999999999999
Q ss_pred c--CCCcEEEeecCccccccCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 558 S--DDFEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 558 ~--~~~~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
+ .++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998665432211 1123469999999999999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.91 Aligned_cols=205 Identities=29% Similarity=0.429 Sum_probs=178.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
+.|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+++++.++||||++++++|...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999986 58899999999643 234578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+. |+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 68888886432 468999999999999999999999 8999999999999999999999999999976543
Q ss_pred CCCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 266 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 2 2357999999999985 5689999999999999999999999999877655444443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=319.77 Aligned_cols=216 Identities=25% Similarity=0.426 Sum_probs=185.3
Q ss_pred ChHHHHHhhcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEE
Q 006480 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLL 483 (643)
Q Consensus 413 ~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~ 483 (643)
.........++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|++++..+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344445567899999999999999999973 356889999997643 4556899999999999 799999999
Q ss_pred eEEEeCC-eEEEEEeeCCCCCHHHHhccCCCC------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006480 484 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (643)
Q Consensus 484 g~~~~~~-~~~LV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL 550 (643)
++|...+ .+++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccC
Confidence 9998754 489999999999999999865431 1238899999999999999999999 89999999
Q ss_pred CCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 006480 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISND 629 (643)
Q Consensus 551 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~ 629 (643)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987765544444445678999999999999999999999999999999998 99999876
Q ss_pred Ch
Q 006480 630 HP 631 (643)
Q Consensus 630 ~~ 631 (643)
..
T Consensus 255 ~~ 256 (316)
T 2xir_A 255 KI 256 (316)
T ss_dssp CC
T ss_pred ch
Confidence 54
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=340.70 Aligned_cols=215 Identities=26% Similarity=0.454 Sum_probs=181.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+++|++++||||+++++++.+ +.+++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 346788999999999999999999888889999998766566789999999999999999999999866 7789999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999974321 358899999999999999999999 8999999999999999999999999999986654221
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
.......+|..|+|||++.++.++.++|||||||+||||++ |+.||.+.........+..+
T Consensus 336 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 336 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred -ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 12223457789999999999999999999999999999999 99999998877666655543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.77 Aligned_cols=205 Identities=25% Similarity=0.393 Sum_probs=180.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999875 7899999998643 3456788999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998643 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
..........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 32223344679999999999987775 77999999999999999999999876543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.71 Aligned_cols=211 Identities=25% Similarity=0.404 Sum_probs=183.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
..++|.+.+.||+|+||.||++... +|+.||+|+++... .....+.+|+++++.++||||+++++++.+.+.+++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999865 78999999997654 334678899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~ 574 (643)
|+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999986543 58899999999999999999999 899999999999999 78899999999998754
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+..+
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (304)
T 2jam_A 160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG 222 (304)
T ss_dssp CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC
T ss_pred CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 4321 22346899999999999999999999999999999999999999988877666666544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=329.29 Aligned_cols=201 Identities=24% Similarity=0.379 Sum_probs=171.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC--CCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~LV 495 (643)
..+|.+.+.||+|+||.||++...+++.||||++... ......+.+|+++|..++ ||||+++++++...+.+++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3469999999999999999999888999999999643 345678999999999996 59999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|| +.+++|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++...
T Consensus 135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 56889999997643 58899999999999999999999 8999999999999995 5899999999998775
Q ss_pred CCCCCccccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
...........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 5443333445689999999999875 469999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=318.99 Aligned_cols=223 Identities=26% Similarity=0.417 Sum_probs=176.8
Q ss_pred HHHHhhcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe
Q 006480 416 DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 488 (643)
Q Consensus 416 el~~~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 488 (643)
++....++|.+.+.||+|+||.||+|... ++..||+|+++.. ......+.+|+.+++.++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445678999999999999999999753 3458999999753 3456789999999999999999999999987
Q ss_pred CC-----eEEEEEeeCCCCCHHHHhccCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 489 DN-----NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 489 ~~-----~~~LV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
.+ ..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCC
Confidence 54 4599999999999999985432 233569999999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 999999999987654433223334567889999999999999999999999999999999 9999999887766665544
Q ss_pred c
Q 006480 641 S 641 (643)
Q Consensus 641 ~ 641 (643)
+
T Consensus 265 ~ 265 (313)
T 3brb_A 265 G 265 (313)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.81 Aligned_cols=209 Identities=28% Similarity=0.458 Sum_probs=183.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999875 67889999996532 2346788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+..
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 226 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc
Confidence 322 2235799999999999999999999999999999999999999998876666555543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=339.52 Aligned_cols=211 Identities=27% Similarity=0.445 Sum_probs=186.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +|+.||||++... ......+.+|++++++++||||++++++|.+.+.+++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457899999999999999999875 8899999998643 24567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 572 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~ 572 (643)
|||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999999754 358999999999999999999999 899999999999999 567899999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|++||.+.+.......+..++
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 7654332 233579999999999876 69999999999999999999999999998888777776654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=329.66 Aligned_cols=211 Identities=23% Similarity=0.341 Sum_probs=176.3
Q ss_pred HhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--------
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-------- 489 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-------- 489 (643)
...++|.+.+.||+|+||.||+|.+ .+|+.||||++...... ..+|+++++.++||||++++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4567899999999999999999986 58899999998765432 23699999999999999999998543
Q ss_pred ------------------------------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 006480 490 ------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539 (643)
Q Consensus 490 ------------------------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~ 539 (643)
..+++||||++ |+|.+.+.........+++..+..++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34899999997 58888776433333578999999999999999999999
Q ss_pred CCCCCeEecCCCCCCEEEc-CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHH
Q 006480 540 GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLL 617 (643)
Q Consensus 540 ~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~ 617 (643)
++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 160 ---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp ---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999997 6899999999999876543322 235789999999998865 5999999999999999
Q ss_pred HHHcCCCCCCCCChhhHHHhhh
Q 006480 618 ELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 618 eLltG~~Pf~~~~~~~~~~li~ 639 (643)
||++|++||.+.+..++...+.
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~ 255 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRII 255 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHH
T ss_pred HHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999988777666554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.26 Aligned_cols=199 Identities=28% Similarity=0.473 Sum_probs=170.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEEeEEEeC----CeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~----~~~~ 493 (643)
..++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++... +.++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 356899999999999999999987 78999999997543 4556677777777 7999999999997653 4689
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
+||||+++|+|.++++. ..+++..++.++.||+.||.||| + ++|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 25899999999999999999999 6 89999999999999999999999
Q ss_pred eecCccccccCCCCCcc--ccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 006480 566 SDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKPIS 627 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~--~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGvvl~eLltG----------~~Pf~ 627 (643)
+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999987655433221 2235799999999999877 556799999999999999999 89996
Q ss_pred CC
Q 006480 628 ND 629 (643)
Q Consensus 628 ~~ 629 (643)
..
T Consensus 235 ~~ 236 (301)
T 3q4u_A 235 DV 236 (301)
T ss_dssp TT
T ss_pred cc
Confidence 64
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=320.94 Aligned_cols=220 Identities=28% Similarity=0.455 Sum_probs=180.7
Q ss_pred cChHHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe-
Q 006480 412 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE- 488 (643)
Q Consensus 412 f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 488 (643)
+++.++....++|.+.+.||+|+||.||+|.+. +|+.||||++.........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 344555567789999999999999999999864 789999999987665667889999999999 79999999999987
Q ss_pred -----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 489 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 489 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
.+.+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 5689999999999999999976432 468899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
||+|||++........ ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...++......+
T Consensus 169 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 9999999876543221 122357999999999997 567899999999999999999999999887765544443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.88 Aligned_cols=211 Identities=25% Similarity=0.418 Sum_probs=182.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-C-----CCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-D-----GKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~-----g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|... + .+.||+|+++... .....+.+|+++++.+ +||||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 568999999999999999999854 2 2479999997643 4567899999999999 89999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 561 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~ 561 (643)
+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999875321 12458999999999999999999999 8999999999999999999
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQ 634 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~ 634 (643)
.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 999999999987655444444444567889999999999999999999999999999999 9999988765443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.63 Aligned_cols=203 Identities=30% Similarity=0.468 Sum_probs=172.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 492 (643)
.++|.+.+.||+|+||.||++.+ .+++.||||+++... ...+.+.+|+++++.++||||++++++|.. ...+
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999973 368899999997644 556789999999999999999999999865 3568
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997653 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 573 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 573 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
......... ......+|..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 765433221 222345788899999999999999999999999999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.81 Aligned_cols=211 Identities=26% Similarity=0.435 Sum_probs=184.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||++... +++.||||++... ......+.+|++++++++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999865 7899999998642 234577899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~ 573 (643)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999886543 58999999999999999999999 8999999999999995 566799999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... ......||+.|+|||++.+ .|+.++|||||||++|+|++|++||.+.+.......+..++
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 238 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 65432 2234579999999999875 59999999999999999999999999998887777776654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.32 Aligned_cols=215 Identities=26% Similarity=0.377 Sum_probs=182.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhcCCCceeEEEeEEE--eCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 492 (643)
.++|.+.+.||+|+||.||++... +++.||+|+++... .....+.+|+++++.++||||+++++++. +.+.+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999864 78899999997532 34578999999999999999999999985 45689
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+.++ |.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 7777765432 468999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.+.+.......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~ 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC
Confidence 766544444445567999999999998654 478999999999999999999999998877666665544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=322.31 Aligned_cols=214 Identities=24% Similarity=0.445 Sum_probs=175.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCE----EEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~----vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.++|.+.+.||+|+||.||+|.+. +++. |++|.+... ....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 467999999999999999999854 4543 577777543 34567899999999999999999999999765 488
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999997653 468999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+..+
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 755444434444567889999999999999999999999999999999 99999998887776666544
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.19 Aligned_cols=206 Identities=20% Similarity=0.326 Sum_probs=178.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+ +++.+|||+++.. ....+.+.+|+.+++.++||||++++++|.+. +.+++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 45789999999999999999998 5889999999764 34567899999999999999999999999876 788999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999976432 368999999999999999999999 77 99999999999999999999999998754
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVND---KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~---ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.+.......+.
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 224 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH
Confidence 322 2246899999999998765544 8999999999999999999999887766544443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=338.42 Aligned_cols=211 Identities=26% Similarity=0.409 Sum_probs=181.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... ++..||+|+++... .....+.+|+++++.++||||++++++|.+.+.+++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456899999999999999999875 78899999997542 33567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla~~ 573 (643)
||+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999999988654 358999999999999999999999 89999999999999976 45599999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... ......||+.|+|||++. +.|+.++|||||||++|+|++|++||.+.+.......+..+.
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 65432 233467999999999986 579999999999999999999999999998888877776654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.95 Aligned_cols=216 Identities=22% Similarity=0.366 Sum_probs=182.3
Q ss_pred HHHhhcCcccc-eeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCC
Q 006480 417 LLSATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 490 (643)
Q Consensus 417 l~~~~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~ 490 (643)
.....+.|.+. +.||+|+||.||+|... +|+.||+|+++.. ......+.+|+.++..+. ||||++++++|...+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 33445667776 89999999999999865 7899999999753 244678999999999995 699999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEee
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSD 567 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~D 567 (643)
.+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred eEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 9999999999999999986432 2468999999999999999999999 89999999999999987 78999999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.+
T Consensus 178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 999987654322 2335799999999999999999999999999999999999999998877666555443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.08 Aligned_cols=200 Identities=23% Similarity=0.325 Sum_probs=175.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC--------CCceeEEEeEEE----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 487 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~g~~~---- 487 (643)
.++|.+.+.||+|+||.||+|... +++.||||+++........+.+|+++++.++ ||||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999854 7889999999988777888999999999985 788999999997
Q ss_pred eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCC-----
Q 006480 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 561 (643)
Q Consensus 488 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~----- 561 (643)
....+++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456899999999 6677777654422 458999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------cEEEeecCccccccCCCCCccccCCCCCCCccCccc
Q 006480 562 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597 (643)
Q Consensus 562 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~ 597 (643)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876543 233579999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 598 l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+.+..++.++|||||||+||||++|+.||...+.
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 9999999999999999999999999999987653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.66 Aligned_cols=203 Identities=32% Similarity=0.530 Sum_probs=164.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|.+.. .+|+|+++.. ....+.|.+|+++++.++||||+++++++ ..+.+++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4679999999999999999997643 5999999753 35567899999999999999999999965 5667899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996443 468999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.+....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 231 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH
Confidence 3333344567999999999987 667899999999999999999999999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.75 Aligned_cols=205 Identities=25% Similarity=0.410 Sum_probs=174.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 490 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+++.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999864 7999999999542 345678999999999999999999999997653
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+|+||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 88999999752 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+...+...|.
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 239 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM 239 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9875442 234578999999999987 689999999999999999999999999988777666554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.91 Aligned_cols=212 Identities=26% Similarity=0.412 Sum_probs=180.6
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEe--------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 488 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+++++.++||||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999987 488999999986532 334578899999999999999999999987
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
.+.+++||||+.+ +|.+.+.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4568999999975 8888776443 358999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCC--CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 569 GLAKWASTSS--SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 569 Gla~~~~~~~--~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+...+...+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9998765322 1122344678999999999976 468999999999999999999999999988777666554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.25 Aligned_cols=202 Identities=22% Similarity=0.351 Sum_probs=159.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+++.+|+++|+.++||||++++++|... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999865 7899999998653 34567899999999999999999999999543 57
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+|+||||+ +|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 99999998 57999999654 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-------------------------ccccCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHc----
Q 006480 572 KWASTSSSH-------------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLT---- 621 (643)
Q Consensus 572 ~~~~~~~~~-------------------------~~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSlGvvl~eLlt---- 621 (643)
+........ ...+..+||+.|+|||++ ....|+.++|||||||+||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 876432111 123446789999999986 46679999999999999999999
Q ss_pred -------CCCCCCCCC
Q 006480 622 -------GRKPISNDH 630 (643)
Q Consensus 622 -------G~~Pf~~~~ 630 (643)
|++||.+.+
T Consensus 284 ~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSS 299 (458)
T ss_dssp TCSSGGGCCCSCC---
T ss_pred cccccccccccCCCCc
Confidence 778887654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=321.80 Aligned_cols=212 Identities=29% Similarity=0.401 Sum_probs=176.7
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
...++|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|+++++.++||||++++++|.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999997532 123468899999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999976 8998886543 468899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+...+...+.
T Consensus 160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~ 226 (346)
T 1ua2_A 160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 226 (346)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 87654322 22345799999999999754 58999999999999999999999999988766655554
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=315.11 Aligned_cols=207 Identities=22% Similarity=0.377 Sum_probs=182.7
Q ss_pred hcCcccceeeeecCceEEEEEEe--CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC------ceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|.. .+++.||||+++........+.+|+++++.++|+ +|+++++++...+.+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 3788999999998777778899999999998765 499999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-------------
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 559 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~------------- 559 (643)
++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976543 468899999999999999999999 89999999999999987
Q ss_pred ------CCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 560 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 560 ------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998654422 23579999999999999999999999999999999999999999887766
Q ss_pred HHHhh
Q 006480 634 QESLV 638 (643)
Q Consensus 634 ~~~li 638 (643)
....+
T Consensus 242 ~~~~~ 246 (339)
T 1z57_A 242 HLAMM 246 (339)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 54443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=310.51 Aligned_cols=208 Identities=29% Similarity=0.458 Sum_probs=183.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
+.|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46889999999999999999864 7899999999754 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999863 358999999999999999999999 899999999999999999999999999997665432
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+......+.
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 232 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP 232 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh
Confidence 2 2234579999999999999999999999999999999999999999877665544443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.23 Aligned_cols=203 Identities=28% Similarity=0.393 Sum_probs=174.5
Q ss_pred hcCcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCCh-----hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 490 (643)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... .....+.+|+++|..+ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35799999999999999999986 478999999997532 2345677899999999 6999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997543 58999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
++....... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 206 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 206 SKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp EEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred CeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 986543222 12234579999999999985 3578999999999999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.33 Aligned_cols=205 Identities=25% Similarity=0.428 Sum_probs=181.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||++.+. +++.||+|++... ....+.+.+|+++++.++||||++++++|...+.+++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999875 7899999999764 4556789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997543 58899999999999999999998 6 899999999999999999999999999975543
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 240 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 21 223579999999999999999999999999999999999999999887665543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=309.35 Aligned_cols=212 Identities=28% Similarity=0.454 Sum_probs=184.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcC-CCceeEEEeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCF 487 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----------~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 487 (643)
..++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999875 78999999996532 23567889999999995 999999999999
Q ss_pred eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 006480 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (643)
Q Consensus 488 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 567 (643)
..+.+++||||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999754 358999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||.+.+.......+..+
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 999987654322 23457999999999985 557899999999999999999999999988776665555443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.81 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=172.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 467999999999999999999854 78999999997543 33567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-----CCCcEEEeecCcc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-----DDFEPQLSDFGLA 571 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-----~~~~vkL~DFGla 571 (643)
||+. |+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 59999997653 48999999999999999999999 8999999999999994 5556999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 251 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence 87654322 22335789999999999875 58999999999999999999999999987766555443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.84 Aligned_cols=216 Identities=23% Similarity=0.320 Sum_probs=171.2
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe----
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 491 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 491 (643)
.....++|.+.+.||+|+||.||+|.+. +|+.||||++.........+.+|++.+..++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3455678999999999999999999874 78999999997766555677888999999999999999999976443
Q ss_pred ---EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCEEEcC-CCcEEE
Q 006480 492 ---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQL 565 (643)
Q Consensus 492 ---~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--~~~~~~iiHrDLKp~NILl~~-~~~vkL 565 (643)
+++||||+.+ +|.+.+.........+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 8999999976 565554432233356899999999999999999999 7 89999999999999996 899999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 999999876543322 235789999999999755 48999999999999999999999999988776666554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.63 Aligned_cols=218 Identities=26% Similarity=0.435 Sum_probs=181.4
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|.. .+++.||||++.. ......++.+|+.+++.++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999973 3577899999964 345567899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCC---CCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEe
Q 006480 493 LLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 566 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~ 566 (643)
++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999865422 2458999999999999999999999 89999999999999984 4569999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
|||++................||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..+
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 9999986554333333334568999999999999999999999999999999998 99999988776666555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.31 Aligned_cols=208 Identities=26% Similarity=0.347 Sum_probs=172.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------CeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~L 494 (643)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|+.++||||++++++|... ..+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 35888999999999999999875 689999999876542 234699999999999999999998642 23779
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-CcEEEeecCcccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 573 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~ 573 (643)
||||+++ +|.+.+.........+++..++.++.||++||.|||+ ++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 6766665322223568999999999999999999999 999999999999999955 6789999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
....... ....||+.|+|||++.+. .++.++|||||||+||||++|++||.+.+...+...++
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~ 270 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6543322 235789999999999765 79999999999999999999999999988766655544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.55 Aligned_cols=203 Identities=26% Similarity=0.438 Sum_probs=169.9
Q ss_pred cCcccc-eeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
+.|.+. +.||+|+||.||+|... +++.||||++.... .....+.+|++++.++ +||||+++++++.+.+.+++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467774 78999999999999854 78999999997543 4467889999999985 79999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla~~~ 574 (643)
|+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999754 358999999999999999999999 89999999999999998776 999999998765
Q ss_pred cCCCC-----CccccCCCCCCCccCcccccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 575 STSSS-----HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 575 ~~~~~-----~~~~~~~~gt~~Y~APE~l~~-----~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 43211 111223469999999999975 5689999999999999999999999987653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=307.96 Aligned_cols=200 Identities=24% Similarity=0.320 Sum_probs=174.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|... +++.||+|+++.. .....++.+|+.++..+ +||||+++++++.+.+.+++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467999999999999999999875 7899999999753 34567888999999999 999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---------------
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--------------- 560 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~--------------- 560 (643)
|||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643333468999999999999999999999 899999999999999844
Q ss_pred ----CcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 561 ----FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 561 ----~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999998665422 23589999999999866 6778999999999999999999887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=324.03 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=175.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+++++.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999985 478899999997642 13346778999999999999999999999999
Q ss_pred eEEEEEeeCCCC-CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 491 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 491 ~~~LV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
.+++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997543 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
++........ .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 9987655432 223579999999999998877 88999999999999999999999763
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=329.86 Aligned_cols=198 Identities=25% Similarity=0.370 Sum_probs=167.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+++.+|+++|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999865 6889999999753 34567899999999999999999999999776 57
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999985 5999999753 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--------------------ccccCCCCCCCccCcccc-cCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 006480 572 KWASTSSSH--------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPI 626 (643)
Q Consensus 572 ~~~~~~~~~--------------------~~~~~~~gt~~Y~APE~l-~~~~~s~ksDIwSlGvvl~eLltG~~Pf 626 (643)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876543221 123556899999999986 4667999999999999999999844443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.96 Aligned_cols=215 Identities=23% Similarity=0.347 Sum_probs=177.7
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC------------hhHHHHHHHHHHHHHhcCCCceeE
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNIIS 481 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~------------~~~~~~~~~Ei~il~~l~HpnIv~ 481 (643)
..++....++|.+.+.||+|+||.||+|...+|+.||||++... ....+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999999888999999998532 123478999999999999999999
Q ss_pred EEeEEEe-----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 006480 482 LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (643)
Q Consensus 482 l~g~~~~-----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 556 (643)
++++|.. ...+++||||+. |+|.+.+.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 9999854 336899999997 68988887443 468999999999999999999999 89999999999999
Q ss_pred EcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 557 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999975443322 233578999999999986 67999999999999999999999999998766655
Q ss_pred Hhh
Q 006480 636 SLV 638 (643)
Q Consensus 636 ~li 638 (643)
..+
T Consensus 244 ~~i 246 (362)
T 3pg1_A 244 NKI 246 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.92 Aligned_cols=206 Identities=24% Similarity=0.336 Sum_probs=171.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 490 (643)
.++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 7889999999653 345678899999999999999999999997654
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+.+ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999964 78888852 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 239 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 98654322 2234579999999999999999999999999999999999999999988766655554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=317.00 Aligned_cols=209 Identities=26% Similarity=0.407 Sum_probs=177.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+++++.++||||++++++|.+.+.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 457999999999999999999875 6899999998543 344667889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+.+++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999898887543 358999999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 177 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 237 (331)
T 4aaa_A 177 PGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred Ccc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 322 22345799999999999875 7899999999999999999999999998766554443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=317.35 Aligned_cols=213 Identities=28% Similarity=0.471 Sum_probs=179.8
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEE--EEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~v--AVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||.||+|... ++..+ ++|.++.. ......+.+|+++++++ +||||+++++++.+.+.+++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999864 56644 99998753 34456789999999999 899999999999999999999
Q ss_pred EeeCCCCCHHHHhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 496 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 223468999999999999999999999 999999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
||+|||+++....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.......+..
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc
Confidence 9999999874332211 122357889999999999899999999999999999998 9999999887666655544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.71 Aligned_cols=205 Identities=29% Similarity=0.470 Sum_probs=167.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .......+.+|+.+++.++||||++++++|...+.+++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999986 4789999999975 234567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999997533334568999999999999999999999 899999999999999999999999999997665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+..
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 4322 1223578999999999999999999999999999999999999997653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=322.96 Aligned_cols=216 Identities=24% Similarity=0.326 Sum_probs=185.9
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CC-----ceeEEEeEEE
Q 006480 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFCF 487 (643)
Q Consensus 415 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g~~~ 487 (643)
.......++|.+.+.||+|+||.||+|.+. +++.||||+++.......++..|++++..++ |+ +|+++++++.
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 333445678999999999999999999865 7889999999987777788889999998885 54 4999999999
Q ss_pred eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEE
Q 006480 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQL 565 (643)
Q Consensus 488 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~--~~~~vkL 565 (643)
..+.+++||||+. |+|.+++..... ..+++..++.++.||+.||.|||.+. .+|+||||||+||||+ .++.+||
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999995 599999976532 35899999999999999999999522 7899999999999995 4788999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+...+...+.
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999876542 223579999999999999999999999999999999999999999988777666554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.11 Aligned_cols=215 Identities=27% Similarity=0.429 Sum_probs=181.7
Q ss_pred HhhcCcccce-eeeecCceEEEEEEe---CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 419 SATSNFLAEN-LIGKGGSSQVYKGCL---PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 419 ~~~~~f~~~~-~LG~G~~g~Vy~~~~---~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
...++|.+.+ .||+|+||.||+|.+ .+++.||||+++... ...+++.+|+++++.++||||+++++++ ..+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788887 999999999999954 256889999997642 3467899999999999999999999999 6678
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 999999999999999997643 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 572 KWASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 572 ~~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
........... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+.......+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 236 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 87655433221 122356789999999999899999999999999999999 99999998877666665543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.37 Aligned_cols=207 Identities=25% Similarity=0.354 Sum_probs=171.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||++... +++.||+|++... ....+.+.+|+.++..++||||+++++++..++.+++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999865 7889999999753 23457899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999754 358999999999999999999999 899999999999999999999999999997665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.....
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence 4321 1223457999999999999999999999999999999999999999987655333
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=344.87 Aligned_cols=216 Identities=25% Similarity=0.449 Sum_probs=186.5
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...++|.+.+.||+|+||.||+|.+.++..||||+++......++|.+|+++|++++||||++++++|.+ +.++|||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 3456789999999999999999999888889999998766566789999999999999999999999865 778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.+|+|.++|..... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999974321 358899999999999999999999 899999999999999999999999999998654321
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
........++..|+|||++.+..++.++|||||||+||||++ |+.||.+.........+..+
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 111122356788999999999999999999999999999999 99999998877666665543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=333.95 Aligned_cols=206 Identities=14% Similarity=0.222 Sum_probs=166.9
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCC----ChhHHHHHHHHHH---HHHhcCCCceeEEE-------eE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIE---IITTLHHKNIISLL-------GF 485 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~----~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------g~ 485 (643)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++. .....+.+.+|++ +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999986 4799999999863 3356678999994 55556899999998 66
Q ss_pred EEeCC-----------------eEEEEEeeCCCCCHHHHhccCCCC---CCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006480 486 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (643)
Q Consensus 486 ~~~~~-----------------~~~LV~E~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 545 (643)
+...+ ..|+||||+ +|+|.+++...... ...+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 65543 289999999 68999999754221 1234568889999999999999999 899
Q ss_pred EecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC-----------CCCchhHHHHHHH
Q 006480 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGV 614 (643)
Q Consensus 546 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-----------~~s~ksDIwSlGv 614 (643)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985432 2334578 999999999987 8999999999999
Q ss_pred HHHHHHcCCCCCCCCChhhHHH
Q 006480 615 VLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 615 vl~eLltG~~Pf~~~~~~~~~~ 636 (643)
++|||++|+.||.+.+......
T Consensus 302 il~elltg~~Pf~~~~~~~~~~ 323 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSE 323 (377)
T ss_dssp HHHHHHHSSCCC------CCSG
T ss_pred HHHHHHHCCCCCcccccccchh
Confidence 9999999999998866544333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=308.37 Aligned_cols=213 Identities=24% Similarity=0.411 Sum_probs=179.0
Q ss_pred hhcCcccceeeeecCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+|+||.||+|.+.+ +..||+|+++.. ......+.+|+++++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35689999999999999999997532 346999999764 3456789999999999999999999999864 5678
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997543 458999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+..
T Consensus 163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~ 229 (281)
T 3cc6_A 163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH
T ss_pred cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc
Confidence 654322 12233467889999999999999999999999999999998 9999988777666555543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.32 Aligned_cols=210 Identities=25% Similarity=0.428 Sum_probs=176.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.++||||+++++++...+.+++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999876 78999999996532 3356788999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997543 58899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+..
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 225 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG 225 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 4321 223578999999999987765 6899999999999999999999998876665555543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.93 Aligned_cols=201 Identities=27% Similarity=0.451 Sum_probs=165.3
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 489 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 489 (643)
..++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999865 78999999986432 22335889999999999999999999974 5
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEe
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLS 566 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~ 566 (643)
+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 6789999999999999988654 358999999999999999999999 899999999999999754 459999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.....
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 999998765432 223467999999999986 36788999999999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=320.14 Aligned_cols=212 Identities=25% Similarity=0.399 Sum_probs=181.9
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----C
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----N 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~ 490 (643)
...++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|++++..++||||+++++++... .
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34568999999999999999999865 7888999999754 34557899999999999999999999999764 3
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+. |+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 6899999996 5999998653 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCc-cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~-~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+.......... ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+...+...+.
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 98665432221 1244689999999998764 458999999999999999999999999988777666554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.67 Aligned_cols=215 Identities=27% Similarity=0.450 Sum_probs=177.6
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..+|.+.+.||+|+||.||+|.+.. +..||||+++.. ......+.+|+++++.++||||+++++++...+.++
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578889999999999999997542 246999999764 345668999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997543 468999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+.......+..+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 6543221 11222356889999999999999999999999999999999 99999988776666655443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=312.62 Aligned_cols=201 Identities=33% Similarity=0.498 Sum_probs=173.9
Q ss_pred cCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeC--CeE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 492 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 492 (643)
++|.+.+.||+|+||.||+|.+ .+++.||+|+++... .....+.+|+++++.++||||+++++++... +.+
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 478899999997543 3457889999999999999999999999876 678
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996443 358999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCC-ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
........ .......||..|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 77654332 222345688899999999999999999999999999999999998643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.82 Aligned_cols=200 Identities=31% Similarity=0.541 Sum_probs=172.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh-----H---HHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-----V---IKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~-----~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... . .+.+.+|+++++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467999999999999999999864 889999999864321 1 167899999999999999999999986655
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCc-----EE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 564 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~~~~~-----vk 564 (643)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999887543 468999999999999999999999 77 999999999999988776 99
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccc--cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF--MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l--~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||...+...
T Consensus 170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 235 (287)
T 4f0f_A 170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235 (287)
T ss_dssp ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH
T ss_pred eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH
Confidence 999999974433 23345799999999999 45568999999999999999999999998765433
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.70 Aligned_cols=208 Identities=23% Similarity=0.339 Sum_probs=172.1
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe------EEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------LLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------~~LV 495 (643)
.+|.+.+.||+|+||.||+|.+..+..+|+|.+...... ..+|+++++.++||||++++++|...+. +++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 468999999999999999999877777998887654322 2369999999999999999999976443 8899
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEEeecCccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWA 574 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~ 574 (643)
|||++++ |...+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999774 444433221223468999999999999999999999 8999999999999999 7999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+...+...+.
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~ 255 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII 255 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 543322 235789999999998765 59999999999999999999999999988776665554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.03 Aligned_cols=200 Identities=30% Similarity=0.509 Sum_probs=168.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||++.. .++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 35788999999999999999987 5788999999754 34578999999999999999999999886 45799999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc-EEEeecCccccccCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSS 579 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~-vkL~DFGla~~~~~~~~ 579 (643)
+|+|.+++..... ...+++..++.++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999975432 234788999999999999999999866578999999999999998886 799999999755432
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 123469999999999999999999999999999999999999998654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=309.94 Aligned_cols=214 Identities=28% Similarity=0.437 Sum_probs=177.9
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~ 493 (643)
..+|.+.+.||+|+||.||+|.+.+ ...+|+|.++.. ....+.+.+|+.++++++||||++++++|.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468889999999999999998532 235899998753 3456789999999999999999999999754 56789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999997533 468899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCC--CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 574 ASTSSS--HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 574 ~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
...... ........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...+.......+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 544221 112233567889999999999999999999999999999999 7788887776665555443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.46 Aligned_cols=202 Identities=25% Similarity=0.412 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC--eEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|+++++.++||||+++++++...+ .+++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999875 68999999997543 34577889999999999999999999998755 78999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEeecCcc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 571 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla 571 (643)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975432 2348999999999999999999999 899999999999999 77888999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
+...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~ 226 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECT
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 8765432 2234579999999999875 56888999999999999999999999753
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.73 Aligned_cols=205 Identities=26% Similarity=0.407 Sum_probs=163.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 490 (643)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+++++.++||||+++++++... +
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999985 47899999999653 34567889999999999999999999998654 5
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 7899988864 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+...+...|.
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~ 243 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 243 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9865432 234579999999999986 689999999999999999999999999988777666654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=307.96 Aligned_cols=213 Identities=26% Similarity=0.403 Sum_probs=178.3
Q ss_pred CcccceeeeecCceEEEEEEeC-C---CCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE-EEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~---g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~LV 495 (643)
.|...+.||+|+||.||+|.+. + +..+|+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999753 2 2379999997533 4567899999999999999999999999876655 999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997533 468999999999999999999999 899999999999999999999999999997554
Q ss_pred CCC--CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 576 TSS--SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~--~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
... .........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...++......+.++
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence 322 1112233568899999999999999999999999999999999 66667777766666555443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=309.83 Aligned_cols=195 Identities=23% Similarity=0.417 Sum_probs=172.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEe--CCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... .+.+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46799999999999999999975 478999999998544 467889999999997 9999999999987 67899999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCcccccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 575 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 575 (643)
||+.+++|.+++. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999985 37889999999999999999999 8999999999999999776 89999999998765
Q ss_pred CCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 4332 233579999999999986 679999999999999999999999996543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=305.10 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=172.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCC---ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~ 492 (643)
...|.+.+.||+|+||.||+|.+. ++..||+|++.. .....+.+.+|+.+++.++||||++++++|.. .+.+
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788899999999999999864 788999999864 34556789999999999999999999999875 3568
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEc-CCCcEEEeecC
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFG 569 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~-~~~~vkL~DFG 569 (643)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 9999999999999999754 358899999999999999999999 77 99999999999998 78999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
++....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||.....
T Consensus 178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 234 (290)
T 1t4h_A 178 LATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234 (290)
T ss_dssp GGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred Ccccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence 997554432 22357999999999887 4699999999999999999999999987544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=343.08 Aligned_cols=214 Identities=26% Similarity=0.452 Sum_probs=178.5
Q ss_pred hcCcccce-eeeecCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~-~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
..++.+.+ .||+|+||.||+|.+. ++..||||+++.. ....++|.+|+++|+.++||||++++++|.. +.+++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34455555 8999999999999763 5667999999864 2456889999999999999999999999976 67999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999997542 468999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 575 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 575 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
........ .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+.......|..+
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 555 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 54322211 122346789999999999999999999999999999998 99999998877777766654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.45 Aligned_cols=202 Identities=25% Similarity=0.437 Sum_probs=173.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CC-------CEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-------KELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g-------~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|.+. ++ ..||+|++.... ...+.+.+|+++++.++||||++++++|.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999754 33 579999997543 556789999999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc--------E
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 563 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~--------v 563 (643)
.++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997643 348999999999999999999999 89999999999999998887 9
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhH
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQ 634 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~ 634 (643)
||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||........
T Consensus 161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 99999998654321 12358899999999987 779999999999999999999 5566666554433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.24 Aligned_cols=205 Identities=26% Similarity=0.434 Sum_probs=176.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+|++++..++||||+++++++...+.+++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 467999999999999999999875 68999999997643 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.+++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999986332 468999999999999999999999 8999999999999999999999999999976654322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+....
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22345799999999999999999999999999999999999999988765443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=321.19 Aligned_cols=200 Identities=21% Similarity=0.285 Sum_probs=167.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCChh------------HHHHHHHHHHHHHhcCCCceeEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
.++|.+.+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999875 578899999876431 1234678889999999999999999
Q ss_pred EEEe----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC
Q 006480 485 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 560 (643)
Q Consensus 485 ~~~~----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~ 560 (643)
++.. .+.+++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997543 68999999999999999999999 899999999999999988
Q ss_pred C--cEEEeecCccccccCCCCC-----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 561 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 561 ~--~vkL~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 9999999999866432211 112345799999999999999999999999999999999999999965
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.99 Aligned_cols=206 Identities=20% Similarity=0.331 Sum_probs=179.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CC-CEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc------eeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g-~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|... ++ +.||+|+++........+.+|+++++.++|++ ++.+++++...+.+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999864 44 68999999987777788999999999997665 99999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---------------
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 557 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl--------------- 557 (643)
++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 6678787765432 458999999999999999999999 899999999999999
Q ss_pred ----cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 558 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 558 ----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999998654422 23579999999999999999999999999999999999999999887655
Q ss_pred HHHh
Q 006480 634 QESL 637 (643)
Q Consensus 634 ~~~l 637 (643)
....
T Consensus 247 ~~~~ 250 (355)
T 2eu9_A 247 HLVM 250 (355)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.13 Aligned_cols=213 Identities=28% Similarity=0.451 Sum_probs=170.3
Q ss_pred CcccceeeeecCceEEEEEEeC--CC--CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV 495 (643)
.|.+.+.||+|+||.||+|.+. ++ ..||+|.++.. ....++|.+|+.++++++||||++++++|.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4778899999999999999853 32 35899998753 3556789999999999999999999999765 4678999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 457899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCCC--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+.......+..+
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence 43211 11223467889999999999999999999999999999999 78899887766665555443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.65 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=160.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh--hHH-HHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--DVI-KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~--~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
..++|.+.+.||+|+||.||++.. .+|+.||+|+++... ... ..+..+..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 356899999999999999999986 488999999997642 223 3344455557888999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
|||++ |+|.+++.........+++..++.++.||+.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 58888876532333579999999999999999999999 7 9999999999999999999999999999866
Q ss_pred cCCCCCccccCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
...... ....||+.|+|||++ ....++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 543222 224799999999996 5667999999999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=309.27 Aligned_cols=208 Identities=32% Similarity=0.510 Sum_probs=173.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-CeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||.||++.. +|+.||||+++... ..+.+.+|+++++.++||||+++++++.+. +.+++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46799999999999999999987 58899999998654 457789999999999999999999997654 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999975321 237899999999999999999999 899999999999999999999999999987554322
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||...+.......+..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~ 229 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 12357889999999999999999999999999999998 9999998877666555543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.11 Aligned_cols=207 Identities=26% Similarity=0.395 Sum_probs=169.4
Q ss_pred HHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc--CCCceeEEEeEEEeC---
Q 006480 415 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFED--- 489 (643)
Q Consensus 415 ~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~g~~~~~--- 489 (643)
.......++|.+.+.||+|+||.||+|.. .|+.||||++..... ..+..|.+++..+ +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33344567899999999999999999987 489999999975443 4455566666654 899999999999887
Q ss_pred -CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCEEEcCCCcE
Q 006480 490 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 490 -~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~-----~~~iiHrDLKp~NILl~~~~~v 563 (643)
+.+++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 7899999999999999999653 4899999999999999999999820 1299999999999999999999
Q ss_pred EEeecCccccccCCCCCc--cccCCCCCCCccCcccccCCCCCch------hHHHHHHHHHHHHHcC----------CCC
Q 006480 564 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYGKVNDK------IDVYAFGVVLLELLTG----------RKP 625 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~k------sDIwSlGvvl~eLltG----------~~P 625 (643)
||+|||+++......... ......||+.|+|||++.+..++.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997665433221 1224579999999999987766654 9999999999999999 778
Q ss_pred CCCC
Q 006480 626 ISND 629 (643)
Q Consensus 626 f~~~ 629 (643)
|...
T Consensus 262 ~~~~ 265 (337)
T 3mdy_A 262 YHDL 265 (337)
T ss_dssp TTTT
T ss_pred Hhhh
Confidence 8654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.72 Aligned_cols=209 Identities=25% Similarity=0.398 Sum_probs=177.5
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
..++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+++++.++||||+++++++... +.
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999865 7899999999754 34567788999999999999999999998754 67
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
.++||||+. |+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 6999998752 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc--------cccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 572 KWASTSSSHI--------TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 572 ~~~~~~~~~~--------~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
.......... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+...+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 234 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 8765422111 1223578999999998764 7899999999999999999999999998876554443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=314.80 Aligned_cols=204 Identities=28% Similarity=0.408 Sum_probs=178.2
Q ss_pred hcCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEE--eCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 492 (643)
.++|.+.+.||+|+||.||++.+ .+++.||||++.... ...+.+.+|+++++.++||||+++++++. ..+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35789999999999999999983 478899999997654 55677999999999999999999999987 45679
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999997543 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 573 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 573 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 765443222 2233568889999999999999999999999999999999999997644
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.70 Aligned_cols=213 Identities=28% Similarity=0.434 Sum_probs=163.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..++|.+.+.||+|+||.||+|... +++.||||++... .....++.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4578999999999999999999854 7899999998754 244567889999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccC----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 497 DFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 497 E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
||+++++|.+++... ......+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998631 1123468999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCC---CccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHH
Q 006480 573 WASTSSS---HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635 (643)
Q Consensus 573 ~~~~~~~---~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~ 635 (643)
....... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||.........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 236 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence 6654321 111233579999999999875 57899999999999999999999999987655443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.93 Aligned_cols=198 Identities=32% Similarity=0.454 Sum_probs=173.7
Q ss_pred cccceeeeecCceEEEEEEeC-----CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 494 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-----~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~L 494 (643)
|.+.+.||+|+||.||++++. +++.||||+++... .....+.+|+++++.++||||+++++++.+ ...+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998642 68899999998643 456789999999999999999999999987 467899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 38999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 575 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 575 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
....... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 6543221 223356888999999999999999999999999999999999999764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=305.90 Aligned_cols=197 Identities=28% Similarity=0.462 Sum_probs=173.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-----------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----------- 488 (643)
..+|.+.+.||+|+||.||+|.+. +|+.||+|+++... ..+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457899999999999999999876 79999999997654 346689999999999999999999864
Q ss_pred -----CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 489 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 489 -----~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4558999999999999999975432 468999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..||..
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999987655332 2235799999999999999999999999999999999999998854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=312.66 Aligned_cols=200 Identities=29% Similarity=0.465 Sum_probs=169.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 467999999999999999999865 68899999997532 2234588999999999999999999998665
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEee
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 567 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~D 567 (643)
.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 489999999999999998653 358999999999999999999999 89999999999999987654 99999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.....
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 99998664321 222356999999999974 56789999999999999999999999987543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.03 Aligned_cols=211 Identities=25% Similarity=0.415 Sum_probs=177.1
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
..++|.+.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|++++..++||||+++++++...+.+++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999875 68999999997543 456789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999987532 358999999999999999999999 89999999999999999999999999987543221
Q ss_pred CCCccccCCCCCCCccCcccc-----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYF-----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l-----~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
. .......||+.|+|||++ ....++.++|||||||++|+|++|+.||...+.......+
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 234 (302)
T 2j7t_A 171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234 (302)
T ss_dssp H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 1 111234689999999998 4677899999999999999999999999987765544333
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.49 Aligned_cols=212 Identities=24% Similarity=0.411 Sum_probs=179.1
Q ss_pred HhhcCcccceeeeecCceEEEEEEe--CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhc---CCCceeEEEeEEE---
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF--- 487 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~--~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~--- 487 (643)
...++|.+.+.||+|+||.||+|.. .+|+.||+|+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999987 468899999986421 2233566777777766 8999999999997
Q ss_pred --eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEE
Q 006480 488 --EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 488 --~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 565 (643)
....+++||||+. |+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567999999997 699999976543 358999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (326)
T 1blx_A 162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 232 (326)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 9999997654321 2334679999999999999999999999999999999999999999987766555443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.90 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=174.1
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEE-EeCCeEEEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 497 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~LV~E 497 (643)
..++|.+.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|+++++.++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999986 5889999999875432 24688999999999988866666655 56778899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~ 574 (643)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 999999997443 368999999999999999999999 899999999999999 48899999999999876
Q ss_pred cCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 575 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 575 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence 6543221 1234679999999999999999999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.02 Aligned_cols=204 Identities=24% Similarity=0.337 Sum_probs=170.9
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEE-EeCCeEEEEEe
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 497 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~LV~E 497 (643)
..++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++.++|++++..++.+ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999986 5889999998765432 24578899999999988877766665 56778899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~ 574 (643)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 999999997543 358999999999999999999999 899999999999999 78999999999999876
Q ss_pred cCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 575 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 575 ~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 5543211 22346799999999999999999999999999999999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.93 Aligned_cols=203 Identities=26% Similarity=0.432 Sum_probs=174.4
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~---- 492 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 7899999999753 34567899999999999999999999999876654
Q ss_pred --EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 493 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 493 --~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
++||||+. ++|.+.+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 68988874 238999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 254 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9865432 233578999999999987 68999999999999999999999999998766555444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=321.87 Aligned_cols=200 Identities=18% Similarity=0.283 Sum_probs=172.7
Q ss_pred hcCcccceeeeecCceEEEEEEeCC---------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeE----------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS---------- 481 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~---------- 481 (643)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++... ..+.+|+++++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4689999999999999999998753 789999999765 45778999999999999887
Q ss_pred -----EEeEEEe-CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCE
Q 006480 482 -----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 555 (643)
Q Consensus 482 -----l~g~~~~-~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NI 555 (643)
+++++.. ++.+++||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6778776 78899999999 999999998642 2468999999999999999999999 8999999999999
Q ss_pred EEcCCC--cEEEeecCccccccCCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 556 LLSDDF--EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 556 Ll~~~~--~vkL~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998665432211 12335799999999999999999999999999999999999999988
Q ss_pred CC
Q 006480 629 DH 630 (643)
Q Consensus 629 ~~ 630 (643)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 64
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.58 Aligned_cols=197 Identities=29% Similarity=0.475 Sum_probs=162.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHH--HHhcCCCceeEEEeEEEe-----CCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~-----~~~~~ 493 (643)
.++|.+.+.||+|+||.||+|.. +++.||||+++.... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999977 789999999975443 344445555 445899999999987653 23678
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC---------CeEecCCCCCCEEEcCCCcEE
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~---------~iiHrDLKp~NILl~~~~~vk 564 (643)
+||||+++|+|.+++.... +++..++.++.||+.||.|||+ + +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 9999999999999997543 5889999999999999999999 6 999999999999999999999
Q ss_pred EeecCccccccCCCC------CccccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 565 LSDFGLAKWASTSSS------HITCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 565 L~DFGla~~~~~~~~------~~~~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999987654221 112234579999999999986 4577899999999999999999776644
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.94 Aligned_cols=210 Identities=26% Similarity=0.425 Sum_probs=171.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEE-----------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 487 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----------- 487 (643)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999876 58999999987543 56678999999999999999999999873
Q ss_pred ---eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcE
Q 006480 488 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 563 (643)
Q Consensus 488 ---~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~v 563 (643)
+.+.+++||||+. |+|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699999863 358899999999999999999999 8999999999999997 67799
Q ss_pred EEeecCccccccCCCCC-ccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 564 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
||+|||+++........ .......+|..|+|||++.. ..++.++|||||||++|||++|+.||.+.+.......+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999866432211 12233467999999998875 689999999999999999999999999988766555443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.00 Aligned_cols=211 Identities=21% Similarity=0.354 Sum_probs=182.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChh------------------HHHHHHHHHHHHHhcCCCceeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 482 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~------------------~~~~~~~Ei~il~~l~HpnIv~l 482 (643)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ....+.+|++++..++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 999999999864321 12789999999999999999999
Q ss_pred EeEEEeCCeEEEEEeeCCCCCHHHH------hccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEE
Q 006480 483 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 556 (643)
Q Consensus 483 ~g~~~~~~~~~LV~E~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NIL 556 (643)
++++.+.+.+++||||+++|+|.++ +... ....+++..++.++.||+.||.|||+ .++|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 5432 13579999999999999999999996 268999999999999
Q ss_pred EcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCh-hh
Q 006480 557 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVND-KIDVYAFGVVLLELLTGRKPISNDHP-KG 633 (643)
Q Consensus 557 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~-ksDIwSlGvvl~eLltG~~Pf~~~~~-~~ 633 (643)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||...+. ..
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876443 23345799999999999977 6776 99999999999999999999998766 55
Q ss_pred HHHhhhc
Q 006480 634 QESLVMQ 640 (643)
Q Consensus 634 ~~~li~~ 640 (643)
....+..
T Consensus 261 ~~~~i~~ 267 (348)
T 2pml_X 261 LFNNIRT 267 (348)
T ss_dssp HHHHHTS
T ss_pred HHHHHhc
Confidence 5555443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.56 Aligned_cols=199 Identities=13% Similarity=0.100 Sum_probs=156.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhc--CCCceeEEE-------eEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL--HHKNIISLL-------GFC 486 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l--~HpnIv~l~-------g~~ 486 (643)
..+|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|++++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345889999999999999999865 78999999998743 4456677885554444 699988865 444
Q ss_pred EeC-----------------CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHH------HHHHHHHHHHHHHHHhCCCC
Q 006480 487 FED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQ 543 (643)
Q Consensus 487 ~~~-----------------~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qia~aL~yLH~~~~~ 543 (643)
... +.++|||||++ |+|.+++.... ..+.+..+ +.++.||+.||.|||+ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 433 34899999998 89999997542 23456666 7888999999999999 9
Q ss_pred CeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHc
Q 006480 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLT 621 (643)
Q Consensus 544 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLlt 621 (643)
+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999998664321 13457799999999987 689999999999999999999
Q ss_pred CCCCCCCCCh
Q 006480 622 GRKPISNDHP 631 (643)
Q Consensus 622 G~~Pf~~~~~ 631 (643)
|+.||.+..+
T Consensus 289 g~~Pf~~~~~ 298 (371)
T 3q60_A 289 LFLPFGLVTP 298 (371)
T ss_dssp SSCSTTBCCT
T ss_pred CCCCCCCcCc
Confidence 9999988744
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.88 Aligned_cols=206 Identities=26% Similarity=0.407 Sum_probs=173.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCC-ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 493 (643)
..++|.+.+.||+|+||.||++.. .+|+.||||++.. .......+.+|+++++.++||||+++++++.. .+.++
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456899999999999999999986 5889999998864 34566789999999999999999999999973 34789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+.+|+|.+++.........+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999997643344679999999999999999999999 8999999999999999999999999999875
Q ss_pred ccCCCCCc-------cccCCCCCCCccCcccccCCC---CCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 574 ASTSSSHI-------TCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 574 ~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~---~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
........ ......||+.|+|||++.... ++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 43211110 112235799999999997554 78999999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=340.68 Aligned_cols=207 Identities=27% Similarity=0.435 Sum_probs=175.1
Q ss_pred ceeeeecCceEEEEEEeC---CCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 427 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.+.||+|+||.||+|.+. +++.||||+++... ...++|.+|+++|++++||||++++++|. .+.+++||||+.
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 358999999999999643 56789999997532 44688999999999999999999999995 566899999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999999754 358999999999999999999999 89999999999999999999999999999876554322
Q ss_pred c-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 581 I-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
. ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+.+.......+..+
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~ 588 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 588 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 2 2223457889999999999999999999999999999998 99999999887777766654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=306.47 Aligned_cols=213 Identities=28% Similarity=0.449 Sum_probs=173.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCC--EEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~--~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|.+. +++ .||||+++.. ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 457999999999999999999753 333 6899998753 345678999999999999999999999997654 8
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997542 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhc
Q 006480 573 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 573 ~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~ 640 (643)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+.......+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 775543322 2223467889999999999899999999999999999999 9999998877666555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.02 Aligned_cols=212 Identities=24% Similarity=0.371 Sum_probs=173.9
Q ss_pred cccChHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcC--CCceeEEEe
Q 006480 410 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLG 484 (643)
Q Consensus 410 ~~f~~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~--HpnIv~l~g 484 (643)
+.+.++.+....++|.+.+.||+|+||.||++...+++.||||++... ......+.+|++++..++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 344455555667889999999999999999999888999999999643 456678999999999997 599999999
Q ss_pred EEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 485 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
++...+.+++||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+|
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~k 166 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLK 166 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEE
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEE
Confidence 9999999999999 56889999997643 58899999999999999999999 8999999999999996 48999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-----------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
|+|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999999987655433333344579999999999875 478999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=309.42 Aligned_cols=202 Identities=31% Similarity=0.455 Sum_probs=174.4
Q ss_pred HHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHh--cCCCceeEEEeEEEeCC----e
Q 006480 418 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----N 491 (643)
Q Consensus 418 ~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~ 491 (643)
....++|.+.+.||+|+||.||+|.. +|+.||||++.... ...+.+|.+++.. ++||||+++++++...+ .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34567899999999999999999988 68999999997543 4667889999988 78999999999998876 7
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH--------~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
+++||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999753 4899999999999999999999 6 899999999999999999999
Q ss_pred EEeecCccccccCCCCCc--cccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcC----------CCC
Q 006480 564 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKP 625 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGvvl~eLltG----------~~P 625 (643)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765543221 22345799999999999866 344789999999999999999 889
Q ss_pred CCCCC
Q 006480 626 ISNDH 630 (643)
Q Consensus 626 f~~~~ 630 (643)
|....
T Consensus 267 ~~~~~ 271 (342)
T 1b6c_B 267 YYDLV 271 (342)
T ss_dssp TTTTS
T ss_pred ccccC
Confidence 97753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.78 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=171.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
+|.....||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+.+++.++||||++++++|.+.+.+++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556899999999999986 478899999997643 456789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeecCccccccCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~ 579 (643)
+++|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997643 23457789999999999999999999 89999999999999987 89999999999986654221
Q ss_pred CccccCCCCCCCccCcccccCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~--~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 123457999999999997653 8999999999999999999999997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.66 Aligned_cols=211 Identities=26% Similarity=0.428 Sum_probs=182.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +++.||+|++... ......+.+|++++++++||||+++++++.+.+.+++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467999999999999999999875 7899999998643 234678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC---CcEEEeecCcccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 573 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~ 573 (643)
||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999886543 58999999999999999999999 899999999999999754 4799999999986
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
...... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.+.+.......+..++
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK 238 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 654322 223458999999999875 49999999999999999999999999988776666665543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.94 Aligned_cols=195 Identities=28% Similarity=0.488 Sum_probs=165.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-----------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----------- 488 (643)
.++|.+.+.||+|+||.||+|... +|+.||||+++........+.+|+++++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467999999999999999999864 78999999998777777889999999999999999999999865
Q ss_pred --CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 489 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 489 --~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
.+.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 457899999999999999997543 467889999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCC------------CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHc
Q 006480 567 DFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLT 621 (643)
Q Consensus 567 DFGla~~~~~~~~------------~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLlt 621 (643)
|||++........ ........||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999976543211 1122345799999999999864 79999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.82 Aligned_cols=208 Identities=25% Similarity=0.346 Sum_probs=158.6
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcC-CCceeEEEeEEE--------
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCF-------- 487 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~-------- 487 (643)
....+|.+.+.||+|+||.||++.+. +++.||||++... ......+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34568999999999999999999864 7899999988544 455678899999999996 999999999995
Q ss_pred eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEcCCCcEEE
Q 006480 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQL 565 (643)
Q Consensus 488 ~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~~~~~vkL 565 (643)
....+++||||+. |+|.+++..... ...+++.+++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEE
Confidence 3345899999995 799998865221 2368999999999999999999999 77 999999999999999999999
Q ss_pred eecCccccccCCCCCc----------cccCCCCCCCccCcccc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 566 SDFGLAKWASTSSSHI----------TCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~----------~~~~~~gt~~Y~APE~l---~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.....
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999998765432211 11134689999999998 566789999999999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.83 Aligned_cols=199 Identities=20% Similarity=0.339 Sum_probs=173.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----------CCceeEEEeEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~ 488 (643)
.++|.+.+.||+|+||.||+|.. .+++.||||++.........+.+|+++++.++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46799999999999999999986 47899999999987777788899999999886 8999999999986
Q ss_pred CC----eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEc-----
Q 006480 489 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 558 (643)
Q Consensus 489 ~~----~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~----- 558 (643)
.+ .+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976443 358999999999999999999999 7 999999999999994
Q ss_pred -CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 559 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 559 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 4458999999999876543 223479999999999999999999999999999999999999998765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.97 Aligned_cols=203 Identities=26% Similarity=0.427 Sum_probs=173.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe-----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 491 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999864 7899999999653 3456788999999999999999999999987654
Q ss_pred -EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 492 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 492 -~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
+++||||+. |+|.+++. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58888774 248999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
+...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i 236 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9765432 223578999999999986 67999999999999999999999999998766555444
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=308.55 Aligned_cols=202 Identities=30% Similarity=0.466 Sum_probs=175.7
Q ss_pred hcCcccceeeeecCceEEEEEEe-----CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC--eE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~ 492 (643)
.++|.+.+.||+|+||.||++.+ .+|+.||||++.... ...+.+.+|+++++.++||||+++++++...+ .+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999973 378899999997643 55678999999999999999999999987644 78
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
++||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997653 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 573 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 573 ~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
.......... .....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 7765433222 2234578889999999998999999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.96 Aligned_cols=204 Identities=26% Similarity=0.405 Sum_probs=156.8
Q ss_pred Cccc-ceeeeecCceEEEEEEeC---CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEEE
Q 006480 423 NFLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 496 (643)
Q Consensus 423 ~f~~-~~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~ 496 (643)
.|.+ .++||+|+||.||+|... +++.||||++..... ...+.+|+++|+.++||||++++++|.. ...+++||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3555 458999999999999854 578899999976432 3467899999999999999999999965 67899999
Q ss_pred eeCCCCCHHHHhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE----cCCCcEEEee
Q 006480 497 DFLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSD 567 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~D 567 (643)
||+. |+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 58888775321 122358999999999999999999999 899999999999999 7789999999
Q ss_pred cCccccccCCCCC-ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 568 FGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 568 FGla~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
||+++........ .......||+.|+|||++.+. .++.++|||||||+||||++|++||.+...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999876543221 223346899999999999874 599999999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=323.03 Aligned_cols=204 Identities=25% Similarity=0.342 Sum_probs=175.5
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ..++..|+++++.++| ++|..+..++...+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46899999999999999999986 5789999999865432 2357889999999987 5666677777788899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE---cCCCcEEEeecCcccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~~~~ 575 (643)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 999999997543 369999999999999999999999 899999999999999 688999999999998766
Q ss_pred CCCCCc-----cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 576 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 576 ~~~~~~-----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 543321 122567999999999999999999999999999999999999999986553
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=307.69 Aligned_cols=200 Identities=25% Similarity=0.388 Sum_probs=148.7
Q ss_pred hcCcccc-eeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeEEE
Q 006480 421 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 494 (643)
Q Consensus 421 ~~~f~~~-~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~L 494 (643)
.++|.+. +.||+|+||.||+|.+. +|+.||||++........++ ...++.++||||+++++++.. .+.+++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 5678885 46999999999999876 78999999998765433332 234566799999999999976 456899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCcc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLA 571 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla 571 (643)
||||+++|+|.+++..... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999986432 468999999999999999999999 89999999999999976 455999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
....... .....||+.|+|||++....++.++|||||||++|+|++|+.||......
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 8655432 22357899999999999999999999999999999999999999776543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.43 Aligned_cols=204 Identities=25% Similarity=0.389 Sum_probs=161.0
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
+.|.+.+.||+|+||+||.+...+|+.||||++... ....+.+|+++|..+ +||||+++++++.+.+.+++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 345567899999999998776678999999998653 345678899999986 89999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCC---CChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC-------------CcEE
Q 006480 501 RGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQ 564 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~-------------~~vk 564 (643)
|+|.+++......... ..+..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999865432221 2344567899999999999999 899999999999999754 4899
Q ss_pred EeecCccccccCCCCCc--cccCCCCCCCccCcccccC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 565 LSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~--~~~~~~gt~~Y~APE~l~~-------~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 99999998775533221 2234579999999999975 679999999999999999999 9999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.45 Aligned_cols=214 Identities=22% Similarity=0.353 Sum_probs=175.7
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.....++|.+.+.||+|+||.||+|...+ .+|+|+++.. ....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33446789999999999999999998743 4999998753 233456778999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++..
T Consensus 106 iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 9999999999999997543 468999999999999999999999 8999999999999998 67999999999875
Q ss_pred ccCCC---CCccccCCCCCCCccCcccccC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 574 ASTSS---SHITCTDVAGTFGYLAPEYFMY---------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 574 ~~~~~---~~~~~~~~~gt~~Y~APE~l~~---------~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
..... .........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.
T Consensus 179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 53221 1122233468999999999874 458999999999999999999999999887766554443
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=332.03 Aligned_cols=214 Identities=24% Similarity=0.405 Sum_probs=180.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC----CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~----~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
..++|.+.+.||+|+||.||+|.+. .+..||||.++.. ......|.+|+.+++.++||||+++++++. ++.++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467999999999999999999864 3467999998753 345678999999999999999999999984 56789
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 458999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+..+
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~ 608 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG 608 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC
Confidence 654322 22233457889999999999999999999999999999997 99999998877666655543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.29 Aligned_cols=199 Identities=25% Similarity=0.391 Sum_probs=165.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh-------HHHHHHHHHHHHHhc----CCCceeEEEeEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-------VIKEFVLEIEIITTL----HHKNIISLLGFCF 487 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~-------~~~~~~~Ei~il~~l----~HpnIv~l~g~~~ 487 (643)
..++|.+.+.||+|+||.||+|... +++.||||++..... ....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4568999999999999999999864 788999999975431 233466799999998 8999999999999
Q ss_pred eCCeEEEEEee-CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEEE
Q 006480 488 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 565 (643)
Q Consensus 488 ~~~~~~LV~E~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL 565 (643)
..+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 78999999997542 58999999999999999999999 8999999999999999 8999999
Q ss_pred eecCccccccCCCCCccccCCCCCCCccCcccccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 566 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 566 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
+|||++....... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999998765432 2345799999999999877765 5899999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=301.68 Aligned_cols=203 Identities=26% Similarity=0.377 Sum_probs=153.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHH-HHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467889999999999999999875 7899999999764 344556667776 677789999999999999999999999
Q ss_pred eeCCCCCHHHHhccCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 497 DFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||+.+ +|.+++.... .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 8888775311 112468999999999999999999999 7 9999999999999999999999999999766
Q ss_pred cCCCCCccccCCCCCCCccCcccc----cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l----~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
..... .....||+.|+|||++ .+..++.++|||||||++|||++|+.||....
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 54322 2234799999999999 46679999999999999999999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=306.12 Aligned_cols=202 Identities=24% Similarity=0.388 Sum_probs=173.7
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcC--CCceeEEEeEE
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFC 486 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~ 486 (643)
.....++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334567899999999999999999985 478999999996532 12345778999999996 59999999999
Q ss_pred EeCCeEEEEEeeCCC-CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc-CCCcEE
Q 006480 487 FEDNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQ 564 (643)
Q Consensus 487 ~~~~~~~LV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vk 564 (643)
...+.+++||||+.+ ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 8999999754 358999999999999999999999 9999999999999999 789999
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99999998765432 234579999999999987766 68899999999999999999999764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=296.81 Aligned_cols=199 Identities=25% Similarity=0.361 Sum_probs=152.5
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHH-HHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVI-KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~-~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ... ..+..+..+++.++||||+++++++.+.+.+++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999875 78999999997643 223 33444555788889999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC-CeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
||+ ++.+..++.... ..+++..++.++.||+.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556665554322 358999999999999999999998 6 89999999999999999999999999997654
Q ss_pred CCCCCccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 4322 22357999999999994 567899999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=312.58 Aligned_cols=203 Identities=23% Similarity=0.358 Sum_probs=162.8
Q ss_pred hhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...+|.+.+.||+|+||+||.....+|+.||||++..... ..+.+|+++|+.+ +||||+++++++.+.+.+|+||||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3456889999999999997655566899999999976432 2356799999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEeecCcccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 573 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGla~~ 573 (643)
+. |+|.+++.... ..+.+..++.++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 69999997554 234555678899999999999999 89999999999999953 33588999999987
Q ss_pred ccCCCCC-ccccCCCCCCCccCccccc---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 574 ASTSSSH-ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 574 ~~~~~~~-~~~~~~~gt~~Y~APE~l~---~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~ 235 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence 6543221 2233467999999999998 4678889999999999999999 9999976544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=329.41 Aligned_cols=192 Identities=22% Similarity=0.341 Sum_probs=167.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC--CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCe-----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 491 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|++++.+++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 6899999998653 3456788999999999999999999999987665
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
.||||||+++++|.+++.. .+++.+++.|+.||+.||.|||+ ++||||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987743 58999999999999999999999 899999999999999886 8999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
+..... ....||+.|+|||++.++ ++.++|||||||+||+|++|.+||.+.
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~ 279 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGR 279 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTE
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccc
Confidence 876543 335799999999998765 489999999999999999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.32 Aligned_cols=191 Identities=21% Similarity=0.246 Sum_probs=163.5
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcC---------CCceeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 482 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~---------HpnIv~l 482 (643)
.++|.+.+.||+|+||.||+|.+ +|+.||||+++... ...+.+.+|+++++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999988 78999999997432 23477889999999886 8888888
Q ss_pred EeEEE------------------------------eCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHH
Q 006480 483 LGFCF------------------------------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532 (643)
Q Consensus 483 ~g~~~------------------------------~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~ 532 (643)
++++. ..+.+||||||+++|+|.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77653 26789999999999977777643 35799999999999999
Q ss_pred HHHHHH-hCCCCCeEecCCCCCCEEEcCCC--------------------cEEEeecCccccccCCCCCccccCCCCCCC
Q 006480 533 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 591 (643)
Q Consensus 533 aL~yLH-~~~~~~iiHrDLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 591 (643)
||.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ..+||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999876542 2379999
Q ss_pred ccCcccccCCCCCchhHHHHHHHH-HHHHHcCCCCCCC
Q 006480 592 YLAPEYFMYGKVNDKIDVYAFGVV-LLELLTGRKPISN 628 (643)
Q Consensus 592 Y~APE~l~~~~~s~ksDIwSlGvv-l~eLltG~~Pf~~ 628 (643)
|+|||++.+.. +.++||||||++ .+++++|..||.+
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999998766 999999998777 7889999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=321.17 Aligned_cols=202 Identities=27% Similarity=0.446 Sum_probs=175.0
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe------CCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~ 491 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ......+.+|+++++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999999999999864 7899999998753 4556789999999999999999999998765 677
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCc---EEEeec
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDF 568 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DF 568 (643)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999976432 2358999999999999999999999 89999999999999997765 999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 169 G~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 99987654332 23467999999999999999999999999999999999999999765
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.16 Aligned_cols=174 Identities=17% Similarity=0.202 Sum_probs=154.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999875 5899999999764 34567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++... ....++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999532 3455788899999999999999 899999999999999999999998543
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
|++ .++.++|||||||++|||++|+.||.+.+..
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 333 3789999999999999999999999987653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.53 Aligned_cols=208 Identities=15% Similarity=0.226 Sum_probs=161.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCC-Cce---------e-----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH-KNI---------I----- 480 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~H-pnI---------v----- 480 (643)
+.+|...+.||+|+||.||+|.+ .+|+.||||+++.. ....+.|.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44577889999999999999985 47999999999842 2335778999999999977 211 1
Q ss_pred -------EEEeEEEe-----CCeEEEEEeeCCCCCHHHHhccC---CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 006480 481 -------SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545 (643)
Q Consensus 481 -------~l~g~~~~-----~~~~~LV~E~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 545 (643)
.++.++.. ...++++|+++ +++|.+++... ......+++..++.++.||+.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11111111 22467777766 67999988421 1223468889999999999999999999 999
Q ss_pred EecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccc----------cCCCCCchhHHHHHHHH
Q 006480 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF----------MYGKVNDKIDVYAFGVV 615 (643)
Q Consensus 546 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l----------~~~~~s~ksDIwSlGvv 615 (643)
+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998865442 334578 999999999 56678999999999999
Q ss_pred HHHHHcCCCCCCCCChhhHHHhh
Q 006480 616 LLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 616 l~eLltG~~Pf~~~~~~~~~~li 638 (643)
+|||++|+.||...+.......+
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~ 329 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI 329 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG
T ss_pred HHHHHHCCCCCCCcchhhhHHHH
Confidence 99999999999987665544444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=278.57 Aligned_cols=178 Identities=26% Similarity=0.431 Sum_probs=152.6
Q ss_pred hcCcccc-eeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHH-HhcCCCceeEEEeEEEe----CCeEE
Q 006480 421 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLL 493 (643)
Q Consensus 421 ~~~f~~~-~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~~ 493 (643)
.++|.+. +.||+|+||.||++.. .+++.||+|+++.. ..+.+|++++ +.++||||++++++|.. .+.++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567766 7899999999999986 47899999999754 3466788887 55689999999999987 67899
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 570 (643)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986532 468999999999999999999999 89999999999999998 78999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
+.... +..++.++|||||||++|||++|+.||.+.+.
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 86432 24578899999999999999999999977543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=294.25 Aligned_cols=183 Identities=17% Similarity=0.103 Sum_probs=129.1
Q ss_pred eeecCceEEEEEE-eCCCCEEEEEEeCCC-----------hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEEE
Q 006480 430 IGKGGSSQVYKGC-LPDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 430 LG~G~~g~Vy~~~-~~~g~~vAVK~l~~~-----------~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
.+.|++|.+..+. +-.|+.++||++... +...++|.+|+++|+++ .|+||+++++++.+++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555443 236888999999653 23456799999999999 7999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||++|++|.+.|.... +++.. +|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997543 45543 588999999999999 9999999999999999999999999999987655
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P 625 (643)
... .....+||++|+|||++.+ .+..++|+|++|+++++|.++..|
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 432 2234679999999999875 577889999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=268.54 Aligned_cols=185 Identities=17% Similarity=0.217 Sum_probs=147.5
Q ss_pred ccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 425 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 425 ~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
...+.||+|+||.||++.. .++.+++|...... ...+++.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999954 67889999864321 1245689999999999999999666666677788999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++++|.+++.. +..++.||+.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999964 45799999999999999 99999999999999998 99999999998775
Q ss_pred CCCCCc-----cccCCCCCCCccCcccccC--CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 576 TSSSHI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 576 ~~~~~~-----~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
...... ......||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 432111 1234679999999999986 678889999999999999998888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=220.96 Aligned_cols=152 Identities=16% Similarity=0.124 Sum_probs=123.8
Q ss_pred hHHHHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-------------------hHHHHHHHHHHHHHhc
Q 006480 414 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTL 474 (643)
Q Consensus 414 ~~el~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~il~~l 474 (643)
+..+......|.+.+.||+|+||.||+|...+|+.||||+++... .....+.+|+++++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 344555566788889999999999999998789999999997432 1356789999999999
Q ss_pred CCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 006480 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 554 (643)
Q Consensus 475 ~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~N 554 (643)
+ | +++.+++. .+..++||||+++|+|.+ +.. .....++.|++.||.|||+ ++|+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 9 4 55555543 356799999999999998 521 2244699999999999999 999999999999
Q ss_pred EEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCccccc
Q 006480 555 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599 (643)
Q Consensus 555 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~ 599 (643)
||++ ++.+||+|||+|+ .+..|+|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999 9999999999985 344588999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-19 Score=183.83 Aligned_cols=137 Identities=20% Similarity=0.193 Sum_probs=108.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCE--EEEEEeCCChh-------------------------HHHHHHHHHHHHHh
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSED-------------------------VIKEFVLEIEIITT 473 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~--vAVK~l~~~~~-------------------------~~~~~~~Ei~il~~ 473 (643)
.-|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+++|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999987 68999 99999865321 12367889999999
Q ss_pred cCCCce--eEEEeEEEeCCeEEEEEeeCCC-C----CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCCCCe
Q 006480 474 LHHKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRV 545 (643)
Q Consensus 474 l~HpnI--v~l~g~~~~~~~~~LV~E~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~i 545 (643)
+.|++| ..++++ +..+|||||+.+ | +|.+.... +++..+..++.|++.||.||| + .+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 988754 344432 356899999942 3 77776532 235567889999999999999 8 899
Q ss_pred EecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 546 iHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999988 9999999999754
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.74 E-value=2e-17 Score=155.73 Aligned_cols=137 Identities=17% Similarity=0.104 Sum_probs=108.8
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCC-----CCCCCC--C----CCc-------hhhhhHHHHHH
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANN-----AIVDRD--G----KSS-------LLSLVKAFDSV 77 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~-----~~~~~~--~----~~~-------~~~~~~~~~~l 77 (643)
-++|+||||+|+.|.+||+||+....+.|..|++|||.++. ...... . ... .....+...+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 47999999999999999999999998889999999999764 110000 0 110 01223345578
Q ss_pred HHHHHhhhhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeCC
Q 006480 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 78 l~~~~~~C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
|+.+...+...+++++..+..| ++.+.|+++|++.++|+||||++|++.+.+... ||+.++++|++ |||++|+.+
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEeCC
Confidence 8888888888999999888885 899999999999999999999999875555333 99999999998 999999754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.2e-17 Score=154.18 Aligned_cols=136 Identities=15% Similarity=0.186 Sum_probs=110.7
Q ss_pred CCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCc----hhhhhHHHHHHHHHHHhhhhhcCC
Q 006480 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS----LLSLVKAFDSVLAVYEGFCNLKQV 90 (643)
Q Consensus 15 ~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~----~~~~~~~~~~ll~~~~~~C~~k~v 90 (643)
.-++|+|++|+|+.|.+||+||+....+.|..|++|||.++........... .....+...+.++.+...+...++
T Consensus 4 ~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 83 (146)
T 3s3t_A 4 RYTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSA 83 (146)
T ss_dssp CCCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSC
T ss_pred ccceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3589999999999999999999999988899999999998754321111000 112334555888999999988899
Q ss_pred -cEEEEEEEcCChhhHHHH-HHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEe
Q 006480 91 -DLKLKICRGTSIRKILVR-EAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 91 -~~~~~v~~g~~~~~~Iv~-~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~ 153 (643)
+++..+..| ++.+.|++ +|++.++|+||||+++++...+... |++.+++++++ |||++|+
T Consensus 84 ~~~~~~~~~g-~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 84 PNLKTEISYG-IPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCCEEEEEEE-CHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred cceEEEEecC-ChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEeC
Confidence 999888886 89999999 9999999999999999875555323 99999999998 9999985
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=153.43 Aligned_cols=133 Identities=15% Similarity=0.118 Sum_probs=108.5
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCC-CCCC--CCCCc-----hhhhhHHHHHHHHHHHhhhhhc
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNA-IVDR--DGKSS-----LLSLVKAFDSVLAVYEGFCNLK 88 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~-~~~~--~~~~~-----~~~~~~~~~~ll~~~~~~C~~k 88 (643)
++|+||+|+|+.|.+||+||+....+.|..|++|||.++.. .... ..... .....+...+.++.+...+...
T Consensus 3 ~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (147)
T 3hgm_A 3 NRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATEL 82 (147)
T ss_dssp SEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHHT
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHhc
Confidence 78999999999999999999999988899999999997642 1000 00111 1233456668899999999999
Q ss_pred CCcE---EEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEE
Q 006480 89 QVDL---KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAV 152 (643)
Q Consensus 89 ~v~~---~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV 152 (643)
++++ +..+..| ++.+.|+++|++.++|+||||+++++...+... |++.+++++++ |||++|
T Consensus 83 g~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 83 GVPADKVRAFVKGG-RPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TCCGGGEEEEEEES-CHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred CCCccceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 9988 8888886 999999999999999999999999865555323 99999999998 999986
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-17 Score=152.83 Aligned_cols=138 Identities=15% Similarity=0.208 Sum_probs=110.2
Q ss_pred CCCCEEEEEec--CCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCc--hhhhhHHHHHHHHHHHhhhhhcC
Q 006480 14 GAGRTVVVGVK--LDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSS--LLSLVKAFDSVLAVYEGFCNLKQ 89 (643)
Q Consensus 14 ~~~r~I~VaVD--~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~~~~C~~k~ 89 (643)
..-++|+|++| +|+.|.+||+||++...+.|..|++|||.++........... .....+...+.++.+...+...+
T Consensus 13 ~~~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 92 (156)
T 3fg9_A 13 LVYRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRG 92 (156)
T ss_dssp CCCC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccCceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 34589999999 999999999999998888899999999998754221111110 11233455688899988898889
Q ss_pred C-cEEEEEEEcCChhhHHHHH-HHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEe
Q 006480 90 V-DLKLKICRGTSIRKILVRE-AQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 90 v-~~~~~v~~g~~~~~~Iv~~-a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
+ .++..+..++++.+.|+++ |++.++|+||||+++++...+...|++.++++|++ |||++|+
T Consensus 93 ~~~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 93 VNQVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp CSSEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCC--CCEEEeC
Confidence 9 5898888856999999999 99999999999999986554433399999999998 9999985
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-16 Score=152.03 Aligned_cols=137 Identities=14% Similarity=0.030 Sum_probs=108.0
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCC-C-C-----------CchhhhhHHHHHHHHHHH
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRD-G-K-----------SSLLSLVKAFDSVLAVYE 82 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~-~-~-----------~~~~~~~~~~~~ll~~~~ 82 (643)
-++|+|+||+|+.|.+||+||+....+.|..|++|||.++....... . . .......+...+.|+.+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 84 (170)
T 2dum_A 5 FRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEKA 84 (170)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHHH
T ss_pred cceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 47999999999999999999999999999999999998764321100 0 0 111123345567888888
Q ss_pred hhhhhcCCcEEE--EEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeCC
Q 006480 83 GFCNLKQVDLKL--KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 83 ~~C~~k~v~~~~--~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
..+...+++++. .+..| ++.+.|+++|+++++|+||||+++++...+... ||+.+++++++ |||++|+.+
T Consensus 85 ~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 85 EEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEccC
Confidence 888888898887 77775 899999999999999999999999865544322 99999999998 999999753
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-17 Score=149.54 Aligned_cols=132 Identities=14% Similarity=0.145 Sum_probs=106.8
Q ss_pred CEEEEEecCCcchHHHHHHHHhhc-cCCCCEEEEEEEecCCCCCCCCCC---Cchhhhh-HHHHHHHHHHHhhhhhcCCc
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKV-AQPGDTVIALHVLANNAIVDRDGK---SSLLSLV-KAFDSVLAVYEGFCNLKQVD 91 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~-~~~gd~vvlvHV~~~~~~~~~~~~---~~~~~~~-~~~~~ll~~~~~~C~~k~v~ 91 (643)
++|+|++|+|+.|..||+||+... .+.|..|++|||.++......... ....... +...+.++.+...+...+++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 689999999999999999999999 889999999999987532211000 0011222 45568889999999989999
Q ss_pred EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEe
Q 006480 92 LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 92 ~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
++..+..| ++.+.|+++|+ ++|+||||+++++...+...|++.+++++++ |||++|+
T Consensus 82 ~~~~v~~g-~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKEG-EPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEES-CHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEecC-ChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCC--CCEEEeC
Confidence 99888886 89999999999 8999999999986444322499999999998 9999984
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.71 E-value=5.6e-17 Score=153.75 Aligned_cols=139 Identities=16% Similarity=0.079 Sum_probs=105.7
Q ss_pred CCCCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEE--EEecCCCC-CCCCC-CCc-hhhhhHHHHHHHHHHHhhhhh
Q 006480 13 SGAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIAL--HVLANNAI-VDRDG-KSS-LLSLVKAFDSVLAVYEGFCNL 87 (643)
Q Consensus 13 ~~~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlv--HV~~~~~~-~~~~~-~~~-~~~~~~~~~~ll~~~~~~C~~ 87 (643)
....++|+||||+|+.|.+||+||++... .|..|++| ||.++... ..... ... .....+...+.|+.+...+..
T Consensus 14 ~~~~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 92 (163)
T 1tq8_A 14 LSAYKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHN 92 (163)
T ss_dssp CCCCCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHT
T ss_pred cccCCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 34568999999999999999999999998 99999999 88765421 11000 000 012233456788888888888
Q ss_pred cCCc-EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEeCC
Q 006480 88 KQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 88 k~v~-~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
.+++ ++..+..| ++.+.|+++|++.++|+||||+++++.+.+.. .||+.+|+++++ |||++|+..
T Consensus 93 ~gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 93 AGAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp TTCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECCC
T ss_pred cCCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEeCC
Confidence 8998 99888875 89999999999999999999999987554432 299999999998 999999753
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-16 Score=150.81 Aligned_cols=138 Identities=17% Similarity=0.270 Sum_probs=102.7
Q ss_pred CCCEEEEEecCCc---------chHHHHHHHHhhccC---CCCEEEEEEEecCCCCCCC---C--CCCchh-----hhhH
Q 006480 15 AGRTVVVGVKLDT---------HSRELLTWALVKVAQ---PGDTVIALHVLANNAIVDR---D--GKSSLL-----SLVK 72 (643)
Q Consensus 15 ~~r~I~VaVD~s~---------~S~~AL~WAl~~~~~---~gd~vvlvHV~~~~~~~~~---~--~~~~~~-----~~~~ 72 (643)
.-++|+|+||+|+ .|.+||+||++.+.+ .+..|++|||.++...... . ...... ...+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 3589999999999 999999999999876 4789999999865321110 0 001011 1122
Q ss_pred HHHHHHHHHHhhhhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEE
Q 006480 73 AFDSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLA 151 (643)
Q Consensus 73 ~~~~ll~~~~~~C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~v 151 (643)
...+.|+.+...+...+++++..+..| ++.+.|+++|++.++|+||||+++++.+.+... ||+.+|+++++ |||++
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlv 160 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEE
Confidence 345788888888888899999888886 899999999999999999999999865544322 99999999998 99999
Q ss_pred EeCC
Q 006480 152 VNNG 155 (643)
Q Consensus 152 V~~g 155 (643)
|+.+
T Consensus 161 v~~~ 164 (175)
T 2gm3_A 161 IKRN 164 (175)
T ss_dssp EECC
T ss_pred EcCC
Confidence 9854
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=150.23 Aligned_cols=131 Identities=17% Similarity=0.140 Sum_probs=108.2
Q ss_pred CCCCEEEEEecC-CcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcE
Q 006480 14 GAGRTVVVGVKL-DTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDL 92 (643)
Q Consensus 14 ~~~r~I~VaVD~-s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~ 92 (643)
..-++|+||+|+ |+.|.+||+||++...+.|..|++|||.++... ......+...+.++.+...+...++++
T Consensus 22 mm~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~-------~~~~~~~~~~~~l~~~~~~~~~~g~~~ 94 (155)
T 3dlo_A 22 MIYMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR-------TKDEDIIEAKETLSWAVSIIRKEGAEG 94 (155)
T ss_dssp CCCCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT-------SCHHHHHHHHHHHHHHHHHHHHTTCCE
T ss_pred cccCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc-------ccHHHHHHHHHHHHHHHHHHHhcCCCc
Confidence 345799999999 999999999999999888999999999975421 112334556688888888888889988
Q ss_pred EEEE-EEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEe
Q 006480 93 KLKI-CRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 93 ~~~v-~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~ 153 (643)
+..+ +..+++.++|+++|++.+||+||||+++++...+.. .||+.+++++++ |||++|+
T Consensus 95 ~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 95 EEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp EEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEEC
T ss_pred eEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEeC
Confidence 8754 455699999999999999999999999986554432 399999999998 9999985
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=3e-16 Score=144.18 Aligned_cols=133 Identities=14% Similarity=0.185 Sum_probs=100.7
Q ss_pred CEEEEEecCCcc--hHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCC---chhhhhHHHHHHHHHHHhhhhhcC--
Q 006480 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS---SLLSLVKAFDSVLAVYEGFCNLKQ-- 89 (643)
Q Consensus 17 r~I~VaVD~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~---~~~~~~~~~~~ll~~~~~~C~~k~-- 89 (643)
++|+|+||+|+. |.+||+||+....+.|..|++|||.++.......... ......+..++.++.++.+++..+
T Consensus 2 k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 81 (143)
T 3fdx_A 2 NAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSIP 81 (143)
T ss_dssp CEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCCC
T ss_pred CEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCCC
Confidence 799999999999 9999999999988889999999999875322111110 011122344567777777887765
Q ss_pred -CcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEe
Q 006480 90 -VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 90 -v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~ 153 (643)
+.++..+..| ++.+.|+++|+++++|+||||+++ +...+.. .|++.+++++++ |||++|+
T Consensus 82 ~~~v~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 82 EDRMHFHVAEG-SPKDKILALAKSLPADLVIIASHR-PDITTYLLGSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp GGGEEEEEEES-CHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred CCceEEEEEec-ChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeeccHHHHHHHhCC--CCEEEeC
Confidence 4578888886 999999999999999999999996 4443332 299999999998 9999985
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=2.6e-16 Score=145.96 Aligned_cols=137 Identities=18% Similarity=0.157 Sum_probs=93.9
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCC----CCCCCCchhh-hhHHHHHHHHHHHhhhhhcCC
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV----DRDGKSSLLS-LVKAFDSVLAVYEGFCNLKQV 90 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~----~~~~~~~~~~-~~~~~~~ll~~~~~~C~~k~v 90 (643)
-++|+|+||+|+.|.+||+||+....+.+..|++|||.++.... .......... ..+..++..+.+..+++..++
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 85 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTLGI 85 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 47999999999999999999999998889999999999764321 1111111000 111222333344445555577
Q ss_pred c-EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeCC
Q 006480 91 D-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 91 ~-~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
. ++..+..| ++.++|+++|+++++|+||||+++++.......|++.+++++++ |||++|+..
T Consensus 86 ~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 86 DPAHRWLVWG-EPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp CGGGEEEEES-CHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred CcceEEEecC-CHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCC--CCEEEEeCC
Confidence 6 46666675 99999999999999999999999986544112299999999998 999999753
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.67 E-value=2.6e-16 Score=143.91 Aligned_cols=131 Identities=17% Similarity=0.160 Sum_probs=97.0
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCC-CCc-hhhhhHHHHHHHHHHHhhhhhcCC-cEE
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KSS-LLSLVKAFDSVLAVYEGFCNLKQV-DLK 93 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~-~~~-~~~~~~~~~~ll~~~~~~C~~k~v-~~~ 93 (643)
++|+|++|+|+.|.+||+||+....+.|..|++|||.++........ ... .....+...+.|+.+.. ..++ +++
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~g~~~~~ 79 (137)
T 2z08_A 3 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARA---LTGVPKED 79 (137)
T ss_dssp SEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHHH---HHCCCGGG
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHHH---HcCCCccE
Confidence 68999999999999999999999888899999999997532100000 000 01112333445554433 3678 777
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEe
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~ 153 (643)
..+..| ++.+.|+++|++.++|+||||+++++...+.. .|++.+++++++ |||++|+
T Consensus 80 ~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 80 ALLLEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp EEEEES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEeC
Confidence 777775 89999999999999999999999986554432 299999999998 9999984
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.5e-16 Score=167.94 Aligned_cols=138 Identities=14% Similarity=0.169 Sum_probs=103.0
Q ss_pred HhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---------------h--------HHHHHHHHHHHHHhcC
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------------D--------VIKEFVLEIEIITTLH 475 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---------------~--------~~~~~~~Ei~il~~l~ 475 (643)
....-|.+.+.||.|+||.||+|...+|+.||||+++... . .......|...|.++.
T Consensus 92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~ 171 (397)
T 4gyi_A 92 ARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY 171 (397)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH
Confidence 3334488999999999999999999999999999986421 0 0111235777777776
Q ss_pred CCcee--EEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006480 476 HKNII--SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (643)
Q Consensus 476 HpnIv--~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~ 553 (643)
+.++. ..+++ . ..+|||||+.|++|..+.. ......++.||+.+|.|||+ .|||||||||.
T Consensus 172 ~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~ 234 (397)
T 4gyi_A 172 EEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAK---HGLIHGDFNEF 234 (397)
T ss_dssp HTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred hcCCCCCeeeec--c--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHH
Confidence 55443 23322 2 2379999999988865432 12335688999999999999 89999999999
Q ss_pred CEEEcCCC----------cEEEeecCcccc
Q 006480 554 NILLSDDF----------EPQLSDFGLAKW 573 (643)
Q Consensus 554 NILl~~~~----------~vkL~DFGla~~ 573 (643)
|||+++++ .+.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999877 389999997643
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=6.9e-16 Score=141.51 Aligned_cols=131 Identities=13% Similarity=0.138 Sum_probs=95.4
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecC-CCCCCCCCCCchh----hhhHHHHHHHHHHHhhhhhcCCc
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN-NAIVDRDGKSSLL----SLVKAFDSVLAVYEGFCNLKQVD 91 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~-~~~~~~~~~~~~~----~~~~~~~~ll~~~~~~C~~k~v~ 91 (643)
++|+|++|+|+.|.+||+||+....+.|..|++|||.++ +............ ...+...+.|+. +++..++.
T Consensus 3 ~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~ 79 (141)
T 1jmv_A 3 KHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLD---LAESVDYP 79 (141)
T ss_dssp SEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHH---HHHHSSSC
T ss_pred ceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHHH---HHHHcCCC
Confidence 689999999999999999999998888999999999854 2111110000000 011222333433 44555776
Q ss_pred E-EEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeCC
Q 006480 92 L-KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 92 ~-~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
+ +..+.. +++.+.|+++|++.++|+||||++ ++...+ ..|++.+++++++ |||++|+.+
T Consensus 80 ~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-lgs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 80 ISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-LMSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp CCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-HHHHHHHHHTTCC--SEEEEEECC
T ss_pred ceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-hcchHHHHHhcCC--CCEEEeeCC
Confidence 6 445555 589999999999999999999999 764444 2499999999998 999999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-15 Score=136.30 Aligned_cols=125 Identities=10% Similarity=-0.044 Sum_probs=95.7
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEe-cC-C-CC-CC---CC-CCCchhhhhHHHHHHHHHHHhhh--
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVL-AN-N-AI-VD---RD-GKSSLLSLVKAFDSVLAVYEGFC-- 85 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~-~~-~-~~-~~---~~-~~~~~~~~~~~~~~ll~~~~~~C-- 85 (643)
-++|+|++|+|+.|.+||+||++...+.|..|++|||. +. + .. .. .. .........+...+.|+.+ ..|
T Consensus 4 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~ 82 (138)
T 1q77_A 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKLT 82 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHHH
T ss_pred ccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHhh
Confidence 47899999999999999999999998889999999998 63 1 10 00 00 0011112233445677777 664
Q ss_pred hhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEe
Q 006480 86 NLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 86 ~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
...+ +++..+.. +++.+.|+++|++.++|+||||++|+ ||+.+++++++ |||++|+
T Consensus 83 ~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~--------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 83 GSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp SCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred ccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC--------chHHHHHHhCC--CceEeeC
Confidence 4455 66666666 58999999999999999999999975 99999999998 9999984
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.51 E-value=9.9e-14 Score=144.77 Aligned_cols=138 Identities=10% Similarity=0.047 Sum_probs=107.6
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCC-Cc-hh----hhhHHHHHHHHHHHhhhhhcC
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK-SS-LL----SLVKAFDSVLAVYEGFCNLKQ 89 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~-~~-~~----~~~~~~~~ll~~~~~~C~~k~ 89 (643)
-++|+|++|+|+.|..||+||+.-..+.|..|++|||.++......... .. .. ...+...+.++.+...+...+
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 86 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAG 86 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 3799999999999999999999999888999999999864321111111 11 11 122344577888888888889
Q ss_pred CcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccC-CCchHHHHhccCCCCcEEEEEeCC
Q 006480 90 VDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 90 v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~-~~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
+.++..+.+.+++.+.|+++|++.++|+||||+++.+...+. ..|++..++++++ |||++|+.+
T Consensus 87 v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 87 IQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp CCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEESS
T ss_pred CeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecCc
Confidence 999999885569999999999999999999999998654443 2399999999998 999999854
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.1e-13 Score=142.98 Aligned_cols=134 Identities=14% Similarity=0.170 Sum_probs=97.8
Q ss_pred CCCEEEEEecCCcc-------hHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhH-HHHHHHHHHHhhhh
Q 006480 15 AGRTVVVGVKLDTH-------SRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVK-AFDSVLAVYEGFCN 86 (643)
Q Consensus 15 ~~r~I~VaVD~s~~-------S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~-~~~~ll~~~~~~C~ 86 (643)
..++|+||+|+|+. |.+||+||+......+..|++|||+++...... .... ...+ ...+..+....+++
T Consensus 133 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~--~~~~-~~~~~~~~~~~~~l~~~~~ 209 (290)
T 3mt0_A 133 TGGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSA--DPTF-QLSETIEARYREACRTFQA 209 (290)
T ss_dssp TTCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC-----------CH-HHHHHHHHHHHHHHHHHHH
T ss_pred CCCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCcccccc--Cchh-HHHHHHHHHHHHHHHHHHH
Confidence 56899999999999 999999999999989999999999976532111 1110 1111 11122333333555
Q ss_pred hcCCc-EEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeC
Q 006480 87 LKQVD-LKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 87 ~k~v~-~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~ 154 (643)
..++. .+..+..| ++.++|+++|+++++|+||||++|++.+.+... ||+.++++|++ |||++|+.
T Consensus 210 ~~g~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 210 EYGFSDEQLHIEEG-PADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHTCCTTTEEEEES-CHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred HcCCCcceEEEecc-CHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 55773 45566775 999999999999999999999999976655433 99999999998 99999974
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=6.7e-14 Score=142.49 Aligned_cols=134 Identities=12% Similarity=0.041 Sum_probs=105.4
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCC-CC-CCCC----c--------hhhhhHHHHHHHHHHH
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIV-DR-DGKS----S--------LLSLVKAFDSVLAVYE 82 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~-~~-~~~~----~--------~~~~~~~~~~ll~~~~ 82 (643)
++|+|++|+|+.|.+||+||+....+.|..|+++||.++.... .. .+.. . .....+...+.++.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5799999999999999999999988889999999998653210 00 0000 0 1112344558889999
Q ss_pred hhhhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCC-ccccCC-CchHHHHhccCCCCcEEEEEeCC
Q 006480 83 GFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNH-HTIRST-TSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 83 ~~C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~-~~~r~~-~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
..+...+++++..+..| ++.+.|+++ +.++|+||||+++++ ...+.. .|++.+++++++ |||++|+.+
T Consensus 81 ~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECCC
Confidence 99988999999888875 899999999 888999999999886 554432 399999999998 999999854
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.49 E-value=7.8e-14 Score=143.99 Aligned_cols=121 Identities=12% Similarity=0.064 Sum_probs=102.5
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLK 95 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~ 95 (643)
-++|+|++|+|+.|..||+||+.-..+.|..|+++||.++ +...+.++.+...+...+++++..
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~----------------~~~~~~l~~~~~~~~~~~~~~~~~ 70 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR----------------RDHSAALNDLAQELREEGYSVSTN 70 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS----------------SCCHHHHHHHHHHHHHTTCCEEEE
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc----------------HHHHHHHHHHHHHHhhCCCeEEEE
Confidence 4799999999999999999999999989999999999863 112244555556666789999999
Q ss_pred EEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEeC
Q 006480 96 ICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 96 v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
+..++++.+.|+++|+..++|+||||+++.+...+.. .|++..++++++ |||++|+.
T Consensus 71 ~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 71 QAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp EECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEECC
T ss_pred EEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEecC
Confidence 8877899999999999999999999999986544432 399999999998 99999974
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=142.37 Aligned_cols=137 Identities=10% Similarity=0.083 Sum_probs=106.0
Q ss_pred CCCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCC-Cch--hhhhHHHHHHHHHHHhhhhhc--
Q 006480 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGK-SSL--LSLVKAFDSVLAVYEGFCNLK-- 88 (643)
Q Consensus 14 ~~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~-~~~--~~~~~~~~~ll~~~~~~C~~k-- 88 (643)
...++|+|++|+|+.|..||+||+....+.|..|++|||.++......... ... ....+..++.++.+...|...
T Consensus 17 ~~~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 96 (309)
T 3cis_A 17 NSSLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASL 96 (309)
T ss_dssp -CTTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred CCCCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhcc
Confidence 346899999999999999999999999888999999999874321101111 111 122344557788888888765
Q ss_pred ---CCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEeCC
Q 006480 89 ---QVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 89 ---~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
+++++..+..| ++.+.|+++|+ ++|+||||+++++...+.. .|++.+++++++ |||++|+.+
T Consensus 97 ~~~~~~~~~~~~~g-~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 97 RAGPPTVHSEIVPA-AAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp SSCCSCEEEEEESS-CHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECTT
T ss_pred cCCCceEEEEEecC-CHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcCC
Confidence 89999888775 89999999997 7999999999986544432 299999999997 999999854
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.1e-13 Score=142.99 Aligned_cols=137 Identities=9% Similarity=0.017 Sum_probs=108.5
Q ss_pred CCCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCC---c-hhhhhHHHHHHHHHHHhhhhhcC
Q 006480 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKS---S-LLSLVKAFDSVLAVYEGFCNLKQ 89 (643)
Q Consensus 14 ~~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~---~-~~~~~~~~~~ll~~~~~~C~~k~ 89 (643)
..-++|+|++|+|+.|..||+||+.-..+.|..|++|||.++.......... . .....+...+.++.+...+...+
T Consensus 20 ~m~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g 99 (294)
T 3loq_A 20 FQSNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAG 99 (294)
T ss_dssp STTCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HhhccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 3458999999999999999999999998899999999999765422111111 1 12333455688999999999999
Q ss_pred CcEEE-EEE-EcCChhhHHHHHHHhcCCCEEEEccCCCCccccCC-CchHHHHhccCCCCcEEEEEeCC
Q 006480 90 VDLKL-KIC-RGTSIRKILVREAQSYSATKFIVGTAKNHHTIRST-TSLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 90 v~~~~-~v~-~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~-~sVs~yc~~~ap~~C~V~vV~~g 155 (643)
++++. .+. . +++.+.| ++++.++|+||||+++++...+.. .|++.+++++++ |||++|+.+
T Consensus 100 ~~~~~~~v~~~-g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 100 IKAEVIKPFPA-GDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp CEEEECSSCCE-ECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECCC
T ss_pred CCcceeEeecc-CChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecCc
Confidence 99998 677 6 5899999 999999999999999986544322 399999999998 999999754
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=4.7e-13 Score=139.37 Aligned_cols=133 Identities=17% Similarity=0.134 Sum_probs=100.2
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhh--cCCcEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNL--KQVDLK 93 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~--k~v~~~ 93 (643)
.++|+||+|+|+.|.+||+||+..+.+.+..|++|||+++..... ..........+...+.++.+...+.. .++.++
T Consensus 171 ~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 249 (309)
T 3cis_A 171 QAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSE-WPGIDWPATQSMAEQVLAERLAGWQERYPNVAIT 249 (309)
T ss_dssp CCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTT-CSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEE
T ss_pred CCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccC-CCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEE
Confidence 478999999999999999999999888899999999987643211 01111122223334445554444433 478888
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeC
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~ 154 (643)
..+..| ++.++|+++|+ +||+||||+++++.+.+... ||+.++++|++ |||++|+.
T Consensus 250 ~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 250 RVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp EEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEECC
T ss_pred EEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeCC
Confidence 887775 99999999998 89999999999875555433 99999999998 99999974
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.3e-13 Score=140.58 Aligned_cols=123 Identities=16% Similarity=0.251 Sum_probs=103.5
Q ss_pred CCCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEE
Q 006480 14 GAGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (643)
Q Consensus 14 ~~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~ 93 (643)
...++|+||+|+|+.|.+||+||+..+...+..|.+|||.++.. ..+.++.+...+...+++++
T Consensus 168 ~~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~----------------~~~~l~~~~~~l~~~~~~~~ 231 (294)
T 3loq_A 168 SLFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD----------------KTADLRVMEEVIGAEGIEVH 231 (294)
T ss_dssp CTTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC----------------CHHHHHHHHHHHHHTTCCEE
T ss_pred ccCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch----------------HHHHHHHHHHHHHHcCCcEE
Confidence 34589999999999999999999999888899999999987532 12445666666677889988
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeCC
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
..+..| ++.++|+++|++.++|+||||+++++++.+... |++.+++++++ |||++|+.+
T Consensus 232 ~~~~~g-~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 232 VHIESG-TPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp EEEECS-CHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECSC
T ss_pred EEEecC-CHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECCC
Confidence 877775 999999999999999999999999875544322 99999999998 999999864
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=136.28 Aligned_cols=137 Identities=12% Similarity=0.064 Sum_probs=98.9
Q ss_pred CCCEEEEEecCCc-------chHHHHHHHHhhccCC--CCEEEEEEEecCCCCCCCCC-C-Cchhhhh-HHHHHHHHHHH
Q 006480 15 AGRTVVVGVKLDT-------HSRELLTWALVKVAQP--GDTVIALHVLANNAIVDRDG-K-SSLLSLV-KAFDSVLAVYE 82 (643)
Q Consensus 15 ~~r~I~VaVD~s~-------~S~~AL~WAl~~~~~~--gd~vvlvHV~~~~~~~~~~~-~-~~~~~~~-~~~~~ll~~~~ 82 (643)
..++|+||+|+|+ .|.+||+||+..+... |..|.+|||+++........ . ....... +...+..+.+.
T Consensus 155 ~~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (319)
T 3olq_A 155 EYGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMK 234 (319)
T ss_dssp TTCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHH
Confidence 4689999999999 4699999999988766 99999999998754321111 0 1111111 11223333444
Q ss_pred hhhhhcCC-cEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeC
Q 006480 83 GFCNLKQV-DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 83 ~~C~~k~v-~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~ 154 (643)
.+++..++ .++..+..| ++.++|+++|+++++|+||||+++++++.+... ||+.++++|++ |||++|+.
T Consensus 235 ~~~~~~~~~~~~~~v~~g-~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 235 ELRQKFSIPEEKTHVKEG-LPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HHHHHTTCCGGGEEEEES-CHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECC
T ss_pred HHHHHhCCCcccEEEecC-CcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECC
Confidence 45555565 345566665 899999999999999999999999876554322 99999999998 99999975
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=4.7e-12 Score=128.74 Aligned_cols=116 Identities=12% Similarity=0.039 Sum_probs=96.8
Q ss_pred CCCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 15 AGRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 15 ~~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
..++|+||+|+|+.|.+||+||.......|..|.+|||.++. +...+.++.+...+...+++++.
T Consensus 153 ~~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~---------------~~~~~~l~~~~~~l~~~~~~~~~ 217 (268)
T 3ab8_A 153 ELEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP---------------ARAEAWALEAEAYLRDHGVEASA 217 (268)
T ss_dssp CCCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH---------------HHHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH---------------HHHHHHHHHHHHHHHHcCCceEE
Confidence 457999999999999999999998877778899999998642 12345566666667777899988
Q ss_pred EEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEe
Q 006480 95 KICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 95 ~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
.+.. +++.++|+++|++. |+||||+ +..+.+.| |++.++++|++ |||++|+
T Consensus 218 ~~~~-g~~~~~i~~~a~~~--dliV~G~-~~~~~~~G--s~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 218 LVLG-GDAADHLLRLQGPG--DLLALGA-PVRRLVFG--STAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp EEEC-SCHHHHHHHHCCTT--EEEEEEC-CCSCCSSC--CHHHHHHHHCS--SCEEEEC
T ss_pred EEeC-CChHHHHHHHHHhC--CEEEECC-cccccEec--cHHHHHHhcCC--CCEEEeC
Confidence 7776 59999999999998 9999999 65556656 99999999998 9999985
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.3e-11 Score=124.88 Aligned_cols=144 Identities=18% Similarity=0.127 Sum_probs=112.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
...|.+...++.|+.+.||++.. .+..+++|+..... .....+.+|+++++.+. +..+.++++++...+..|+||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 34677888889999999999876 46889999987421 12245788999999884 67788999999888899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS------------------------------------- 541 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~------------------------------------- 541 (643)
++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 92 i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876421 1223467889999999999821
Q ss_pred -------------------CCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 542 -------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 542 -------------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+..++|+|++|.|||++++..+.|+||+.+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 145899999999999987666679999987543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=1.4e-11 Score=123.44 Aligned_cols=138 Identities=17% Similarity=0.086 Sum_probs=101.6
Q ss_pred CcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEEeEEEeCCeEEEEEeeCC
Q 006480 423 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.|.+..+.+.|..+.||++...+|..+++|+.... ....+..|+++++.+.+.+ +.++++++...+..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 34443333456669999998777888999998754 2245778999999886444 5668888888788999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (643)
|.+|. ... .. ...++.++++.|..||+..
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98874 211 11 1256778888888888732
Q ss_pred ----------------CCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 542 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 542 ----------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+..++|+|++|.|||+++++.+.|+|||.+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766779999987644
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=4.8e-10 Score=118.97 Aligned_cols=142 Identities=13% Similarity=0.244 Sum_probs=107.6
Q ss_pred cceeeeecCceEEEEEEeCCCCEEEEEEeC--CCh--hHHHHHHHHHHHHHhcC--CCceeEEEeEEEeC---CeEEEEE
Q 006480 426 AENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLVY 496 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~--~~~--~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~LV~ 496 (643)
..+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|.++++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35778999999999987754 678888876 432 22456788999999997 45688899988766 4589999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----------------------------------- 541 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~----------------------------------- 541 (643)
||++|..|.+.. ...++..++..++.+++++|..||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997775421 123678888999999999999999731
Q ss_pred --------------------CCCeEecCCCCCCEEEcCCCc--EEEeecCccccc
Q 006480 542 --------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWA 574 (643)
Q Consensus 542 --------------------~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~~ 574 (643)
...++|+|++|.|||++.++. +.|+||+.+.+.
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=4.3e-10 Score=116.58 Aligned_cols=186 Identities=18% Similarity=0.197 Sum_probs=126.7
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCc--eeEEEeEEEeCC---eEEEEEeeCC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 500 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~LV~E~~~ 500 (643)
.+.++.|....||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++......+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999852 45888986543 44567889999998883 332 445555443332 3488999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 541 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--------------------------------------- 541 (643)
|.+|.+... ..++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988875432 13567778888888998888888621
Q ss_pred ----------------CCCeEecCCCCCCEEEcC--CCcEEEeecCccccccCCCCCccccCCCCCCCc---cCccccc-
Q 006480 542 ----------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---LAPEYFM- 599 (643)
Q Consensus 542 ----------------~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y---~APE~l~- 599 (643)
...++|+|++|.||++++ +..+.|+||+.+....... +......+ ..|+.+.
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 135899999999999998 4567899999987543310 01111111 2333221
Q ss_pred ----CCCC---------CchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 600 ----YGKV---------NDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 600 ----~~~~---------s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
++.. ....+.|++|.++|.+.+|+.+|...
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~ 290 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEE 290 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHH
Confidence 1111 22379999999999999999988654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=9.7e-07 Score=91.62 Aligned_cols=138 Identities=20% Similarity=0.196 Sum_probs=99.1
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC---ceeEEEeEEE-eCCeEEEEEeeCCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 502 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~LV~E~~~~g 502 (643)
.+.++.|....||+. |..+++|+-. .......+..|.++|..+.+. .+.+++.++. ..+..++||+|++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 466888999999987 5668888853 334567788999999999752 3566777764 345678999999998
Q ss_pred CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 006480 503 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 540 (643)
Q Consensus 503 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~------------------------------------------ 540 (643)
.|.+.... .++..+...++.++++.|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88764221 234555556666666666666652
Q ss_pred ---------------CCCCeEecCCCCCCEEEcC---CCcE-EEeecCcccccc
Q 006480 541 ---------------SAQRVIHRDVKSSNILLSD---DFEP-QLSDFGLAKWAS 575 (643)
Q Consensus 541 ---------------~~~~iiHrDLKp~NILl~~---~~~v-kL~DFGla~~~~ 575 (643)
.+..++|+|++|.|||++. ++.+ .|+||+.+....
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2235799999999999987 4554 899999886544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2e-06 Score=86.72 Aligned_cols=137 Identities=19% Similarity=0.124 Sum_probs=99.0
Q ss_pred eeeecCce-EEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 429 LIGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 429 ~LG~G~~g-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
.+..|..+ .||+.... ++..+++|+-... ....+..|..+|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34455554 68987654 5667899987643 3456788999998884 334678889998889999999999998887
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCC-------------------------------------------
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA------------------------------------------- 542 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------------------------------------------- 542 (643)
+..... ......+..+++..|.-||....
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765321 12334466667777777775210
Q ss_pred ------------CCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 543 ------------QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 543 ------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
..++|+|+.+.|||+++++.+-|+||+.+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 137999999999999988777899999886443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=8.6e-06 Score=87.26 Aligned_cols=74 Identities=16% Similarity=0.139 Sum_probs=50.2
Q ss_pred ceeeeecCceEEEEEEeC-CCCEEEEEEeCCChh--------HHHHHHHHHHHHHhcCC--Cc-eeEEEeEEEeCCeEEE
Q 006480 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLL 494 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~--------~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~~L 494 (643)
.+.||.|.++.||++... +++.++||...+... ...++..|.++|..+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 568899998754321 23456779999888742 33 4455544 3455689
Q ss_pred EEeeCCCC
Q 006480 495 VYDFLSRG 502 (643)
Q Consensus 495 V~E~~~~g 502 (643)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=2e-05 Score=81.74 Aligned_cols=144 Identities=18% Similarity=0.276 Sum_probs=82.5
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----CCceeEEE-e--EEEeCCeEEEEEee
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISLL-G--FCFEDNNLLLVYDF 498 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-g--~~~~~~~~~LV~E~ 498 (643)
.+.|+.|..+.||+....+| .+++|+...... ++..|.+++..|. .|.++... | +....+..+++|+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPEK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSCHH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCCHH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566677899999877555 489999986432 3334555555442 34444311 1 12346678999999
Q ss_pred CCCCCHH--------------HHhccCC-CC--C-------CCCChHHHH------------------------------
Q 006480 499 LSRGSLE--------------ENLHGNK-KD--P-------AAFGWSERY------------------------------ 524 (643)
Q Consensus 499 ~~~gsL~--------------~~l~~~~-~~--~-------~~l~~~~~~------------------------------ 524 (643)
++|..+. -.+|... .. + ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 1122110 00 0 011232211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 525 -KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 525 -~i~~qia~aL~yLH~----------~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 111223445667763 12478999999999999988889999999987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=1.8e-05 Score=83.37 Aligned_cols=79 Identities=13% Similarity=0.084 Sum_probs=55.6
Q ss_pred ceee-eecCceEEEEEEeC-------CCCEEEEEEeCCChh----HHHHHHHHHHHHHhcC-C--CceeEEEeEEEeC--
Q 006480 427 ENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLH-H--KNIISLLGFCFED-- 489 (643)
Q Consensus 427 ~~~L-G~G~~g~Vy~~~~~-------~g~~vAVK~l~~~~~----~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~-- 489 (643)
.+.| +.|..+.+|+.... ++..+++|+...... ....+..|..+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999988654 267789998765331 1245677888888774 2 3577788887654
Q ss_pred -CeEEEEEeeCCCCCHH
Q 006480 490 -NNLLLVYDFLSRGSLE 505 (643)
Q Consensus 490 -~~~~LV~E~~~~gsL~ 505 (643)
+..++||||++|..|.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999887654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00019 Score=77.54 Aligned_cols=78 Identities=18% Similarity=0.224 Sum_probs=49.3
Q ss_pred CCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCC--CCCccCcccccCC---CCCchhHHHHHHHHH
Q 006480 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYG---KVNDKIDVYAFGVVL 616 (643)
Q Consensus 542 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g--t~~Y~APE~l~~~---~~s~ksDIwSlGvvl 616 (643)
+..++|+|++|.|||++.++ +.|+||+.+.+...... .. .... ...|++|+..... .-....++..+...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IG--AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HH--HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HH--HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 37899999999999998876 99999999875543110 00 0000 1346666655421 122345566777777
Q ss_pred HHHHcCC
Q 006480 617 LELLTGR 623 (643)
Q Consensus 617 ~eLltG~ 623 (643)
|++++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 7777653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00025 Score=73.76 Aligned_cols=139 Identities=16% Similarity=0.211 Sum_probs=93.4
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEEeEEEeCCeEEEEEeeCCCCC
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~LV~E~~~~gs 503 (643)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 56789999999999876 5678889987643 3566788998888874 3678889998887888999999999875
Q ss_pred HH--------H---HhccCCC-CCC-----------------CCChHHHHH---HHH----------------HHHHH-H
Q 006480 504 LE--------E---NLHGNKK-DPA-----------------AFGWSERYK---VAM----------------GVAEA-L 534 (643)
Q Consensus 504 L~--------~---~l~~~~~-~~~-----------------~l~~~~~~~---i~~----------------qia~a-L 534 (643)
+. . .|+.... ... .-+|.+.+. +.. .++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 1 2333221 000 114544321 111 11111 1
Q ss_pred HHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 535 EYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 535 ~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
..|.. .....++|+|+.+.|++++.++ +.|+||.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23421 1236799999999999999887 9999984
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00016 Score=74.28 Aligned_cols=141 Identities=13% Similarity=0.108 Sum_probs=77.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEEeEEEeCCeEEEEEeeC-CCCCH
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 504 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E~~-~~gsL 504 (643)
.+.|+.|....+|+. ..+++|+.........+...|..+++.+..-++ .++++++ .+.-++++||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 678999999999998 558889886542222223457777777642222 4555543 33347899999 55444
Q ss_pred HH------------------HhccCCC-CCCCCC-hHHHHHHHH--------------HHHHHHH----HHHh-CCCCCe
Q 006480 505 EE------------------NLHGNKK-DPAAFG-WSERYKVAM--------------GVAEALE----YLHS-GSAQRV 545 (643)
Q Consensus 505 ~~------------------~l~~~~~-~~~~l~-~~~~~~i~~--------------qia~aL~----yLH~-~~~~~i 545 (643)
.. .+|.... ....+. +..+..+.. .+.+.+. .|.. ..+..+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 21 1111110 000011 111111110 0111111 1111 223568
Q ss_pred EecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 546 iHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
+|+|+.+.||+ ..++.+.|+||..+....
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 99999999999 566788999999876443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0012 Score=67.99 Aligned_cols=145 Identities=17% Similarity=0.138 Sum_probs=81.2
Q ss_pred ceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc--eeEEEeE------EEeCCeEEEEEee
Q 006480 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 498 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~~~~LV~E~ 498 (643)
.+.|+.|....+|+....+| .+++|+..... ....+..|++++..+...+ +.+++.. ....+..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 35677788899999887666 58899887621 1234456777776663211 2233311 1234667999999
Q ss_pred CCCCCHHH--------------HhccCC-CCCCC-------CChHHHHHH------------HHHHHHHHHHHHhC----
Q 006480 499 LSRGSLEE--------------NLHGNK-KDPAA-------FGWSERYKV------------AMGVAEALEYLHSG---- 540 (643)
Q Consensus 499 ~~~gsL~~--------------~l~~~~-~~~~~-------l~~~~~~~i------------~~qia~aL~yLH~~---- 540 (643)
++|..+.. .++... ....+ ..|...+.- ...+...+.+|+..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98864311 122110 10000 113221110 11244555666531
Q ss_pred CCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 541 ~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
.+.+++|+|+++.|||++.+..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 246899999999999998876668999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00072 Score=68.88 Aligned_cols=78 Identities=21% Similarity=0.228 Sum_probs=56.2
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCC---CceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHH---KNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~~~~~LV~E 497 (643)
......+.+|.|..+.||+....+|+.|.+|+..... .....|..|.+.|+.|.. --+.+++++ .. -++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence 3455678899999999999999999999999875432 222346779998888742 234455554 22 388999
Q ss_pred eCCCCC
Q 006480 498 FLSRGS 503 (643)
Q Consensus 498 ~~~~gs 503 (643)
|+.++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00069 Score=70.03 Aligned_cols=144 Identities=17% Similarity=0.235 Sum_probs=84.0
Q ss_pred eeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCC--ceeEEEeE-----EEeCCeEEEEEeeCC
Q 006480 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF-----CFEDNNLLLVYDFLS 500 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~-----~~~~~~~~LV~E~~~ 500 (643)
..|+ |....||+....+|+.+++|+..+.......+..|..++..+... .+.+++.. ...++..+++|+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 888899998776787899999975433345666788888777421 23334332 223556788999998
Q ss_pred CCCHH-----H---------HhccC----CC-CCCCCChHHH----HHH---------------HHHHHHHHHHHHh---
Q 006480 501 RGSLE-----E---------NLHGN----KK-DPAAFGWSER----YKV---------------AMGVAEALEYLHS--- 539 (643)
Q Consensus 501 ~gsL~-----~---------~l~~~----~~-~~~~l~~~~~----~~i---------------~~qia~aL~yLH~--- 539 (643)
|..+. . .++.. .. ....+.+... ..+ ...+...+..|..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 1 01110 00 0112222211 001 1111122333322
Q ss_pred -CCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 540 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 540 -~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
..+..++|+|+++.|||++ + .+.|+||+.+...
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1246789999999999998 4 8999999887644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00068 Score=70.48 Aligned_cols=145 Identities=14% Similarity=0.128 Sum_probs=76.3
Q ss_pred eeeeecCceE-EEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 428 NLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 428 ~~LG~G~~g~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
+.|+.|+... +|+....+|..+++|...+... ..+..|+.++..+.. -.+.+++.+....+ +++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence 4566665554 6676654477788887655321 223446666666632 23556666643333 789999977676
Q ss_pred HHHhccCC---------------------CC-CCCCChHHHH-------H-H------------HHHHHHHHHHHH---h
Q 006480 505 EENLHGNK---------------------KD-PAAFGWSERY-------K-V------------AMGVAEALEYLH---S 539 (643)
Q Consensus 505 ~~~l~~~~---------------------~~-~~~l~~~~~~-------~-i------------~~qia~aL~yLH---~ 539 (643)
.+.+.... .. -..+...... . + ...+...+..|- .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 65443211 00 0112211100 0 0 001112222331 1
Q ss_pred CCCCCeEecCCCCCCEEEcCC----CcEEEeecCccccccC
Q 006480 540 GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWAST 576 (643)
Q Consensus 540 ~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~~~~ 576 (643)
..+..++|||+.+.|||++.+ +.+.|+||+.+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 224689999999999999875 6899999998865443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00026 Score=76.95 Aligned_cols=73 Identities=15% Similarity=0.175 Sum_probs=50.2
Q ss_pred cceeeeecCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEEeEEEeCCeEEEEE
Q 006480 426 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 426 ~~~~LG~G~~g~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 496 (643)
..+.|+.|....+|+....+ ++.+++|+.... .....+..|..++..|...+ ..++++.+. + .+||
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 35678889899999998653 578999998442 11245567998888885333 356776653 3 3899
Q ss_pred eeCCCCC
Q 006480 497 DFLSRGS 503 (643)
Q Consensus 497 E~~~~gs 503 (643)
+|++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00061 Score=74.69 Aligned_cols=74 Identities=22% Similarity=0.191 Sum_probs=48.4
Q ss_pred ceeeeecCceEEEEEEeCC-CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEEeEEEeCCeEEEEEeeCCCCCH
Q 006480 427 ENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSL 504 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E~~~~gsL 504 (643)
.+.|+.|-...+|+....+ +..+++|+........-+...|..++..|...++ .++++++ .+ .+||||++|..|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 4678889899999988754 4788999875432111112478889998865444 5677766 23 359999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00079 Score=71.92 Aligned_cols=143 Identities=17% Similarity=0.237 Sum_probs=85.4
Q ss_pred ceeeeecCceEEEEEEeC--------CCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEe
Q 006480 427 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+.|..|-...+|+.... +++.+++|+..........+.+|.++++.|. +.-..++++++. + .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 456777888889998764 3578999987443233456678999988874 322356666653 3 39999
Q ss_pred eCCCCCHHH-----------------HhccCC-CCCCCC--ChHHHHHHHHHHHH-------------------HHHHHH
Q 006480 498 FLSRGSLEE-----------------NLHGNK-KDPAAF--GWSERYKVAMGVAE-------------------ALEYLH 538 (643)
Q Consensus 498 ~~~~gsL~~-----------------~l~~~~-~~~~~l--~~~~~~~i~~qia~-------------------aL~yLH 538 (643)
|++|..|.. .||... ...... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998765431 112111 011112 24555555544321 233333
Q ss_pred h-----CCCCCeEecCCCCCCEEEcCC----CcEEEeecCcccc
Q 006480 539 S-----GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKW 573 (643)
Q Consensus 539 ~-----~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~ 573 (643)
. ..+..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 234679999999999999876 7899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00039 Score=73.56 Aligned_cols=73 Identities=16% Similarity=0.190 Sum_probs=45.6
Q ss_pred ceeeeecCceEEEEEEeCC---------CCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCc-eeEEEeEEEeCCeEEEEE
Q 006480 427 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 496 (643)
...|+.|....+|+....+ +..+++|+.........+...|.++++.+...+ ..++++.+ .+ ++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 4567888889999987653 268999988654332223457888888774333 44666544 33 7899
Q ss_pred eeCCCCC
Q 006480 497 DFLSRGS 503 (643)
Q Consensus 497 E~~~~gs 503 (643)
+|++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0018 Score=67.85 Aligned_cols=66 Identities=18% Similarity=0.189 Sum_probs=43.3
Q ss_pred cCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC---CCceeEEEeE------EEeCCeEEEEEeeCCCCC
Q 006480 433 GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGF------CFEDNNLLLVYDFLSRGS 503 (643)
Q Consensus 433 G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~------~~~~~~~~LV~E~~~~gs 503 (643)
|....||+....+| .+++|+...... ..|+.++..|. -|++.+++.. ....+..+++|+|++|..
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 33688999987777 899998876441 34666665552 2224444432 234577899999999875
Q ss_pred H
Q 006480 504 L 504 (643)
Q Consensus 504 L 504 (643)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.56 E-value=0.019 Score=62.08 Aligned_cols=142 Identities=13% Similarity=0.169 Sum_probs=86.1
Q ss_pred ceeeeecCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEe
Q 006480 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+.|..|-...+|+....+ ++.+++|+........-+..+|..+++.+. +.-..++++.+ .+ ++||+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 4667778888999987653 678999997553322223356888888774 32345555533 33 78999
Q ss_pred eCCCCCHHH-----------------HhccC-------CC--CCCCCChHHHHHHHHHH-------------------HH
Q 006480 498 FLSRGSLEE-----------------NLHGN-------KK--DPAAFGWSERYKVAMGV-------------------AE 532 (643)
Q Consensus 498 ~~~~gsL~~-----------------~l~~~-------~~--~~~~l~~~~~~~i~~qi-------------------a~ 532 (643)
|++|..|.. .||.. .. ...+..|.++..+..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999865321 01110 00 11222355544444322 22
Q ss_pred HHHHHHh---------------------CCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 533 ALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 533 aL~yLH~---------------------~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
.+.+|.+ ..+..++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 12357899999999999 7888999999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.16 Score=49.75 Aligned_cols=103 Identities=17% Similarity=0.102 Sum_probs=69.1
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
-+|.+.|.... .+++++++|.++.|.+.+|.-+-.. +.-..+=+-|..|+|..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 38999998665 5899999999999999988766210 1112344567899999999987774 2110
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P 625 (643)
.....|.|||.+. ...+.+.=|||||++||.-+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223467888764 4567899999999999999985554
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.46 E-value=0.17 Score=53.99 Aligned_cols=31 Identities=32% Similarity=0.469 Sum_probs=25.7
Q ss_pred CCeEecCCCCCCEEE------cCCCcEEEeecCcccc
Q 006480 543 QRVIHRDVKSSNILL------SDDFEPQLSDFGLAKW 573 (643)
Q Consensus 543 ~~iiHrDLKp~NILl------~~~~~vkL~DFGla~~ 573 (643)
..++|+|+.+.|||+ +++..+.++||-+|..
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 346899999999999 4567799999998754
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=91.34 E-value=0.65 Score=50.59 Aligned_cols=97 Identities=21% Similarity=0.168 Sum_probs=67.5
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLK 95 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~ 95 (643)
+.+|+||+.|-..|.-+|.++.....+.|-.|+++||.+... + ...+.-.+..+.+|+..+|.+...
T Consensus 18 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr-----g--------~~s~~~~~~v~~~~~~lgi~~~v~ 84 (464)
T 3a2k_A 18 GAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR-----G--------RESEEEMEFVKRFCVERRILCETA 84 (464)
T ss_dssp SSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC-----T--------HHHHHHHHHHHHHHHHTTCEEEEE
T ss_pred CCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC-----c--------cccHHHHHHHHHHHHHcCCcEEEE
Confidence 468999999999999888877665545688999999975421 0 112233455677899999987765
Q ss_pred EEEc--------CCh--------hhHHHHHHHhcCCCEEEEccCCC
Q 006480 96 ICRG--------TSI--------RKILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 96 v~~g--------~~~--------~~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
-+.. .++ -..+.+.|++++++.|++|.+..
T Consensus 85 ~~~~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~d 130 (464)
T 3a2k_A 85 QIDVPAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHGD 130 (464)
T ss_dssp ECCCHHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCHH
T ss_pred EechhhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCChH
Confidence 4431 111 13466788899999999998743
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=90.84 E-value=1.3 Score=45.51 Aligned_cols=96 Identities=15% Similarity=0.014 Sum_probs=64.3
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCE-EEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDT-VIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~-vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
+.+|+||+.|-..|.-+|.++.......|-. |+++||..... .....-.+..+.+|+..+|++..
T Consensus 24 ~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r--------------~~s~~~~~~v~~~a~~lgi~~~v 89 (317)
T 1wy5_A 24 ERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIFV 89 (317)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEEE
T ss_pred CCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC--------------cccHHHHHHHHHHHHHcCCcEEE
Confidence 4689999999999998887766544444666 99999964321 11223345566788888998765
Q ss_pred EEEE--------cCCh-------h-hHHHHHHHhcCCCEEEEccCCC
Q 006480 95 KICR--------GTSI-------R-KILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 95 ~v~~--------g~~~-------~-~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
.-+. |.++ + ..+.+.|++++++.|++|.+..
T Consensus 90 ~~~~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 90 GKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp EECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred EEEechhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 4432 1111 1 2466778889999999998743
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=87.57 E-value=2.5 Score=45.70 Aligned_cols=36 Identities=17% Similarity=0.227 Sum_probs=31.9
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecC
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~ 55 (643)
..+|+||+-|-..|.-+|.|+.+. |..|+++|+...
T Consensus 10 ~~KVvVA~SGGlDSSvll~~L~e~----G~eViavtvd~G 45 (455)
T 1k92_A 10 GQRIGIAFSGGLDTSAALLWMRQK----GAVPYAYTANLG 45 (455)
T ss_dssp TSEEEEECCSSHHHHHHHHHHHHT----TCEEEEEEEECC
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEEcC
Confidence 468999999999999999999774 889999999754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.54 E-value=1.7 Score=42.24 Aligned_cols=115 Identities=10% Similarity=0.175 Sum_probs=79.8
Q ss_pred CCCceeEEEeEEEeCCeEEEEEeeCCCC-CHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 006480 475 HHKNIISLLGFCFEDNNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 553 (643)
Q Consensus 475 ~HpnIv~l~g~~~~~~~~~LV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~ 553 (643)
.||+++.. .+-.+++.+.+.|+.-+.+ ++.. +. .++..+++.++..|+....+++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68988876 5666777777777765433 2322 32 36788999999999988766664 488999999
Q ss_pred CEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 006480 554 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 627 (643)
Q Consensus 554 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~ 627 (643)
||+++.++.++|.=.|+-..+.+ . .++...=+-.+=|++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998876432222 1 12222223356678888888887775
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=86.12 E-value=1.1 Score=48.18 Aligned_cols=94 Identities=18% Similarity=0.191 Sum_probs=59.1
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccC-CCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQ-PGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~-~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
+.+|+||+.|-..|.-+|.++.....+ .|-.|+++||.+.... ..+.-.+..+.+|+..+|.+..
T Consensus 13 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhglr~--------------~s~~~~~~v~~~~~~lgi~~~v 78 (433)
T 1ni5_A 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA--------------NADAWVTHCENVCQQWQVPLVV 78 (433)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS--------------SHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCCCc--------------ccHHHHHHHHHHHHHcCCcEEE
Confidence 468999999999999877776654444 6889999999753210 1112234566788888998775
Q ss_pred EEEEcCChh---hH---------HHHHHHhcCCCEEEEccCCC
Q 006480 95 KICRGTSIR---KI---------LVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 95 ~v~~g~~~~---~~---------Iv~~a~~~~a~~LVvGs~~~ 125 (643)
.-+.....+ +. +.+.|+ +++.|++|.+..
T Consensus 79 ~~~~~~~~~~~~e~~aR~~Ry~~l~~~a~--~~~~i~tgH~~d 119 (433)
T 1ni5_A 79 ERVQLAQEGLGIEAQARQARYQAFARTLL--PGEVLVTAQHLD 119 (433)
T ss_dssp ECCCCCCSSSTTTTHHHHHHHHHHHHTCC--TTEEEECCCCHH
T ss_pred EEecCCCCCCCHHHHHHHHHHHHHHHHHh--hCCeEEeeccch
Confidence 443311111 11 222232 388889887743
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.68 E-value=2.4 Score=41.28 Aligned_cols=84 Identities=12% Similarity=0.093 Sum_probs=63.1
Q ss_pred CCCceeEEEeEEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 006480 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE-YLHSGSAQRVIHRDVKSS 553 (643)
Q Consensus 475 ~HpnIv~l~g~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~-yLH~~~~~~iiHrDLKp~ 553 (643)
.||++ -..+-.+++.+.+.|+.-+++.=...++ .++..+++.++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 4455567888888888765543333442 3678899999999887666 5543 689999999
Q ss_pred CEEEcCCCcEEEeecCccc
Q 006480 554 NILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 554 NILl~~~~~vkL~DFGla~ 572 (643)
||+++.++.++|.-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999999888643
|
| >2nz2_A Argininosuccinate synthase; amino-acid biosynthesis, aspartate, citrulline, ST genomics, structural genomics consortium, SGC, ligase; HET: CIR; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.37 E-value=4.3 Score=43.42 Aligned_cols=88 Identities=19% Similarity=0.107 Sum_probs=60.5
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCc-EEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVD-LKL 94 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~-~~~ 94 (643)
..+|+||+-|-..|.-++.|+.+. |..|+++|+..... .. ++..+.+|+..++. +..
T Consensus 5 ~~kVvvalSGGlDSsvll~lL~e~----G~eV~av~vd~g~~--------~e----------~e~a~~~A~~lGi~~~~v 62 (413)
T 2nz2_A 5 KGSVVLAYSGGLDTSCILVWLKEQ----GYDVIAYLANIGQK--------ED----------FEEARKKALKLGAKKVFI 62 (413)
T ss_dssp CEEEEEECCSSHHHHHHHHHHHHT----TEEEEEEEEESSCC--------CC----------HHHHHHHHHHHTCSEEEE
T ss_pred CCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEECCcH--------HH----------HHHHHHHHHHhCCCEEEE
Confidence 368999999999999999999874 78999999975421 00 23344455555554 332
Q ss_pred EEE------------------------EcCC-----hhhHHHHHHHhcCCCEEEEccCCC
Q 006480 95 KIC------------------------RGTS-----IRKILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 95 ~v~------------------------~g~~-----~~~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
.-+ .|.. +.+.+++.|++++|+.|+.|.++.
T Consensus 63 vd~~~ef~~~~~~~~i~~~a~~e~~y~~g~~~aRp~i~~~l~~~A~~~Ga~~IatGh~~~ 122 (413)
T 2nz2_A 63 EDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGK 122 (413)
T ss_dssp EECHHHHHHHTHHHHHHTTCCBTTTBCCTTTTHHHHHHHHHHHHHHHHTCSEEECCCCTT
T ss_pred EeChHHHHHHHHHHHHHhCcccccccccccccchHHHHHHHHHHHHHcCCCEEEECCcCc
Confidence 211 1111 146788999999999999999974
|
| >3bl5_A Queuosine biosynthesis protein QUEC; PREQ1 biosynthesis, RNA modification, tRNA, hydrolase; 2.95A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=81.14 E-value=9.8 Score=36.07 Aligned_cols=89 Identities=18% Similarity=0.115 Sum_probs=56.4
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEE
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKI 96 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v 96 (643)
.+|+|++-|-..|.-++.|+.+. |..|+++|+...... . .+ .+..+.+|+..++++...-
T Consensus 4 ~~v~v~lSGG~DS~~ll~ll~~~----~~~v~~~~~~~~~~~------~------~e----~~~a~~~a~~lgi~~~~~~ 63 (219)
T 3bl5_A 4 EKAIVVFSGGQDSTTCLLWALKE----FEEVETVTFHYNQRH------S------QE----VEVAKSIAEKLGVKNHLLD 63 (219)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHH----CSEEEEEEEESSCTT------C------HH----HHHHHHHHHTTCCCEEEEE
T ss_pred CCEEEEccCcHHHHHHHHHHHHc----CCceEEEEEeCCCCC------H------HH----HHHHHHHHHHhCCCeEEEe
Confidence 57999999999999999888764 478999999753210 0 11 2344556766677655433
Q ss_pred EEc-C--------------------C----------hh-hHHHHHHHhcCCCEEEEccCCC
Q 006480 97 CRG-T--------------------S----------IR-KILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 97 ~~g-~--------------------~----------~~-~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
+.. . . .. ..+.+.|++++++.|+.|.+..
T Consensus 64 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~a~~~g~~~i~tG~~~d 124 (219)
T 3bl5_A 64 MSLLNQLAPNALTRNDIEIEVKDGELPSTFVPGRNLVFLSFASILAYQIGARHIITGVCET 124 (219)
T ss_dssp CGGGGGGSTGGGC--------------CCCCTTHHHHHHHHHHHHHHHHTCSEEECCCCC-
T ss_pred ChHHhhhcccccccccccccccccCCCCceeechHHHHHHHHHHHHHHcCCCEEEEecccc
Confidence 221 0 0 01 2335777888888888887654
|
| >2pg3_A Queuosine biosynthesis protein QUEC; YP_049261.1, hypothetical protein, structural genomics, JOIN for structural genomics; 2.40A {Pectobacterium atrosepticum SCRI1043} SCOP: c.26.2.1 | Back alignment and structure |
|---|
Probab=80.34 E-value=5.7 Score=38.45 Aligned_cols=34 Identities=24% Similarity=0.078 Sum_probs=29.3
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEec
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLA 54 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~ 54 (643)
.+|+|++-|-..|.-+|.|+.+. +..|++||+..
T Consensus 3 ~kvvv~lSGG~DS~~~l~ll~~~----~~~v~av~~~~ 36 (232)
T 2pg3_A 3 KRAVVVFSGGQDSTTCLIQALQD----YDDVHCITFDY 36 (232)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHH----CSEEEEEEEES
T ss_pred CCEEEEecCcHHHHHHHHHHHHc----CCCEEEEEEEC
Confidence 58999999999999999999875 36899999964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 643 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-50 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 2e-61
Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 15/228 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 478
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 599 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-60
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 13/216 (6%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 476
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
L +++HRDVK SNIL++ E +L DFG++ S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
+ + D+++ G+ L+E+ GR PI K
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 4e-58
Identities = 48/213 (22%), Positives = 93/213 (43%), Gaps = 7/213 (3%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ IHRD++++NIL+SD +++DFGLA+ + + APE YG
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
K DV++FG++L E++T + +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-56
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 7/213 (3%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
VIHRD+ + N L+ ++ ++SDFG+ ++ + + +PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ + K DV++FGV++ E+ + K + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 16/227 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
HS +RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 174
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
++K+D+++ GV+ E L G+ P + + + + +F
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-56
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 10/233 (4%)
Query: 419 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 474
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 475 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 533 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 591 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
Y++PE N+K D+++ G +L EL P + K + + +F
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-54
Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 8/220 (3%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
++ +HRD+ + N L++D ++SDFGL+++ + + PE MY
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 602 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQ 640
K + K D++AFGV++ E+ + G+ P + Q
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 2e-54
Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 7/204 (3%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+HRD++++NIL+ ++ +++DFGLA+ + + APE +YG
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 602 KVNDKIDVYAFGVVLLELLTGRKP 625
+ K DV++FG++L EL T +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV 213
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 3e-54
Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 21/224 (9%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 482
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 483 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 542
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 543 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 599
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++APE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 600 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
G+ + K+DV++ G+ +EL + P+ N + + Q++
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-53
Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 15/223 (6%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+K+ NIL + D + +L+DFG++ + + GT ++APE M D
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKD 189
Query: 606 -----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
K DV++ G+ L+E+ P +P + +S+
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 1e-53
Identities = 63/248 (25%), Positives = 114/248 (45%), Gaps = 25/248 (10%)
Query: 412 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 456
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 457 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 516
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 517 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 577 SSSHITCTDVAG---TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632
+S T T G + APE Y K DV+++G+V+ E+++ G +P + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 633 GQESLVMQ 640
+ + Q
Sbjct: 241 DVINAIEQ 248
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-53
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 13/211 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 482 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+HRD+ + N+L+S+D ++SDFGL K AS+ T + APE
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE 174
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
K + K DV++FG++L E+ + + P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 205
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-53
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 11/224 (4%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 479
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 480 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 539
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 540 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 599
+ HRD+K N+LL + ++SDFGLA ++ + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 600 YGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642
+ + +DV++ G+VL +L G P QE + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 222
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 9e-53
Identities = 58/236 (24%), Positives = 110/236 (46%), Gaps = 15/236 (6%)
Query: 415 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 468
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 469 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 528
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 529 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 587
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 588 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642
+ APE + K + + DV+++GV + E L+ G+KP + + Q +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-52
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 12/215 (5%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 485
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 546 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
IHRD+KS NILL D +L+DFG + S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
K+D+++ G++ +E++ G P N++P L+
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-52
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 12/226 (5%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
H + +IHRD+K NILL++D Q++DFG AK S S GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
D++A G ++ +L+ G P + +++ ++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-51
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 425 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEY 597
+HRD+ + N+LL ++SDFGL+K ++ + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 598 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642
Y K + K DV++FGV++ E + G+KP +++ + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 227
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-51
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 19/217 (8%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 482
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 483 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 539 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ K ++ +DVYAFG+ +LE+ T P S Q
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 55/251 (21%), Positives = 109/251 (43%), Gaps = 32/251 (12%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 473
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 513
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 514 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632
+ S+++ + ++APE G K DV+++G++L E+ + G P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 633 GQESLVMQSQF 643
++Q+ F
Sbjct: 274 ANFYKLIQNGF 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 53/237 (22%), Positives = 100/237 (42%), Gaps = 26/237 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 473
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 518
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
+++ + ++APE + DV+++G+ L EL + P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 3e-50
Identities = 56/223 (25%), Positives = 103/223 (46%), Gaps = 7/223 (3%)
Query: 413 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 471
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 472 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 531
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 532 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 591
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ APE Y K + K DV+AFGV+L E+ T Q
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-50
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 23/223 (10%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 486
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 487 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 539
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 540 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAP 595
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 596 EYF------MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
E + + + D+YA G+V E+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 1e-49
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 31/232 (13%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 514
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 515 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
++ + + A ++ PE Y + + DV+A+GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 8e-49
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 13/225 (5%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 480
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
+H D+K NI+ + + L DFGL S T GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
V D+++ GV+ LL+G P ++ V +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 17/216 (7%)
Query: 423 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 476
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 477 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 536 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGYL 593
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T ++
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 629
A E K K DV++FGV+L EL+T P D
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 237
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 14/221 (6%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 474
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYL 593
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 594 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
APE Y K DV++FG+V+ E++T + + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 1e-47
Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 24/222 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 475
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 476 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 523
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 524 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 583
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 584 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
++A E Y DV+++GV+L E+++
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 5e-47
Identities = 49/214 (22%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634
+ DV+++GV + EL+T + P +
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 7e-47
Identities = 50/219 (22%), Positives = 85/219 (38%), Gaps = 13/219 (5%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 486
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 487 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 546
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 547 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
H D+K NI+ + DFGLA + T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
D++A GV+ LL+G P + + V + +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (422), Expect = 1e-46
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 474
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 475 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 534
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 535 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 595 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638
PE G D D ++ G +L +LL G P K + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 163 bits (414), Expect = 1e-46
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 17/227 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 481
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 482 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPE 596
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
V+ + DVY+ G VL E+LTG P + D P ++
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 4e-46
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 28/239 (11%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 471
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 472 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 530
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 531 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 590
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 591 GYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
YLAPE + ++D+++ GV++ LL G P + ++M +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-45
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 15/216 (6%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 476
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + +++RD+K NILL D +++DFG+ K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 173
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632
+ K N +D ++FGV+L E+L G+ P +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-45
Identities = 44/218 (20%), Positives = 87/218 (39%), Gaps = 12/218 (5%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 487
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 488 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 547
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 548 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 605
D++ NI+ + +FG A+ + Y APE + V+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 606 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
D+++ G ++ LL+G P + + +M +++
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-45
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 430 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 481
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMY 600
+R IHRD+ + N+LL+ ++ DFGL + + H + F + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 632
+ D + FGV L E+ T G++P +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 7e-45
Identities = 52/223 (23%), Positives = 100/223 (44%), Gaps = 16/223 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 483
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 544 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++HRD+K N+L +D + +SDFGL+K S + GT GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 601 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+ +D ++ GV+ LL G P +++ ++++++
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 226
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 7e-45
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 17/227 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 476
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
N ID ++FG+++ E+L G P + + ++ ++
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 15/223 (6%)
Query: 427 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 480
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 601 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642
+ DV+ FGV + E+L G KP + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-44
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 25/236 (10%)
Query: 422 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 472
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 473 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 519
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 520 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 635
++ D ++APE + DV++FGV+L E+ + +E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 9e-44
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 480
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 600
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 601 GKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
++ +D++A G +L ELL + D Q + + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 215
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 9e-44
Identities = 46/218 (21%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 422 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 473
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 474 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 527
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 528 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 587
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 588 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 625
+++PE G DV++FGVVL E+ T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 234
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 4e-43
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 26/233 (11%)
Query: 422 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 471
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 472 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 518
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 519 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 631
+ T+ ++APE + DV++FGV+L E+ T P
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-43
Identities = 53/229 (23%), Positives = 91/229 (39%), Gaps = 17/229 (7%)
Query: 421 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 477
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 478 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 533
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 534 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 592
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 593 LAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
APE + K ID+++ G +L E+L+ R H Q + ++
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 3e-42
Identities = 47/223 (21%), Positives = 87/223 (39%), Gaps = 16/223 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 486 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 545
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 546 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGYLAPEY 597
IHRDVK N L+ + DFGLAK + +H ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
+ + + + D+ + G VL+ G P + +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 7e-42
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 11/216 (5%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
V+HRD+K N+L++ + E +++DFGLA+ ++ + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYS 179
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
ID+++ G + E++ G Q + +
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 9e-42
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 13/223 (5%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 478
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE-Y 597
S RV+HRD+K N+L++ + +L+DFGLA+ T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
+ +D+++ G + E++T R D Q + +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 48/219 (21%), Positives = 89/219 (40%), Gaps = 13/219 (5%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 486 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 542 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 601
+ HRDVK N+L + + +A ++SH + T T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 602 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
K + D+++ GV++ LL G P ++H +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 147 bits (372), Expect = 1e-40
Identities = 38/229 (16%), Positives = 85/229 (37%), Gaps = 18/229 (7%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 482 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 541
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 542 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 591
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 592 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
Y++ + + + + D+ A G V + L G P + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-40
Identities = 51/227 (22%), Positives = 95/227 (41%), Gaps = 22/227 (9%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 480
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 481 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 540
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 541 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 596
++ H D+K NI+L D P+ + DFGLA + ++ GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 597 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
Y + + D+++ GV+ LL+G P D + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY 233
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-40
Identities = 50/234 (21%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 420 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 474
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 475 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 526
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 527 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 586
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 587 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
T Y APE + +D+++ G + E+ + Q ++
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 58/234 (24%), Positives = 108/234 (46%), Gaps = 22/234 (9%)
Query: 422 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 477
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 478 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 529
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 530 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 587
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 588 GTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
T Y PE + + ID++ G ++ E+ T + + + Q +L+ Q
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 19/227 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 481
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 482 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 535
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLA 136
Query: 536 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 594
Y+HS + HRD+K N+LL D +L DFG AK +++ + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 595 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
PE IDV++ G VL ELL G+ D Q +++
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-39
Identities = 47/227 (20%), Positives = 92/227 (40%), Gaps = 22/227 (9%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 478
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 479 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 539 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
+ V+HRD+K NIL+ + E +L DFG + TD GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 598 FMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
Y + + + V++ G++L +++ G P +D + + + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 14/226 (6%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 477
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 478 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 537
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 538 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
HS + V++RD+K N++L D +++DFGL K + + + GT YLAPE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 598 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+D + GVV+ E++ GR P N + L++ +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI 222
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 142 bits (358), Expect = 5e-38
Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 17/219 (7%)
Query: 430 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+I+RD+K N+L+ Q++DFG AK + GT LAPE + N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+D +A GV++ E+ G P D P ++ +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-37
Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 11/219 (5%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 544
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 545 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 604
+IHRD+K N+ +++D E ++ DFGLA+ A + + V + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVTRWYRAPEVILNWMRYT 197
Query: 605 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+D+++ G ++ E++TG+ Q +M+
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 12/203 (5%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
V+HRD+K N+L++ + E +L++FGLA+ + V + F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLY 179
Query: 604 NDKIDVYAFGVVLLELLTGRKPI 626
+ ID+++ G + EL +P+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-35
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 20/233 (8%)
Query: 423 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 473
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 474 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 532
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 533 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
ALE+LH +I+RD+K NILL + L+DFGL+K + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 593 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643
+AP+ G +D ++ GV++ ELLTG P + D K ++ + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (323), Expect = 2e-33
Identities = 45/214 (21%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 423 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 480
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 481 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 539 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 597
S ++HRDVK N+++ + + +L D+GLA++ + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 598 FM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630
+ Y + +D+++ G +L ++ ++P + H
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 11/217 (5%)
Query: 428 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 483
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 484 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 543
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 544 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 603
+IHRD+K SN+ +++D E ++ DFGLA+ + T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196
Query: 604 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
N +D+++ G ++ ELLTGR Q L+++
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-31
Identities = 51/222 (22%), Positives = 92/222 (41%), Gaps = 23/222 (10%)
Query: 429 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 484
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 485 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 538
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 539 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 598
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 599 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
+ + +D+++ G ++ E++ + Q + V++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (305), Expect = 7e-31
Identities = 41/228 (17%), Positives = 80/228 (35%), Gaps = 16/228 (7%)
Query: 427 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 485
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 486 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 533
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 534 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 592
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 593 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640
+PE + D+++ ++ EL+TG D
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 428 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 476
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 477 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 536
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 537 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 643 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.86 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.82 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.78 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.74 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.72 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.55 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.09 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.84 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 93.16 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 89.52 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 87.56 | |
| d1np7a2 | 204 | Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: | 83.83 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=394.01 Aligned_cols=214 Identities=26% Similarity=0.400 Sum_probs=188.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||+|.+. +|+.||||++++. ....+.+.+|++++++++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999864 7899999999743 234567999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++...+ .+++..++.++.|++.||.|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987553 58999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.++..+...|..++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC
Confidence 544444556789999999999999999999999999999999999999999999888888877765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=387.50 Aligned_cols=211 Identities=29% Similarity=0.479 Sum_probs=190.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|.+. +|+.||+|++.+. ....+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999875 7899999998643 234567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997543 58999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
.. .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......|.++++
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 221 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 221 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 32 2335799999999999999999999999999999999999999999998888888777653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=389.94 Aligned_cols=207 Identities=25% Similarity=0.394 Sum_probs=181.3
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... ...+++.+|+++|++++||||+++++++.+++.+|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999864 78999999986543 345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999643 369999999999999999999999 99999999999999999999999999999977654
Q ss_pred CCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
.........+||+.|+|||++.+..+ +.++|||||||+||||++|++||........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 214 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence 44444556789999999999998876 5789999999999999999999987655433
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=388.80 Aligned_cols=220 Identities=25% Similarity=0.363 Sum_probs=178.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--CCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV 495 (643)
++|.+.+.||+|+||.||+|... +|+.||||+++.. +...+.+.+|++++++++||||++++++|.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999864 7899999999754 3456778999999999999999999999965 4678999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
|||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754333457999999999999999999999821 13499999999999999999999999999987
Q ss_pred ccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 574 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 574 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||++||.+.+.......|..+++
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~ 231 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 754322 22346899999999999999999999999999999999999999999988888777776653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=385.96 Aligned_cols=208 Identities=28% Similarity=0.461 Sum_probs=185.7
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|++++++++||||++++++|.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 479999999987543 34577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988643 48999999999999999999999 9999999999999999999999999999987754332
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+.
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~ 229 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 2344689999999999999999999999999999999999999999888766555443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=378.25 Aligned_cols=214 Identities=25% Similarity=0.476 Sum_probs=180.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|.+.+++.||||+++......++|.+|++++++++||||++++|+|.+++.+++||||++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 35789999999999999999999888899999998877667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987543 468999999999999999999999 89999999999999999999999999999876553322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++.+..|+.++|||||||++|||+| |++||...+.......|..+
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 218 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred -eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence 2233578999999999999999999999999999999999 67788877776666666554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=381.14 Aligned_cols=207 Identities=32% Similarity=0.511 Sum_probs=174.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.++|.+.+.||+|+||.||+|.++ ..||||+++.. ....+.|.+|+++|++++||||+++++++. .+.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 467889999999999999999864 35999999643 456788999999999999999999999875 467899999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+++|+|.+++...+ ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999997543 468999999999999999999999 89999999999999999999999999999877665
Q ss_pred CCCccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 636 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~ 636 (643)
..........||+.|+|||++.+ ..|+.++|||||||+||||+||+.||.+.++..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~ 219 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH
Confidence 54445556789999999999974 358999999999999999999999999876654443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=383.29 Aligned_cols=212 Identities=26% Similarity=0.419 Sum_probs=186.1
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC-hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
+.|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+++|++++||||++++++|.+.+.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45889999999999999999864 7899999999653 455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999976432 368999999999999999999999 999999999999999999999999999997654321
Q ss_pred CccccCCCCCCCccCccccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~-----~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
.......||+.|+|||++. ...|+.++|||||||+||||++|++||.+.++......+..+
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~ 230 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 1233468999999999984 456899999999999999999999999998887777666654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-45 Score=384.37 Aligned_cols=209 Identities=27% Similarity=0.420 Sum_probs=189.5
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||+||+|... +|+.||||++++. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56999999999999999999864 7999999999753 234578899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+.||+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999987654 57889999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
. ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......|.+++
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 217 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 217 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 3 234689999999999999999999999999999999999999999999888888887765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=388.17 Aligned_cols=213 Identities=28% Similarity=0.405 Sum_probs=191.2
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
.++|.+.+.||+|+||.||+|.. .+|+.||||++++. ....+.+.+|+++|+.++||||++++++|.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999986 48999999999753 23467789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++...+ .+++..++.++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999997653 58899999999999999999999 999999999999999999999999999998654
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+...+...+..++
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~ 221 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC
Confidence 4322 3345689999999999999999999999999999999999999999999888877776654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.1e-46 Score=386.85 Aligned_cols=212 Identities=24% Similarity=0.401 Sum_probs=173.2
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+.|.+.+.||+|+||+||+|.+. +|+.||||++.... .....+.+|+++|++++||||+++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999865 78999999997543 334668899999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecCccccc
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 574 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~ 574 (643)
|++||+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999754 359999999999999999999999 9999999999999995 5789999999999866
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... ....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+.......|.+++
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence 54322 234679999999999999999999999999999999999999999998888877777654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=377.11 Aligned_cols=214 Identities=24% Similarity=0.419 Sum_probs=185.8
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|++++++++||||++++|+|. ++.+++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence 4578899999999999999999988899999999877666788999999999999999999999885 466799999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++..... ..+++..++.|+.||++||.|||+ ++|+||||||+||||++++.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-
Confidence 9999998864332 358999999999999999999999 8999999999999999999999999999987754322
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
.......||+.|+|||++.++.++.++|||||||+||||+| |++||...+.......+..+
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 22334579999999999999999999999999999999999 56667777666666655544
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-46 Score=389.73 Aligned_cols=203 Identities=25% Similarity=0.431 Sum_probs=180.4
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
..++|.+.+.||+|+||+||+|.+. +|+.||+|+++.. .....++.+|+.+|++++||||++++++|.+.+.+|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3568999999999999999999864 7899999999753 345678999999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+++|+|.+++.... .+++..++.++.||+.||.|||+. ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997543 589999999999999999999961 3799999999999999999999999999987654
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 632 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~ 632 (643)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 32 23468999999999999999999999999999999999999999887654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-45 Score=385.79 Aligned_cols=212 Identities=23% Similarity=0.349 Sum_probs=189.0
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+++|++++||||++++++|.+++.+||||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999864 78999999997654 45677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC--CCcEEEeecCccccccCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~ 577 (643)
++|+|.+++.... ..+++.+++.|+.||+.||.|||+ ++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999996432 469999999999999999999999 99999999999999964 678999999999877654
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.. .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...|..++
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 241 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 241 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 32 233589999999999999999999999999999999999999999998887777776554
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-44 Score=384.54 Aligned_cols=213 Identities=22% Similarity=0.295 Sum_probs=189.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+++|++++||||++++++|.+++.+||||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999864 79999999997654 4456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc--CCCcEEEeecCccccccC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~~~~ 576 (643)
+++|+|.+.+.... ..+++.+++.|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999876432 469999999999999999999999 9999999999999998 678999999999987765
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
... .....||+.|+|||++.+..|+.++|||||||+||||++|++||.+.+...+...|..+.
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 182 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred CCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 432 233579999999999999999999999999999999999999999998888777776654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-45 Score=381.37 Aligned_cols=215 Identities=25% Similarity=0.429 Sum_probs=186.7
Q ss_pred hhcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
..++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+++|++++||||++++++|.+++.+++||||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 3467889999999999999999875 688999999987776678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+......
T Consensus 95 ~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999975433 568999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCC-CCCCChhhHHHhhhc
Q 006480 579 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMQ 640 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~P-f~~~~~~~~~~li~~ 640 (643)
. .......||+.|+|||++.++.|+.++|||||||++|||++|..| |.+.+.......+..
T Consensus 170 ~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~ 231 (287)
T d1opja_ 170 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231 (287)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred c-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc
Confidence 2 233345689999999999999999999999999999999996555 555555555554443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-45 Score=379.64 Aligned_cols=214 Identities=28% Similarity=0.484 Sum_probs=174.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC---EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~---~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||+||+|.+. +|+ .||||.+... ....++|.+|+++|++++||||++++|+|.+.+.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999864 332 5889988653 45567899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... ..++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999887543 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCcc---ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 576 TSSSHIT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 576 ~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....... .....||+.|+|||++.++.++.++|||||||+||||+| |++||.+.+.......|..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~ 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 5432222 122457999999999999999999999999999999998 89999999888777776654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=369.25 Aligned_cols=214 Identities=24% Similarity=0.456 Sum_probs=193.0
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 500 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~ 500 (643)
.++|.+.+.||+|+||.||+|.+++++.||||+++......++|.+|++++++++||||++++|+|.+++.+++||||++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 36889999999999999999999888899999998877667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCC
Q 006480 501 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 580 (643)
Q Consensus 501 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 580 (643)
+|+|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 999999976543 468899999999999999999999 89999999999999999999999999999876554332
Q ss_pred ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 581 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 581 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++....++.++|||||||++|||+| |+.||.+.+.......|..+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~ 217 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred -eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 2334579999999999999999999999999999999998 89999999888887777665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=374.36 Aligned_cols=215 Identities=26% Similarity=0.462 Sum_probs=185.6
Q ss_pred hcCccccee-eeecCceEEEEEEeC---CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~-LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+. ||+|+||.||+|.+. ++..||||+++.. ....++|.+|+++|++++||||++++|+|.. +.+||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456777774 999999999999753 4557999999754 3556789999999999999999999999864 57899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++...+ ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986443 468999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.+.......|.++.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~ 229 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 6543322 2233568999999999999999999999999999999998 999999988877777776653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=377.51 Aligned_cols=206 Identities=27% Similarity=0.396 Sum_probs=181.6
Q ss_pred CcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 423 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.|...+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+++|++++||||++++++|.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999985 47889999998653 2445779999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+|+|..++... ..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776543 358999999999999999999999 99999999999999999999999999999865432
Q ss_pred CCCccccCCCCCCCccCcccccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhcc
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~---~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~ 641 (643)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||.+.+.......+..+
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 23579999999999863 46999999999999999999999999998877666655544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=371.20 Aligned_cols=212 Identities=24% Similarity=0.364 Sum_probs=188.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++++.. ...+.|.+|+++|++++||||++++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45799999999999999999986 479999999986421 2467899999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC----cEEEeec
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 568 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DF 568 (643)
||||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997543 58999999999999999999999 9999999999999998776 4999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
|+|+....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......|..++
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 99987654332 234579999999999999999999999999999999999999999998887777776654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-44 Score=383.57 Aligned_cols=209 Identities=25% Similarity=0.358 Sum_probs=189.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 496 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 496 (643)
++|.+.+.||+|+||.||+|.+. +|+.||||++.+.. ...+.+.+|+++|+.++||||+++++++.+.+.+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999864 79999999996432 34567899999999999999999999999999999999
Q ss_pred eeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccC
Q 006480 497 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 576 (643)
Q Consensus 497 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 576 (643)
||+.+|+|.+++...+ .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997653 58999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
. .....||+.|+|||++.+..|+.++|||||||+||||+||++||.+.++..+...|..+.
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Confidence 2 234579999999999999999999999999999999999999999999888888777654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=379.59 Aligned_cols=216 Identities=24% Similarity=0.432 Sum_probs=184.1
Q ss_pred hcCcccceeeeecCceEEEEEEeCC-C-----CEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~-g-----~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||+||+|.... + ..||+|.+... ......+.+|+.+|.++ +||||++++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578899999999999999998532 2 36999998654 34456789999999998 89999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 552 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp 552 (643)
+++||||+++|+|.++|+..+. ....+++..++.++.||+.||.|||+ ++||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999976532 12358999999999999999999999 8999999999
Q ss_pred CCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCh
Q 006480 553 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 631 (643)
Q Consensus 553 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~ 631 (643)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||+||||+| |++||.+.+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998776655555556678999999999999999999999999999999998 8999998776
Q ss_pred hhHHHhhh
Q 006480 632 KGQESLVM 639 (643)
Q Consensus 632 ~~~~~li~ 639 (643)
......+.
T Consensus 273 ~~~~~~~~ 280 (325)
T d1rjba_ 273 DANFYKLI 280 (325)
T ss_dssp SHHHHHHH
T ss_pred HHHHHHHH
Confidence 55444443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-44 Score=366.21 Aligned_cols=204 Identities=27% Similarity=0.408 Sum_probs=173.5
Q ss_pred cccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe----CCeEEEE
Q 006480 424 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLV 495 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~LV 495 (643)
|.+.+.||+|+||+||+|.+. +++.||+|++... ....+.|.+|+++|++++||||++++++|.+ .+.+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356778999999999999865 7889999998643 3456789999999999999999999999875 3568999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCEEEc-CCCcEEEeecCccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAK 572 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~--iiHrDLKp~NILl~-~~~~vkL~DFGla~ 572 (643)
|||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++ |+||||||+||||+ +++.+||+|||+|+
T Consensus 91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 9999999999999754 358999999999999999999998 66 99999999999996 57899999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCh-hhHHHhhh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP-KGQESLVM 639 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~-~~~~~li~ 639 (643)
...... ....+||+.|+|||++.+ .|+.++|||||||+||||++|+.||..... ......+.
T Consensus 164 ~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~ 226 (270)
T d1t4ha_ 164 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 226 (270)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT
T ss_pred eccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHH
Confidence 654432 234689999999999875 699999999999999999999999986543 33344443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=374.03 Aligned_cols=214 Identities=21% Similarity=0.307 Sum_probs=191.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++........+.+|+++|+.++||||++++++|.+++.+|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467999999999999999999865 7889999999887766677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCC--CcEEEeecCccccccCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 577 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~~~~~~ 577 (643)
+||+|.+++.... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 368999999999999999999999 999999999999999854 58999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccCC
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQF 643 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~f 643 (643)
.. .....||+.|+|||.+.+..|+.++|||||||++|+|++|+.||.+.+.......|+.+++
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 22 2335799999999999999999999999999999999999999999998888888877653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=369.09 Aligned_cols=207 Identities=27% Similarity=0.438 Sum_probs=178.3
Q ss_pred eeeeecCceEEEEEEeC---CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 428 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 428 ~~LG~G~~g~Vy~~~~~---~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
+.||+|+||+||+|.+. .++.||||+++.. ....++|.+|+++|++++||||++++|+|.. +.++|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999754 3568999999753 2346789999999999999999999999854 568999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997643 58999999999999999999999 899999999999999999999999999998765543332
Q ss_pred -cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 582 -TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 582 -~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
......||+.|+|||++.+..++.++|||||||++|||+| |++||.+.+.......|.+++
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC
Confidence 2234579999999999999999999999999999999998 999999998888777777654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-44 Score=373.11 Aligned_cols=212 Identities=25% Similarity=0.447 Sum_probs=187.6
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC----hhHHHHHHHHHHHHH-hcCCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||+||+|.+. +|+.||||++++. ......+..|+.++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999865 7899999999753 233456777877765 68999999999999999999999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 575 (643)
|||+++|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997543 58899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 576 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 576 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
.... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++..+...|..++
T Consensus 155 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 155 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219 (320)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred cccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 4332 3344689999999999999999999999999999999999999999999888887777654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-43 Score=361.19 Aligned_cols=211 Identities=29% Similarity=0.476 Sum_probs=187.3
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh----------hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 489 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~----------~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 489 (643)
++|.+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.++++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999986 488999999986531 23456889999999997 99999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecC
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 569 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 569 (643)
+.+||||||+++|+|.++|... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999754 358999999999999999999999 999999999999999999999999999
Q ss_pred ccccccCCCCCccccCCCCCCCccCccccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhccC
Q 006480 570 LAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 570 la~~~~~~~~~~~~~~~~gt~~Y~APE~l~------~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~~~ 642 (643)
+++....... .....||+.|+|||++. ...++.++|||||||+||||++|+.||.+.++......|+.++
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred heeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 9998765432 23468999999999986 3357899999999999999999999999999888777777654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-43 Score=361.97 Aligned_cols=213 Identities=26% Similarity=0.408 Sum_probs=178.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----e
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----N 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 491 (643)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++.. ......|.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 47999999999753 345678999999999999999999999998754 3
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
+||||||++||+|.+++...+ .+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 899999999999999987543 58999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCC-CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 572 KWASTSSS-HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 572 ~~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
+....... .......+||+.|+|||++.+..++.++|||||||++|||+||++||.+.++......+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~ 228 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence 76544322 2233456899999999999999999999999999999999999999999887666555443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=367.65 Aligned_cols=213 Identities=26% Similarity=0.459 Sum_probs=180.7
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeCCC
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 501 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~~~ 501 (643)
++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++++++||||++++|+|.+ +.+++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 5789999999999999999999888899999998777667889999999999999999999999854 568999999999
Q ss_pred CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCCCc
Q 006480 502 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 581 (643)
Q Consensus 502 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 581 (643)
|+|..++..... ..++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....... .
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 999999875432 358999999999999999999999 8999999999999999999999999999987654332 2
Q ss_pred cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 582 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 582 ~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
......||+.|+|||++..+.++.++|||||||+||||++ |++||.+.........|.++
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 2334579999999999999999999999999999999999 56667777777777777665
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=362.81 Aligned_cols=215 Identities=26% Similarity=0.436 Sum_probs=175.3
Q ss_pred hcCcccceeeeecCceEEEEEEeCCC-----CEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g-----~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
.+.|...++||+|+||.||+|.+.++ ..||||+++.. .....+|.+|++++++++||||++++|+|.+.+.++
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999986532 36999999753 345668999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+.+|+|.+.+.... ..++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999887543 469999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-cccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~~~~li~~~ 641 (643)
........ ......||+.|+|||++.++.++.++|||||||+||||++| .+||...+.......+..+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 65533222 22335689999999999999999999999999999999995 5556666666666555543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-43 Score=374.74 Aligned_cols=206 Identities=26% Similarity=0.401 Sum_probs=177.1
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh----hHHHHHH---HHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~---~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
-++|.+.+.||+|+||.||+|... +|+.||||++.+.. .....+. .|+++++.++||||++++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999865 79999999986432 1122333 446777778899999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
|+||||+++|+|.++|... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 9999999999999999754 357899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHh
Q 006480 573 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 637 (643)
Q Consensus 573 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~l 637 (643)
....... ....||+.|+|||++.. ..|+.++|||||||+||||+||+.||.+.+......+
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 217 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 7655332 33579999999999975 5699999999999999999999999998776555443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=368.03 Aligned_cols=214 Identities=24% Similarity=0.446 Sum_probs=181.7
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC----EEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~----~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.+|.+.+.||+|+||+||+|.+. +|+ +||+|.++.. ....++|.+|++++++++||||++++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999854 444 5899988753 3456789999999999999999999999976 45788
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
+|||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887653 468999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
.............||+.|+|||++.++.|+.++|||||||+||||+| |++||.+.+.......+.++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 66555544555679999999999999999999999999999999998 899999998888877777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-43 Score=366.18 Aligned_cols=221 Identities=25% Similarity=0.436 Sum_probs=191.4
Q ss_pred HhhcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC
Q 006480 419 SATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 490 (643)
Q Consensus 419 ~~~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 490 (643)
...++|.+.+.||+|+||+||+|... +++.||||+++.. ....++|.+|+++|++++||||++++++|.+.+
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 34578999999999999999999753 4578999999754 345678999999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 550 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDL 550 (643)
.+++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+ ++||||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEE
Confidence 99999999999999999975321 12358999999999999999999999 99999999
Q ss_pred CCCCEEEcCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCC
Q 006480 551 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISND 629 (643)
Q Consensus 551 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~ 629 (643)
||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence 999999999999999999999877655444455567899999999999999999999999999999999998 4789999
Q ss_pred ChhhHHHhhhccC
Q 006480 630 HPKGQESLVMQSQ 642 (643)
Q Consensus 630 ~~~~~~~li~~~~ 642 (643)
++.+....|..+.
T Consensus 247 ~~~e~~~~v~~~~ 259 (301)
T d1lufa_ 247 AHEEVIYYVRDGN 259 (301)
T ss_dssp CHHHHHHHHHTTC
T ss_pred CHHHHHHHHHcCC
Confidence 9888888877664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=356.24 Aligned_cols=214 Identities=24% Similarity=0.408 Sum_probs=175.4
Q ss_pred hcCcccceeeeecCceEEEEEEeCC----CCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~----g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 494 (643)
.++|.+.+.||+|+||.||+|.+.. +..||||.++.. ....+.|.+|++++++++||||++++|+|. ++.+++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578999999999999999998642 356899998753 345678999999999999999999999985 577899
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999886543 468999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhccC
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~~ 642 (643)
..... .......||+.|+|||++.++.++.++|||||||++|||++ |++||.+.+.......|..+.
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~ 226 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 54322 22334578999999999999999999999999999999998 899999999888887777654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=358.98 Aligned_cols=204 Identities=28% Similarity=0.371 Sum_probs=174.4
Q ss_pred ceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh------hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEeeC
Q 006480 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 499 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~~ 499 (643)
.++||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+++|++++||||++++++|.+++++|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999864 78999999997532 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
.++++..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 888777665432 468899999999999999999999 9999999999999999999999999999987655332
Q ss_pred CccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 580 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
.....+||+.|+|||++... .|+.++|||||||++|||++|++||.+.+..++...|.
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~ 214 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF 214 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHH
Confidence 22345799999999998754 68999999999999999999999999988877766654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=364.92 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=172.9
Q ss_pred hcCcccce-eeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhc-CCCceeEEEeEEEe----CCeEE
Q 006480 421 TSNFLAEN-LIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNLL 493 (643)
Q Consensus 421 ~~~f~~~~-~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~~ 493 (643)
.++|.+.. .||+|+||+||+|.+ .+|+.||||+++... .+.+|++++.++ +||||++++++|.+ ++.+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 45788764 699999999999986 578999999997653 466799887654 89999999999875 46799
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC---CCcEEEeecCc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 570 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 570 (643)
+|||||+||+|.++|..... ..|++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999975432 469999999999999999999999 99999999999999985 56799999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
|+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||.+.+...
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 987655432 234689999999999999999999999999999999999999998776433
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=357.01 Aligned_cols=210 Identities=26% Similarity=0.414 Sum_probs=172.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC-C
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 490 (643)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+..|+.++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999743 3568999999754 34567788899888887 689999999998764 4
Q ss_pred eEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 558 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~ 558 (643)
.+++||||+++|+|.++|+.... ....+++.+++.++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 12458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhh
Q 006480 559 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKG 633 (643)
Q Consensus 559 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~ 633 (643)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| .+||.+.+...
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999877666555555667899999999999999999999999999999999996 57888765443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=353.48 Aligned_cols=209 Identities=32% Similarity=0.505 Sum_probs=176.2
Q ss_pred hcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEEEEEeeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV~E~~ 499 (643)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++.+. ..+.|.+|++++++++||||++++|+|.+ .+.+++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35688899999999999999998 57889999997654 45789999999999999999999999965 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.++|..... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999975422 358999999999999999999999 899999999999999999999999999998654422
Q ss_pred CccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 580 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 580 ~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
....+|..|+|||++.++.++.++|||||||++|||+| |++||...+.......|..+
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 22468999999999999999999999999999999998 89999998888877777654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=355.26 Aligned_cols=209 Identities=28% Similarity=0.432 Sum_probs=178.1
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ....++.+|+++|++++||||++++++|.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999986 479999999996543 335789999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
|+.+ .+.+++.... ...+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 4555554332 2468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
. .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+...+...+
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i 215 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 215 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH
Confidence 2 2334467999999999987665 578999999999999999999999988776655444
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=353.02 Aligned_cols=213 Identities=27% Similarity=0.442 Sum_probs=175.2
Q ss_pred cCcccceeeeecCceEEEEEEeC--CC--CEEEEEEeCCC----hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 493 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~--~g--~~vAVK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 493 (643)
++|.+.+.||+|+||.||+|.+. ++ ..||||++++. ....++|.+|+++|++++||||++++|+|.+ +.++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56899999999999999999753 33 36899998753 3456789999999999999999999999965 5778
Q ss_pred EEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 494 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 494 LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887543 469999999999999999999999 8999999999999999999999999999997
Q ss_pred ccCCCCCcc-ccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHHhhhcc
Q 006480 574 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 574 ~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~li~~~ 641 (643)
......... .....||..|+|||++.+..++.++|||||||++|||+| |++||.+.+.......|...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 765543332 233568889999999999999999999999999999998 89999999888776666543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=352.75 Aligned_cols=218 Identities=28% Similarity=0.454 Sum_probs=185.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC--------CCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFED 489 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~--------~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~ 489 (643)
.++|.+.+.||+|+||.||+|... ++..||||+++... ....++.+|..++.++ +||||++++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357889999999999999999743 23479999997643 4567899999999888 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHHhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 490 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 490 ~~~~LV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+.+++||||+.+|+|.++|..... ....+++.+++.++.||+.||.|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999976532 12468999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |++||.+.+......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999998776655555556789999999999999999999999999999999998 799999988877776
Q ss_pred hhhcc
Q 006480 637 LVMQS 641 (643)
Q Consensus 637 li~~~ 641 (643)
.+..+
T Consensus 249 ~i~~~ 253 (299)
T d1fgka_ 249 LLKEG 253 (299)
T ss_dssp HHHTT
T ss_pred HHHcC
Confidence 66554
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=354.73 Aligned_cols=214 Identities=25% Similarity=0.409 Sum_probs=187.0
Q ss_pred hcCcccceeeeecCceEEEEEEe------CCCCEEEEEEeCCCh--hHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCe
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~------~~g~~vAVK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 491 (643)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... .....|.+|+.++.++ +||||++++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35788999999999999999974 356789999997643 4566899999999999 69999999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEE
Q 006480 492 LLLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 557 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl 557 (643)
+++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence 9999999999999999976542 22468999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCChhhHHH
Q 006480 558 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 636 (643)
Q Consensus 558 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLlt-G~~Pf~~~~~~~~~~ 636 (643)
+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998877666666666789999999999999999999999999999999999 677777776655443
Q ss_pred h
Q 006480 637 L 637 (643)
Q Consensus 637 l 637 (643)
.
T Consensus 259 ~ 259 (311)
T d1t46a_ 259 K 259 (311)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-41 Score=349.59 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=179.1
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh---hHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEee
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E~ 498 (643)
++|.+.+.||+|+||+||+|.+++|+.||||+++... ...+++.+|+.+|++++||||++++++|..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999999899999999997542 3457899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCC
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 578 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 578 (643)
+.++.+..+.... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877666665433 469999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 579 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 579 ~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
. ......|++.|+|||.+.. ..++.++|||||||++|||++|+.||.+.+...+...+.
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~ 214 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred c--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 2 2234578999999999875 457999999999999999999999999887766655543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=352.26 Aligned_cols=214 Identities=27% Similarity=0.455 Sum_probs=181.4
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCC--EEEEEEeCCC--hhHHHHHHHHHHHHHhc-CCCceeEEEeEEEeCCeEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~--~vAVK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV 495 (643)
++|.+.+.||+|+||.||+|.+. +|. .||||.++.. ....+.|.+|+++|.++ +||||++++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57889999999999999999865 444 4678887543 34566899999999998 799999999999999999999
Q ss_pred EeeCCCCCHHHHhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcE
Q 006480 496 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 563 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 563 (643)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 234579999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHhhhcc
Q 006480 564 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMQS 641 (643)
Q Consensus 564 kL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~~~~li~~~ 641 (643)
||+|||+|+........ ....||..|+|||.+.++.|+.++|||||||++|||++| .+||.+.+.......|..+
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999765443222 234689999999999999999999999999999999996 5689988888877777654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=354.27 Aligned_cols=219 Identities=22% Similarity=0.380 Sum_probs=190.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC------CCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeE
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 492 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~------~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 492 (643)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|++++++++||||++++|+|...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888999999999999999753 3578999999764 34456799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHHhccCC------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEe
Q 006480 493 LLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 566 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 566 (643)
++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+ ++|+||||||+||||+.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432 122457899999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCChhhHHHhhhccC
Q 006480 567 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMQSQ 642 (643)
Q Consensus 567 DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG-~~Pf~~~~~~~~~~li~~~~ 642 (643)
|||+|+...............||+.|+|||.+.++.++.++|||||||+||||+|| ++||.+.+.......|..+.
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC
Confidence 99999877665554445556799999999999999999999999999999999998 68999988888887777654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=350.75 Aligned_cols=210 Identities=23% Similarity=0.395 Sum_probs=176.0
Q ss_pred hcCcccceeeeecCceEEEEEEe-CC-CCEEEEEEeCCC---hhHHHHHHHHHHHHHhc---CCCceeEEEeEEEe----
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PD-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~-g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~---- 488 (643)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||+++.. ......+.+|+++|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999986 34 567999998642 22334566788777766 79999999999863
Q ss_pred -CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEee
Q 006480 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 567 (643)
Q Consensus 489 -~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 567 (643)
...++++|||+.++.+........ ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 347899999998877765544332 468999999999999999999999 9999999999999999999999999
Q ss_pred cCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 568 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 568 FGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
||+++..... .......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.++..+...++
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 228 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9998755432 23345689999999999999999999999999999999999999999988877666654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=348.02 Aligned_cols=198 Identities=25% Similarity=0.393 Sum_probs=170.9
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCCh-------hHHHHHHHHHHHHHhcC--CCceeEEEeEEEeCC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~ 490 (643)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ....++.+|+.+|++++ ||||++++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999864 78999999986421 12244678999999997 899999999999999
Q ss_pred eEEEEEeeCCC-CCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-CCcEEEeec
Q 006480 491 NLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDF 568 (643)
Q Consensus 491 ~~~LV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DF 568 (643)
.+++||||+.+ ++|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 6788887654 358999999999999999999999 99999999999999985 579999999
Q ss_pred CccccccCCCCCccccCCCCCCCccCcccccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 006480 569 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISND 629 (643)
Q Consensus 569 Gla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSlGvvl~eLltG~~Pf~~~ 629 (643)
|+|+..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 999865443 2344689999999999987765 56799999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=350.06 Aligned_cols=199 Identities=30% Similarity=0.433 Sum_probs=165.9
Q ss_pred cCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHH--HHHhcCCCceeEEEeEEEeCC----eEEEE
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE--IITTLHHKNIISLLGFCFEDN----NLLLV 495 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~--il~~l~HpnIv~l~g~~~~~~----~~~LV 495 (643)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++.... +++..|.+ .+.+++||||++++++|.+.+ .+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~--~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch--hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 4678899999999999999987 789999999976543 34444444 456789999999999998754 58999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-----~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
|||+++|+|.++|+.. .++|..++.++.|++.||.|||+. ..++|+||||||+||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999753 489999999999999999999973 136999999999999999999999999999
Q ss_pred cccccCCCCC--ccccCCCCCCCccCcccccCC------CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 006480 571 AKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISN 628 (643)
Q Consensus 571 a~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~------~~s~ksDIwSlGvvl~eLltG~~Pf~~ 628 (643)
++........ .......||+.|+|||++... .++.++|||||||+||||+||..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9877554322 223456899999999998754 367899999999999999999988754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-40 Score=344.38 Aligned_cols=209 Identities=28% Similarity=0.452 Sum_probs=173.1
Q ss_pred ceeeeecCceEEEEEEeCCC----CEEEEEEeCC--ChhHHHHHHHHHHHHHhcCCCceeEEEeEEEe-CCeEEEEEeeC
Q 006480 427 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 499 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~g----~~vAVK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV~E~~ 499 (643)
.++||+|+||+||+|.+.++ ..||||.++. .....++|.+|+++|++++||||++++|+|.+ ++.+++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 2589999974 34566889999999999999999999999876 46899999999
Q ss_pred CCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCCCC
Q 006480 500 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 579 (643)
Q Consensus 500 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 579 (643)
++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987543 467888999999999999999999 8999999999999999999999999999987655432
Q ss_pred C--ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC-ChhhHHHhhhcc
Q 006480 580 H--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND-HPKGQESLVMQS 641 (643)
Q Consensus 580 ~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~-~~~~~~~li~~~ 641 (643)
. .......||+.|+|||.+..+.++.++||||||+++|||+||+.||... +.......+..+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g 250 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 2 2223457899999999999999999999999999999999977776554 333344444443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-40 Score=348.33 Aligned_cols=212 Identities=25% Similarity=0.365 Sum_probs=176.5
Q ss_pred hhcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC--hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC----eE
Q 006480 420 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NL 492 (643)
Q Consensus 420 ~~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~ 492 (643)
.+.+|.+.+.||+|+||+||+|.+ .+|+.||||++++. ....+.+++|+++|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356799999999999999999975 48999999999754 345678999999999999999999999997643 23
Q ss_pred EEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 493 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 493 ~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
+++++|+.+|+|.+++... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 4455667799999999643 48999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCC-ccccCCCCCCCccCccccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 573 WASTSSSH-ITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 573 ~~~~~~~~-~~~~~~~gt~~Y~APE~l~-~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
........ ......+||+.|+|||++. ...++.++||||+||++|||++|+.||.+.+...+.....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~ 226 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh
Confidence 76543222 2234467999999999985 4567899999999999999999999999988766655543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=343.04 Aligned_cols=213 Identities=26% Similarity=0.394 Sum_probs=176.3
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe--------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 488 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 488 (643)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++... +....++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999986 48999999998643 2345678999999999999999999999855
Q ss_pred CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeec
Q 006480 489 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 568 (643)
Q Consensus 489 ~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 568 (643)
.+.+++||||+.++.+....... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999887666554322 468899999999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCC--ccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 569 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 569 Gla~~~~~~~~~--~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
|+++........ ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++......+.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 999866543211 122235799999999999865 689999999999999999999999999887776665543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-39 Score=337.17 Aligned_cols=205 Identities=20% Similarity=0.272 Sum_probs=176.7
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-CceeEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||++..... ...+.+|++++..++| +||+.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999865 789999999865432 2456788999999975 8999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcC-----CCcEEEeecCcccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 573 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGla~~ 573 (643)
+ +++|.+++.... ..+++.++..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 789999987554 368999999999999999999999 99999999999999974 57899999999987
Q ss_pred ccCCCCC-----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhh
Q 006480 574 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 633 (643)
Q Consensus 574 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~ 633 (643)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 6543222 12334689999999999999999999999999999999999999998765543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-40 Score=348.24 Aligned_cols=207 Identities=27% Similarity=0.354 Sum_probs=171.8
Q ss_pred CcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC------CeEEEE
Q 006480 423 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 495 (643)
Q Consensus 423 ~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~LV 495 (643)
+|...++||+|+||+||+|.+. +|+.||||+++..... +.+|+++|++++||||++++++|... .+++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4777899999999999999875 7999999999765432 34699999999999999999998643 357999
Q ss_pred EeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccccc
Q 006480 496 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 574 (643)
Q Consensus 496 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~ 574 (643)
|||++++.+..+.. .......+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99997654433332 11223569999999999999999999999 9999999999999999775 8999999999876
Q ss_pred cCCCCCccccCCCCCCCccCcccccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 575 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 575 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
..... .....||+.|+|||.+.+ ..|+.++|||||||++|||++|++||...+...+...+.
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~ 236 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence 54332 233579999999998875 579999999999999999999999999988777666554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=345.23 Aligned_cols=204 Identities=25% Similarity=0.404 Sum_probs=171.8
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCC------
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 490 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+++|+.++||||++++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 7999999999753 345678999999999999999999999997654
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+|+||||+ +++|..+++.. .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 66788777542 48999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 638 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li 638 (643)
|+...... +...||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+...+...+
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~ 231 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHH
Confidence 98765432 345799999999998764 5789999999999999999999999988766554443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=328.90 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=177.9
Q ss_pred cCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeCCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 497 (643)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. .....++.+|+.+|+.++||||++++++|.+.+.+++||+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999864 8899999998643 3457889999999999999999999999999999999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCccccccCC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 577 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 577 (643)
++.+++|..++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988887654 357899999999999999999999 99999999999999999999999999999877654
Q ss_pred CCCccccCCCCCCCccCcccccCCC-CCchhHHHHHHHHHHHHHcCCCCCC-CCChhhHHH
Q 006480 578 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPIS-NDHPKGQES 636 (643)
Q Consensus 578 ~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSlGvvl~eLltG~~Pf~-~~~~~~~~~ 636 (643)
... .....+++.|+|||.+.... ++.++|||||||++|||++|+.||. +.+...+..
T Consensus 155 ~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred Ccc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence 332 22346788999999988665 6999999999999999999999864 444444433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=342.47 Aligned_cols=210 Identities=28% Similarity=0.406 Sum_probs=179.3
Q ss_pred cCcccceeeeecCceEEEEEEe----CCCCEEEEEEeCCC-----hhHHHHHHHHHHHHHhcCC-CceeEEEeEEEeCCe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNN 491 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~----~~g~~vAVK~l~~~-----~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 491 (643)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 25889999998643 2345678899999999976 899999999999999
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
++++|||+.+|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999997654 46788999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
+........ ......|++.|+|||.+.+. .++.++|||||||+||||++|+.||.+.+.......+.
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~ 245 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 876543222 23345799999999999754 47889999999999999999999999887665544443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=334.23 Aligned_cols=195 Identities=23% Similarity=0.409 Sum_probs=170.4
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEe--CCeEEEEEe
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVYD 497 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~LV~E 497 (643)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... .+++.+|+++|++++ ||||++++++|.. .+.+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5899999999999999999986 478999999998643 467889999999995 9999999999974 456999999
Q ss_pred eCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC-cEEEeecCccccccC
Q 006480 498 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 576 (643)
Q Consensus 498 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~ 576 (643)
|+.+++|..+. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999987664 258999999999999999999999 9999999999999998655 699999999987655
Q ss_pred CCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCh
Q 006480 577 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 631 (643)
Q Consensus 577 ~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~ 631 (643)
... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 432 2345799999999998865 589999999999999999999999987654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=330.11 Aligned_cols=206 Identities=23% Similarity=0.289 Sum_probs=169.4
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce-eEEEeEEEeCCeEEEEEee
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDF 498 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E~ 498 (643)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ..++..|+++++.++|+|+ +.+.+++.+.+..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 35799999999999999999986 4789999999875432 2457889999999987664 5555666778889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEc---CCCcEEEeecCcccccc
Q 006480 499 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWAS 575 (643)
Q Consensus 499 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~~~ 575 (643)
+ +++|.+.+.... ..+++..+..++.|++.||.|||+ ++||||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 567777765433 468999999999999999999999 9999999999999986 45679999999999775
Q ss_pred CCCCC-----ccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhH
Q 006480 576 TSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 634 (643)
Q Consensus 576 ~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~ 634 (643)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~ 221 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence 54322 223456899999999999999999999999999999999999999987665443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-39 Score=337.68 Aligned_cols=207 Identities=26% Similarity=0.378 Sum_probs=175.1
Q ss_pred hcCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEeC-----Ce
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 491 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 491 (643)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+++.+|+++|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999985 47999999999754 24556789999999999999999999998643 34
Q ss_pred EEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCcc
Q 006480 492 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 571 (643)
Q Consensus 492 ~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 571 (643)
.+++|+|+.+|+|.+++... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 56677888899999999542 48999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCCccccCCCCCCCccCcccccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhhc
Q 006480 572 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMQ 640 (643)
Q Consensus 572 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~~ 640 (643)
..... ......||+.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......|.+
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~ 233 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 75543 23345799999999987765 468999999999999999999999999887766666543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=336.87 Aligned_cols=206 Identities=25% Similarity=0.324 Sum_probs=168.6
Q ss_pred hcCcccceeeeecCceEEEEEEeC-CCCEEEEEEeCCC---hhHHHHHHHHHHHHHhcCCCceeEEEeEEEe------CC
Q 006480 421 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 490 (643)
Q Consensus 421 ~~~f~~~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 490 (643)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. .....++.+|+.+|++++||||++++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999999865 7999999999753 3456678999999999999999999999964 36
Q ss_pred eEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEEEeecCc
Q 006480 491 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 570 (643)
Q Consensus 491 ~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 570 (643)
.+|+||||+.++ |.+.+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 899999999665 555553 247899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCChhhHHHhhh
Q 006480 571 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 639 (643)
Q Consensus 571 a~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~~~~~~~li~ 639 (643)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||.+.+...+...++
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~ 231 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 87665433 2334579999999999999999999999999999999999999999988766665553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-33 Score=299.75 Aligned_cols=201 Identities=20% Similarity=0.278 Sum_probs=163.8
Q ss_pred cCcccceeeeecCceEEEEEEe-CCCCEEEEEEeCCChhHHHHHHHHHHHHHhcC-----------CCceeEEEeEEEe-
Q 006480 422 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE- 488 (643)
Q Consensus 422 ~~f~~~~~LG~G~~g~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~- 488 (643)
++|.+.++||+|+||+||+|.. .+|+.||||+++......+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3599999999999999999986 48999999999988777778889999998875 4789999998864
Q ss_pred -CCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCC------
Q 006480 489 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF------ 561 (643)
Q Consensus 489 -~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~------ 561 (643)
....+++|+++..+......... .....+++..+..++.||+.||.|||+ ..||+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence 35667777777655433332221 223568899999999999999999996 27899999999999998665
Q ss_pred cEEEeecCccccccCCCCCccccCCCCCCCccCcccccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 006480 562 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 630 (643)
Q Consensus 562 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSlGvvl~eLltG~~Pf~~~~ 630 (643)
.++|+|||.+....... ...+||+.|+|||++....++.++|||||||+++||++|+.||....
T Consensus 170 ~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 39999999998665432 33579999999999999999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=6.4e-24 Score=204.58 Aligned_cols=163 Identities=16% Similarity=0.160 Sum_probs=122.2
Q ss_pred cccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-------------------hHHHHHHHHHHHHHhcCCCceeEEEe
Q 006480 424 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLG 484 (643)
Q Consensus 424 f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-------------------~~~~~~~~Ei~il~~l~HpnIv~l~g 484 (643)
+.+.+.||+|+||+||+|.+.+|+.||||+++... .....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34678999999999999998899999999976421 11234557888999999999999887
Q ss_pred EEEeCCeEEEEEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCEEEcCCCcEE
Q 006480 485 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 564 (643)
Q Consensus 485 ~~~~~~~~~LV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 564 (643)
+. . .+++|||++++.+.+ ++......++.|++++|.|||+ ++|+||||||+|||++++ .++
T Consensus 82 ~~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ec--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 63 2 389999998765432 3344556799999999999999 999999999999999865 599
Q ss_pred EeecCccccccCCCCCccccCCCCCCCccC------cccccCCCCCchhHHHHHHHHH
Q 006480 565 LSDFGLAKWASTSSSHITCTDVAGTFGYLA------PEYFMYGKVNDKIDVYAFGVVL 616 (643)
Q Consensus 565 L~DFGla~~~~~~~~~~~~~~~~gt~~Y~A------PE~l~~~~~s~ksDIwSlGvvl 616 (643)
|+|||+|......... .|+. .+.| .+.|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999998755432111 1111 1222 35788899999975443
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.86 E-value=6.4e-22 Score=187.05 Aligned_cols=136 Identities=18% Similarity=0.292 Sum_probs=105.2
Q ss_pred CEEEEEecCCc---------chHHHHHHHHhhccCCCC---EEEEEEEecCCCCCCCCC-C--Cch-------hhhhHHH
Q 006480 17 RTVVVGVKLDT---------HSRELLTWALVKVAQPGD---TVIALHVLANNAIVDRDG-K--SSL-------LSLVKAF 74 (643)
Q Consensus 17 r~I~VaVD~s~---------~S~~AL~WAl~~~~~~gd---~vvlvHV~~~~~~~~~~~-~--~~~-------~~~~~~~ 74 (643)
+||+||||+|. .|++||+||++++.+.|| .|+++||.++........ . ... ....+..
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAKG 81 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHHH
T ss_pred CEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 69999999986 799999999999999999 599999987643221111 1 111 1223455
Q ss_pred HHHHHHHHhhhhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEe
Q 006480 75 DSVLAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 75 ~~ll~~~~~~C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~ 153 (643)
.++|+.+...|..+++.++..+..| ++.++|+++|++.++|+||||++|++.+.|... ||++||++|++ |||++|+
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV~ 158 (171)
T d2gm3a1 82 LHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTIK 158 (171)
T ss_dssp HHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEEE
T ss_pred HHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEEe
Confidence 6899999999999999999988885 999999999999999999999999976665433 99999999998 9999998
Q ss_pred CC
Q 006480 154 NG 155 (643)
Q Consensus 154 ~g 155 (643)
.+
T Consensus 159 ~~ 160 (171)
T d2gm3a1 159 RN 160 (171)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.82 E-value=8.5e-20 Score=169.81 Aligned_cols=137 Identities=18% Similarity=0.135 Sum_probs=111.4
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCC------C----Cch--------hhhhHHHHHH
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG------K----SSL--------LSLVKAFDSV 77 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~------~----~~~--------~~~~~~~~~l 77 (643)
-|+|+||||+|+.|++||+||++...+.++.|+++||+++........ . ... ....+...+.
T Consensus 3 ~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 3 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHH
Confidence 389999999999999999999999999999999999987653221110 0 000 0223344578
Q ss_pred HHHHHhhhhhcCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEEeCC
Q 006480 78 LAVYEGFCNLKQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAVNNG 155 (643)
Q Consensus 78 l~~~~~~C~~k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV~~g 155 (643)
++.+...|...+++++..+..| ++.+.|+++|++.+||+||||+++++.+.+.+. |+++||++|++ |||++|++.
T Consensus 83 l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHhcCCeEEEEEEec-cHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcCC
Confidence 8889999999999999999986 999999999999999999999999876665433 99999999998 999999864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.78 E-value=4.2e-19 Score=160.25 Aligned_cols=133 Identities=16% Similarity=0.113 Sum_probs=100.5
Q ss_pred CEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEEEE
Q 006480 17 RTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKLKI 96 (643)
Q Consensus 17 r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~~v 96 (643)
++|+||||+|+.|++|++||++.+.+.++.|+++||+++....... ........+..+++.+.++.+++..++.....+
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 80 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGE-PFFEEALRRRLERAEGVLEEARALTGVPKEDAL 80 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCT-THHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCcccccc-chhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEE
Confidence 6899999999999999999999999999999999999865332111 111112222233444444455555566555555
Q ss_pred EEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCC-chHHHHhccCCCCcEEEEE
Q 006480 97 CRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTT-SLAKYCAKKLSKDCSVLAV 152 (643)
Q Consensus 97 ~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~-sVs~yc~~~ap~~C~V~vV 152 (643)
+.++++.++|+++|+++++|+||||+++++...|... |+++||++|++ |||++|
T Consensus 81 ~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 81 LLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred EEcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 6567999999999999999999999999865555433 99999999998 999997
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.74 E-value=2e-18 Score=156.50 Aligned_cols=135 Identities=13% Similarity=0.131 Sum_probs=102.5
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCCCCchh-hhh-HHHHHHHHHHHhhhhhcCCcEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDGKSSLL-SLV-KAFDSVLAVYEGFCNLKQVDLK 93 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~~~~~~-~~~-~~~~~ll~~~~~~C~~k~v~~~ 93 (643)
-++|+||||+|+.|++||.||...+.+.|+.|+++||++++............ ... +..++....+...+...++...
T Consensus 2 yk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T d1jmva_ 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPIS 81 (140)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCC
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceE
Confidence 37999999999999999999999999999999999999876432221111111 000 1112445555556666666655
Q ss_pred EEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEeC
Q 006480 94 LKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 94 ~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
..++.++++.++|+++|++++||+||||+++++....+ |+++|+++|++ |||++|+-
T Consensus 82 ~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lg--s~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 82 EKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLM--SSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp CEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHH--HHHHHHHTTCC--SEEEEEEC
T ss_pred EEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcc--cHHHHHHhccC--CCEEEEec
Confidence 56666679999999999999999999999988655445 99999999998 99999973
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.72 E-value=1.6e-17 Score=151.74 Aligned_cols=136 Identities=15% Similarity=0.023 Sum_probs=98.0
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCCCC-CC----chhhhhHHHHHHHHHHHhhhhhcCC
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDRDG-KS----SLLSLVKAFDSVLAVYEGFCNLKQV 90 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~~~-~~----~~~~~~~~~~~ll~~~~~~C~~k~v 90 (643)
-|+|+||||+|+.|++||+||++.+. .++.++++|+..+........ .. ......+...+.++.++..|...++
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~la~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 83 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGA 83 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTC
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHh-cCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 48999999999999999999998665 555555555554432211111 11 1112334456889999999999888
Q ss_pred cEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccC-CCchHHHHhccCCCCcEEEEEeC
Q 006480 91 DLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKKLSKDCSVLAVNN 154 (643)
Q Consensus 91 ~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~-~~sVs~yc~~~ap~~C~V~vV~~ 154 (643)
......+..|++++.|+++|+++++|+||||+++++...+. ..|++.||++|++ |||++|+.
T Consensus 84 ~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 84 KNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp CEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred CcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEec
Confidence 74334444469999999999999999999999998755543 2399999999998 99999974
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.55 E-value=5.4e-15 Score=132.80 Aligned_cols=127 Identities=12% Similarity=-0.002 Sum_probs=95.2
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecCCCCCCC----CCCCc----hhhhhHHHHHHHHHHHhhhhh
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLANNAIVDR----DGKSS----LLSLVKAFDSVLAVYEGFCNL 87 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~----~~~~~----~~~~~~~~~~ll~~~~~~C~~ 87 (643)
-|+|+||+|+|+.|++||+||++...+.|+.|+++||.++...... .+... .....+...+.++.+...+..
T Consensus 4 mk~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~ 83 (138)
T d1q77a_ 4 MKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTG 83 (138)
T ss_dssp CEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred CCEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhcccccc
Confidence 4899999999999999999999999999999999999875321110 01111 112223344556666555666
Q ss_pred cCCcEEEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccCCCchHHHHhccCCCCcEEEEEe
Q 006480 88 KQVDLKLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRSTTSLAKYCAKKLSKDCSVLAVN 153 (643)
Q Consensus 88 k~v~~~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~~~sVs~yc~~~ap~~C~V~vV~ 153 (643)
.+++++.++..| ++.+.|+++|++.++|+||||++|++ ....++.... ||+++|+
T Consensus 84 ~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g~~--------~l~r~l~g~~--~~~livk 138 (138)
T d1q77a_ 84 STEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPSA--------YLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp CCCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCGG--------GTHHHHHHSS--SEEEECC
T ss_pred cceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCCCc--------HHHHHhcCCC--CCEEEeC
Confidence 678888888875 89999999999999999999999863 3345666665 9999885
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=2.6e-07 Score=90.48 Aligned_cols=148 Identities=18% Similarity=0.135 Sum_probs=99.8
Q ss_pred HHHhhcCcccceeeeecCceEEEEEEeCCCCEEEEEEeCCCh-hHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEE
Q 006480 417 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 417 l~~~~~~f~~~~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~L 494 (643)
+......|...+..+.++.+.||+... +++.+.+|+..... .....+.+|..++..+. +--+.+++.++..++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 333344566665555555578999765 55667788876432 23335677888887774 3336677888888889999
Q ss_pred EEeeCCCCCHHHHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCC--------------------------------
Q 006480 495 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-------------------------------- 542 (643)
Q Consensus 495 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~-------------------------------- 542 (643)
||++++|.++.+..... .....++.++++.|..||+...
T Consensus 88 v~~~l~G~~~~~~~~~~---------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHTTTC---------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEeccccccccccccc---------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999998886654211 1122345566666666665211
Q ss_pred ------------------------CCeEecCCCCCCEEEcCCCcEEEeecCccccc
Q 006480 543 ------------------------QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 574 (643)
Q Consensus 543 ------------------------~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 574 (643)
..++|+|+.|.|||+++++.+-|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 23799999999999998776779999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=3.9e-06 Score=81.36 Aligned_cols=131 Identities=18% Similarity=0.090 Sum_probs=86.1
Q ss_pred eeeecCc-eEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC--CceeEEEeEEEeCCeEEEEEeeCCCCCHH
Q 006480 429 LIGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLE 505 (643)
Q Consensus 429 ~LG~G~~-g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~LV~E~~~~gsL~ 505 (643)
.+..|.. ..||+....++..+++|....... ..+..|.+.|+.+.. -.+.+++.++.+++..++||+|++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 3445543 678999887888889998776542 345667777777642 33677888888888899999999876543
Q ss_pred HHhccCCCCCCCCChHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006480 506 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS---------------------------------------------- 539 (643)
Q Consensus 506 ~~l~~~~~~~~~l~~~~~~~i~~qia~aL~yLH~---------------------------------------------- 539 (643)
+.. ... ..++.++.+.|.-||.
T Consensus 95 ~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 95 SSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 210 010 0112223333333332
Q ss_pred -----C----CCCCeEecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 540 -----G----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 540 -----~----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
. .+..++|+|+.|.|||++++..+-|+||+.+.+
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112479999999999999877678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.68 E-value=6.6e-05 Score=78.07 Aligned_cols=75 Identities=17% Similarity=0.127 Sum_probs=49.4
Q ss_pred ceeeeecCceEEEEEEeC-CCCEEEEEEeCCC--------hhHHHHHHHHHHHHHhcC-C--CceeEEEeEEEeCCeEEE
Q 006480 427 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--------EDVIKEFVLEIEIITTLH-H--KNIISLLGFCFEDNNLLL 494 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~-~g~~vAVK~l~~~--------~~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~L 494 (643)
.+.||.|....||+.... +++.++||.-.+. .....+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999865 4678999975431 112334556888887663 2 345666654 4455689
Q ss_pred EEeeCCCCC
Q 006480 495 VYDFLSRGS 503 (643)
Q Consensus 495 V~E~~~~gs 503 (643)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.37 E-value=0.00025 Score=71.41 Aligned_cols=137 Identities=16% Similarity=0.227 Sum_probs=81.2
Q ss_pred ceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCCCce--eEEE-----eEEEeCCeEEEEEeeCCCCCHH--
Q 006480 435 SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLE-- 505 (643)
Q Consensus 435 ~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~HpnI--v~l~-----g~~~~~~~~~LV~E~~~~gsL~-- 505 (643)
-..||++...+|..|++|+.++......++..|++.+..|....| +..+ ..+..++..+.+++++.|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 468999999999999999998876566778889988888742221 1111 1223456788999998764221
Q ss_pred ---H---------Hhc----cCC-CCCCCCChH-------------------HHHHHHHHHHHHHHHHHh----CCCCCe
Q 006480 506 ---E---------NLH----GNK-KDPAAFGWS-------------------ERYKVAMGVAEALEYLHS----GSAQRV 545 (643)
Q Consensus 506 ---~---------~l~----~~~-~~~~~l~~~-------------------~~~~i~~qia~aL~yLH~----~~~~~i 545 (643)
. .++ ... .....+++. .+..+...+...+..+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 011 000 001111111 111122222233333322 234689
Q ss_pred EecCCCCCCEEEcCCCcEEEeecCcccc
Q 006480 546 IHRDVKSSNILLSDDFEPQLSDFGLAKW 573 (643)
Q Consensus 546 iHrDLKp~NILl~~~~~vkL~DFGla~~ 573 (643)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999744 46899998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.09 E-value=0.00042 Score=71.64 Aligned_cols=73 Identities=18% Similarity=0.176 Sum_probs=50.9
Q ss_pred ceeeeecCceEEEEEEeCC--------CCEEEEEEeCCChhHHHHHHHHHHHHHhcC-CCceeEEEeEEEeCCeEEEEEe
Q 006480 427 ENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 497 (643)
Q Consensus 427 ~~~LG~G~~g~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~E 497 (643)
.+.|+.|-.-.+|++..++ .+.|.+++.-..... -+..+|..+++.+. +.-..+++++|. + .+|||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEE
Confidence 4678889999999987643 356888887643332 34567988988885 433457777763 3 78999
Q ss_pred eCCCCCH
Q 006480 498 FLSRGSL 504 (643)
Q Consensus 498 ~~~~gsL 504 (643)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987533
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.84 E-value=0.0034 Score=62.11 Aligned_cols=156 Identities=13% Similarity=0.063 Sum_probs=79.0
Q ss_pred HHHHHhhcCcccc-----eeeeecCceEEEEEEeCCCCEEEEEEeCCChhHHHHHHHHHHHHHhcCC-----CceeEEE-
Q 006480 415 QDLLSATSNFLAE-----NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-----KNIISLL- 483 (643)
Q Consensus 415 ~el~~~~~~f~~~-----~~LG~G~~g~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~~Ei~il~~l~H-----pnIv~l~- 483 (643)
+++.....+|.+. +.|..|--.+.|+...++|+ +++|+..... ...++..|++++..|.. |..+...
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecC
Confidence 4445555556553 33446666888998886665 8899986532 22344556667766632 2222111
Q ss_pred --eEEEeCCeEEEEEeeCCCCCHHH--------------HhccCC---CCC--CCCC------------------hHHHH
Q 006480 484 --GFCFEDNNLLLVYDFLSRGSLEE--------------NLHGNK---KDP--AAFG------------------WSERY 524 (643)
Q Consensus 484 --g~~~~~~~~~LV~E~~~~gsL~~--------------~l~~~~---~~~--~~l~------------------~~~~~ 524 (643)
.+.......+.++.++.+..... .++... ... .... .....
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 01223455667777766542211 010000 000 0000 00111
Q ss_pred HHHHHHHHHHHHHHh-CCCCCeEecCCCCCCEEEcCCCcEEEeecCccc
Q 006480 525 KVAMGVAEALEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 572 (643)
Q Consensus 525 ~i~~qia~aL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 572 (643)
..+..+...+.-.+. .-+.++||+|+.++||+++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 112222222222221 235789999999999999988777899999874
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=93.16 E-value=0.21 Score=46.29 Aligned_cols=97 Identities=13% Similarity=-0.016 Sum_probs=63.4
Q ss_pred CCCEEEEEecCCcchHHHHHHHHhhccCC-CCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEE
Q 006480 15 AGRTVVVGVKLDTHSRELLTWALVKVAQP-GDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLK 93 (643)
Q Consensus 15 ~~r~I~VaVD~s~~S~~AL~WAl~~~~~~-gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~ 93 (643)
++++|+|||-|-..|.-+|.++...-... ...|.++||-+... +..+.-....+.+|+..+|++.
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~lL~~~~~~~~~~~i~~~~vdh~~r--------------~~s~~~~~~~~~~~~~l~i~~~ 88 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR--------------ESAERDEEFCKEFAKERNMKIF 88 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS--------------THHHHHHHHHHHHHHHHTCCEE
T ss_pred CCCeEEEEeCCcHHHHHHHHHHHHHHHhcCCCcEEEEEeecccc--------------cchhhhhhHHHHHHHhhhhhhh
Confidence 45799999999999986666655432322 34799999964311 0111222445778888888876
Q ss_pred EEEEEc--------CC-------h-hhHHHHHHHhcCCCEEEEccCCC
Q 006480 94 LKICRG--------TS-------I-RKILVREAQSYSATKFIVGTAKN 125 (643)
Q Consensus 94 ~~v~~g--------~~-------~-~~~Iv~~a~~~~a~~LVvGs~~~ 125 (643)
..-... .. . ...+.+.|++.+++.|++|-+..
T Consensus 89 i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 89 VGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp EEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred hhccchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 433211 00 1 24678899999999999998854
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=89.52 E-value=0.27 Score=45.69 Aligned_cols=95 Identities=17% Similarity=0.145 Sum_probs=59.6
Q ss_pred CCEEEEEecCCcchHHHHHHHHhhcc-CCCCEEEEEEEecCCCCCCCCCCCchhhhhHHHHHHHHHHHhhhhhcCCcEEE
Q 006480 16 GRTVVVGVKLDTHSRELLTWALVKVA-QPGDTVIALHVLANNAIVDRDGKSSLLSLVKAFDSVLAVYEGFCNLKQVDLKL 94 (643)
Q Consensus 16 ~r~I~VaVD~s~~S~~AL~WAl~~~~-~~gd~vvlvHV~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~C~~k~v~~~~ 94 (643)
.++|+|||-|-..|..+|..+.+... .++-.|+++||-+.... ..+.-......+|...++.+..
T Consensus 13 ~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r~--------------~s~~~~~~~~~~~~~~~i~~~i 78 (227)
T d1ni5a1 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLSA--------------NADAWVTHCENVCQQWQVPLVV 78 (227)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCCS--------------SHHHHHHHHHHHHHHTTCCEEE
T ss_pred CCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCCc--------------chhhhHHHHHHHHhhccCccee
Confidence 57999999999999987776655433 25789999999753210 1123345567789888988775
Q ss_pred EEEEcCCh----------hhHHHHHHHhcCCCEEEEccCC
Q 006480 95 KICRGTSI----------RKILVREAQSYSATKFIVGTAK 124 (643)
Q Consensus 95 ~v~~g~~~----------~~~Iv~~a~~~~a~~LVvGs~~ 124 (643)
.-...... .......+...+++.|++|-+.
T Consensus 79 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 79 ERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp ECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred eeccccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 43332111 1123334455667777777553
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=87.56 E-value=2 Score=38.54 Aligned_cols=34 Identities=21% Similarity=0.112 Sum_probs=28.5
Q ss_pred EEEEEecCCcchHHHHHHHHhhccCCCCEEEEEEEecC
Q 006480 18 TVVVGVKLDTHSRELLTWALVKVAQPGDTVIALHVLAN 55 (643)
Q Consensus 18 ~I~VaVD~s~~S~~AL~WAl~~~~~~gd~vvlvHV~~~ 55 (643)
||+||+-|-..|.-|+.|+.+ .|..|++||+...
T Consensus 6 Kvvv~~SGG~DS~vla~ll~k----~g~~v~av~~~~~ 39 (218)
T d2c5sa1 6 KVMVLLSGGIDSPVAAYLTMK----RGVSVEAVHFHSP 39 (218)
T ss_dssp EEEEECCSSSHHHHHHHHHHH----BTEEEEEEEEECT
T ss_pred EEEEEecCcHHHHHHHHHHHH----cCCeEEEEEEeCC
Confidence 799999999999888877754 3789999999743
|
| >d1np7a2 c.28.1.1 (A:1-204) Cryptochrome {Synechocystis sp., pcc 6803 [TaxId: 1143]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Cryptochrome/photolyase, N-terminal domain superfamily: Cryptochrome/photolyase, N-terminal domain family: Cryptochrome/photolyase, N-terminal domain domain: Cryptochrome species: Synechocystis sp., pcc 6803 [TaxId: 1143]
Probab=83.83 E-value=1.8 Score=39.00 Aligned_cols=118 Identities=14% Similarity=0.067 Sum_probs=69.5
Q ss_pred CEEEEEecCCcc--hHHHHHHHHhhccCCCCEEEEEEEecCCCCCCC-CCCCchh-hhhHHHHHHHHHHHhhhhhcCCcE
Q 006480 17 RTVVVGVKLDTH--SRELLTWALVKVAQPGDTVIALHVLANNAIVDR-DGKSSLL-SLVKAFDSVLAVYEGFCNLKQVDL 92 (643)
Q Consensus 17 r~I~VaVD~s~~--S~~AL~WAl~~~~~~gd~vvlvHV~~~~~~~~~-~~~~~~~-~~~~~~~~ll~~~~~~C~~k~v~~ 92 (643)
++|+|=...|=. --.||..|+. .|+.|+.|.|+.+...... .+..... ....-+.+-|..+..-.++.|+.
T Consensus 6 ~~~lvWfr~DLRl~DN~aL~~A~~----~~~~vi~vyi~dp~~~~~~~~~~~~~~~~r~~fl~~sL~~L~~~L~~~g~~- 80 (204)
T d1np7a2 6 PTVLVWFRNDLRLHDHEPLHRALK----SGLAITAVYCYDPRQFAQTHQGFAKTGPWRSNFLQQSVQNLAESLQKVGNK- 80 (204)
T ss_dssp CEEEEEESSCCCSTTCHHHHHHHH----TTSEEEEEEEECGGGGSBCTTSCBSSCHHHHHHHHHHHHHHHHHHHHTTCC-
T ss_pred CcEEEEeCCCCccccHHHHHHHHh----cCCcEEEEEEECchHhcCcccccccccHHHHHHHHHHHHHHHHHHHhccch-
Confidence 567765544432 3457777764 5789999999987532221 1111111 11122235555555555666776
Q ss_pred EEEEEEcCChhhHHHHHHHhcCCCEEEEccCCCCccccC-CCchHHHHhcc
Q 006480 93 KLKICRGTSIRKILVREAQSYSATKFIVGTAKNHHTIRS-TTSLAKYCAKK 142 (643)
Q Consensus 93 ~~~v~~g~~~~~~Iv~~a~~~~a~~LVvGs~~~~~~~r~-~~sVs~yc~~~ 142 (643)
..+..| ++.++|.+.+++++|+.|.. .+..+..-+. -..|.+.|-++
T Consensus 81 -L~v~~G-~~~~~l~~l~~~~~i~~V~~-n~~~~~~e~~rd~~v~~~l~~~ 128 (204)
T d1np7a2 81 -LLVTTG-LPEQVIPQIAKQINAKTIYY-HREVTQEELDVERNLVKQLTIL 128 (204)
T ss_dssp -EEEEES-CHHHHHHHHHHHTTEEEEEE-ECCCSHHHHHHHHHHHHHHHHH
T ss_pred -hhhhhh-hhHHHHHHHHHHhhhhheee-eccccHHHHHHHHHHhhhhccc
Confidence 445675 89999999999999999775 3433322221 12677777654
|